diff --git a/data/processed/trials.csv b/data/processed/trials.csv index a8f678d..0355ae5 100644 --- a/data/processed/trials.csv +++ b/data/processed/trials.csv @@ -14,7 +14,7 @@ NCT00094497,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT00094653,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Düsseldorf Erlangen Duisburg-Essen Heidelberg Jena Mannheim TU-München Tübingen Würzburg,"MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma",No lead center,Industry,Interventional,Drug,Phase 3,1783,Completed,Triple,Randomized,TRUE,TRUE,FALSE,TRUE,2004-10-21,2004-09-01,2009-10-01,2009,2009-08-01,2009,2011-04-22,568,629,-50,1806,1745,247,308,2053,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1003466,20525992,https://www.ncbi.nlm.nih.gov/pubmed/20525992?dopt=Abstract,2010-06-05,journal publication,TRUE,TRUE,doi,Improved survival with ipilimumab in patients with metastatic melanoma,The New England journal of medicine,2010-Aug-19,2010-06-05,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,2983,4336,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2010-08-19,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2011-02-19,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00095875,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Frankfurt,Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial),No lead center,Other,Interventional,Drug,Phase 3,145,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2004-11-09,2004-08-01,2012-04-01,2012,2012-04-01,2012,2013-05-15,409,409,-100,2700,2700,318,318,3018,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(13)70011-1,23414589,http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2813%2970011-1/abstract,2013-02-13,journal publication,TRUE,TRUE,doi,Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial,The Lancet. Oncology,2013-Mar,2013-02-13,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,2,2,2070,3423,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2013-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2013-08-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00098137,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg Magdeburg,NA,Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation,large,Other,Interventional,Drug,Phase 3,422,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2004-12-03,2005-01-01,2009-05-01,2009,2009-05-01,2009,NA,NA,NA,29,1610,1610,950,950,2560,2017-07-01,2017-12-01,2021-08-15,10.1161/circep.111.965178,22157519,https://www.ncbi.nlm.nih.gov/pubmed/22157519,2011-12-07,journal publication,TRUE,TRUE,doi,Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial,Circulation. Arrhythmia and electrophysiology,2012-Feb,2011-12-07,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,3136,4489,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1941-3149,1941-3084",Circulation: Arrhythmia and Electrophysiology,Ovid Technologies (Wolters Kluwer Health),2012-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00111345,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Münster Hannover Münster,NA,Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents,large,Other,Interventional,Drug,Phase 2/Phase 3,550,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-05-19,2004-03-01,2017-03-01,2017,2012-03-01,2012,NA,NA,NA,-444,4304,2478,-1378,448,2926,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2013-02-484097,23704089,https://www.ncbi.nlm.nih.gov/pubmed/23704089?dopt=Abstract,2013-05-23,journal publication,TRUE,TRUE,doi,Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004,Blood,2013-Jul-04,2013-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,6,6,275,1628,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-07-04,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-07-04,TRUE,TRUE,TRUE,TRUE,TRUE,NA +NCT00111345,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Münster,NA,Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents,large,Other,Interventional,Drug,Phase 2/Phase 3,550,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-05-19,2004-03-01,2017-03-01,2017,2012-03-01,2012,NA,NA,NA,-444,4304,2478,-1378,448,2926,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2013-02-484097,23704089,https://www.ncbi.nlm.nih.gov/pubmed/23704089?dopt=Abstract,2013-05-23,journal publication,TRUE,TRUE,doi,Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004,Blood,2013-Jul-04,2013-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,6,6,275,1628,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-07-04,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-07-04,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT00114348,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia,large,Other,Interventional,Procedure,Phase 4,338,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-06-14,2003-08-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-683,2574,2574,351,351,2925,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2012.48.5680,23775972,https://www.ncbi.nlm.nih.gov/pubmed/23775972?dopt=Abstract,2013-06-17,journal publication,TRUE,TRUE,doi,Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2013-Jul-20,2013-06-17,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-07-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-07-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00115518,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC),large,Other,Interventional,Drug,Phase 2,30,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2005-06-22,2005-05-01,2010-08-01,2010,2009-06-01,2009,NA,NA,NA,-52,1866,1440,176,602,2042,2017-07-01,2017-12-01,2021-08-15,10.1002/cncr.25888,21264838,http://onlinelibrary.wiley.com/doi/10.1002/cncr.25888/full,2011-01-24,journal publication,TRUE,TRUE,doi,Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial,Cancer,2011-Jul-01,2011-01-24,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2679,4032,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2011-01-24,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00118573,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair,No lead center,Other,Interventional,Procedure,Phase 4,360,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-06-30,2004-09-01,2017-09-01,2017,2010-05-01,2010,NA,NA,NA,-302,4446,1766,-2533,147,1913,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ejvs.2010.08.026,20869890,https://linkinghub.elsevier.com/retrieve/pii/S1078-5884(10)00527-7,2010-09-25,journal publication,TRUE,TRUE,doi,Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial,European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,2011-Jan,2010-09-25,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,91,1444,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1078-5884,European Journal of Vascular and Endovascular Surgery,Elsevier BV,2011-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -35,7 +35,7 @@ NCT00182819,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00185159,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Olmesartan Medoxomil in Diabetes Mellitus,large,Industry,Interventional,Drug,Phase 3,4449,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-10-01,2009-07-01,2009,2009-07-01,2009,NA,NA,NA,-346,1388,1388,121,121,1509,2017-07-01,2017-12-01,2021-08-15,10.1007/s00125-009-1577-3,19876613,https://www.ncbi.nlm.nih.gov/pubmed/19876613?dopt=Abstract,2009-10-30,journal publication,TRUE,TRUE,doi,Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study,Diabetologia,2010-Jan,2009-10-30,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,3075,4428,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0012-186X,1432-0428",Diabetologia,Springer Science and Business Media LLC,2009-10-30,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00199082,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,"Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults",large,Other,Interventional,Drug,Phase 4,650,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2005-09-12,2002-07-01,2010-06-01,2010,2010-06-01,2010,NA,NA,NA,-1169,1723,1723,1612,1612,3335,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2014-03-563627,25359988,http://www.bloodjournal.org/content/124/26/3870.long?sso-checked=true,2014-10-30,journal publication,TRUE,TRUE,doi,Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial,Blood,2014-Dec-18,2014-10-30,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2014-12-18,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2015-12-18,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT00202917,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,Dresden Hamburg Münster Würzburg,Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies,large,Other,Interventional,Drug,Phase 1/Phase 2,61,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2005-09-12,2004-02-01,2010-12-01,2010,2009-07-01,2009,NA,NA,NA,-589,1906,1388,490,1008,2396,2017-07-01,2017-12-01,2021-08-15,10.3324/haematol.2011.059378,22491731,https://www.ncbi.nlm.nih.gov/pubmed/22491731,2012-04-04,journal publication,TRUE,TRUE,doi,Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study,Haematologica,2012-Oct,2012-04-04,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"0390-6078,1592-8721",Haematologica,Ferrata Storti Foundation (Haematologica),2012-04-04,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00204529,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB,large,Other,Interventional,Drug,Phase 3,901,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-10-01,2016-12-01,2016,2013-05-01,2013,NA,NA,NA,-346,4098,2788,-174,1136,3924,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdw225,27287206,https://www.ncbi.nlm.nih.gov/pubmed/27287206?dopt=Abstract,2016-06-10,journal publication,TRUE,TRUE,doi,Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial,Annals of oncology : official journal of the European Society for Medical Oncology,2016-08,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00204529,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB,large,Other,Interventional,Drug,Phase 3,901,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-10-01,2016-12-01,2016,2013-05-01,2013,NA,NA,NA,-346,4098,2788,-174,1136,3924,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdw225,27287206,https://www.ncbi.nlm.nih.gov/pubmed/27287206?dopt=Abstract,2016-06-10,journal publication,TRUE,TRUE,doi,Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial,Annals of oncology : official journal of the European Society for Medical Oncology,2016-08,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00211237,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,CAFE Study - Cancer Patient Fracture Evaluation,No lead center,Industry,Interventional,Device,NA,134,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2005-09-13,2005-05-01,2009-12-01,2009,2009-04-01,2009,2010-03-31,120,364,-135,1540,1296,442,686,1982,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(11)70008-0,21333599,https://www.ncbi.nlm.nih.gov/pubmed/21333599,2011-02-16,journal publication,TRUE,TRUE,doi,"Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial",The Lancet. Oncology,2011-Mar,2011-02-16,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2922,4275,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2011-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2011-08-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00222222,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,"Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis",small,Other,Interventional,Procedure,NA,105,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2005-09-13,2003-03-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-927,2270,2270,288,288,2558,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2334-12-217,22973876,https://www.ncbi.nlm.nih.gov/pubmed/22973876?dopt=Abstract,2012-09-14,journal publication,TRUE,TRUE,doi,Alterations of leptin in the course of inflammation and severe sepsis,BMC infectious diseases,2012-Sep-14,2012-09-14,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2334,BMC Infectious Diseases,Springer Science and Business Media LLC,2012-09-14,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00224770,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg,Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation,No lead center,Other,Interventional,Drug,Phase 2,141,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2005-09-21,2005-08-01,2013-04-01,2013,2012-08-01,2012,2014-09-21,538,781,-51,2749,2506,1289,1532,4038,2017-07-01,2017-12-01,2021-08-15,10.1016/s1474-4422(16)30234-4,27751554,NA,2016-10-11,journal publication,TRUE,TRUE,doi,"Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial",The Lancet. Neurology,2016-Nov,2016-10-11,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1705,3058,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,green,green,1474-4422,The Lancet Neurology,Elsevier BV,2016-11-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -71,7 +71,7 @@ NCT00351403,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT00353496,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Schleswig-Holstein Mainz,Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours,No lead center,Industry,Interventional,Drug,Phase 3,264,Completed,Double,Randomized,TRUE,TRUE,FALSE,TRUE,2006-07-17,2006-06-01,2013-04-01,2013,2013-04-01,2013,2015-01-15,654,654,-46,2450,2450,472,472,2922,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1316158,25014687,https://www.ncbi.nlm.nih.gov/pubmed/25014687?dopt=Abstract,2014-07-17,journal publication,TRUE,TRUE,doi,Lanreotide in metastatic enteropancreatic neuroendocrine tumors,The New England journal of medicine,2014-Jul-17,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,3,3,1705,3058,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2014-07-17,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2015-01-17,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT00354133,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,FALSE,TRUE,TRUE,Schleswig-Holstein,Berlin Düsseldorf Freiburg Heidelberg LMU-München Tübingen,Controlled Trial With Deep Brain Stimulation in Patients With Early Parkinson's Disease,small,Other,Interventional,Device,Phase 4,251,"Active, not recruiting",None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-19,2006-07-01,2022-03-01,2022,2022-03-01,2022,NA,NA,NA,-18,5704,5704,-3302,-3302,2402,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1205158,23406026,https://www.ncbi.nlm.nih.gov/pubmed/23406026?dopt=Abstract,2013-02-14,journal publication,TRUE,TRUE,doi,Neurostimulation for Parkinson's disease with early motor complications,The New England journal of medicine,2013-Feb-14,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,13,13,-1551,-198,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2013-02-14,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2013-08-13,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00355095,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,Göttingen Hamburg,Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis,small,Other,Interventional,Drug,Phase 2,40,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-20,2006-08-01,2011-07-01,2011,2011-02-01,2011,NA,NA,NA,12,1807,1657,423,573,2230,2017-07-01,2017-12-01,2021-08-15,10.1002/ana.23573,22926853,http://onlinelibrary.wiley.com/doi/10.1002/ana.23573/abstract,2012-08-27,journal publication,TRUE,TRUE,doi,"A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis",Annals of neurology,2012-Aug,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,4,4,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0364-5134,Annals of Neurology,Wiley,2012-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00355862,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma,small,Other,Interventional,Drug,Phase 3,525,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2006-07-24,2006-01-01,2014-05-01,2014,2009-04-01,2009,NA,NA,NA,-204,2838,982,610,2466,3448,2017-07-01,2017-12-01,2021-08-15,10.1097/tp.0000000000000965,26555945,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683033/,2016-01-01,journal publication,TRUE,TRUE,doi,"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial",Transplantation,2016-Jan,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,0,1,1,5,5,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0041-1337,Transplantation,Ovid Technologies (Wolters Kluwer Health),2016-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT00355862,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma,small,Other,Interventional,Drug,Phase 3,525,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2006-07-24,2006-01-01,2014-05-01,2014,2009-04-01,2009,NA,NA,NA,-204,2838,982,610,2466,3448,2017-07-01,2017-12-01,2021-08-15,10.1097/tp.0000000000000965,26555945,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683033/,2016-01-01,journal publication,TRUE,TRUE,doi,"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial",Transplantation,2016-Jan,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,0,1,1,5,5,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0041-1337,Transplantation,Ovid Technologies (Wolters Kluwer Health),2016-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00359424,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Freiburg Greifswald Halle-Wittenberg,Interventional Management of Stroke (IMS) III Trial,No lead center,Other,Interventional,Drug,Phase 3,656,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2006-07-31,2006-08-01,2013-04-01,2013,2012-07-01,2012,2013-07-04,94,368,1,2436,2162,-53,221,2383,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1214300,23390923,https://www.ncbi.nlm.nih.gov/pubmed/23390923?dopt=Abstract,2013-02-07,journal publication,TRUE,TRUE,doi,Endovascular therapy after intravenous t-PA versus t-PA alone for stroke,The New England journal of medicine,2013-Mar-07,2013-02-07,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,16,16,1705,3058,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2013-03-07,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2013-09-06,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00359918,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI),large,Other,Interventional,Drug,Phase 4,162,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2006-08-01,2006-08-01,2009-08-01,2009,2009-08-01,2009,NA,NA,NA,0,1096,1096,669,669,1765,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jcin.2011.01.013,21700245,https://www.ncbi.nlm.nih.gov/pubmed/21700245?dopt=Abstract,2011-06-01,journal publication,TRUE,TRUE,doi,Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction),JACC. Cardiovascular interventions,2011-Jun,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,3044,4397,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2011-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00362089,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns,large,Other,Interventional,Dietary Supplement,NA,208,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2006-08-08,2006-06-01,2010-11-01,2010,2010-11-01,2010,NA,NA,NA,-68,1546,1546,1983,1983,3529,2017-07-01,2017-12-01,2021-08-15,10.3945/ajcn.115.128520,27053380,https://www.ncbi.nlm.nih.gov/pubmed/27053380?dopt=Abstract,2016-04-06,journal publication,TRUE,TRUE,doi,Reduction of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring body composition: follow-up results from a randomized controlled trial up to 5 y of age,The American journal of clinical nutrition,2016-Jun,2016-04-06,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,17,17,2587,3940,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,bronze,"0002-9165,1938-3207",The American Journal of Clinical Nutrition,Oxford University Press (OUP),2016-04-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -177,7 +177,7 @@ NCT00556608,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00557921,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Hamburg Leipzig Schleswig-Holstein Mainz Mannheim Regensburg Tübingen,Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1),No lead center,Industry,Interventional,Drug,Phase 3,5000,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2007-11-12,2007-12-01,2009-11-01,2009,2009-11-01,2009,NA,NA,NA,19,720,720,339,339,1059,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1007964,20925534,https://www.ncbi.nlm.nih.gov/pubmed/20925534?dopt=Abstract,2010-10-06,journal publication,TRUE,TRUE,doi,Clopidogrel with or without omeprazole in coronary artery disease,The New England journal of medicine,2010-Nov-11,2010-10-06,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,2952,4305,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2010-11-11,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2011-05-10,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT00558311,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Erlangen Duisburg-Essen Frankfurt Hamburg Heidelberg LMU-München TU-München Regensburg,Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping,No lead center,Industry,Interventional,Drug,Phase 3,1157,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2007-11-13,2007-12-14,2010-07-13,2010,2010-06-15,2010,NA,NA,NA,31,973,945,324,352,1297,2017-07-01,2017-12-01,2021-08-15,10.1016/s1474-4422(11)70108-9,21640651,https://www.ncbi.nlm.nih.gov/pubmed/21640651?dopt=Abstract,2011-06-02,journal publication,TRUE,TRUE,doi,"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)",The Lancet. Neurology,2011-Jul,2011-06-02,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2698,4051,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1474-4422,The Lancet Neurology,Elsevier BV,2011-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00559442,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction,large,Other,Interventional,Other,NA,30,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2007-11-15,2007-06-01,2011-07-01,2011,2010-12-01,2010,NA,NA,NA,-167,1324,1112,1339,1551,2663,2017-07-01,2017-12-01,2021-08-15,10.1089/ham.2014.1117,25803140,http://online.liebertpub.com/doi/10.1089/ham.2014.1117,2015-03-01,journal publication,TRUE,TRUE,doi,Exaggerated hypoxic pulmonary vasoconstriction without susceptibility to high altitude pulmonary edema,High altitude medicine & biology,2015-Mar,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1527-0297,1557-8682",High Altitude Medicine & Biology,Mary Ann Liebert Inc,2015-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00560794,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,21,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-11-19,2008-01-01,2014-11-01,2014,2009-09-01,2009,2014-12-23,52,1939,43,2539,652,-899,988,1640,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2012-01-400515,22592608,https://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=22592608,2012-05-16,journal publication,TRUE,TRUE,doi,Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab,Blood,2012-Jun-28,2012-05-16,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,1126,2479,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-06-28,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-06-28,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00560794,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,Dresden Frankfurt Schleswig-Holstein Münster Ulm,Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,21,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-11-19,2008-01-01,2014-11-01,2014,2009-09-01,2009,2014-12-23,52,1939,43,2539,652,-899,988,1640,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2012-01-400515,22592608,https://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=22592608,2012-05-16,journal publication,TRUE,TRUE,doi,Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab,Blood,2012-Jun-28,2012-05-16,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,1126,2479,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-06-28,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-06-28,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00567554,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Frankfurt,"Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer",No lead center,Other,Interventional,Drug,Phase 3,2600,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2007-12-04,2007-10-01,2015-10-01,2015,2011-08-01,2011,NA,NA,NA,-64,2858,1336,-1353,169,1505,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(11)70397-7,22257523,http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(11)70397-7/abstract,2012-01-17,journal publication,TRUE,TRUE,doi,"Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial",The Lancet. Oncology,2012-Feb,2012-01-17,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,5,5,792,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2012-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-07-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00567736,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Efficacy of Disci/Rhus Toxicodendron Comp.®, in Patients With Chronic Low Back Pain",large,Other,Interventional,Drug,Phase 3,150,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2007-12-04,2007-08-01,2009-01-01,2009,2009-01-01,2009,NA,NA,NA,-125,394,394,1041,1041,1435,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0026166,22087222,https://www.ncbi.nlm.nih.gov/pubmed/22087222,2011-11-08,journal publication,TRUE,TRUE,doi,Efficacy of injections with Disci/Rhus toxicodendron compositum for chronic low back pain--a randomized placebo-controlled trial,PloS one,2011,2011-11-08,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,3256,4609,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLoS ONE,Public Library of Science (PLoS),2011-11-08,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00568841,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC),large,Other,Interventional,Drug,Phase 2,40,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2007-12-05,2007-10-01,2009-12-01,2009,2009-12-01,2009,NA,NA,NA,-65,727,727,1130,1130,1857,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0053081,23308140,https://www.ncbi.nlm.nih.gov/pubmed/23308140?dopt=Abstract,2013-01-04,journal publication,TRUE,TRUE,doi,Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib,PloS one,2013,2013-01-04,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,54,54,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLoS ONE,Public Library of Science (PLoS),2013-01-04,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -219,7 +219,7 @@ NCT00631371,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00634881,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,Heidelberg Mannheim,Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia,large,Other,Interventional,Biological,Phase 1/Phase 2,13,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-03-12,2003-11-01,2012-02-17,2012,2010-01-01,2010,NA,NA,NA,-1593,1437,660,1749,2526,3186,2017-07-01,2017-12-01,2021-08-15,10.1111/ejh.12825,27862308,https://www.ncbi.nlm.nih.gov/pubmed/27862308?dopt=Abstract,2016-12-01,journal publication,TRUE,TRUE,doi,Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial,European journal of haematology,2017-Mar,2016-12-01,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2114,3467,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0902-4441,European Journal of Haematology,Wiley,2016-12-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00636181,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Positive Pressure Treatment of Obstructive Sleep Apnea,No lead center,Industry,Interventional,Device,NA,168,Completed,Double,Randomized,TRUE,TRUE,FALSE,TRUE,2008-02-06,2008-01-01,2009-03-01,2009,2009-03-01,2009,2018-10-18,3518,3518,-36,389,389,883,883,1272,2017-07-01,2017-12-01,2021-08-15,10.5665/sleep.1166,21804670,https://www.ncbi.nlm.nih.gov/pubmed/21804670,2011-08-01,journal publication,TRUE,TRUE,doi,"Positive airway pressure initiation: a randomized controlled trial to assess the impact of therapy mode and titration process on efficacy, adherence, and outcomes",Sleep,2011-Aug-01,2011-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,3197,4550,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,bronze,green,1550-9109,Sleep,Oxford University Press (OUP),2011-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2012-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00637169,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Canadian Oxygen Trial (COT),large,Other,Interventional,Other,Phase 3,1201,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-03-06,2006-12-01,2012-12-01,2012,2012-09-01,2012,NA,NA,NA,-461,1731,1640,172,263,1903,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2013.5555,23644995,https://www.ncbi.nlm.nih.gov/pubmed/23644995?dopt=Abstract,2013-05-22,journal publication,TRUE,TRUE,doi,Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial,JAMA,2013-May-22,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,1,0,0,1,4,4,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2013-05-22,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2013-11-22,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT00639743,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Göttingen Göttingen,NA,PEITHO Pulmonary Embolism Thrombolysis Study,small,Other,Interventional,Drug,Phase 3,1005,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-03-13,2007-11-16,2014-11-01,2014,2012-07-26,2012,NA,NA,NA,-118,2424,1596,-205,623,2219,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1302097,24716681,https://www.ncbi.nlm.nih.gov/pubmed/24716681?dopt=Abstract,2014-04-10,journal publication,TRUE,TRUE,doi,Fibrinolysis for patients with intermediate-risk pulmonary embolism,The New England journal of medicine,2014-Apr-10,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,2,0,5,5,1126,2479,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2014-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2014-10-10,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT00639743,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Göttingen,Freiburg,PEITHO Pulmonary Embolism Thrombolysis Study,small,Other,Interventional,Drug,Phase 3,1005,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-03-13,2007-11-16,2014-11-01,2014,2012-07-26,2012,NA,NA,NA,-118,2424,1596,-205,623,2219,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1302097,24716681,https://www.ncbi.nlm.nih.gov/pubmed/24716681?dopt=Abstract,2014-04-10,journal publication,TRUE,TRUE,doi,Fibrinolysis for patients with intermediate-risk pulmonary embolism,The New England journal of medicine,2014-Apr-10,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,2,0,5,5,1126,2479,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2014-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2014-10-10,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00640679,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation,large,Other,Interventional,Drug,Phase 4,782,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-03-17,2008-04-01,2012-08-01,2012,2012-08-01,2012,NA,NA,NA,15,1598,1598,589,589,2187,2017-07-01,2017-12-01,2021-08-15,10.1160/th13-11-0900,24633406,https://www.ncbi.nlm.nih.gov/pubmed/24633406?dopt=Abstract,2014-03-13,journal publication,TRUE,TRUE,doi,"Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy--ISAR-CAUTION",Thrombosis and haemostasis,2014-Jun,2014-03-13,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1948,3301,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0340-6245,2567-689X",Thrombosis and Haemostasis,Georg Thieme Verlag KG,2014-01-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00640770,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease,large,Industry,Interventional,Device,Phase 4,200,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-03-14,2008-03-01,2011-01-01,2011,2011-01-01,2011,NA,NA,NA,-13,1023,1023,1831,1831,2854,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jcin.2015.10.038,26777329,https://www.ncbi.nlm.nih.gov/pubmed/ 26777329?dopt=Abstract,2016-01-06,journal publication,TRUE,TRUE,doi,Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial: 1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease,JACC. Cardiovascular interventions,2016-Feb-08,2016-01-06,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2016-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00644059,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz,"Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines",No lead center,Industry,Interventional,Biological,Phase 3,4902,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-03-20,2007-11-01,2010-08-01,2010,2010-04-01,2010,2011-10-06,431,553,-140,864,742,438,560,1302,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1010331,21995388,https://www.ncbi.nlm.nih.gov/pubmed/21995388?dopt=Abstract,2011-10-13,journal publication,TRUE,TRUE,doi,Oil-in-water emulsion adjuvant with influenza vaccine in young children,The New England journal of medicine,2011-Oct-13,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,2,2,2,2679,4032,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2011-10-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2012-04-13,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE @@ -242,11 +242,11 @@ NCT00667810,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00668759,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,Berlin Bonn Göttingen,A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation,large,Industry,Interventional,Drug,Phase 3,254,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-04-25,2008-04-01,2009-11-01,2009,2009-10-01,2009,NA,NA,NA,-24,555,524,443,474,998,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2010.07.046,21232669,https://www.ncbi.nlm.nih.gov/pubmed/21232669,2011-01-18,journal publication,TRUE,TRUE,doi,A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation,Journal of the American College of Cardiology,2011-Jan-18,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2952,4305,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2011-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00669227,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,TRUE,Ulm,NA,Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI),large,Other,Interventional,Other,Phase 2,42,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-04-28,2005-10-01,NA,NA,2009-01-01,2009,NA,NA,NA,-940,NA,248,NA,438,686,2017-07-01,2017-12-01,2021-08-15,10.1016/j.amjcard.2009.10.060,20211323,https://www.ncbi.nlm.nih.gov/pubmed/20211323?dopt=Abstract,2010-03-15,journal publication,TRUE,TRUE,doi,Results of intracoronary stem cell therapy after acute myocardial infarction,The American journal of cardiology,2010-Mar-15,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,0002-9149,The American Journal of Cardiology,Elsevier BV,2010-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2011-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00670254,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin Jena Leipzig,Aachen Bonn Dresden Freiburg Greifswald Halle-Wittenberg Hamburg Schleswig-Holstein,Hydrocortisone for Prevention of Septic Shock,large,Other,Interventional,Drug,Phase 3,380,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-04-29,2009-01-01,2013-08-01,2013,2013-08-01,2013,NA,NA,NA,247,1920,1920,1188,1188,3108,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2016.14799,27695824,http://jamanetwork.com/journals/jama/fullarticle/2565176,2016-11-01,journal publication,TRUE,TRUE,doi,Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial,JAMA,2016-Nov-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,15,15,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2016-11-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-04-30,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT00670436,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions,large,Other,Interventional,Device,Phase 2,48,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-04-29,2008-02-01,2014-03-01,2014,2009-09-01,2009,NA,NA,NA,-88,2132,490,-478,1164,1654,2017-07-01,2017-12-01,2021-08-15,10.1002/ccd.24409,22511572,https://www.ncbi.nlm.nih.gov/pubmed/22511572,2012-11-08,journal publication,TRUE,TRUE,doi,Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2013-Apr,2012-11-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2012-11-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00670436,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions,large,Other,Interventional,Device,Phase 2,48,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-04-29,2008-02-01,2014-03-01,2014,2009-09-01,2009,NA,NA,NA,-88,2132,490,-478,1164,1654,2017-07-01,2017-12-01,2021-08-15,10.1002/ccd.24409,22511572,https://www.ncbi.nlm.nih.gov/pubmed/22511572,2012-11-08,journal publication,TRUE,TRUE,doi,Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2013-Apr,2012-11-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2012-11-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00672334,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Sodium Bicarbonate in Cardiac Surgery Study,large,Other,Interventional,Drug,Phase 2/Phase 3,350,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-05-01,2008-05-01,2012-01-01,2012,2011-06-01,2011,NA,NA,NA,0,1340,1126,471,685,1811,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pmed.1001426,23610561,https://www.ncbi.nlm.nih.gov/pubmed/23610561?dopt=Abstract,2013-04-16,journal publication,TRUE,TRUE,doi,Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial,PLoS medicine,2013,2013-04-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1549-1676,PLoS Medicine,Public Library of Science (PLoS),2013-04-16,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00674700,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis,large,Industry,Interventional,Drug,Phase 2/Phase 3,509,Completed,Double,Randomized,TRUE,TRUE,FALSE,TRUE,2008-05-06,2007-10-01,2010-02-01,2010,2009-02-01,2009,2016-01-25,2184,2549,-218,636,271,973,1338,1609,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1365-2222.2012.04044.x,22994348,https://www.ncbi.nlm.nih.gov/pubmed/22994348/,2012-10-01,journal publication,TRUE,TRUE,doi,Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy,Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,2012-Oct,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2860,4213,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,closed,closed,0954-7894,Clinical & Experimental Allergy,Wiley,2012-09-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00676143,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Dresden Freiburg Ulm,Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients,No lead center,Industry,Interventional,Drug,Phase 3,1100,Terminated,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2008-05-02,2008-01-01,2012-11-01,2012,2012-10-01,2012,2013-10-14,347,378,-122,1644,1613,890,921,2534,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jval.2015.03.1787,26297092,NA,2015-04-10,journal publication,TRUE,TRUE,doi,Quality of Life and Utility Measurement in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer's Disease: Determinants and Level of Changes Observed,Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,2015-Jul,2015-04-10,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,1,0,1,2,2,2,1856,3209,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,bronze,bronze,1098-3015,Value in Health,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00677638,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease,large,Industry,Interventional,Device,NA,30,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-05-12,2008-06-01,2014-12-01,2014,2010-01-01,2010,NA,NA,NA,20,2394,599,-1453,342,941,2017-07-01,2017-12-01,2021-08-15,10.1093/eurheartj/ehq445,21148541,https://www.ncbi.nlm.nih.gov/pubmed/21148541?dopt=Abstract,2010-12-09,journal publication,TRUE,TRUE,doi,Transapical aortic valve implantation with a self-expanding anatomically oriented valve,European heart journal,2011-Apr,2010-12-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2010-12-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2011-12-09,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00677638,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,Homburg,Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease,large,Industry,Interventional,Device,NA,30,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-05-12,2008-06-01,2014-12-01,2014,2010-01-01,2010,NA,NA,NA,20,2394,599,-1453,342,941,2017-07-01,2017-12-01,2021-08-15,10.1093/eurheartj/ehq445,21148541,https://www.ncbi.nlm.nih.gov/pubmed/21148541?dopt=Abstract,2010-12-09,journal publication,TRUE,TRUE,doi,Transapical aortic valve implantation with a self-expanding anatomically oriented valve,European heart journal,2011-Apr,2010-12-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2010-12-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2011-12-09,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00678392,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Berlin Duisburg-Essen Mainz LMU-München,Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer,No lead center,Industry,Interventional,Drug,Phase 3,723,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2008-05-12,2008-09-03,2016-02-25,2016,2010-08-31,2010,2012-02-25,-1461,543,114,2845,841,-1574,430,1271,2017-07-01,2017-12-01,2021-08-15,10.1016/s0140-6736(11)61613-9,22056247,https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(11)61613-9,2011-11-04,journal publication,TRUE,TRUE,doi,Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial,"Lancet (London, England)",2011-Dec-03,2011-11-04,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,10,10,645,1998,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,0140-6736,The Lancet,Elsevier BV,2011-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-05-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00682305,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,"Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)",large,Other,Interventional,Procedure,Phase 2,50,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2008-05-16,2007-03-01,2013-08-01,2013,2013-01-01,2013,NA,NA,NA,-442,1903,1691,774,986,2677,2017-07-01,2017-12-01,2021-08-15,10.1038/bmt.2015.202,26367236,https://www.nature.com/bmt/journal/v50/n12/full/bmt2015202a.html,2015-09-14,journal publication,TRUE,TRUE,doi,"Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)",Bone marrow transplantation,2015-Dec,2015-09-14,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0268-3369,1476-5365",Bone Marrow Transplantation,Springer Science and Business Media LLC,2015-09-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00683696,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Duisburg-Essen Hamburg Jena Leipzig Magdeburg,Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT),No lead center,Industry,Interventional,Device,Phase 2/Phase 3,1680,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,TRUE,2007-08-30,2008-08-01,2013-03-01,2013,2013-03-01,2013,2014-03-12,376,376,337,2010,2010,185,185,2195,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1306687,23998714,https://www.ncbi.nlm.nih.gov/pubmed/23998714,2013-09-02,journal publication,TRUE,TRUE,doi,Cardiac-resynchronization therapy in heart failure with a narrow QRS complex,The New England journal of medicine,2013-Oct-10,2013-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1736,3089,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2013-10-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2014-04-10,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -266,7 +266,7 @@ NCT00711425,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,FALS NCT00711503,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf Frankfurt TU-München Ulm,Anti-Interleukin-1 in Diabetes Action,No lead center,Other,Interventional,Drug,Phase 2/Phase 3,69,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-03,2009-01-01,2012-06-01,2012,2012-01-01,2012,NA,NA,NA,182,1429,1277,308,460,1737,2017-07-01,2017-12-01,2021-08-15,10.1016/s0140-6736(13)60023-9,23562090,https://www.ncbi.nlm.nih.gov/pubmed/23562090?dopt=Abstract,2013-04-05,journal publication,TRUE,TRUE,doi,"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","Lancet (London, England)",2013-Jun-01,2013-04-05,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,2,2,2,3,3,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0140-6736,The Lancet,Elsevier BV,2013-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2013-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00712101,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig Ulm,NA,Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction,large,Other,Interventional,Drug,Phase 3,1912,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-03,2008-07-01,2011-04-01,2011,2011-04-01,2011,NA,NA,NA,-2,1002,1002,326,326,1328,2017-07-01,2017-12-01,2021-08-15,10.1016/s0140-6736(11)61872-2,22357109,NA,2012-02-21,journal publication,TRUE,TRUE,doi,Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial,"Lancet (London, England)",2012-Mar-10,2012-02-21,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,24,24,2436,3789,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0140-6736,The Lancet,Elsevier BV,2012-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-08-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00712309,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Hamburg Tübingen,Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting,No lead center,Other,Interventional,Device,NA,250,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-08,2007-02-01,NA,NA,2010-06-01,2010,NA,NA,NA,-523,NA,693,NA,1085,1778,2017-07-01,2017-12-01,2021-08-15,10.1161/circulationaha.113.001849,23694965,NA,2013-05-21,journal publication,TRUE,TRUE,doi,"Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial",Circulation,2013-Jun-25,2013-05-21,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,bronze,bronze,"0009-7322,1524-4539",Circulation,Ovid Technologies (Wolters Kluwer Health),2013-06-25,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-06-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00714311,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Münster Münster,NA,Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder,large,Other,Interventional,Behavioral,NA,104,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-07-09,2004-10-01,2015-02-01,2015,2009-02-01,2009,2015-02-04,3,2194,-1377,2398,207,-1737,454,661,2017-07-01,2017-12-01,2021-08-15,10.1192/bjp.bp.109.070177,20435966,http://bjp.rcpsych.org/content/196/5/389.long,2010-05-01,journal publication,TRUE,TRUE,doi,Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial,The British journal of psychiatry : the journal of mental science,2010-May,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1034,2387,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2010-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2010-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00714311,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Münster,TU-München,Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder,large,Other,Interventional,Behavioral,NA,104,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-07-09,2004-10-01,2015-02-01,2015,2009-02-01,2009,2015-02-04,3,2194,-1377,2398,207,-1737,454,661,2017-07-01,2017-12-01,2021-08-15,10.1192/bjp.bp.109.070177,20435966,http://bjp.rcpsych.org/content/196/5/389.long,2010-05-01,journal publication,TRUE,TRUE,doi,Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial,The British journal of psychiatry : the journal of mental science,2010-May,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1034,2387,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2010-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2010-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00714883,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Homburg,Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions,No lead center,Industry,Interventional,Device,Phase 2,3,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-07-10,2008-06-01,2012-10-01,2012,2009-11-01,2009,NA,NA,NA,-39,1544,479,-573,492,971,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.110.957175,21386089,http://circinterventions.ahajournals.org/content/4/2/146,2011-03-08,journal publication,TRUE,TRUE,doi,"Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions",Circulation. Cardiovascular interventions,2011-Apr-01,2011-03-08,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2011-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2012-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00715091,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,Düsseldorf Tübingen,Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis,large,Other,Interventional,Drug,Phase 4,180,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-14,2008-09-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,49,1966,1966,611,611,2577,2017-07-01,2017-12-01,2021-08-15,10.1136/annrheumdis-2015-207897,26242443,https://www.ncbi.nlm.nih.gov/pubmed/26242443,2015-08-04,journal publication,TRUE,TRUE,doi,Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS),Annals of the rheumatic diseases,2016-Aug,2015-08-04,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,4,4,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0003-4967,1468-2060",Annals of the Rheumatic Diseases,BMJ,2015-08-04,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00715637,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Berlin Duisburg-Essen Hannover Schleswig-Holstein Mannheim,Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study,No lead center,Industry,Interventional,Drug,Phase 3,420,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-14,2007-06-01,NA,NA,2010-06-01,2010,NA,NA,NA,-409,NA,687,NA,1735,2422,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.57.0952,25732165,https://www.ncbi.nlm.nih.gov/pubmed/25732165?dopt=Abstract,2015-03-02,journal publication,TRUE,TRUE,doi,Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2015-Apr-10,2015-03-02,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2015-04-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-04-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE @@ -279,7 +279,7 @@ NCT00722566,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00723411,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Hannover Leipzig,A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU),No lead center,Industry,Interventional,Drug,Phase 3,334,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-24,2008-07-01,2011-08-01,2011,2011-05-01,2011,NA,NA,NA,-23,1103,1011,185,277,1288,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1107096,22296077,https://www.ncbi.nlm.nih.gov/pubmed/22296077?dopt=Abstract,2012-02-02,journal publication,TRUE,TRUE,doi,GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus,The New England journal of medicine,2012-Feb-02,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2012-02-02,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2012-08-01,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT00729703,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München TU-München,Berlin Bonn Hamburg Schleswig-Holstein Münster Regensburg Homburg Ulm,Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without Pacing Indications,large,Industry,Interventional,Device,Phase 4,462,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2008-08-04,2006-06-01,2013-10-01,2013,2011-12-01,2011,NA,NA,NA,-795,1884,1214,365,1035,2249,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jchf.2014.05.015,25282033,https://www.ncbi.nlm.nih.gov/pubmed/25282033?dopt=Abstract,2014-10-01,journal publication,TRUE,TRUE,doi,Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study,JACC. Heart failure,2014-Dec,2014-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,2213-1779,JACC: Heart Failure,Elsevier BV,2014-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00730548,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Compare Remote Patient Management and Standard Care in CRT-D and ICD-patients to Assess the Effect on Heart Failure,small,Industry,Interventional,Behavioral,NA,180,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2008-06-19,2007-11-01,2013-08-01,2013,2011-04-01,2011,NA,NA,NA,-231,1869,1016,654,1507,2523,2017-07-01,2017-12-01,2021-08-15,10.1093/europace/euv039,25983310,https://www.ncbi.nlm.nih.gov/pubmed/25983310?dopt=Abstract,2015-05-17,journal publication,TRUE,TRUE,doi,A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices,"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2015-Aug,2015-05-17,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2015-05-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00732953,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries,large,Other,Interventional,Device,Phase 2/Phase 3,120,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-07,2009-02-01,2014-02-01,2014,2010-01-01,2010,NA,NA,NA,178,2004,512,-982,510,1022,2017-07-01,2017-12-01,2021-08-15,10.1136/hrt.2011.226563,21617163,NA,2011-05-26,journal publication,TRUE,TRUE,doi,Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease,Heart (British Cardiac Society),2011-Aug,2011-05-26,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1355-6037,Heart,BMJ,2011-05-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT00732953,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries,large,Other,Interventional,Device,Phase 2/Phase 3,120,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-07,2009-02-01,2014-02-01,2014,2010-01-01,2010,NA,NA,NA,178,2004,512,-982,510,1022,2017-07-01,2017-12-01,2021-08-15,10.1136/hrt.2011.226563,21617163,NA,2011-05-26,journal publication,TRUE,TRUE,doi,Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease,Heart (British Cardiac Society),2011-Aug,2011-05-26,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1355-6037,Heart,BMJ,2011-05-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00732979,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Infrahepatic Inferior Vena Cava Clamping During Hepatectomy,large,Other,Interventional,Procedure,NA,152,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2008-08-07,2008-03-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-159,1211,1211,-183,-183,1028,2017-07-01,2017-12-01,2021-08-15,10.1097/sla.0b013e318214bee5,21412143,http://journals.lww.com/annalsofsurgery/pages/articleviewer.aspx?year=2011&issue=06000&article=00009&type=abstract,2011-06-01,journal publication,TRUE,TRUE,doi,Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial,Annals of surgery,2011-Jun,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2011-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2012-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00734747,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz,Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD),No lead center,Industry,Interventional,Device,Phase 3,72,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2008-08-13,2008-05-01,2015-07-01,2015,2011-05-01,2011,2015-05-15,-47,1475,-104,2513,991,-316,1206,2197,2017-07-01,2017-12-01,2021-08-15,10.1007/s00464-014-3731-3,25135443,NA,2014-08-19,journal publication,TRUE,TRUE,doi,Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial,Surgical endoscopy,2015-Jan,2014-08-19,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,884,2237,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0930-2794,1432-2218",Surgical Endoscopy,Springer Science and Business Media LLC,2014-08-19,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00734942,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Development and Implementation of Evidence-Based Family-Oriented Support for Young Carers and Their Families in Germany,small,Other,Interventional,Other,NA,150,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2008-08-12,2009-01-01,2010-03-01,2010,2009-12-01,2009,NA,NA,NA,142,566,476,604,694,1170,2017-07-01,2017-12-01,2021-08-15,10.2174/1874434601105010086,22135716,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227871/,2011-10-26,journal publication,TRUE,TRUE,doi,Germany's First Young Carers Project's Impact on the Children: Relieving the Entire Family. A Qualitative Evaluation,The open nursing journal,2011,2011-10-26,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1874-4346,The Open Nursing Journal,Bentham Science Publishers Ltd.,2011-10-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -301,9 +301,9 @@ NCT00764881,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00764933,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,Giessen Marburg,Structured Information During the Intensive Care Unit Stay,small,Other,Interventional,Behavioral,NA,211,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-01,2008-01-01,2010-03-01,2010,2009-12-01,2009,NA,NA,NA,-274,516,426,1580,1670,2096,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2253-14-48,25071414,https://bmcanesthesiol.biomedcentral.com/articles/10.1186/1471-2253-14-48,2014-06-28,journal publication,TRUE,TRUE,doi,Does an additional structured information program during the intensive care unit stay reduce anxiety in ICU patients?: a multicenter randomized controlled trial,BMC anesthesiology,2014,2014-06-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2253,BMC Anesthesiology,Springer Science and Business Media LLC,2014-06-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00765323,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Frankfurt Hamburg Köln Schleswig-Holstein Magdeburg Marburg,Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly,No lead center,Industry,Interventional,Drug,Phase 3,169,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-09-30,2008-09-01,2011-06-01,2011,2011-02-01,2011,NA,NA,NA,-29,974,854,813,933,1787,2017-07-01,2017-12-01,2021-08-15,10.1210/jc.2013-2262,23969184,https://www.ncbi.nlm.nih.gov/pubmed/23969184?dopt=Abstract,2013-08-22,journal publication,TRUE,TRUE,doi,Efficacy and safety of an octreotide implant in the treatment of patients with acromegaly,The Journal of clinical endocrinology and metabolism,2013-Oct,2013-08-22,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"0021-972X,1945-7197",The Journal of Clinical Endocrinology & Metabolism,The Endocrine Society,2013-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2014-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00769561,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Biofeedback-Based Cognitive Behavioral Treatment for Temporomandibular Disorders,small,Other,Interventional,Behavioral,Phase 2/Phase 3,58,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-10-08,2008-08-01,2011-04-01,2011,2010-07-01,2010,2013-05-24,784,1058,-68,905,631,975,1249,1880,2017-07-01,2017-12-01,2021-08-15,10.1097/ajp.0b013e3182850559,23446073,https://www.ncbi.nlm.nih.gov/pubmed/23446073?dopt=Abstract,2013-12-01,journal publication,TRUE,TRUE,doi,Biofeedback-based cognitive-behavioral treatment compared with occlusal splint for temporomandibular disorder: a randomized controlled trial,The Clinical journal of pain,2013-Dec,NA,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,4,2436,3789,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,closed,closed,0749-8047,The Clinical Journal of Pain,Ovid Technologies (Wolters Kluwer Health),2013-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00772655,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Zevalin® First Line in Follicular Lymphoma,large,Other,Interventional,Drug,Phase 2,60,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-10-14,2007-10-01,2015-06-01,2015,2010-06-01,2010,NA,NA,NA,-379,2421,595,-903,923,1518,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2011.41.1553,23233718,https://www.ncbi.nlm.nih.gov/pubmed/23233718,2012-12-10,journal publication,TRUE,TRUE,doi,(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2013-Jan-20,2012-12-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,914,2267,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-01-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-01-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00772655,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Zevalin® First Line in Follicular Lymphoma,large,Other,Interventional,Drug,Phase 2,60,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-10-14,2007-10-01,2015-06-01,2015,2010-06-01,2010,NA,NA,NA,-379,2421,595,-903,923,1518,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2011.41.1553,23233718,https://www.ncbi.nlm.nih.gov/pubmed/23233718,2012-12-10,journal publication,TRUE,TRUE,doi,(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2013-Jan-20,2012-12-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,914,2267,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-01-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-01-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00774072,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,Tübingen,Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization,small,Other,Interventional,Drug,Phase 2,9,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-10-16,2008-10-01,2010-11-01,2010,2010-11-01,2010,NA,NA,NA,-15,746,746,1197,1197,1943,2017-07-01,2017-12-01,2021-08-15,10.2147/dddt.s54064,24596456,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930477/,2014-02-10,journal publication,TRUE,TRUE,doi,"Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study","Drug design, development and therapy",2014,2014-02-10,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,6,6,2587,3940,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1177-8881,"Drug Design, Development and Therapy",Informa UK Limited,2014-02-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00776633,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation,large,Other,Interventional,Drug,Phase 4,614,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-20,2008-09-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-49,2142,1868,239,513,2381,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2015.02.050,25908066,https://www.ncbi.nlm.nih.gov/pubmed/25908066?dopt=Abstract,2015-04-28,journal publication,TRUE,TRUE,doi,Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial,Journal of the American College of Cardiology,2015-Apr-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00776633,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation,large,Other,Interventional,Drug,Phase 4,614,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-20,2008-09-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-49,2142,1868,239,513,2381,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2015.02.050,25908066,https://www.ncbi.nlm.nih.gov/pubmed/25908066?dopt=Abstract,2015-04-28,journal publication,TRUE,TRUE,doi,Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial,Journal of the American College of Cardiology,2015-Apr-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00778752,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,Heidelberg,Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma,large,Other,Interventional,Drug,Phase 1/Phase 2,24,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-10-22,2009-04-01,2013-12-01,2013,2013-03-01,2013,NA,NA,NA,161,1866,1591,-410,-135,1456,2017-07-01,2017-12-01,2021-08-15,10.1016/j.exphem.2012.10.004,23085463,http://www.sciencedirect.com/science/article/pii/S0301472X12004353,2012-10-17,journal publication,TRUE,TRUE,doi,Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study,Experimental hematology,2013-Feb,2012-10-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0301-472X,Experimental Hematology,Elsevier BV,2013-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00783120,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,Düsseldorf Regensburg,Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia,small,Other,Interventional,Other,NA,197,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-30,2008-01-01,2011-12-01,2011,2011-08-01,2011,NA,NA,NA,-303,1127,1005,1057,1179,2184,2017-07-01,2017-12-01,2021-08-15,10.1016/j.biopsych.2014.10.009,25582269,https://www.ncbi.nlm.nih.gov/pubmed/25582269?dopt=Abstract,2014-10-23,journal publication,TRUE,TRUE,doi,"Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial",Biological psychiatry,2015-Jun-01,2014-10-23,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0006-3223,Biological Psychiatry,Elsevier BV,2015-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00783159,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Fit in the Aged by Professional Training,large,Other,Interventional,Procedure,NA,69,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-30,2008-06-01,2010-05-01,2010,2009-12-01,2009,NA,NA,NA,-151,548,397,551,702,1099,2017-07-01,2017-12-01,2021-08-15,10.1159/000332207,22056537,https://www.karger.com/Article/Abstract/332207,2011-11-03,journal publication,TRUE,TRUE,doi,Effects of strength training versus power training on physical performance in prefrail community-dwelling older adults,Gerontology,2012,2011-11-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2771,4124,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"1423-0003,0304-324X",Gerontology,S. Karger AG,2012-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2013-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -342,11 +342,11 @@ NCT00833248,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00833612,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg Leipzig,Counterpulsation Reduces Infarct Size Pre-PCI for AMI,No lead center,Industry,Interventional,Device,Phase 4,339,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-01-27,2008-12-01,2011-03-01,2011,2011-03-01,2011,NA,NA,NA,-57,763,763,181,181,944,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2011.1280,21878431,https://www.ncbi.nlm.nih.gov/pubmed/21878431?dopt=Abstract,2011-08-29,journal publication,TRUE,TRUE,doi,Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial,JAMA,2011-Sep-28,2011-08-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2011-09-28,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2012-03-28,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT00835978,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf Frankfurt Hannover Tübingen,Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer,No lead center,Industry,Interventional,Drug,Phase 2,213,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-02-02,2009-08-01,2016-02-01,2016,2012-10-01,2012,2013-10-11,-843,375,180,2555,1337,-836,382,1719,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(13)70464-9,24140184,http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70464-9/fulltext,2013-10-18,journal publication,TRUE,TRUE,doi,Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial,The Lancet. Oncology,2013-Nov,2013-10-18,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,4,4,669,2022,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,green,green,1470-2045,The Lancet Oncology,Elsevier BV,2013-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2014-04-30,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00837603,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Physical Training in Transposition of the Great Arteries,large,Other,Interventional,Behavioral,NA,48,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-04,2009-02-01,2011-01-01,2011,2010-09-01,2010,NA,NA,NA,-3,696,574,874,996,1570,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ijcard.2013.05.030,23711443,NA,2013-05-24,journal publication,TRUE,TRUE,doi,Symmetrical dimethylarginine is superior to NT-proBNP for detecting systemic ventricular dysfunction in adults after atrial repair for transposition of the great arteries,International journal of cardiology,2013-Oct-09,2013-05-24,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0167-5273,International Journal of Cardiology,Elsevier BV,2013-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00841256,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children,large,Industry,Interventional,Biological,Phase 3,207,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-04-22,2008-02-01,2015-08-01,2015,2012-06-01,2012,NA,NA,NA,-81,2657,1501,-1067,89,1590,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jaci.2012.06.047,22939758,https://www.ncbi.nlm.nih.gov/pubmed/22939758,2012-08-29,journal publication,TRUE,TRUE,doi,"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study",The Journal of allergy and clinical immunology,2012-Oct,2012-08-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,853,2206,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2012-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00841256,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children,large,Industry,Interventional,Biological,Phase 3,207,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-04-22,2008-02-01,2015-08-01,2015,2012-06-01,2012,NA,NA,NA,-81,2657,1501,-1067,89,1590,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jaci.2012.06.047,22939758,https://www.ncbi.nlm.nih.gov/pubmed/22939758,2012-08-29,journal publication,TRUE,TRUE,doi,"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study",The Journal of allergy and clinical immunology,2012-Oct,2012-08-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,853,2206,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2012-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00844142,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS),large,Other,Interventional,Drug,Phase 2,80,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-02-12,2005-11-01,2013-07-01,2013,2013-07-01,2013,NA,NA,NA,-1199,1600,1600,213,213,1813,2017-07-01,2017-12-01,2021-08-15,10.1186/ar4464,24476416,https://www.ncbi.nlm.nih.gov/pubmed/24476416?dopt=Abstract,2014-01-30,journal publication,TRUE,TRUE,doi,Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers,Arthritis research & therapy,2014-Jan-30,2014-01-30,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,3,3,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1478-6354,Arthritis Research & Therapy,Springer Science and Business Media LLC,2014-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00844649,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,LMU-München Würzburg,Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas,No lead center,Industry,Interventional,Drug,Phase 3,861,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-02-13,2009-03-01,2013-04-09,2013,2012-09-17,2012,2013-10-21,195,399,16,1516,1312,190,394,1706,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1304369,24131140,https://www.ncbi.nlm.nih.gov/pubmed/24131140?dopt=Abstract,2013-10-16,journal publication,TRUE,TRUE,doi,Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine,The New England journal of medicine,2013-Oct-31,2013-10-16,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,30,30,1697,3050,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2013-10-31,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2014-04-30,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00850031,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bochum,Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes,No lead center,Industry,Interventional,Device,NA,119,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2009-02-20,2009-01-01,2013-10-01,2013,2013-10-01,2013,2016-07-20,1023,1023,-50,1684,1684,-681,-681,1003,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajo.2011.08.044,22105801,https://www.ncbi.nlm.nih.gov/pubmed/22105801,2011-11-20,journal publication,TRUE,TRUE,doi,Reading performance after implantation of a modified corneal inlay design for the surgical correction of presbyopia: 1-year follow-up,American journal of ophthalmology,2012-May,2011-11-20,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1522,2875,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,closed,closed,0002-9394,American Journal of Ophthalmology,Elsevier BV,2012-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00850629,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Hormonal Regulation of Body Weight Maintenance,large,Other,Interventional,Behavioral,NA,286,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2010-01-01,2016-01-01,2016,2015-12-01,2015,NA,NA,NA,318,2509,2478,-359,-328,2150,2017-07-01,2017-12-01,2021-08-15,10.1016/j.neuroimage.2014.12.073,25576647,http://www.sciencedirect.com/science/article/pii/S1053811914010799,2015-01-07,journal publication,TRUE,TRUE,doi,Impulse control in the dorsolateral prefrontal cortex counteracts post-diet weight regain in obesity,NeuroImage,2015-Apr-01,2015-01-07,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,700,2053,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1053-8119,NeuroImage,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE +NCT00850629,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Hormonal Regulation of Body Weight Maintenance,large,Other,Interventional,Behavioral,NA,286,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2010-01-01,2016-01-01,2016,2015-12-01,2015,NA,NA,NA,318,2509,2478,-359,-328,2150,2017-07-01,2017-12-01,2021-08-15,10.1016/j.neuroimage.2014.12.073,25576647,http://www.sciencedirect.com/science/article/pii/S1053811914010799,2015-01-07,journal publication,TRUE,TRUE,doi,Impulse control in the dorsolateral prefrontal cortex counteracts post-diet weight regain in obesity,NeuroImage,2015-Apr-01,2015-01-07,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,700,2053,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1053-8119,NeuroImage,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT00851578,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leipzig,ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology,No lead center,Industry,Interventional,Device,NA,150,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-02-24,2009-01-01,2013-12-01,2013,2012-02-01,2012,NA,NA,NA,-54,1741,1072,-235,434,1506,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2013.03.035,23583249,https://www.ncbi.nlm.nih.gov/pubmed/23583249?dopt=Abstract,2013-04-10,journal publication,TRUE,TRUE,doi,Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology),Journal of the American College of Cardiology,2013-Jun-25,2013-04-10,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2013-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00864253,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Dresden Duisburg-Essen Göttingen Hamburg Hannover Heidelberg Jena Köln Leipzig Mainz Tübingen Würzburg,A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma,No lead center,Industry,Interventional,Drug,Phase 3,529,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-03-16,2009-04-23,2014-02-12,2014,2012-06-01,2012,2014-04-16,63,684,38,1794,1173,591,1212,2385,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdv324,26410620,https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdv324,2015-09-26,journal publication,TRUE,TRUE,doi,"A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma",Annals of oncology : official journal of the European Society for Medical Oncology,2015-Nov,2015-09-26,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1388,2741,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2015-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00865917,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,Berlin,Cardiovascular Effects of Selective I(f)-Channel Blockade,large,Other,Interventional,Drug,Phase 2,40,Unknown status,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2009-03-18,2008-11-01,2010-12-01,2010,2010-11-01,2010,NA,NA,NA,-137,623,593,1869,1899,2492,2017-07-01,2017-12-01,2021-08-15,10.1161/jaha.115.002674,26764413,https://www.ncbi.nlm.nih.gov/pubmed/26764413,2016-01-13,journal publication,TRUE,TRUE,doi,Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping,Journal of the American Heart Association,2016-Jan-13,2016-01-13,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,2047-9980,Journal of the American Heart Association,Ovid Technologies (Wolters Kluwer Health),2016-01-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -363,7 +363,7 @@ NCT00886704,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT00887978,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Greifswald Heidelberg,Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension,No lead center,Industry,Interventional,Drug,Phase 3,310,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-23,2009-06-01,2011-07-01,2011,2011-07-01,2011,2012-11-02,490,490,39,799,799,793,793,1592,2017-07-01,2017-12-01,2021-08-15,10.1378/chest.12-2875,23669822,https://www.ncbi.nlm.nih.gov/pubmed/23669822?dopt=Abstract,2013-09-01,journal publication,TRUE,TRUE,doi,Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial,Chest,2013-Sep,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2345,3698,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,0012-3692,Chest,Elsevier BV,2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00888433,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf Erlangen Duisburg-Essen Köln Leipzig Schleswig-Holstein Homburg,Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2),No lead center,Industry,Interventional,Device,NA,106,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-24,2009-06-01,2015-05-01,2015,2010-09-01,2010,2013-09-13,-595,1108,38,2198,495,-1461,242,737,2017-07-01,2017-12-01,2021-08-15,10.1097/hjh.0b013e328344db3a,21358414,NA,2011-05-01,journal publication,TRUE,TRUE,doi,Renal denervation: a potential new treatment modality for polycystic ovary syndrome?,Journal of hypertension,2011-May,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,945,2298,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,0263-6352,Journal of Hypertension,Ovid Technologies (Wolters Kluwer Health),2011-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2012-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00888940,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Bonn Dresden Erlangen Frankfurt Freiburg Göttingen Halle-Wittenberg Hamburg Heidelberg Köln Leipzig Schleswig-Holstein TU-München Würzburg,Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery,No lead center,Industry,Interventional,Drug,Phase 2,243,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-26,2009-06-01,2010-01-01,2010,2009-12-01,2009,2010-12-14,347,378,36,250,219,547,578,797,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jtcvs.2011.06.001,21724197,https://linkinghub.elsevier.com/retrieve/pii/S0022-5223(11)00600-3,2011-07-02,journal publication,TRUE,TRUE,doi,"A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial)",The Journal of thoracic and cardiovascular surgery,2012-May,2011-07-02,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2891,4244,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,0022-5223,The Journal of Thoracic and Cardiovascular Surgery,Elsevier BV,2012-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00893373,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age,large,Other,Interventional,Drug,Phase 2,276,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-05-04,2009-03-01,2014-09-01,2014,2011-11-01,2011,NA,NA,NA,-64,1946,911,431,1466,2377,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(15)00362-9,26549589,https://www.ncbi.nlm.nih.gov/pubmed/26549589?dopt=Abstract,2015-11-06,journal publication,TRUE,TRUE,doi,"Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial",The Lancet. Oncology,2015-Dec,2015-11-06,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,2,2,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-05-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00893373,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,Berlin,Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age,large,Other,Interventional,Drug,Phase 2,276,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-05-04,2009-03-01,2014-09-01,2014,2011-11-01,2011,NA,NA,NA,-64,1946,911,431,1466,2377,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(15)00362-9,26549589,https://www.ncbi.nlm.nih.gov/pubmed/26549589?dopt=Abstract,2015-11-06,journal publication,TRUE,TRUE,doi,"Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial",The Lancet. Oncology,2015-Dec,2015-11-06,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,2,2,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-05-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00895778,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Neuromuscular Blockade Improves Surgical Conditions,large,Other,Interventional,Other,NA,57,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2009-04-29,2009-03-01,2012-12-01,2012,2010-12-01,2010,NA,NA,NA,-59,1312,581,622,1353,1934,2017-07-01,2017-12-01,2021-08-15,10.1007/s00464-014-3711-7,25125097,https://www.ncbi.nlm.nih.gov/pubmed/25125097?dopt=Abstract,2014-08-15,journal publication,TRUE,TRUE,doi,Neuromuscular blockade improves surgical conditions (NISCO),Surgical endoscopy,2015-Mar,2014-08-15,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0930-2794,1432-2218",Surgical Endoscopy,Springer Science and Business Media LLC,2014-08-15,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-08-15,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00895830,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Heidelberg Leipzig Marburg Würzburg,Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV),No lead center,Industry,Interventional,Drug,Phase 2,257,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-05-07,2009-05-01,2009-11-01,2009,2009-11-01,2009,2011-02-24,480,480,-6,178,178,912,912,1090,2017-07-01,2017-12-01,2021-08-15,10.1007/s00228-012-1284-8,22546895,https://link.springer.com/article/10.1007%2Fs00228-012-1284-8,2012-05-01,journal publication,TRUE,TRUE,doi,Intravenous buspirone for the prevention of postoperative nausea and vomiting,European journal of clinical pharmacology,2012-Nov,2012-05-01,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2952,4305,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,green,green,"0031-6970,1432-1041",European Journal of Clinical Pharmacology,Springer Science and Business Media LLC,2012-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2013-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00900146,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz,"Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients",No lead center,Industry,Interventional,Drug,Phase 2/Phase 3,556,Terminated,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2009-05-06,2009-04-01,2010-11-01,2010,2010-11-01,2010,2011-11-22,386,386,-35,544,544,735,735,1279,2017-07-01,2017-12-01,2021-08-15,10.1161/circulationaha.112.122556,23129601,NA,2012-11-05,journal publication,TRUE,TRUE,doi,"Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial",Circulation,2012-Dec-04,2012-11-05,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2587,3940,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,bronze,bronze,"0009-7322,1524-4539",Circulation,Ovid Technologies (Wolters Kluwer Health),2012-12-04,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-12-04,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -408,7 +408,7 @@ NCT00958477,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT00958776,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Regensburg,A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza,No lead center,Industry,Interventional,Drug,Phase 3,405,Terminated,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2009-08-12,2009-11-01,2013-10-01,2013,2012-11-01,2012,2015-01-16,472,806,81,1511,1177,315,649,1826,2017-07-01,2017-12-01,2021-08-15,10.1093/cid/ciu632,25115871,https://www.ncbi.nlm.nih.gov/pubmed/25115871?dopt=Abstract,2014-08-12,journal publication,TRUE,TRUE,doi,Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2014-Dec-15,2014-08-12,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1522,2875,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,bronze,green,"1058-4838,1537-6591",Clinical Infectious Diseases,Oxford University Press (OUP),2014-08-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-12-15,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00961181,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis,large,Industry,Interventional,Device,NA,81,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2009-08-13,2009-08-01,2011-05-01,2011,2010-12-01,2010,2013-03-19,688,839,-12,626,475,461,612,1087,2017-07-01,2017-12-01,2021-08-15,10.1016/j.carrev.2012.06.002,22867706,http://www.sciencedirect.com/science/article/pii/S1553838912001595?via%3Dihub,2012-08-04,journal publication,TRUE,TRUE,doi,Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial,Cardiovascular revascularization medicine : including molecular interventions,2012 Sep-Oct,2012-08-04,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2406,3759,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,1553-8389,Cardiovascular Revascularization Medicine,Elsevier BV,2012-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00963261,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,Köln,Quality of Life and Psychological Well-being in Patients With Malignant Melanoma,large,Other,Interventional,Behavioral,NA,600,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-08-20,2009-04-01,2012-04-01,2012,2011-02-01,2011,NA,NA,NA,-141,955,530,277,702,1232,2017-07-01,2017-12-01,2021-08-15,10.1002/pon.3238,23288588,NA,2013-01-03,journal publication,TRUE,TRUE,doi,Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression,Psycho-oncology,2013-Sep,2013-01-03,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1057-9249,Psycho-Oncology,Wiley,2013-01-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00970437,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Hamburg Freiburg Hamburg,NA,A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression,large,Other,Interventional,Behavioral,NA,268,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-09-01,2010-04-01,2014-12-01,2014,2013-10-01,2013,NA,NA,NA,212,1917,1491,821,1247,2738,2017-07-01,2017-12-01,2021-08-15,10.1001/jamapsychiatry.2016.3880,28146251,http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2600225,2017-03-01,journal publication,TRUE,TRUE,doi,Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial,JAMA psychiatry,2017-Mar-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,2168-622X,JAMA Psychiatry,American Medical Association (AMA),2017-03-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-08-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT00970437,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Hamburg,NA,A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression,large,Other,Interventional,Behavioral,NA,268,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-09-01,2010-04-01,2014-12-01,2014,2013-10-01,2013,NA,NA,NA,212,1917,1491,821,1247,2738,2017-07-01,2017-12-01,2021-08-15,10.1001/jamapsychiatry.2016.3880,28146251,http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2600225,2017-03-01,journal publication,TRUE,TRUE,doi,Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial,JAMA psychiatry,2017-Mar-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,2168-622X,JAMA Psychiatry,American Medical Association (AMA),2017-03-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-08-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT00974077,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Psychophysiological Correlates of Mindfulness Based Cognitive Therapy (MBCT) in Recurrent Depression,large,Other,Interventional,Behavioral,NA,120,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2009-09-09,2008-09-01,2011-07-01,2011,2011-07-01,2011,NA,NA,NA,-373,660,660,371,371,1031,2017-07-01,2017-12-01,2021-08-15,10.1016/j.psychres.2012.05.031,22771173,https://www.ncbi.nlm.nih.gov/pubmed/22771173,2012-07-06,journal publication,TRUE,TRUE,doi,Event-related brain potentials reflect increased concentration ability after mindfulness-based cognitive therapy for depression: a randomized clinical trial,Psychiatry research,2012-Oct-30,2012-07-06,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0165-1781,Psychiatry Research,Elsevier BV,2012-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00974779,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,High-cutoff Hemodialyzer to Reduce Chronic Inflammation in Hemodialysis Patients,small,Other,Interventional,Device,Phase 2/Phase 3,19,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2009-09-09,2009-11-01,2011-12-01,2011,2011-08-01,2011,NA,NA,NA,53,813,691,242,364,1055,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1525-1594.2012.01479.x,22845695,https://www.ncbi.nlm.nih.gov/pubmed/22845695?dopt=Abstract,2012-07-30,journal publication,TRUE,TRUE,doi,Randomized controlled pilot study of 2 weeks' treatment with high cutoff membrane for hemodialysis patients with elevated C-reactive protein,Artificial organs,2012-Oct,2012-07-30,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0160-564X,Artificial Organs,Wiley,2012-07-30,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00976521,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Mannheim Regensburg Ulm,The INFUSE - Anterior Myocardial Infarction (AMI) Study,No lead center,Industry,Interventional,Drug,NA,452,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2009-09-11,2009-09-01,2013-04-01,2013,2012-02-01,2012,2013-04-12,11,436,-10,1298,873,-372,53,926,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2012.421,22447888,https://www.ncbi.nlm.nih.gov/pubmed/22447888?dopt=Abstract,2012-03-25,journal publication,TRUE,TRUE,doi,Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial,JAMA,2012-May-02,2012-03-25,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1705,3058,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2012-05-02,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2012-11-02,TRUE,FALSE,FALSE,TRUE,FALSE,NA @@ -449,13 +449,13 @@ NCT01022242,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT01025167,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,Dresden Frankfurt Göttingen Halle-Wittenberg Rostock Homburg Tübingen Ulm,The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients,large,Industry,Interventional,Dietary Supplement,NA,111,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2009-12-02,2006-09-01,2010-01-01,2010,2010-01-01,2010,NA,NA,NA,-1188,30,30,1259,1259,1289,2017-07-01,2017-12-01,2021-08-15,10.1002/cncr.28197,23765693,https://www.ncbi.nlm.nih.gov/pubmed/23765693?dopt=Abstract,2013-06-13,journal publication,TRUE,TRUE,doi,"A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial",Cancer,2013-Sep-15,2013-06-13,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2013-06-13,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01026233,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Cardiac Safety Study of Brentuximab Vedotin (SGN-35),No lead center,Industry,Interventional,Drug,Phase 1,52,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2009-12-02,2010-01-01,2011-08-01,2011,2010-08-01,2010,NA,NA,NA,30,607,242,260,625,867,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2011-12-397893,22510871,http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=22510871,2012-04-17,journal publication,TRUE,TRUE,doi,Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation,Blood,2012-Jul-19,2012-04-17,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,2,0,2,0,4,4,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-07-19,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-07-19,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT01030666,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,Heidelberg,Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy,large,Other,Interventional,Drug,Phase 4,61,Terminated,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2009-12-10,2007-04-01,2011-02-01,2011,2011-01-01,2011,2012-09-22,599,630,-984,418,387,397,428,815,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1600-051x.2012.01861.x,22385260,http://onlinelibrary.wiley.com/doi/10.1111/j.1600-051X.2012.01861.x/abstract,2012-03-04,journal publication,TRUE,TRUE,doi,Regenerative therapy of infrabony defects with or without systemic doxycycline. A randomized placebo-controlled trial,Journal of clinical periodontology,2012-May,2012-03-04,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,4,4,2495,3848,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0303-6979,Journal of Clinical Periodontology,Wiley,2012-03-04,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01035190,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia,large,Other,Interventional,Drug,Phase 3,863,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-17,2010-04-01,2016-07-01,2016,2013-10-01,2013,NA,NA,NA,105,2388,1384,-260,744,2128,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1501917,26465983,https://www.ncbi.nlm.nih.gov/pubmed/26465983,2015-10-15,journal publication,TRUE,TRUE,doi,Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia,The New England journal of medicine,2015-Oct-15,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,518,1871,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-10-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-04-15,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01035190,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,Aachen Dresden Erlangen Duisburg-Essen Göttingen Hamburg Hannover Heidelberg,Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia,large,Other,Interventional,Drug,Phase 3,863,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-17,2010-04-01,2016-07-01,2016,2013-10-01,2013,NA,NA,NA,105,2388,1384,-260,744,2128,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1501917,26465983,https://www.ncbi.nlm.nih.gov/pubmed/26465983,2015-10-15,journal publication,TRUE,TRUE,doi,Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia,The New England journal of medicine,2015-Oct-15,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,518,1871,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-10-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-04-15,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01035242,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,"""Association Splitting"" in Obsessive-Compulsive Disorder (OCD)",large,Other,Interventional,Behavioral,NA,156,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2009-12-17,2009-03-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-291,927,927,692,692,1619,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jbtep.2014.05.002,24929782,https://www.sciencedirect.com/science/article/pii/S000579161400041X,2014-05-24,journal publication,TRUE,TRUE,doi,Further evidence for biased semantic networks in obsessive-compulsive disorder (OCD): when knives are no longer associated with buttering bread but only with stabbing people,Journal of behavior therapy and experimental psychiatry,2014-Dec,2014-05-24,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0005-7916,Journal of Behavior Therapy and Experimental Psychiatry,Elsevier BV,2014-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2016-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01045746,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Frankfurt,Effects of Whole-Body Vibration on Balance in the Elderly Population,No lead center,Other,Interventional,Device,NA,20,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-08,2010-01-01,2010-09-01,2010,2010-09-01,2010,NA,NA,NA,-7,236,236,1653,1653,1889,2017-07-01,2017-12-01,2021-08-15,10.1186/s12877-015-0021-4,25886789,https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-015-0021-4,2015-03-12,journal publication,TRUE,TRUE,doi,Feasibility and effects of applying stochastic resonance whole-body vibration on untrained elderly: a randomized crossover pilot study,BMC geriatrics,2015-Mar-12,2015-03-12,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,3,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2318,BMC Geriatrics,Springer Science and Business Media LLC,2015-03-12,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01045772,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS),large,Other,Interventional,Drug,Phase 2,10,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2010-01-07,2009-01-01,2010-09-01,2010,2010-09-01,2010,NA,NA,NA,-371,237,237,622,622,859,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1398-9995.2012.02843.x,22583335,https://www.ncbi.nlm.nih.gov/pubmed/22583335?dopt=Abstract,2012-05-15,journal publication,TRUE,TRUE,doi,Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study,Allergy,2012-Jul,2012-05-15,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0105-4538,Allergy,Wiley,2012-05-15,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01049607,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Stapler Hepatectomy for Elective Liver Resection,large,Other,Interventional,Procedure,Phase 3,130,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-01-13,2010-01-01,2012-03-01,2012,2011-10-01,2011,NA,NA,NA,-12,778,626,702,854,1480,2017-07-01,2017-12-01,2021-08-15,10.1002/bjs.9387,24402888,http://onlinelibrary.wiley.com/doi/10.1002/bjs.9387/abstract,2014-02-01,journal publication,TRUE,TRUE,doi,Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection,The British journal of surgery,2014-Feb,2014-01-08,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0007-1323,1365-2168",British Journal of Surgery,Oxford University Press (OUP),2014-01-08,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01051258,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg LMU-München,AeriSeal System for Lung Volume Reduction,No lead center,Industry,Interventional,Device,Phase 1/Phase 2,55,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-01-14,2009-11-01,2013-04-01,2013,2011-08-01,2011,NA,NA,NA,-74,1173,564,-398,211,775,2017-07-01,2017-12-01,2021-08-15,10.1136/thoraxjnl-2011-201038,22374920,http://thorax.bmj.com/content/67/4/302,2012-02-28,journal publication,TRUE,TRUE,doi,Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema,Thorax,2012-Apr,2012-02-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,1,1,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0040-6376,1468-3296",Thorax,BMJ,2012-02-28,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01055522,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma,large,Industry,Interventional,Drug,Phase 2,102,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-22,2008-06-01,2014-02-01,2014,2013-02-01,2013,NA,NA,NA,-600,1471,1106,-830,-465,641,2017-07-01,2017-12-01,2021-08-15,10.1158/1078-0432.ccr-11-1203,22028492,http://clincancerres.aacrjournals.org/content/17/24/7732,2011-10-25,journal publication,TRUE,TRUE,doi,A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma,Clinical cancer research : an official journal of the American Association for Cancer Research,2011-Dec-15,2011-10-25,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2011-10-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2012-10-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01055522,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,Berlin Schleswig-Holstein,Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma,large,Industry,Interventional,Drug,Phase 2,102,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-22,2008-06-01,2014-02-01,2014,2013-02-01,2013,NA,NA,NA,-600,1471,1106,-830,-465,641,2017-07-01,2017-12-01,2021-08-15,10.1158/1078-0432.ccr-11-1203,22028492,http://clincancerres.aacrjournals.org/content/17/24/7732,2011-10-25,journal publication,TRUE,TRUE,doi,A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma,Clinical cancer research : an official journal of the American Association for Cancer Research,2011-Dec-15,2011-10-25,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2011-10-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2012-10-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01056341,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg Schleswig-Holstein LMU-München,Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy,No lead center,Industry,Interventional,Drug,Phase 2/Phase 3,512,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-01-24,2010-01-01,2013-11-01,2013,2012-05-01,2012,2014-04-09,159,708,-23,1377,828,475,1024,1852,2017-07-01,2017-12-01,2021-08-15,10.1056/nejmoa1404710,25693013,http://www.nejm.org/doi/full/10.1056/NEJMoa1404710,2015-02-19,journal publication,TRUE,TRUE,doi,"A randomized, controlled trial of oral propranolol in infantile hemangioma",The New England journal of medicine,2015-Feb-19,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1491,2844,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-02-19,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2015-08-18,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01056744,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents,small,Other,Interventional,Device,Phase 4,90,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2010-01-25,2009-06-01,2012-06-01,2012,2011-05-01,2011,NA,NA,NA,-238,858,461,886,1283,1744,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.113.001146,25371536,http://circinterventions.ahajournals.org/cgi/pmidlookup?view=long&pmid=25371536,2014-11-04,journal publication,TRUE,TRUE,doi,Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up,Circulation. Cardiovascular interventions,2014-Dec,2014-11-04,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2014-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01057043,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Cupping in Osteoarthritis of the Knee,large,Other,Interventional,Device,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-01-26,2010-01-01,2011-01-01,2011,2010-07-01,2010,NA,NA,NA,-25,340,156,650,834,990,2017-07-01,2017-12-01,2021-08-15,10.1186/1472-6882-12-184,23057611,https://www.ncbi.nlm.nih.gov/pubmed/23057611?dopt=Abstract,2012-10-12,journal publication,TRUE,TRUE,doi,Pulsatile dry cupping in patients with osteoarthritis of the knee - a randomized controlled exploratory trial,BMC complementary and alternative medicine,2012-Oct-12,2012-10-12,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1472-6882,BMC Complementary and Alternative Medicine,Springer Science and Business Media LLC,2012-10-12,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -488,10 +488,10 @@ NCT01101139,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01101958,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg,A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR),No lead center,Industry,Interventional,Device,NA,96,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2010-04-08,2012-01-01,2013-03-01,2013,2013-03-01,2013,2013-12-04,278,278,633,1058,1058,-302,-302,756,2017-07-01,2017-12-01,2021-08-15,10.1183/09031936.00015312,22556025,http://erj.ersjournals.com/content/41/2/302,2012-05-03,journal publication,TRUE,TRUE,doi,Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment,The European respiratory journal,2013-Feb,2012-05-03,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0903-1936,1399-3003",European Respiratory Journal,European Respiratory Society (ERS),2012-05-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2014-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01102712,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Heidelberg,Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction,No lead center,Industry,Interventional,Device,NA,34,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-04-08,2009-11-01,2011-08-01,2011,2010-12-01,2010,NA,NA,NA,-158,480,237,101,344,581,2017-07-01,2017-12-01,2021-08-15,10.1183/09031936.00092411,22075481,NA,2011-11-10,journal publication,TRUE,TRUE,doi,Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema,The European respiratory journal,2012-Jun,2011-11-10,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,0,1,0,2,2,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0903-1936,1399-3003",European Respiratory Journal,European Respiratory Society (ERS),2011-11-10,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2013-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01105351,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Effect of Folic Acid on Primary Folate Forms in Relation to MTHFR,small,Other,Interventional,Dietary Supplement,NA,75,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-15,2010-06-01,2013-12-01,2013,2012-12-01,2012,NA,NA,NA,47,1326,961,521,886,1847,2017-07-01,2017-12-01,2021-08-15,10.1007/s00394-015-0916-z,25943647,https://link.springer.com/article/10.1007%2Fs00394-015-0916-z,2015-05-06,journal publication,TRUE,TRUE,doi,Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial,European journal of nutrition,2016-Apr,2015-05-06,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1436-6207,1436-6215",European Journal of Nutrition,Springer Science and Business Media LLC,2015-05-06,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01106391,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,"A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS (INNOVATION)",large,Industry,Interventional,Device,Phase 2,60,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2010-04-16,2010-03-01,2016-10-01,2016,2011-08-01,2011,2013-09-23,-1104,784,-46,2360,472,-1352,536,1008,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jvs.2012.09.079,23332982,https://www.ncbi.nlm.nih.gov/pubmed/23332982?dopt=Abstract,2013-01-18,journal publication,TRUE,TRUE,doi,First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial,Journal of vascular surgery,2013-Apr,2013-01-18,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,426,1779,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0741-5214,Journal of Vascular Surgery,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01106391,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS (INNOVATION)",large,Industry,Interventional,Device,Phase 2,60,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2010-04-16,2010-03-01,2016-10-01,2016,2011-08-01,2011,2013-09-23,-1104,784,-46,2360,472,-1352,536,1008,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jvs.2012.09.079,23332982,https://www.ncbi.nlm.nih.gov/pubmed/23332982?dopt=Abstract,2013-01-18,journal publication,TRUE,TRUE,doi,First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial,Journal of vascular surgery,2013-Apr,2013-01-18,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,426,1779,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0741-5214,Journal of Vascular Surgery,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01106430,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg Mannheim,Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate,No lead center,Industry,Interventional,Drug,Phase 3,267,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-04-14,2010-06-28,2012-07-19,2012,2012-07-19,2012,2013-05-03,288,288,75,827,827,500,500,1327,2017-07-01,2017-12-01,2021-08-15,10.1007/s40263-013-0104-8,23959815,NA,2013-12-01,journal publication,TRUE,TRUE,doi,"Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study",CNS drugs,2013-Dec,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1961,3314,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"1172-7047,1179-1934",CNS Drugs,Springer Science and Business Media LLC,2013-08-20,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01106586,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Frankfurt Hamburg Köln,"Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults",No lead center,Industry,Interventional,Drug,Phase 3,708,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-04-14,2010-04-01,2014-09-01,2014,2011-09-01,2011,2012-09-20,-711,385,-13,1601,505,-793,303,808,2017-07-01,2017-12-01,2021-08-15,10.1016/s0140-6736(12)60918-0,22748590,https://www.ncbi.nlm.nih.gov/pubmed/22748590?dopt=Abstract,2012-06-30,journal publication,TRUE,TRUE,doi,"Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial","Lancet (London, England)",2012-Jun-30,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,6,6,1187,2540,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,0140-6736,The Lancet,Elsevier BV,2012-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01106820,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life,large,Other,Interventional,Other,NA,101,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2010-04-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,-13,1631,1266,76,441,1707,2017-07-01,2017-12-01,2021-08-15,10.1002/ijc.29383,25484317,https://www.ncbi.nlm.nih.gov/pubmed/25484317?dopt=Abstract,2014-12-16,journal publication,TRUE,TRUE,doi,Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial,International journal of cancer,2015-Jul-15,2014-12-16,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2014-12-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01106820,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life,large,Other,Interventional,Other,NA,101,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2010-04-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,-13,1631,1266,76,441,1707,2017-07-01,2017-12-01,2021-08-15,10.1002/ijc.29383,25484317,https://www.ncbi.nlm.nih.gov/pubmed/25484317?dopt=Abstract,2014-12-16,journal publication,TRUE,TRUE,doi,Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial,International journal of cancer,2015-Jul-15,2014-12-16,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2014-12-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01108146,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,Hydrocortisone in the Treatment of Intrusions in Patients With Posttraumatic Stress Disorder,small,Other,Interventional,Drug,NA,30,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-02-16,2008-10-01,2012-10-01,2012,2012-10-01,2012,NA,NA,NA,-503,958,958,1008,1008,1966,2017-07-01,2017-12-01,2021-08-15,10.1177/0269881115592339,26152322,https://www.ncbi.nlm.nih.gov/pubmed/26152322?dopt=Abstract,2015-07-06,journal publication,TRUE,TRUE,doi,"No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder--a randomized, double-blind, placebo-controlled, crossover study","Journal of psychopharmacology (Oxford, England)",2015-Oct,2015-07-06,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0269-8811,1461-7285",Journal of Psychopharmacology,SAGE Publications,2015-07-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01108510,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Hamburg Köln,"Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults",No lead center,Industry,Interventional,Drug,Phase 3,698,Completed,Triple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-04-20,2010-04-01,2015-04-01,2015,2011-11-01,2011,2014-10-23,-160,1087,-19,1807,560,-736,511,1071,2017-07-01,2017-12-01,2021-08-15,10.1093/infdis/jit122,23532097,https://academic.oup.com/jid/article-lookup/doi/10.1093/infdis/jit122,2013-03-26,journal publication,TRUE,TRUE,doi,Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results,The Journal of infectious diseases,2013-Jul,2013-03-26,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,5,5,975,2328,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,"1537-6613,0022-1899",The Journal of Infectious Diseases,Oxford University Press (OUP),2013-03-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01110720,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bochum Dresden Marburg Rostock Ulm,Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy,No lead center,Industry,Interventional,Drug,Phase 2/Phase 3,313,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-04-23,2010-10-01,2012-12-01,2012,2012-11-01,2012,NA,NA,NA,161,953,923,542,572,1495,2017-07-01,2017-12-01,2021-08-15,10.1016/s1474-4422(14)70088-2,24873720,https://www.ncbi.nlm.nih.gov/pubmed/24873720,2014-05-27,journal publication,TRUE,TRUE,doi,"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial",The Lancet. Neurology,2014-Jul,2014-05-27,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,1474-4422,The Lancet Neurology,Elsevier BV,2014-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -529,8 +529,8 @@ NCT01178255,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01179789,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,New E-Service for a Dietary Approach to the Elderly,large,Other,Interventional,Behavioral,Early Phase 1,48,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-08-05,2009-10-01,2011-06-01,2011,2010-08-01,2010,NA,NA,NA,-308,300,-4,1225,1529,1525,2017-07-01,2017-12-01,2021-08-15,10.1016/j.clnu.2014.09.023,25453395,https://www.ncbi.nlm.nih.gov/pubmed/25453395?dopt=Abstract,2014-10-08,journal publication,TRUE,TRUE,doi,"Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The ""RISTOMED project"": Randomized controlled trial in healthy older people","Clinical nutrition (Edinburgh, Scotland)",2015-Aug,2014-10-08,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,10,10,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,0261-5614,Clinical Nutrition,Elsevier BV,2015-08-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-sa', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01179971,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,Jena,n-3 and n-6 Fatty Acids in Rheumatoid Arthritis,large,Other,Interventional,Dietary Supplement,Phase 2,60,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-08-04,2008-12-01,2010-01-01,2010,2010-01-01,2010,NA,NA,NA,-611,-215,-215,580,580,365,2017-07-01,2017-12-01,2021-08-15,10.1186/1476-511x-10-130,21816071,https://www.ncbi.nlm.nih.gov/pubmed/21816071?dopt=Abstract,2011-08-04,journal publication,TRUE,TRUE,doi,Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial,Lipids in health and disease,2011-Aug-04,2011-08-04,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1476-511X,Lipids in Health and Disease,Springer Science and Business Media LLC,2011-08-04,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01180400,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder,large,Industry,Interventional,Drug,Phase 3,295,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-08-05,2010-09-01,2011-09-01,2011,2011-09-01,2011,2012-06-26,299,299,27,392,392,842,842,1234,2017-07-01,2017-12-01,2021-08-15,10.1016/j.euroneuro.2013.12.008,24507016,https://www.sciencedirect.com/science/article/pii/S0924977X13003532,2013-12-21,journal publication,TRUE,TRUE,doi,Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant,European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2014-Apr,2013-12-21,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,1,1,2283,3636,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,closed,closed,0924-977X,European Neuropsychopharmacology,Elsevier BV,2014-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01180504,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer,large,Other,Interventional,Radiation,Phase 2,36,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2016-08-01,2016,2013-08-01,2013,NA,NA,NA,-10,2182,1086,-2012,-916,170,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2407-11-41,21276234,https://www.ncbi.nlm.nih.gov/pubmed/21276234,2011-01-28,journal publication,TRUE,TRUE,doi,Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study,BMC cancer,2011-Jan-28,2011-01-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,487,1840,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2011-01-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01181206,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität München,large,Other,Interventional,Procedure,NA,516,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2014-02-01,2014,2013-08-01,2013,NA,NA,NA,-10,1270,1086,273,457,1543,2017-07-01,2017-12-01,2021-08-15,10.1097/sla.0000000000000954,25379844,https://www.ncbi.nlm.nih.gov/pubmed/25379844?dopt=Abstract,2014-11-01,journal publication,TRUE,TRUE,doi,Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206),Annals of surgery,2014-Nov,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01180504,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer,large,Other,Interventional,Radiation,Phase 2,36,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2016-08-01,2016,2013-08-01,2013,NA,NA,NA,-10,2182,1086,-2012,-916,170,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2407-11-41,21276234,https://www.ncbi.nlm.nih.gov/pubmed/21276234,2011-01-28,journal publication,TRUE,TRUE,doi,Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study,BMC cancer,2011-Jan-28,2011-01-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,487,1840,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2011-01-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01181206,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität München,large,Other,Interventional,Procedure,NA,516,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2014-02-01,2014,2013-08-01,2013,NA,NA,NA,-10,1270,1086,273,457,1543,2017-07-01,2017-12-01,2021-08-15,10.1097/sla.0000000000000954,25379844,https://www.ncbi.nlm.nih.gov/pubmed/25379844?dopt=Abstract,2014-11-01,journal publication,TRUE,TRUE,doi,Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206),Annals of surgery,2014-Nov,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01186510,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Lung Perfusion With Oxygenated Blood During Aortic Clamping,large,Other,Interventional,Procedure,NA,50,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-19,2010-08-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,-18,805,805,498,498,1303,2017-07-01,2017-12-01,2021-08-15,10.1093/icvts/ivu062,24632426,https://academic.oup.com/icvts/article-lookup/doi/10.1093/icvts/ivu062,2014-03-14,journal publication,TRUE,TRUE,doi,The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass,Interactive cardiovascular and thoracic surgery,2014-Jun,2014-03-14,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1569-9293,1569-9285",Interactive CardioVascular and Thoracic Surgery,Oxford University Press (OUP),2014-03-14,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01187134,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,Aachen Berlin Dresden Greifswald Schleswig-Holstein Leipzig Tübingen Ulm,Medical Education for Sepsis Source Control and Antibiotics,small,Other,Interventional,Behavioral,NA,4138,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-20,2011-07-01,2013-07-01,2013,2013-06-01,2013,NA,NA,NA,315,1046,1016,245,275,1291,2017-07-01,2017-12-01,2021-08-15,10.1186/cc13755,24589043,https://www.ncbi.nlm.nih.gov/pubmed/24589043?dopt=Abstract,2014-03-03,journal publication,TRUE,TRUE,doi,Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study,"Critical care (London, England)",2014-Mar-03,2014-03-03,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,13,13,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1364-8535,Critical Care,Springer Science and Business Media LLC,2014-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01197508,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.,large,Industry,Interventional,Drug,Phase 3,696,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-09-08,2010-09-01,2012-01-01,2012,2012-01-01,2012,2012-06-26,177,177,-7,480,480,1115,1115,1595,2017-07-01,2017-12-01,2021-08-15,10.3109/15622975.2014.989261,25602163,https://www.ncbi.nlm.nih.gov/pubmed/25602163?dopt=Abstract,2015-01-20,journal publication,TRUE,TRUE,doi,Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy,The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,2015-Oct,2015-01-20,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,0,1,0,1,1,2161,3514,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,closed,closed,"1562-2975,1814-1412",The World Journal of Biological Psychiatry,Informa UK Limited,2015-01-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-01-20,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -539,13 +539,13 @@ NCT01203254,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT01205906,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Comparison of an Internet-based Guided Self-help and a Group Therapy for Chronic Tinnitus,large,Other,Interventional,Behavioral,NA,128,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-09-17,2010-05-01,2012-03-01,2012,2011-03-01,2011,NA,NA,NA,-139,531,165,840,1206,1371,2017-07-01,2017-12-01,2021-08-15,10.1159/000360705,24970708,NA,2014-06-19,journal publication,TRUE,TRUE,doi,Internet-based guided self-help versus group cognitive behavioral therapy for chronic tinnitus: a randomized controlled trial,Psychotherapy and psychosomatics,2014,2014-06-19,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0033-3190,1423-0348",Psychotherapy and Psychosomatics,S. Karger AG,2014-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2015-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01205919,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Internet-based Guided Self-help for Chronic Tinnitus,large,Other,Interventional,Behavioral,NA,124,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-09-17,2010-05-01,2011-10-01,2011,2010-10-01,2010,NA,NA,NA,-139,379,14,1674,2039,2053,2017-07-01,2017-12-01,2021-08-15,10.1097/psy.0000000000000310,26867083,https://www.ncbi.nlm.nih.gov/pubmed/26867083?dopt=Abstract,2016-05-01,journal publication,TRUE,TRUE,doi,Internet-Delivered Cognitive-Behavior Therapy for Tinnitus: A Randomized Controlled Trial,Psychosomatic medicine,2016-05,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0033-3174,Psychosomatic Medicine,Ovid Technologies (Wolters Kluwer Health),2016-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01208233,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leipzig TU-München Münster Regensburg,Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke,No lead center,Industry,Interventional,Drug,Phase 2,181,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-09-22,2010-12-01,2013-12-01,2013,2013-12-01,2013,2015-02-19,445,445,70,1166,1166,757,757,1923,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jstrokecerebrovasdis.2015.11.026,26738812,https://www.ncbi.nlm.nih.gov/pubmed/26738812?dopt=Abstract,2015-12-28,journal publication,TRUE,TRUE,doi,"Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial",Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,2016-Mar,2015-12-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,1052-3057,Journal of Stroke and Cerebrovascular Diseases,Elsevier BV,2016-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01209286,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,36,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2010-09-23,2010-10-01,2016-10-01,2016,2012-03-01,2012,2014-12-23,-648,1027,8,2200,525,-691,984,1509,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.56.3247,25385737,https://www.ncbi.nlm.nih.gov/pubmed/25385737?dopt=Abstract,2014-11-10,journal publication,TRUE,TRUE,doi,Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2014-Dec-20,2014-11-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,426,1779,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2014-12-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01209286,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,36,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2010-09-23,2010-10-01,2016-10-01,2016,2012-03-01,2012,2014-12-23,-648,1027,8,2200,525,-691,984,1509,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.56.3247,25385737,https://www.ncbi.nlm.nih.gov/pubmed/25385737?dopt=Abstract,2014-11-10,journal publication,TRUE,TRUE,doi,Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2014-Dec-20,2014-11-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,426,1779,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2014-12-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01209637,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CAD,large,Other,Interventional,Behavioral,NA,60,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-09-24,2010-03-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-207,799,799,1200,1200,1999,2017-07-01,2017-12-01,2021-08-15,10.1161/circulationaha.115.016442,26979085,https://www.ncbi.nlm.nih.gov/pubmed/26979085?dopt=Abstract,2016-03-15,journal publication,TRUE,TRUE,doi,Coronary Collateral Growth Induced by Physical Exercise: Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial,Circulation,2016-Apr-12,2016-03-15,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0009-7322,1524-4539",Circulation,Ovid Technologies (Wolters Kluwer Health),2016-04-12,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-04-12,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01210729,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke,small,Other,Interventional,Device,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-09-27,2010-09-01,2011-11-01,2011,2011-11-01,2011,NA,NA,NA,-26,400,400,505,505,905,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jcin.2012.11.013,23523460,http://www.sciencedirect.com/science/article/pii/S1936879813004378,2013-03-20,journal publication,TRUE,TRUE,doi,Mechanical recanalization with flow restoration in acute ischemic stroke: the ReFlow (mechanical recanalization with flow restoration in acute ischemic stroke) study,JACC. Cardiovascular interventions,2013-Apr,2013-03-20,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01212302,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan),small,Other,Interventional,Drug,NA,500,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2010-09-29,2008-10-01,2010-04-01,2010,2010-03-01,2010,2011-02-28,333,364,-728,-181,-212,286,317,105,2017-07-01,2017-12-01,2021-08-15,10.1186/1741-7015-9-3,21226927,https://www.ncbi.nlm.nih.gov/pubmed/21226927,2011-01-12,journal publication,TRUE,TRUE,doi,Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance--the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy,BMC medicine,2011-Jan-12,2011-01-12,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,11,11,2801,4154,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,gold,gold,1741-7015,BMC Medicine,Springer Science and Business Media LLC,2011-01-12,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01215071,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Göttingen Homburg Ulm,Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA,No lead center,Other,Interventional,Procedure,NA,401,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-09-29,2006-02-01,2015-08-01,2015,2015-08-01,2015,NA,NA,NA,-1701,1767,1767,-347,-347,1420,2017-07-01,2017-12-01,2021-08-15,10.1016/j.eururo.2014.07.046,25150172,http://www.sciencedirect.com/science/article/pii/S0302283814007362,2014-08-19,journal publication,TRUE,TRUE,doi,Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy,European urology,2014-Dec,2014-08-19,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,0,0,0,2,2,853,2206,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0302-2838,European Urology,Elsevier BV,2014-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01217528,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,Aachen Erlangen Freiburg Giessen Hamburg Schleswig-Holstein Marburg LMU-München Münster Rostock,Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients,large,Industry,Interventional,Device,NA,543,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-09-10,2009-08-01,2013-01-01,2013,2012-09-01,2012,NA,NA,NA,-405,844,722,872,994,1716,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-015-0870-z,26002818,https://link.springer.com/article/10.1007%2Fs00392-015-0870-z,2015-05-23,journal publication,TRUE,TRUE,doi,Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study,Clinical research in cardiology : official journal of the German Cardiac Society,2015-Dec,2015-05-23,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2015-05-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01220856,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Reparixin in Pancreatic Islet Transplantation,large,Industry,Interventional,Drug,Phase 2,9,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2010-10-07,2010-07-28,2013-04-30,2013,2013-04-30,2013,2021-01-07,2809,2809,-71,936,936,-211,-211,725,2017-07-01,2017-12-01,2021-08-15,10.1172/jci63089,22996693,https://www.ncbi.nlm.nih.gov/pubmed/22996693,2012-10-01,journal publication,TRUE,TRUE,doi,CXCR1/2 inhibition enhances pancreatic islet survival after transplantation,The Journal of clinical investigation,2012-Oct,2012-09-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,1,1,1676,3029,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,bronze,green,0021-9738,Journal of Clinical Investigation,American Society for Clinical Investigation,2012-10-01,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01220856,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Reparixin in Pancreatic Islet Transplantation,large,Industry,Interventional,Drug,Phase 2,9,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2010-10-07,2010-07-28,2013-04-30,2013,2013-04-30,2013,2021-01-07,2809,2809,-71,936,936,-211,-211,725,2017-07-01,2017-12-01,2021-08-15,10.1172/jci63089,22996693,https://www.ncbi.nlm.nih.gov/pubmed/22996693,2012-10-01,journal publication,TRUE,TRUE,doi,CXCR1/2 inhibition enhances pancreatic islet survival after transplantation,The Journal of clinical investigation,2012-Oct,2012-09-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,1,1,1676,3029,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,bronze,green,0021-9738,Journal of Clinical Investigation,American Society for Clinical Investigation,2012-10-01,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01220908,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema,large,Industry,Interventional,Device,NA,36,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-09-30,2008-01-01,2012-03-01,2012,2011-03-01,2011,NA,NA,NA,-1003,518,152,184,550,702,2017-07-01,2017-12-01,2021-08-15,10.1378/chest.11-0730,22116796,http://www.sciencedirect.com/science/article/pii/S0012369212605005,2012-09-01,journal publication,TRUE,TRUE,doi,Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema,Chest,2012-Sep,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0012-3692,Chest,Elsevier BV,2012-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01221493,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,EBUS Guided Cryo Biopsy of Solitary Pulmonary Nodules,large,Other,Interventional,Procedure,NA,30,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2010-10-14,2010-04-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-196,48,48,972,972,1020,2017-07-01,2017-12-01,2021-08-15,10.1183/09031936.00011313,23900983,http://erj.ersjournals.com/content/43/1/233,2013-07-30,journal publication,TRUE,TRUE,doi,Endobronchial ultrasound-guided cryobiopsies in peripheral pulmonary lesions: a feasibility study,The European respiratory journal,2014-Jan,2013-07-30,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0903-1936,1399-3003",European Respiratory Journal,European Respiratory Society (ERS),2013-07-30,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2015-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01221571,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln Würzburg,NA,A Study to Assess AFM13 in Patients With Hodgkin Lymphoma,large,Industry,Interventional,Drug,Phase 1,28,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-10-05,2010-10-01,2013-06-01,2013,2013-05-01,2013,NA,NA,NA,-4,970,939,-88,-57,882,2017-07-01,2017-12-01,2021-08-15,10.1038/mt.2013.14,23459515,NA,2013-03-05,journal publication,TRUE,TRUE,doi,Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients,Molecular therapy : the journal of the American Society of Gene Therapy,2013-Apr,2013-03-05,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1644,2997,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1525-0016,Molecular Therapy,Elsevier BV,2013-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -565,7 +565,7 @@ NCT01249677,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01250106,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications,small,Other,Interventional,Dietary Supplement,Phase 1/Phase 2,20,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-24,2010-11-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-23,372,372,1294,1294,1666,2017-07-01,2017-12-01,2021-08-15,10.2337/dc14-2690,26084343,https://www.ncbi.nlm.nih.gov/pubmed/26084343,2015-06-17,journal publication,TRUE,TRUE,doi,Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept,Diabetes care,2015-Oct,2015-06-17,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0149-5992,1935-5548",Diabetes Care,American Diabetes Association,2015-06-17,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use only'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01250587,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg Mainz,Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea,No lead center,Industry,Interventional,Drug,Phase 1,24,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-11-29,2010-11-01,2012-06-01,2012,2012-06-01,2012,NA,NA,NA,-28,550,550,817,817,1367,2017-07-01,2017-12-01,2021-08-15,10.1093/humrep/deu205,25164021,https://www.ncbi.nlm.nih.gov/pubmed/25164021?dopt=Abstract,2014-08-27,journal publication,TRUE,TRUE,doi,A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrhea,"Human reproduction (Oxford, England)",2014-Nov,2014-08-27,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0268-1161,1460-2350",Human Reproduction,Oxford University Press (OUP),2014-08-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01251328,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Near INfrared Spectroscopy in Aortic valvE ReplacemenT,large,Other,Interventional,Procedure,NA,62,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-29,2010-12-01,2012-04-01,2012,2012-04-01,2012,NA,NA,NA,2,489,489,1276,1276,1765,2017-07-01,2017-12-01,2021-08-15,10.1093/bja/aev294,26424178,https://www.ncbi.nlm.nih.gov/pubmed/26424178?dopt=Abstract,2015-09-29,journal publication,TRUE,TRUE,doi,Comparison of sedation and general anaesthesia for transcatheter aortic valve implantation on cerebral oxygen saturation and neurocognitive outcome†,British journal of anaesthesia,2016-Jan,2015-09-29,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0007-0912,British Journal of Anaesthesia,Elsevier BV,2016-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01252459,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-02,2011-07-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,211,1307,942,461,826,1768,2017-07-01,2017-12-01,2021-08-15,10.1186/s12885-016-2806-z,27716184,https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2806-z,2015-10-05,journal publication,TRUE,TRUE,doi,Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1),BMC cancer,2016-10-05,2016-10-05,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,2,3,0,17,17,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2016-10-05,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01252459,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-02,2011-07-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,211,1307,942,461,826,1768,2017-07-01,2017-12-01,2021-08-15,10.1186/s12885-016-2806-z,27716184,https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2806-z,2015-10-05,journal publication,TRUE,TRUE,doi,Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1),BMC cancer,2016-10-05,2016-10-05,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,2,3,0,17,17,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2016-10-05,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01256424,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia,large,Industry,Interventional,Drug,Phase 2,262,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-12-07,2011-04-01,2012-12-01,2012,2012-09-01,2012,2014-08-06,613,704,115,725,634,699,790,1424,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajog.2014.10.1107,25467012,https://linkinghub.elsevier.com/retrieve/pii/S0002-9378(14)02199-1,2014-10-31,journal publication,TRUE,TRUE,doi,A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2,American journal of obstetrics and gynecology,2015-Apr,2014-10-31,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1826,3179,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0002-9378,American Journal of Obstetrics and Gynecology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01258738,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen,Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes,No lead center,Industry,Interventional,Biological,Phase 3,225,Completed,Triple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-12-09,2011-02-01,2014-10-01,2014,2012-11-01,2012,2013-11-11,-324,375,54,1392,693,-61,638,1331,2017-07-01,2017-12-01,2021-08-15,10.1002/art.38721,24891317,http://onlinelibrary.wiley.com/doi/10.1002/art.38721/abstract,2014-08-01,journal publication,TRUE,TRUE,doi,"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial","Arthritis & rheumatology (Hoboken, N.J.)",2014-Aug,NA,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,9,9,1157,2510,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"2326-5191,2326-5205",Arthritis & Rheumatology,Wiley,2014-07-28,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01259739,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Cocoa Flavanols and Exercise Capacity,small,Other,Interventional,Other,NA,13,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-12-13,2010-11-01,2013-11-01,2013,2013-10-01,2013,NA,NA,NA,-42,1054,1023,137,168,1191,2017-07-01,2017-12-01,2021-08-15,10.1161/circresaha.114.303822,24643960,https://www.ncbi.nlm.nih.gov/pubmed/24643960,2014-03-18,journal publication,TRUE,TRUE,doi,Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning,Circulation research,2014-May-09,2014-03-18,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0009-7330,1524-4571",Circulation Research,Ovid Technologies (Wolters Kluwer Health),2014-05-09,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-05-09,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -643,9 +643,9 @@ NCT01406730,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01407887,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Efficacy and Safety of Artesunate-amodiaquine-methylene for Malaria Treatment in Children,large,Other,Interventional,Drug,Phase 2,180,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-01,2011-08-01,2011-12-01,2011,2011-08-01,2011,NA,NA,NA,0,122,0,1032,1154,1154,2017-07-01,2017-12-01,2021-08-15,10.1093/infdis/jiu540,25267980,https://academic.oup.com/jid/article-lookup/doi/10.1093/infdis/jiu540,2014-09-28,journal publication,TRUE,TRUE,doi,Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in Burkina Faso,The Journal of infectious diseases,2015-Mar-01,2014-09-28,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0022-1899,1537-6613",The Journal of Infectious Diseases,Oxford University Press (OUP),2014-09-28,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01409330,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Dresden Heidelberg LMU-München Tübingen,German Diabetes-Diet-Intervention and Energy Restriction-Trial (DDIET),No lead center,Other,Interventional,Dietary Supplement,Phase 4,40,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2011-06-08,2011-02-01,2013-12-01,2013,2013-09-01,2013,NA,NA,NA,-127,907,816,360,451,1267,2017-07-01,2017-12-01,2021-08-15,10.1007/s00125-014-3457-8,25425219,NA,2014-11-26,journal publication,TRUE,TRUE,doi,"Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial",Diabetologia,2015-Feb,2014-11-26,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0012-186X,1432-0428",Diabetologia,Springer Science and Business Media LLC,2014-11-26,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01409720,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Isometric Muscle Training in Patients With Spinal Bony Metastases Under Radiation Therapy,large,Other,Interventional,Other,Phase 2,60,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-02,2011-09-01,2013-09-01,2013,2012-09-01,2012,NA,NA,NA,30,761,396,157,522,918,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2407-14-67,24499460,https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-67,2014-02-05,journal publication,TRUE,TRUE,doi,Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial,BMC cancer,2014-Feb-05,2014-02-05,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,38,34,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2014-02-05,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01409824,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Health Care Intervention Research- Improving Pre-natal and Maternal Care,large,Other,Interventional,Other,NA,36,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-08-03,2009-05-01,2014-04-01,2014,2010-09-01,2010,NA,NA,NA,-824,972,-336,-356,952,616,2017-07-01,2017-12-01,2021-08-15,10.1186/1472-6947-13-44,23574764,https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/1472-6947-13-44,2013-04-10,journal publication,TRUE,TRUE,doi,"""Quality of prenatal and maternal care: bridging the know-do gap"" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa",BMC medical informatics and decision making,2013-Apr-10,2013-04-10,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1472-6947,BMC Medical Informatics and Decision Making,Springer Science and Business Media LLC,2013-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01409824,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Health Care Intervention Research- Improving Pre-natal and Maternal Care,large,Other,Interventional,Other,NA,36,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-08-03,2009-05-01,2014-04-01,2014,2010-09-01,2010,NA,NA,NA,-824,972,-336,-356,952,616,2017-07-01,2017-12-01,2021-08-15,10.1186/1472-6947-13-44,23574764,https://bmcmedinformdecismak.biomedcentral.com/articles/10.1186/1472-6947-13-44,2013-04-10,journal publication,TRUE,TRUE,doi,"""Quality of prenatal and maternal care: bridging the know-do gap"" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa",BMC medical informatics and decision making,2013-Apr-10,2013-04-10,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1472-6947,BMC Medical Informatics and Decision Making,Springer Science and Business Media LLC,2013-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01412320,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Cocoa Flavanols in Renal Disease,small,Other,Interventional,Other,Phase 1/Phase 2,22,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-05,2011-08-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-4,484,484,1053,1053,1537,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0140215,26485680,https://www.ncbi.nlm.nih.gov/pubmed/26485680,2015-10-20,journal publication,TRUE,TRUE,doi,Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis,PloS one,2015,2015-10-20,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-10-20,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01414231,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a,large,Other,Interventional,Drug,Phase 3,850,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-05,2002-04-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-3413,1061,849,-659,-447,402,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2012.42.2907,22965967,https://www.ncbi.nlm.nih.gov/pubmed/22965967?dopt=Abstract,2012-09-10,journal publication,TRUE,TRUE,doi,Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2012-Oct-10,2012-09-10,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,4,0,4,0,1,1,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2012-10-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-10-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01414231,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a,large,Other,Interventional,Drug,Phase 3,850,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-05,2002-04-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-3413,1061,849,-659,-447,402,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2012.42.2907,22965967,https://www.ncbi.nlm.nih.gov/pubmed/22965967?dopt=Abstract,2012-09-10,journal publication,TRUE,TRUE,doi,Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2012-Oct-10,2012-09-10,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,4,0,4,0,1,1,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2012-10-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-10-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01414634,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,"Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells",large,Other,Interventional,Biological,Phase 1/Phase 2,9,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,TRUE,2011-08-08,2010-02-01,2012-10-01,2012,2012-10-01,2012,2014-01-24,480,480,-553,420,420,247,247,667,2017-07-01,2017-12-01,2021-08-15,10.1126/scitranslmed.3006168,23740901,http://stm.sciencemag.org/content/5/188/188ra75.full,2013-06-05,journal publication,TRUE,TRUE,doi,Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis,Science translational medicine,2013-Jun-05,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1887,3240,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,green,green,"1946-6234,1946-6242",Science Translational Medicine,American Association for the Advancement of Science (AAAS),2013-06-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01415622,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,"Feasibility, Efficacy, and Safety of Venous Ulcer Treatment Using a Hand Plasma Generator (PlasmaDerm) Chronisch venöser Ulzerationen (PlasmaDerm)",small,Industry,Interventional,Device,NA,30,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-11,2011-04-01,2012-08-01,2012,2012-07-01,2012,NA,NA,NA,-132,356,325,601,632,957,2017-07-01,2017-12-01,2021-08-15,10.1111/jdv.12490,24666170,https://www.ncbi.nlm.nih.gov/pubmed/24666170?dopt=Abstract,2014-03-25,journal publication,TRUE,TRUE,doi,"Alleviation of chronic venous leg ulcers with a hand-held dielectric barrier discharge plasma generator (PlasmaDerm(®) VU-2010): results of a monocentric, two-armed, open, prospective, randomized and controlled trial (NCT01415622)",Journal of the European Academy of Dermatology and Venereology : JEADV,2015-Jan,2014-03-25,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1948,3301,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0926-9959,Journal of the European Academy of Dermatology and Venereology,Wiley,2014-03-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01415804,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Investigation of Stent-grafts in Aortic Dissection (INSTEAD),small,Other,Interventional,Device,Phase 2/Phase 3,140,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-11,2002-02-01,2011-03-01,2011,2010-10-01,2010,NA,NA,NA,-3478,-163,-314,899,1050,736,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.113.000463,23922146,https://www.ncbi.nlm.nih.gov/pubmed/23922146?dopt=Abstract,2013-08-16,journal publication,TRUE,TRUE,doi,Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial,Circulation. Cardiovascular interventions,2013-Aug,2013-08-06,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,5,5,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2013-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -666,13 +666,13 @@ NCT01453712,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,TRUE NCT01456351,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab,small,Other,Interventional,Drug,Phase 3,230,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-11,2003-09-01,2010-12-01,2010,2010-08-01,2010,NA,NA,NA,-2962,-314,-436,1830,1952,1516,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(15)00447-7,26655425,http://www.sciencedirect.com/science/article/pii/S1470204515004477?via%3Dihub,2015-12-05,journal publication,TRUE,TRUE,doi,"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial",The Lancet. Oncology,2016-Jan,2015-12-05,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,3,0,1,1,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2016-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-06-30,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01458457,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Life Quality and Mental State in Patients With Breast Cancer,large,Other,Interventional,Other,Phase 4,275,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-21,2011-05-01,2013-07-01,2013,2012-12-01,2012,NA,NA,NA,-173,619,407,551,763,1170,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-014-3249-3,25555830,https://www.ncbi.nlm.nih.gov/pubmed/25555830?dopt=Abstract,2015-01-03,journal publication,TRUE,TRUE,doi,Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial,Breast cancer research and treatment,2015-Jan,2015-01-03,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2015-01-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01466387,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,LMU-München Rostock,"A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults",No lead center,Industry,Interventional,Biological,Phase 3,552,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-11-03,2011-11-01,2012-04-01,2012,2012-04-01,2012,2013-08-21,507,507,-2,150,150,768,768,918,2017-07-01,2017-12-01,2021-08-15,10.1016/j.tmaid.2014.04.011,24873986,NA,2014-05-09,journal publication,TRUE,TRUE,doi,"Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center study",Travel medicine and infectious disease,2014 Sep-Oct,2014-05-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,2070,3423,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,1477-8939,Travel Medicine and Infectious Disease,Elsevier BV,2014-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01468766,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy,large,Other,Interventional,Other,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-11,2011-02-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,-252,994,629,953,1318,1947,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-017-4141-8,28181128,https://link.springer.com/article/10.1007%2Fs10549-017-4141-8,2017-02-08,journal publication,TRUE,TRUE,doi,Effects of exercise on sleep problems in breast cancer patients receiving radiotherapy: a randomized clinical trial,Breast cancer research and treatment,2017-04,2017-02-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2017-02-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01468766,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy,large,Other,Interventional,Other,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-11,2011-02-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,-252,994,629,953,1318,1947,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-017-4141-8,28181128,https://link.springer.com/article/10.1007%2Fs10549-017-4141-8,2017-02-08,journal publication,TRUE,TRUE,doi,Effects of exercise on sleep problems in breast cancer patients receiving radiotherapy: a randomized clinical trial,Breast cancer research and treatment,2017-04,2017-02-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2017-02-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01472939,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Magdeburg,Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD),No lead center,Industry,Interventional,Drug,Phase 2,480,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2011-11-14,2012-02-27,2013-05-14,2013,2013-05-14,2013,2014-03-04,294,294,105,547,547,646,646,1193,2017-07-01,2017-12-01,2021-08-15,10.1111/apt.13115,25693609,http://onlinelibrary.wiley.com/doi/10.1111/apt.13115/abstract,2015-02-19,journal publication,TRUE,TRUE,doi,Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy,Alimentary pharmacology & therapeutics,2015-Apr,2015-02-19,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1662,3015,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,0269-2813,Alimentary Pharmacology & Therapeutics,Wiley,2015-02-19,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01474109,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bochum Freiburg Köln Tübingen,Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients,No lead center,Industry,Interventional,Drug,Phase 3,289,Completed,Triple,Randomized,TRUE,TRUE,TRUE,TRUE,2011-10-31,2011-12-01,2013-11-01,2013,2013-11-01,2013,2014-12-03,397,397,31,732,732,921,921,1653,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2016.5258,27163986,https://www.ncbi.nlm.nih.gov/pubmed/27163986?dopt=Abstract,2016-05-10,journal publication,TRUE,TRUE,doi,Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials,JAMA,2016-May-10,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,1,1,1491,2844,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,bronze,green,0098-7484,JAMA,American Medical Association (AMA),2016-05-10,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2016-11-10,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01475838,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Duisburg-Essen Frankfurt Hamburg Hannover Köln LMU-München,"Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients",No lead center,Industry,Interventional,Drug,Phase 3,438,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-11-17,2011-11-01,2014-12-01,2014,2013-11-01,2013,2015-01-08,38,433,-16,1110,715,-179,216,931,2017-07-01,2017-12-01,2021-08-15,10.1016/s1473-3099(14)70782-0,24908551,NA,2014-06-05,journal publication,TRUE,TRUE,doi,"Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial",The Lancet. Infectious diseases,2014-Jul,2014-06-05,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,6,6,1096,2449,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,1473-3099,The Lancet Infectious Diseases,Elsevier BV,2014-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01481584,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Nutritional Evaluation of Canola Protein in Comparison With Soy Protein,small,Other,Interventional,Dietary Supplement,NA,28,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-11-24,2010-05-01,2011-11-01,2011,2010-07-01,2010,NA,NA,NA,-572,-23,-511,379,867,356,2017-07-01,2017-12-01,2021-08-15,10.1016/j.clnu.2012.11.005,23260747,https://linkinghub.elsevier.com/retrieve/pii/S0261-5614(12)00237-3,2012-11-14,journal publication,TRUE,TRUE,doi,"Nutritional evaluation of rapeseed protein compared to soy protein for quality, plasma amino acids, and nitrogen balance--a randomized cross-over intervention study in humans","Clinical nutrition (Edinburgh, Scotland)",2013-Aug,2012-11-14,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0261-5614,Clinical Nutrition,Elsevier BV,2013-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01490268,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Pain Therapy After Elective Cardiac Surgery,large,Other,Interventional,Drug,Phase 4,50,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-28,2011-11-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-27,278,278,-32,-32,246,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jpba.2012.07.025,22884788,NA,2012-07-31,journal publication,TRUE,TRUE,doi,Analysis of total and unbound hydromorphone in human plasma by ultrafiltration and LC-MS/MS: application to clinical trial in patients undergoing open heart surgery,Journal of pharmaceutical and biomedical analysis,2012-Dec,2012-07-31,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,8,8,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0731-7085,Journal of Pharmaceutical and Biomedical Analysis,Elsevier BV,2012-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2014-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01495533,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Homburg Homburg,NA,Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter,small,Other,Interventional,Device,Phase 3,60,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-13,2011-12-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-12,931,719,428,640,1359,2017-07-01,2017-12-01,2021-08-15,10.1002/ccd.26216,26331782,http://onlinelibrary.wiley.com/doi/10.1002/ccd.26216/abstract,2015-09-02,journal publication,TRUE,TRUE,doi,A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2016-Jul,2015-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2015-09-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-09-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01495533,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Homburg,Leipzig,Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter,small,Other,Interventional,Device,Phase 3,60,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-13,2011-12-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-12,931,719,428,640,1359,2017-07-01,2017-12-01,2021-08-15,10.1002/ccd.26216,26331782,http://onlinelibrary.wiley.com/doi/10.1002/ccd.26216/abstract,2015-09-02,journal publication,TRUE,TRUE,doi,A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2016-Jul,2015-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2015-09-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-09-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01495702,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Freiburg,"Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients",No lead center,Industry,Interventional,Drug,Phase 3,439,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-12-14,2011-12-01,2014-12-01,2014,2013-11-01,2013,2014-12-31,30,425,-13,1083,688,-179,216,904,2017-07-01,2017-12-01,2021-08-15,10.1016/s1473-3099(14)70796-0,24908550,http://www.sciencedirect.com/science/article/pii/S1473309914707960?via%3Dihub,2014-06-05,journal publication,TRUE,TRUE,doi,"Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial",The Lancet. Infectious diseases,2014-Jul,2014-06-05,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1096,2449,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,1473-3099,The Lancet Infectious Diseases,Elsevier BV,2014-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01500330,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Home Use of Cupping Massage in Chronic Neck Pain,large,Other,Interventional,Procedure,NA,84,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-12-22,2012-01-01,2012-05-01,2012,2012-05-01,2012,NA,NA,NA,10,131,131,402,402,533,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0065378,23762355,https://www.ncbi.nlm.nih.gov/pubmed/23762355,2013-06-07,journal publication,TRUE,TRUE,doi,Effectiveness of home-based cupping massage compared to progressive muscle relaxation in patients with chronic neck pain--a randomized controlled trial,PloS one,2013,2013-06-07,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLoS ONE,Public Library of Science (PLoS),2013-06-07,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01500993,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg Jena Mannheim,NA,Capecitabine in the Perioperative Treatment of Rectal Cancer,large,Other,Interventional,Drug,Phase 3,401,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2011-12-21,2002-03-01,2011-03-01,2011,2011-03-01,2011,NA,NA,NA,-3582,-295,-295,409,409,114,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(12)70116-x,22503032,https://linkinghub.elsevier.com/retrieve/pii/S1470-2045(12)70116-X,2012-04-13,journal publication,TRUE,TRUE,doi,"Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial",The Lancet. Oncology,2012-Jun,2012-04-13,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,3,3,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2012-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2012-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -708,12 +708,12 @@ NCT01618565,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01624961,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults,large,Industry,Interventional,Biological,Phase 1,30,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-06-19,2012-06-01,2013-02-01,2013,2012-10-01,2012,NA,NA,NA,-18,227,104,775,898,1002,2017-07-01,2017-12-01,2021-08-15,10.1186/s12936-015-0628-0,25889522,https://www.ncbi.nlm.nih.gov/pubmed/25889522?dopt=Abstract,2015-03-18,journal publication,TRUE,TRUE,doi,Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres,Malaria journal,2015-Mar-18,2015-03-18,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,4,4,1764,3117,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1475-2875,Malaria Journal,Springer Science and Business Media LLC,2015-03-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01628627,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf,Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy,No lead center,Industry,Interventional,Device,Phase 4,164,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2012-06-23,2006-05-01,2010-04-01,2010,2010-04-01,2010,NA,NA,NA,-2245,-814,-814,987,987,173,2017-07-01,2017-12-01,2021-08-15,10.1007/s00125-012-2795-7,23238789,https://www.ncbi.nlm.nih.gov/pubmed/23238789,2012-12-13,journal publication,TRUE,TRUE,doi,"Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial",Diabetologia,2013-Mar,2012-12-13,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2801,4154,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0012-186X,1432-0428",Diabetologia,Springer Science and Business Media LLC,2012-12-13,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01631123,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,Berlin Heidelberg Tübingen,NUtriGenomic Analysis in Twins,large,Other,Interventional,Other,NA,120,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-06-01,2009-09-01,2012-09-01,2012,2010-01-01,2010,NA,NA,NA,-1004,92,-882,940,1914,1032,2017-07-01,2017-12-01,2021-08-15,10.1210/jc.2014-3868,25822100,https://www.ncbi.nlm.nih.gov/pubmed/25822100?dopt=Abstract,2015-03-30,journal publication,TRUE,TRUE,doi,Changes of Dietary Fat and Carbohydrate Content Alter Central and Peripheral Clock in Humans,The Journal of clinical endocrinology and metabolism,2015-Jun,2015-03-30,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0021-972X,1945-7197",The Journal of Clinical Endocrinology & Metabolism,The Endocrine Society,2015-06-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2016-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01644006,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome,small,Other,Interventional,Procedure,NA,39,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,457,1249,1603,2017-07-01,2017-12-01,2021-08-15,10.2196/jmir.6358,27908843,http://www.jmir.org/2016/12/e314/,2016-12-01,journal publication,TRUE,TRUE,doi,"Treatment of Acute Coronary Syndrome by Telemedically Supported Paramedics Compared With Physician-Based Treatment: A Prospective, Interventional, Multicenter Trial",Journal of medical Internet research,2016-12-01,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1438-8871,Journal of Medical Internet Research,JMIR Publications Inc.,2016-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01644006,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome,small,Other,Interventional,Procedure,NA,39,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,457,1249,1603,2017-07-01,2017-12-01,2021-08-15,10.2196/jmir.6358,27908843,http://www.jmir.org/2016/12/e314/,2016-12-01,journal publication,TRUE,TRUE,doi,"Treatment of Acute Coronary Syndrome by Telemedically Supported Paramedics Compared With Physician-Based Treatment: A Prospective, Interventional, Multicenter Trial",Journal of medical Internet research,2016-12-01,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1438-8871,Journal of Medical Internet Research,JMIR Publications Inc.,2016-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01650805,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Berlin Dresden Freiburg Hamburg Heidelberg Jena Köln Mannheim TU-München,Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC),No lead center,Industry,Interventional,Drug,Phase 3,307,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2012-07-18,2012-06-01,2013-10-01,2013,2013-10-01,2013,2014-10-15,379,379,-47,440,440,924,924,1364,2017-07-01,2017-12-01,2021-08-15,10.1016/s1470-2045(16)00080-2,27083332,http://www.sciencedirect.com/science/article/pii/S1470204516000802?via%3Dihub,2016-04-12,journal publication,TRUE,TRUE,doi,"Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial",The Lancet. Oncology,2016-05,2016-04-12,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,1,1,1522,2875,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2016-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01652391,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Modulation of Cognitive Control by Transcranial Direct Current Stimulation,large,Other,Interventional,Device,NA,44,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-23,2011-07-01,2012-12-01,2012,2012-06-01,2012,NA,NA,NA,-388,131,-52,5,188,136,2017-07-01,2017-12-01,2021-08-15,10.1016/j.biopsych.2012.10.010,23219367,https://www.ncbi.nlm.nih.gov/pubmed/23219367,2012-12-06,journal publication,TRUE,TRUE,doi,Amelioration of cognitive control in depression by transcranial direct current stimulation,Biological psychiatry,2013-Apr-01,2012-12-06,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0006-3223,Biological Psychiatry,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01654679,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Impact of Preoperative Local Water-Filtered Infrared-A (wIRA) Irradiation on Postoperative Wound Healing,large,Other,Interventional,Device,NA,400,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-22,2008-08-01,2012-07-01,2012,2010-06-01,2010,NA,NA,NA,-1451,-21,-782,518,1279,497,2017-07-01,2017-12-01,2021-08-15,10.1097/sla.0000000000000235,24169161,https://www.ncbi.nlm.nih.gov/pubmed/24169161?dopt=Abstract,2013-12-01,journal publication,TRUE,TRUE,doi,Impact of preoperative local water-filtered infrared A irradiation on postoperative wound healing: a randomized patient- and observer-blinded controlled clinical trial,Annals of surgery,2013-Dec,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2013-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01656928,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg Mannheim,NA,Effects of a Pre-school-based Nutritional Intervention on Children's Eating Behavior and Anthropometric Parameters,large,Other,Interventional,Behavioral,NA,375,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-27,2008-09-01,2011-04-01,2011,2010-09-01,2010,NA,NA,NA,-1425,-483,-695,144,356,-339,2017-07-01,2017-12-01,2021-08-15,10.1017/s136898001100200x,21859516,https://www.ncbi.nlm.nih.gov/pubmed/21859516?dopt=Abstract,2011-08-23,journal publication,TRUE,TRUE,doi,Positive impact of a pre-school-based nutritional intervention on children's fruit and vegetable intake: results of a cluster-randomized trial,Public health nutrition,2012-Mar,2011-08-23,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2436,3789,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1368-9800,1475-2727",Public Health Nutrition,Cambridge University Press (CUP),2011-08-23,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01663649,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders,large,Other,Interventional,Behavioral,NA,180,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-08,2012-06-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,-68,542,480,291,353,833,2017-07-01,2017-12-01,2021-08-15,10.1111/epi.12833,25410633,http://onlinelibrary-1wiley-1com-1mf9loauk4513.han.mh-hannover.de/doi/10.1111/epi.12833/abstract;jsessionid=C2B193D783490D67B5606ADD663B3338.f02t03,2014-11-19,journal publication,TRUE,TRUE,doi,Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial,Epilepsia,2014-Dec,2014-11-19,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0013-9580,Epilepsia,Wiley,2014-11-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01663649,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders,large,Other,Interventional,Behavioral,NA,180,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-08,2012-06-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,-68,542,480,291,353,833,2017-07-01,2017-12-01,2021-08-15,10.1111/epi.12833,25410633,http://onlinelibrary-1wiley-1com-1mf9loauk4513.han.mh-hannover.de/doi/10.1111/epi.12833/abstract;jsessionid=C2B193D783490D67B5606ADD663B3338.f02t03,2014-11-19,journal publication,TRUE,TRUE,doi,Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial,Epilepsia,2014-Dec,2014-11-19,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0013-9580,Epilepsia,Wiley,2014-11-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01668485,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation,small,Other,Interventional,Procedure,Phase 4,36,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-08-13,2001-11-01,2011-11-01,2011,2010-11-01,2010,NA,NA,NA,-3938,-286,-651,1130,1495,844,2017-07-01,2017-12-01,2021-08-15,10.1007/s00125-013-3120-9,24305963,https://link.springer.com/article/10.1007%2Fs00125-013-3120-9,2014-12-05,journal publication,TRUE,TRUE,doi,Magnitude and mechanisms of glucose counterregulation following islet transplantation in patients with type 1 diabetes suffering from severe hypoglycaemic episodes,Diabetologia,2014-Mar,2013-12-05,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0012-186X,1432-0428",Diabetologia,Springer Science and Business Media LLC,2013-12-05,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01669109,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Hatha Yoga for Patients With Colorectal Cancer,large,Other,Interventional,Behavioral,NA,54,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2012-08-16,2012-09-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,16,472,472,605,605,1077,2017-07-01,2017-12-01,2021-08-15,10.1002/pon.3927,26228466,https://www.ncbi.nlm.nih.gov/pubmed/26228466?dopt=Abstract,2015-07-29,journal publication,TRUE,TRUE,doi,A randomized controlled bicenter trial of yoga for patients with colorectal cancer,Psycho-oncology,2016-Apr,2015-07-29,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1057-9249,Psycho-Oncology,Wiley,2015-07-29,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01673048,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Modification of ESIN-osteosynthesis in a Femoral Fracture Model and Its Transmission to Clinical Practice,small,Other,Interventional,Procedure,NA,18,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-08-12,2009-01-01,2012-12-01,2012,2012-10-01,2012,NA,NA,NA,-1319,111,50,403,464,514,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2474-15-3,24397612,https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/1471-2474-15-3,2014-01-08,journal publication,TRUE,TRUE,doi,Modification of elastic stable intramedullary nailing with a 3rd nail in a femoral spiral fracture model - results of biomechanical testing and a prospective clinical study,BMC musculoskeletal disorders,2014-Jan-08,2014-01-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2474,BMC Musculoskeletal Disorders,Springer Science and Business Media LLC,2014-01-08,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -735,7 +735,7 @@ NCT01777815,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE NCT01778270,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Not Invasive Monitoring of Pleural Drainage,small,Other,Interventional,Device,NA,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2013-01-25,2011-10-01,2013-04-01,2013,2013-04-01,2013,NA,NA,NA,-482,66,66,709,709,775,2017-07-01,2017-12-01,2021-08-15,10.1155/2015/810797,25861647,https://www.hindawi.com/journals/bmri/2015/810797/,2015-03-11,journal publication,TRUE,TRUE,doi,Feasibility of bioelectrical impedance spectroscopy measurement before and after thoracentesis,BioMed research international,2015,2015-03-11,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"2314-6133,2314-6141",BioMed Research International,Hindawi Limited,2015-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01789021,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Analytical Performance Evaluation of Blood Glucose Monitoring Systems- Investigator Sponsored Contour® XT Comparator Study - Ulm Germany,large,Other,Interventional,Device,NA,120,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2013-02-08,2013-02-01,2013-04-01,2013,2013-04-01,2013,NA,NA,NA,-7,52,52,743,743,795,2017-07-01,2017-12-01,2021-08-15,10.1177/1932296815580161,25872967,NA,2015-04-14,journal publication,TRUE,TRUE,doi,System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method,Journal of diabetes science and technology,2015-Apr-14,2015-04-14,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1932-2968,1932-2968",Journal of Diabetes Science and Technology,SAGE Publications,2015-04-14,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01792713,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Münster,Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis,No lead center,Industry,Interventional,Drug,Phase 2,70,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2013-02-13,2013-02-01,2014-02-01,2014,2013-09-01,2013,NA,NA,NA,-12,353,200,934,1087,1287,2017-07-01,2017-12-01,2021-08-15,10.2340/00015555-2268,26527564,https://www.ncbi.nlm.nih.gov/pubmed/26527564,2016-08-23,journal publication,TRUE,TRUE,doi,"Anti-pruritic Effect of Sertaconazole 2% Cream in Atopic Dermatitis Subjects: A Prospective, Randomized, Double-blind, Vehicle-controlled, Multi-centre Clinical Trial of Efficacy, Safety and Local Tolerability",Acta dermato-venereologica,2016-Aug-23,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,0001-5555,Acta Dermato Venereologica,Acta Dermato-Venereologica,2014-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01797458,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth,small,Other,Interventional,Procedure,NA,169,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2013-02-20,2011-05-01,2014-12-01,2014,2013-12-01,2013,2017-05-16,897,1262,-661,649,284,-269,96,380,2017-07-01,2017-12-01,2021-08-15,10.1111/ipd.12097,24602167,NA,2014-03-07,journal publication,TRUE,TRUE,doi,Acceptability of different caries management methods for primary molars in a RCT,International journal of paediatric dentistry,2015-Jan,2014-03-07,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1096,2449,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,closed,closed,0960-7439,International Journal of Paediatric Dentistry,Wiley,2014-03-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-03-07,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01797458,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth,small,Other,Interventional,Procedure,NA,169,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2013-02-20,2011-05-01,2014-12-01,2014,2013-12-01,2013,2017-05-16,897,1262,-661,649,284,-269,96,380,2017-07-01,2017-12-01,2021-08-15,10.1111/ipd.12097,24602167,NA,2014-03-07,journal publication,TRUE,TRUE,doi,Acceptability of different caries management methods for primary molars in a RCT,International journal of paediatric dentistry,2015-Jan,2014-03-07,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1096,2449,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,closed,closed,0960-7439,International Journal of Paediatric Dentistry,Wiley,2014-03-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-03-07,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01806012,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Use of the Enseal Intrument for Laparoscopic Supracervical Hysterectomy,large,Other,Interventional,Device,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-02-19,2010-08-01,2011-08-01,2011,2011-08-01,2011,NA,NA,NA,-933,-568,-568,652,652,84,2017-07-01,2017-12-01,2021-08-15,10.1007/s00464-013-2994-4,23670744,NA,2013-05-14,journal publication,TRUE,TRUE,doi,"A prospective, randomized clinical comparison between UltraCision and the novel sealing and cutting device BiCision in patients with laparoscopic supracervical hysterectomy",Surgical endoscopy,2013-Oct,2013-05-14,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0930-2794,1432-2218",Surgical Endoscopy,Springer Science and Business Media LLC,2013-05-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-05-14,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01810471,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,External Ankle Supports - 3D Motion Analysis,large,Other,Interventional,Device,NA,40,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-03-10,2010-02-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-1133,-830,-830,1737,1737,907,2017-07-01,2017-12-01,2021-08-15,10.1016/j.physio.2015.07.004,26422550,https://www.sciencedirect.com/science/article/pii/S0031940615038146,2015-09-03,journal publication,TRUE,TRUE,doi,"Effect of kinesiotaping, non-elastic taping and bracing on segmental foot kinematics during drop landing in healthy subjects and subjects with chronic ankle instability",Physiotherapy,2016-Sep,2015-09-03,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0031-9406,Physiotherapy,Elsevier BV,2016-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01812304,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Theoretical Compared With hands-on Training of Vaginal Breech Management,small,Other,Interventional,Other,Phase 3,172,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-03-08,2011-10-01,2013-11-01,2013,2013-10-01,2013,NA,NA,NA,-524,238,207,-37,-6,201,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ejogrb.2013.09.015,24103530,https://www.ncbi.nlm.nih.gov/pubmed/24103530,2013-09-25,journal publication,TRUE,TRUE,doi,Objective Structured Assessment of Technical Skills (OSATS) evaluation of theoretical versus hands-on training of vaginal breech delivery management: a randomized trial,"European journal of obstetrics, gynecology, and reproductive biology",2013-Dec,2013-09-25,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0301-2115,European Journal of Obstetrics & Gynecology and Reproductive Biology,Elsevier BV,2013-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -743,30 +743,30 @@ NCT01845194,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01847456,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,TRUE,Tübingen,NA,Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity,large,Other,Interventional,Drug,NA,10,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-04-28,2013-04-01,NA,NA,2013-11-01,2013,NA,NA,NA,-27,NA,187,NA,256,443,2017-07-01,2017-12-01,2021-08-15,10.2337/db14-0477,25028522,https://www.ncbi.nlm.nih.gov/pubmed/25028522?dopt=Abstract,2014-07-15,journal publication,TRUE,TRUE,doi,Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men,Diabetes,2014-Dec,2014-07-15,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,bronze,green,"0012-1797,1939-327X",Diabetes,American Diabetes Association,2014-11-13,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use only'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01856179,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Supplementation of Land-based Stearidonic Acid (SDA)-Rich Oils in Humans,small,Other,Interventional,Dietary Supplement,Early Phase 1,78,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-11-29,2011-03-01,2012-04-01,2012,2011-08-01,2011,NA,NA,NA,-273,124,-120,689,933,813,2017-07-01,2017-12-01,2021-08-15,10.3945/jn.113.180802,24553695,http://jn.nutrition.org/cgi/pmidlookup?view=long&pmid=24553695,2014-02-19,journal publication,TRUE,TRUE,doi,"Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome",The Journal of nutrition,2014-Apr,2014-02-19,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0022-3166,1541-6100",The Journal of Nutrition,Oxford University Press (OUP),2014-02-19,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01871831,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Assessment of Blood Glucose Monitoring Systems - Evaluation of Oxygen Dependency,large,Other,Interventional,Device,NA,20,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2013-05-29,2013-06-01,2013-10-01,2013,2013-10-01,2013,NA,NA,NA,3,125,125,31,31,156,2017-07-01,2017-12-01,2021-08-15,10.1177/193229681300700611,24351177,https://www.ncbi.nlm.nih.gov/pubmed/24351177?dopt=Abstract,2013-11-01,journal publication,TRUE,TRUE,doi,Influence of partial pressure of oxygen in blood samples on measurement performance in glucose-oxidase-based systems for self-monitoring of blood glucose,Journal of diabetes science and technology,2013-Nov-01,2013-11-01,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1932-2968,1932-2968",Journal of Diabetes Science and Technology,SAGE Publications,2013-11-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01879111,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback,large,Other,Interventional,Other,NA,4151,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-06-12,2011-10-01,2014-05-01,2014,2013-10-01,2013,NA,NA,NA,-620,323,111,1007,1219,1330,2017-07-01,2017-12-01,2021-08-15,10.1192/bjp.bp.116.184168,27908896,http://bjp.rcpsych.org/content/210/2/132.long,2017-02-01,journal publication,TRUE,TRUE,doi,Depression screening with patient-targeted feedback in cardiology: DEPSCREEN-INFO randomised clinical trial,The British journal of psychiatry : the journal of mental science,2017-02,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,1,1,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2017-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-07-31,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01879111,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback,large,Other,Interventional,Other,NA,4151,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-06-12,2011-10-01,2014-05-01,2014,2013-10-01,2013,NA,NA,NA,-620,323,111,1007,1219,1330,2017-07-01,2017-12-01,2021-08-15,10.1192/bjp.bp.116.184168,27908896,http://bjp.rcpsych.org/content/210/2/132.long,2017-02-01,journal publication,TRUE,TRUE,doi,Depression screening with patient-targeted feedback in cardiology: DEPSCREEN-INFO randomised clinical trial,The British journal of psychiatry : the journal of mental science,2017-02,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,1,1,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2017-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-07-31,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01885000,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Düsseldorf Frankfurt Münster Tübingen,Patient-Reported Outcome Of Facial Erythema (PROOF),No lead center,Industry,Interventional,Drug,Phase 3,92,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2013-06-20,2013-07-01,2013-11-01,2013,2013-11-01,2013,2016-11-17,1112,1112,11,134,134,696,696,830,2017-07-01,2017-12-01,2021-08-15,10.1111/jdv.13305,26416154,http://onlinelibrary.wiley.com/doi/10.1111/jdv.13305/abstract,2015-09-28,journal publication,TRUE,TRUE,doi,"Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study",Journal of the European Academy of Dermatology and Venereology : JEADV,2015-Dec,2015-09-28,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1491,2844,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,hybrid,hybrid,"0926-9959,1468-3083",Journal of the European Academy of Dermatology and Venereology,Wiley,2015-09-28,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01886014,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers,large,Other,Interventional,Drug,NA,80,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-06-20,2012-01-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-536,-292,-292,417,417,125,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2013.277446,24150470,https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2013.277446,2013-10-23,journal publication,TRUE,TRUE,doi,Effect of oxytocin on placebo analgesia: a randomized study,JAMA,2013-Oct-23,NA,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2013-10-23,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2014-04-23,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01886365,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Computerized Tight Glycemic Control in Cardiac Surgery,large,Other,Interventional,Device,NA,75,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-06-12,2011-10-01,2012-10-01,2012,2012-10-01,2012,NA,NA,NA,-620,-254,-254,730,730,476,2017-07-01,2017-12-01,2021-08-15,10.1053/j.jvca.2014.04.017,25281044,http://www.sciencedirect.com/science/article/pii/S105307701400175X,2014-10-01,journal publication,TRUE,TRUE,doi,Perioperative glycemic control with a computerized algorithm versus conventional glycemic control in cardiac surgical patients undergoing cardiopulmonary bypass with blood cardioplegia,Journal of cardiothoracic and vascular anesthesia,2014-Oct,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1053-0770,Journal of Cardiothoracic and Vascular Anesthesia,Elsevier BV,2014-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01909687,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Assessment of Blood Glucose Monitoring Systems,large,Other,Interventional,Device,NA,163,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2013-07-02,2013-07-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-1,152,152,571,571,723,2017-07-01,2017-12-01,2021-08-15,10.1089/dia.2015.0085,26110670,https://www.ncbi.nlm.nih.gov/pubmed/26110670?dopt=Abstract,2015-06-25,journal publication,TRUE,TRUE,doi,System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods,Diabetes technology & therapeutics,2015-Sep,2015-06-25,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1520-9156,1557-8593",Diabetes Technology & Therapeutics,Mary Ann Liebert Inc,2015-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01917305,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,FALSE,TRUE,TRUE,TRUE,Bonn,NA,Influence of Platform-switching on Bone Level Alterations: a 3 Year Randomized Clinical Trial (RCT).,large,Other,Interventional,Device,NA,25,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-07-31,2007-02-01,NA,NA,2010-03-01,2010,NA,NA,NA,-2372,NA,-1248,NA,1333,85,2017-07-01,2017-12-01,2021-08-15,10.1177/0022034513504953,24158333,https://www.ncbi.nlm.nih.gov/pubmed/24158333?dopt=Abstract,2013-10-24,journal publication,TRUE,TRUE,doi,Influence of platform switching on bone-level alterations: a three-year randomized clinical trial,Journal of dental research,2013-Dec,2013-10-24,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,green,green,"0022-0345,1544-0591",Journal of Dental Research,SAGE Publications,2013-10-24,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01942473,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-03,2012-08-01,2014-04-01,2014,2013-09-01,2013,NA,NA,NA,-2,606,394,231,443,837,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jpeds.2014.10.007,25454938,https://www.ncbi.nlm.nih.gov/pubmed/25454938?dopt=Abstract,2014-11-18,journal publication,TRUE,TRUE,doi,Effects of automated adjustment of the inspired oxygen on fluctuations of arterial and regional cerebral tissue oxygenation in preterm infants with frequent desaturations,The Journal of pediatrics,2015-Feb,2014-11-18,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3476,The Journal of Pediatrics,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01942473,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-03,2012-08-01,2014-04-01,2014,2013-09-01,2013,NA,NA,NA,-2,606,394,231,443,837,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jpeds.2014.10.007,25454938,https://www.ncbi.nlm.nih.gov/pubmed/25454938?dopt=Abstract,2014-11-18,journal publication,TRUE,TRUE,doi,Effects of automated adjustment of the inspired oxygen on fluctuations of arterial and regional cerebral tissue oxygenation in preterm infants with frequent desaturations,The Journal of pediatrics,2015-Feb,2014-11-18,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3476,The Journal of Pediatrics,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02007005,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer,large,Industry,Interventional,Drug,Phase 1/Phase 2,37,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-12-05,2004-01-01,2013-09-01,2013,2012-02-01,2012,NA,NA,NA,-3626,-95,-673,598,1176,503,2017-07-01,2017-12-01,2021-08-15,10.1016/j.juro.2015.04.073,25910967,https://www.ncbi.nlm.nih.gov/pubmed/25910967?dopt=Abstract,2015-04-22,journal publication,TRUE,TRUE,doi,Mistletoe Plant Extract in Patients with Nonmuscle Invasive Bladder Cancer: Results of a Phase Ib/IIa Single Group Dose Escalation Study,The Journal of urology,2015-Oct,2015-04-22,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0022-5347,1527-3792",Journal of Urology,Ovid Technologies (Wolters Kluwer Health),2015-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02027038,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"Pelvic Belt Effects on Osseous Anatomy, Muscule Activation and Ground Reaction Forces",large,Other,Interventional,Device,NA,42,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2014-01-01,2011-08-01,2013-01-01,2013,2012-12-01,2012,NA,NA,NA,-884,-365,-396,966,997,601,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0136375,26305790,https://www.ncbi.nlm.nih.gov/pubmed/26305790?dopt=Abstract,2015-08-25,journal publication,TRUE,TRUE,doi,Pelvic Belt Effects on Health Outcomes and Functional Parameters of Patients with Sacroiliac Joint Pain,PloS one,2015,2015-08-25,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-08-25,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02038062,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery,small,Other,Interventional,Procedure,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-01-14,2010-05-01,2012-01-01,2012,2012-01-01,2012,NA,NA,NA,-1354,-744,-744,926,926,182,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2253-14-54,25132803,https://bmcanesthesiol.biomedcentral.com/articles/10.1186/1471-2253-14-54,2014-07-15,journal publication,TRUE,TRUE,doi,Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy--a pilot study,BMC anesthesiology,2014,2014-07-15,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2253,BMC Anesthesiology,Springer Science and Business Media LLC,2014-07-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02056951,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,Würzburg,Interprofessional Rehabilitation for Adults With Chronic Non-specific Low Back Pain,large,Other,Interventional,Procedure,NA,536,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2014-02-04,2008-01-01,2011-03-01,2011,2010-12-01,2010,NA,NA,NA,-2226,-1071,-1161,1473,1563,402,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0118609,25768735,http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0118609,2015-03-13,journal publication,TRUE,TRUE,doi,"Long-term effects of interprofessional biopsychosocial rehabilitation for adults with chronic non-specific low back pain: a multicentre, quasi-experimental study",PloS one,2015,2015-03-13,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-03-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT02120859,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Jena Jena,NA,Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty,small,Other,Interventional,Device,Phase 4,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2014-04-19,2012-10-01,2014-04-01,2014,2013-12-01,2013,NA,NA,NA,-565,-18,-139,826,947,808,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-016-1019-4,27379610,https://dx.doi.org/10.1007/s00392-016-1019-4,2016-07-05,journal publication,TRUE,TRUE,doi,"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography",Clinical research in cardiology : official journal of the German Cardiac Society,2017-Jan,2016-07-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2016-07-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT02120859,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty,small,Other,Interventional,Device,Phase 4,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2014-04-19,2012-10-01,2014-04-01,2014,2013-12-01,2013,NA,NA,NA,-565,-18,-139,826,947,808,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-016-1019-4,27379610,https://dx.doi.org/10.1007/s00392-016-1019-4,2016-07-05,journal publication,TRUE,TRUE,doi,"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography",Clinical research in cardiology : official journal of the German Cardiac Society,2017-Jan,2016-07-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2016-07-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02130115,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,LungPoint ATV for Biopsy in Patients Undergoing Lobectomy,large,Industry,Interventional,Device,NA,12,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-25,2013-03-01,2013-12-01,2013,2013-09-01,2013,NA,NA,NA,-420,-145,-236,460,551,315,2017-07-01,2017-12-01,2021-08-15,10.1136/thoraxjnl-2014-206211,25746631,http://thorax.bmj.com/content/70/4/326,2015-03-06,journal publication,TRUE,TRUE,doi,Bronchoscopic transparenchymal nodule access (BTPNA): first in human trial of a novel procedure for sampling solitary pulmonary nodules,Thorax,2015-Apr,2015-03-06,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0040-6376,Thorax,BMJ,2015-03-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT02163863,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,BioMimics 3D Stent Clinical Investigation: The Mimics Study,large,Industry,Interventional,Device,NA,86,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-09,2010-02-01,2014-07-01,2014,2012-10-01,2012,NA,NA,NA,-1589,22,-616,701,1339,723,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.115.002930,27208046,https://www.ncbi.nlm.nih.gov/pubmed/27208046,2016-06-01,journal publication,TRUE,TRUE,doi,Helical Centerline Stent Improves Patency: Two-Year Results From the Randomized Mimics Trial,Circulation. Cardiovascular interventions,2016-06,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT02163863,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,BioMimics 3D Stent Clinical Investigation: The Mimics Study,large,Industry,Interventional,Device,NA,86,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-09,2010-02-01,2014-07-01,2014,2012-10-01,2012,NA,NA,NA,-1589,22,-616,701,1339,723,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.115.002930,27208046,https://www.ncbi.nlm.nih.gov/pubmed/27208046,2016-06-01,journal publication,TRUE,TRUE,doi,Helical Centerline Stent Improves Patency: Two-Year Results From the Randomized Mimics Trial,Circulation. Cardiovascular interventions,2016-06,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02168790,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden,Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access),No lead center,Other,Interventional,Device,Early Phase 1,7,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-06-12,2011-02-01,2013-08-01,2013,2011-08-01,2011,NA,NA,NA,-1227,-315,-1046,645,1376,330,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0125035,25955359,https://www.ncbi.nlm.nih.gov/pubmed/25955359?dopt=Abstract,2015-05-08,journal publication,TRUE,TRUE,doi,Sutureless fixation of amniotic membrane for therapy of ocular surface disorders,PloS one,2015,2015-05-08,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,1,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-05-08,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02181101,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial",large,Other,Interventional,Drug,Phase 3,3754,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-04,2005-09-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-3198,-276,-276,747,747,471,2017-07-01,2017-12-01,2021-08-15,10.1186/s13058-015-0639-3,26385214,NA,2015-09-18,journal publication,TRUE,TRUE,doi,"The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial",Breast cancer research : BCR,2015-Sep-18,2015-09-18,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,5,5,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1465-542X,Breast Cancer Research,Springer Science and Business Media LLC,2015-09-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02189408,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration,small,Other,Interventional,Biological,Phase 4,58,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-11,2010-07-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-1441,-557,-557,890,890,333,2017-07-01,2017-12-01,2021-08-15,10.1007/s00402-015-2227-5,25957981,https://link.springer.com/article/10.1007%2Fs00402-015-2227-5,2015-05-10,journal publication,TRUE,TRUE,doi,"Does intraoperative application of leukocyte-poor platelet-rich plasma during arthroscopy for knee degeneration affect postoperative pain, function and quality of life? A 12-month randomized controlled double-blind trial",Archives of orthopaedic and trauma surgery,2015-Jul,2015-05-10,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0936-8051,1434-3916",Archives of Orthopaedic and Trauma Surgery,Springer Science and Business Media LLC,2015-05-10,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02196545,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Physical Activity Training Program for Patients With Alzheimer's Dementia,large,Other,Interventional,Behavioral,NA,30,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-07-14,2011-08-01,2013-07-01,2013,2013-07-01,2013,NA,NA,NA,-1078,-378,-378,655,655,277,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0121478,25884637,https://www.ncbi.nlm.nih.gov/pubmed/25884637?dopt=Abstract,2015-04-17,journal publication,TRUE,TRUE,doi,Effects of physical activity training in patients with Alzheimer's dementia: results of a pilot RCT study,PloS one,2015,2015-04-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-04-17,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02220764,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Zirconia Based Fixed Dental Prostheses,large,Other,Interventional,Device,NA,32,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,TRUE,2014-07-16,2008-05-01,2013-12-01,2013,2013-11-01,2013,2015-03-04,458,488,-2267,-227,-257,339,369,112,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jdent.2014.10.011,25446240,https://www.ncbi.nlm.nih.gov/pubmed/25446240?dopt=Abstract,2014-11-05,journal publication,TRUE,TRUE,doi,Prospective evaluation of zirconia based tooth- and implant-supported fixed dental prostheses: 3-year results,Journal of dentistry,2015-Jan,2014-11-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0300-5712,Journal of Dentistry,Elsevier BV,2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02349490,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hannover,Seraseal for Endoscopic Hemostasis,No lead center,Other,Interventional,Device,Phase 4,37,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-01-18,2011-11-01,2015-01-01,2015,2013-07-01,2013,NA,NA,NA,-1174,-17,-566,315,864,298,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0034-1393312,26561916,http://www.thieme-connect.com/DOI/DOI?10.1055/s-0034-1393312,2015-11-12,journal publication,TRUE,TRUE,doi,Efficacy and safety of bovine activated factors IIa/VIIa/IXa/Xa in patients with active gastrointestinal bleeding: a proof of concept study,Endoscopy,2016-Apr,2015-11-12,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0013-726X,1438-8812",Endoscopy,Georg Thieme Verlag KG,2015-11-12,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT02436083,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Antibiotics in Free Flaps Reconstructions,large,Other,Interventional,Drug,Phase 4,350,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-03-09,2007-07-01,2014-12-01,2014,2012-06-01,2012,NA,NA,NA,-2808,-98,-1011,249,1162,151,2017-07-01,2017-12-01,2021-08-15,10.1002/micr.22470,26251066,https://www.ncbi.nlm.nih.gov/pubmed/26251066?dopt=Abstract,2015-08-07,journal publication,TRUE,TRUE,doi,The value of perioperative antibiotics on the success of oral free flap reconstructions,Microsurgery,2015-Oct,2015-08-07,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0738-1085,Microsurgery,Wiley,2015-08-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT02436083,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Antibiotics in Free Flaps Reconstructions,large,Other,Interventional,Drug,Phase 4,350,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-03-09,2007-07-01,2014-12-01,2014,2012-06-01,2012,NA,NA,NA,-2808,-98,-1011,249,1162,151,2017-07-01,2017-12-01,2021-08-15,10.1002/micr.22470,26251066,https://www.ncbi.nlm.nih.gov/pubmed/26251066?dopt=Abstract,2015-08-07,journal publication,TRUE,TRUE,doi,The value of perioperative antibiotics on the success of oral free flap reconstructions,Microsurgery,2015-Oct,2015-08-07,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0738-1085,Microsurgery,Wiley,2015-08-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02586181,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Effect of 1 Year Vitamin D or D Plus B-vitamins on Bone Markers in Elderly People (KnoVIB),small,Other,Interventional,Dietary Supplement,NA,93,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-10-21,2009-08-01,2011-07-01,2011,2011-07-01,2011,NA,NA,NA,-2272,-1573,-1573,609,609,-964,2017-07-01,2017-12-01,2021-08-15,10.1515/cclm-2012-0599,23183751,NA,2013-03-01,journal publication,TRUE,TRUE,doi,One year B and D vitamins supplementation improves metabolic bone markers,Clinical chemistry and laboratory medicine,2013-Mar-01,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1437-4331,1434-6621",Clinical Chemistry and Laboratory Medicine,Walter de Gruyter GmbH,2013-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-01-01,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT02595229,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Pronator Quadratus Repair After Volar Plating of Distal Radius Fractures,large,Other,Interventional,Procedure,NA,60,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-10-25,2010-05-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-2003,-968,-968,999,999,31,2017-07-01,2017-12-01,2021-08-15,10.1186/s40001-015-0187-4,26607745,https://www.ncbi.nlm.nih.gov/pubmed/26607745?dopt=Abstract,2015-11-25,journal publication,TRUE,TRUE,doi,Pronator quadratus repair after volar plating of distal radius fractures or not? Results of a prospective randomized trial,European journal of medical research,2015-Nov-25,2015-11-25,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2047-783X,European Journal of Medical Research,Springer Science and Business Media LLC,2015-11-25,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT02620553,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Primary Intervention With Mucosal Insulin,large,Other,Interventional,Drug,Phase 1/Phase 2,25,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-08,2007-09-01,2014-01-01,2014,2013-06-01,2013,NA,NA,NA,-2837,-523,-737,475,689,-48,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2015.2928,25898052,https://www.ncbi.nlm.nih.gov/pubmed/25898052?dopt=Abstract,2015-04-21,journal publication,TRUE,TRUE,doi,Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial,JAMA,2015-Apr-21,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,2,2,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2015-04-21,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2015-10-21,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT02620553,ClinicalTrials.gov,TRUE,1,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Primary Intervention With Mucosal Insulin,large,Other,Interventional,Drug,Phase 1/Phase 2,25,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-08,2007-09-01,2014-01-01,2014,2013-06-01,2013,NA,NA,NA,-2837,-523,-737,475,689,-48,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2015.2928,25898052,https://www.ncbi.nlm.nih.gov/pubmed/25898052?dopt=Abstract,2015-04-21,journal publication,TRUE,TRUE,doi,Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial,JAMA,2015-Apr-21,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,2,2,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2015-04-21,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2015-10-21,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT02697539,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster Würzburg,NA,Plaque Formation Rate and Toothpaste,large,Other,Interventional,Other,NA,74,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2016-02-23,2011-03-01,2011-12-01,2011,2011-09-01,2011,NA,NA,NA,-1820,-1545,-1636,1701,1792,156,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0160142,27467683,http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160142,2016-07-28,journal publication,TRUE,TRUE,doi,Impact of the Daily Use of a Microcrystal Hydroxyapatite Dentifrice on De Novo Plaque Formation and Clinical/Microbiological Parameters of Periodontal Health. A Randomized Trial,PloS one,2016,2016-07-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2016-07-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02799069,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy,small,Industry,Interventional,Drug,Phase 3,571,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2016-05-26,2008-04-01,2009-08-01,2009,2009-08-01,2009,2016-09-07,2594,2594,-2977,-2490,-2490,872,872,-1618,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1365-2133.2011.10613.x,21910711,http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2011.10613.x/full,2011-12-21,journal publication,TRUE,TRUE,doi,"Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo",The British journal of dermatology,2012-Jan,2011-12-21,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,3044,4397,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,closed,closed,0007-0963,British Journal of Dermatology,Wiley,2011-12-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02925377,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen Jena,NA,Neuromuscular Warm-up Intervention to Improve Postural Control in Female Handball Players,large,Other,Interventional,Behavioral,NA,41,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2016-10-04,2010-09-01,2011-05-01,2011,2010-12-01,2010,NA,NA,NA,-2225,-1983,-2134,1992,2143,9,2017-07-01,2017-12-01,2021-08-15,10.1186/s13102-016-0058-5,27757240,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064777/,2016-10-13,journal publication,TRUE,TRUE,doi,Time-dependent postural control adaptations following a neuromuscular warm-up in female handball players: a randomized controlled trial,"BMC sports science, medicine & rehabilitation",2016,2016-10-13,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,2052-1847,"BMC Sports Science, Medicine and Rehabilitation",Springer Science and Business Media LLC,2016-10-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -782,13 +782,13 @@ NCT00626548,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA NCT00669708,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Topical Therapy With Cooling Effect in Dry Itchy Skin,large,Other,Interventional,Device,NA,70,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2008-04-22,2008-04-01,2010-02-01,2010,2010-02-01,2010,NA,NA,NA,-21,650,650,2501,2501,3151,2017-07-01,2017-12-01,2021-08-15,10.1111/jdv.14041,27862339,https://www.ncbi.nlm.nih.gov/pubmed/27862339,2016-12-07,journal publication,TRUE,TRUE,doi,"Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin",Journal of the European Academy of Dermatology and Venereology : JEADV,2017-Jun,2016-12-07,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2860,4213,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,0926-9959,Journal of the European Academy of Dermatology and Venereology,Wiley,2016-12-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00746720,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Modulation of the Surgical Inflammatory Response by Etoricoxib,large,Other,Interventional,Drug,Phase 2,23,Terminated,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-09-03,2006-05-01,2010-12-01,2010,2009-07-01,2009,NA,NA,NA,-856,819,301,383,901,1202,2017-07-01,2017-12-01,2021-08-15,10.1002/j.1532-2149.2011.00062.x,22337568,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00746720,2011-12-19,journal publication,TRUE,TRUE,doi,Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief,"European journal of pain (London, England)",2012-Jul,2011-12-19,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,6,6,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1090-3801,1532-2149",European Journal of Pain,Wiley,2011-12-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2012-12-19,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00827606,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Atorvastatin Three Year Pediatric Study,No lead center,Industry,Interventional,Drug,Phase 3,272,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2009-01-21,2009-03-01,2013-10-01,2013,2013-10-01,2013,2014-09-11,345,345,39,1714,1714,980,980,2694,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacl.2016.05.010,27678432,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00827606,2016-06-07,journal publication,TRUE,TRUE,doi,A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia,Journal of clinical lipidology,2016 Sep-Oct,2016-06-07,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1522,2875,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,hybrid,hybrid,1933-2874,Journal of Clinical Lipidology,Elsevier BV,2016-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT00847444,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf LMU-München Düsseldorf,NA,"Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention",large,Other,Interventional,Drug,Phase 3,3547,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2009-02-01,2016-09-01,2016,2011-09-01,2011,NA,NA,NA,-16,2753,926,131,1958,2884,2017-07-01,2017-12-01,2021-08-15,10.1016/j.clbc.2016.11.008,28190761,https://www.ncbi.nlm.nih.gov/pubmed/28190761,2017-01-10,journal publication,TRUE,TRUE,doi,"Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer",Clinical breast cancer,2017-07,2017-01-10,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,456,1809,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1526-8209,Clinical Breast Cancer,Elsevier BV,2017-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00849615,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,"Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction",large,Other,Interventional,Drug,Phase 2,252,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-02-23,2009-02-01,2016-01-01,2016,2012-01-01,2012,NA,NA,NA,-22,2503,1042,609,2070,3112,2017-07-01,2017-12-01,2021-08-15,10.1001/jamaoncol.2017.0515,28448662,NA,2017-09-01,journal publication,TRUE,TRUE,doi,Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial,JAMA oncology,2017-Sep-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,700,2053,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,2374-2437,JAMA Oncology,American Medical Association (AMA),2017-09-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2018-03-01,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT00874848,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,large,Industry,Interventional,Biological,Phase 2,90,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-01,2009-08-01,2015-08-01,2015,2012-11-01,2012,2016-07-15,349,1352,122,2313,1310,593,1596,2906,2017-07-01,2017-12-01,2021-08-15,10.1007/s10637-017-0450-3,28303530,https://www.ncbi.nlm.nih.gov/pubmed/28303530,2017-03-16,journal publication,TRUE,TRUE,doi,"A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer",Investigational new drugs,2017-06,2017-03-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,1,1,853,2206,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0167-6997,1573-0646",Investigational New Drugs,Springer Science and Business Media LLC,2017-03-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT00847444,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf LMU-München,NA,"Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention",large,Other,Interventional,Drug,Phase 3,3547,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2009-02-01,2016-09-01,2016,2011-09-01,2011,NA,NA,NA,-16,2753,926,131,1958,2884,2017-07-01,2017-12-01,2021-08-15,10.1016/j.clbc.2016.11.008,28190761,https://www.ncbi.nlm.nih.gov/pubmed/28190761,2017-01-10,journal publication,TRUE,TRUE,doi,"Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer",Clinical breast cancer,2017-07,2017-01-10,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,456,1809,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1526-8209,Clinical Breast Cancer,Elsevier BV,2017-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00849615,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,"Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction",large,Other,Interventional,Drug,Phase 2,252,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-02-23,2009-02-01,2016-01-01,2016,2012-01-01,2012,NA,NA,NA,-22,2503,1042,609,2070,3112,2017-07-01,2017-12-01,2021-08-15,10.1001/jamaoncol.2017.0515,28448662,NA,2017-09-01,journal publication,TRUE,TRUE,doi,Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial,JAMA oncology,2017-Sep-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,700,2053,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,2374-2437,JAMA Oncology,American Medical Association (AMA),2017-09-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2018-03-01,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT00874848,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,Göttingen Heidelberg Ulm,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,large,Industry,Interventional,Biological,Phase 2,90,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-01,2009-08-01,2015-08-01,2015,2012-11-01,2012,2016-07-15,349,1352,122,2313,1310,593,1596,2906,2017-07-01,2017-12-01,2021-08-15,10.1007/s10637-017-0450-3,28303530,https://www.ncbi.nlm.nih.gov/pubmed/28303530,2017-03-16,journal publication,TRUE,TRUE,doi,"A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer",Investigational new drugs,2017-06,2017-03-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,1,1,853,2206,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0167-6997,1573-0646",Investigational New Drugs,Springer Science and Business Media LLC,2017-03-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00883623,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis,large,Other,Interventional,Drug,Phase 2,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-04-15,2009-04-01,2013-02-01,2013,2013-02-01,2013,NA,NA,NA,-14,1388,1388,1567,1567,2955,2017-07-01,2017-12-01,2021-08-15,10.3324/haematol.2016.163246,28522573,https://www.ncbi.nlm.nih.gov/pubmed/28522573,2017-05-18,journal publication,TRUE,TRUE,doi,Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up,Haematologica,2017-08,2017-05-18,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,1,1,1764,3117,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"0390-6078,1592-8721",Haematologica,Ferrata Storti Foundation (Haematologica),2017-05-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00893867,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Erlangen Duisburg-Essen Freiburg Göttingen Greifswald Leipzig Magdeburg Mainz Rostock Ulm,Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke,No lead center,Industry,Interventional,Drug,Phase 3,446,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-05-04,2009-12-01,2012-04-01,2012,2012-04-01,2012,NA,NA,NA,211,1063,1063,312,312,1375,2017-07-01,2017-12-01,2021-08-15,10.1161/strokeaha.111.000013,23391764,https://www.ncbi.nlm.nih.gov/pubmed/23391764,2013-02-07,journal publication,TRUE,TRUE,doi,Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke,Stroke,2013-Mar,2013-02-07,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0039-2499,1524-4628",Stroke,Ovid Technologies (Wolters Kluwer Health),2013-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00903331,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Giessen Köln LMU-München,Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study,No lead center,Industry,Interventional,Drug,Phase 2,178,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-05-14,2009-05-01,2011-08-01,2011,2011-06-01,2011,2013-10-29,820,881,-13,809,748,654,715,1463,2017-07-01,2017-12-01,2021-08-15,10.1183/09031936.00104612,23682110,NA,2013-05-16,journal publication,TRUE,TRUE,doi,Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial,The European respiratory journal,2013-Dec,2013-05-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2314,3667,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,bronze,green,"0903-1936,1399-3003",European Respiratory Journal,European Respiratory Society (ERS),2013-05-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2014-05-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00942747,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma,large,Other,Interventional,Drug,Phase 2,37,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-07-20,2009-07-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-19,1777,1595,652,834,2429,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2015.64.9897,26976424,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00942747,2016-03-14,journal publication,TRUE,TRUE,doi,Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2016-05-20,2016-03-14,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,13,11,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,TRUE,TRUE,NA +NCT00942747,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,Bochum Bonn Heidelberg LMU-München,Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma,large,Other,Interventional,Drug,Phase 2,37,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-07-20,2009-07-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-19,1777,1595,652,834,2429,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2015.64.9897,26976424,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT00942747,2016-03-14,journal publication,TRUE,TRUE,doi,Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2016-05-20,2016-03-14,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,13,11,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT00947414,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Cellulite and Extracorporeal Shock Wave,large,Other,Interventional,Device,NA,100,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2009-07-27,2009-06-01,2011-10-01,2011,2011-10-01,2011,NA,NA,NA,-56,796,796,794,794,1590,2017-07-01,2017-12-01,2021-08-15,10.1007/s13555-013-0039-5,24297647,https://www.ncbi.nlm.nih.gov/pubmed/24297647,2013-12-03,journal publication,TRUE,TRUE,doi,Cellulite and focused extracorporeal shockwave therapy for non-invasive body contouring: a randomized trial,Dermatology and therapy,2013-Dec,2013-12-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"2193-8210,2190-9172",Dermatology and Therapy,Springer Science and Business Media LLC,2013-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01016002,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,FALSE,TRUE,TRUE,TRUE,Hamburg,NA,Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma,large,Other,Interventional,Drug,Phase 2,35,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-11-16,2006-01-01,NA,NA,2011-12-01,2011,NA,NA,NA,-1415,NA,745,NA,490,1235,2017-07-01,2017-12-01,2021-08-15,10.1039/c3pp25425a,23558738,NA,2013-04-04,journal publication,TRUE,TRUE,doi,Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin,Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology,2013-Jun,2013-04-04,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,"1474-905X,1474-9092",Photochemical & Photobiological Sciences,Springer Science and Business Media LLC,2013-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,12,2014-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01020630,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,Berlin Duisburg-Essen Halle-Wittenberg Hamburg Rostock Homburg,Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI,large,Other,Interventional,Drug,Phase 2,91,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-11-23,2009-11-01,2013-07-01,2013,2012-11-01,2012,NA,NA,NA,-22,1316,1074,1157,1399,2473,2017-07-01,2017-12-01,2021-08-15,10.1186/s12885-016-2736-9,27582078,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT01020630,2016-08-31,journal publication,TRUE,TRUE,doi,"Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program",BMC cancer,2016-08-31,2016-08-31,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2016-08-31,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -809,14 +809,14 @@ NCT01401296,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,N NCT01540877,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,FALSE,TRUE,TRUE,TRUE,Bochum,NA,A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics,small,Other,Interventional,Procedure,NA,28,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-02-23,2011-04-01,NA,NA,2011-09-01,2011,NA,NA,NA,-328,NA,-175,NA,2030,1855,2017-07-01,2017-12-01,2021-08-15,10.1186/s12883-017-0839-9,28335745,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT01540877,2017-03-23,journal publication,TRUE,TRUE,doi,Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia,BMC neurology,2017-Mar-23,2017-03-23,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,gold,gold,1471-2377,BMC Neurology,Springer Science and Business Media LLC,2017-03-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01593540,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Clinical Examination of Metal Free Interdental Brushes,large,Other,Interventional,Device,Phase 4,39,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-04-28,2010-09-01,2011-09-01,2011,2011-08-01,2011,NA,NA,NA,-605,-240,-271,862,893,622,2017-07-01,2017-12-01,2021-08-15,10.1007/s00784-013-1164-3,24407549,NA,2014-01-10,journal publication,TRUE,TRUE,doi,Clinical efficacy and patients' acceptance of a rubber interdental bristle. A randomized controlled trial,Clinical oral investigations,2014-Sep,2014-01-10,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1432-6981,1436-3771",Clinical Oral Investigations,Springer Science and Business Media LLC,2014-01-10,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-01-10,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01686893,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden,Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD,No lead center,Other,Interventional,Device,Phase 1,50,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2012-09-13,2009-02-01,2013-03-01,2013,2013-02-01,2013,NA,NA,NA,-1320,169,141,1722,1750,1891,2017-07-01,2017-12-01,2021-08-15,10.1186/s12890-017-0486-3,29149867,https://www.ncbi.nlm.nih.gov/pubmed/?term=NCT01686893,2017-11-17,journal publication,TRUE,TRUE,doi,Efficacy and safety of nasal high-flow oxygen in COPD patients,BMC pulmonary medicine,2017-Nov-17,2017-11-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2466,BMC Pulmonary Medicine,Springer Science and Business Media LLC,2017-11-17,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01783639,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Leipzig Hamburg,NA,Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting,large,Industry,Interventional,Procedure,NA,120,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2013-01-13,2013-02-01,2015-04-01,2015,2013-12-01,2013,2015-06-08,68,554,19,808,322,700,1186,1508,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.116.004244,28283511,https://www.ncbi.nlm.nih.gov/pubmed/28283511,2017-03-01,journal publication,TRUE,TRUE,doi,Independent Modular Filter for Embolic Protection in Carotid Stenting,Circulation. Cardiovascular interventions,2017-Mar,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,975,2328,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01783639,ClinicalTrials.gov,TRUE,1,Pubmed,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Leipzig,NA,Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting,large,Industry,Interventional,Procedure,NA,120,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2013-01-13,2013-02-01,2015-04-01,2015,2013-12-01,2013,2015-06-08,68,554,19,808,322,700,1186,1508,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.116.004244,28283511,https://www.ncbi.nlm.nih.gov/pubmed/28283511,2017-03-01,journal publication,TRUE,TRUE,doi,Independent Modular Filter for Embolic Protection in Carotid Stenting,Circulation. Cardiovascular interventions,2017-Mar,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,975,2328,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02435056,ClinicalTrials.gov,TRUE,1,Pubmed,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Medication Overuse Headache (MOH) and an Innovative Approach,large,Other,Interventional,Other,NA,690,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-04-30,2008-07-01,2010-06-01,2010,2009-07-01,2009,NA,NA,NA,-2494,-1794,-2129,2241,2576,447,2017-07-01,2017-12-01,2021-08-15,10.1177/0333102416660549,27440251,https://www.ncbi.nlm.nih.gov/pubmed/27440251,2016-07-20,journal publication,TRUE,TRUE,doi,The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study,Cephalalgia : an international journal of headache,2017-Oct,2016-07-20,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,"0333-1024,1468-2982",Cephalalgia,SAGE Publications,2016-07-20,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00030680,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Tübingen,Radiation Therapy in Treating Patients With Aggressive Fibromatoses,No lead center,Other,Interventional,Radiation,Phase 2,44,Completed,NA,NA,NA,TRUE,FALSE,FALSE,2002-02-14,2001-11-01,2012-03-01,2012,2012-03-01,2012,NA,NA,NA,-105,3668,3668,503,503,4171,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdt254,23868907,https://www.ncbi.nlm.nih.gov/pubmed/23868907,2013-07-17,journal publication,TRUE,TRUE,doi,Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998),Annals of oncology : official journal of the European Society for Medical Oncology,2013-Oct,2013-07-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2013-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00047099,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München TU-München,NA,Combination Chemotherapy in Treating Women With Breast Cancer,large,Other,Interventional,Drug,Phase 3,446,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2002-10-03,2001-08-01,2012-03-01,2012,2012-02-01,2012,NA,NA,NA,-428,3437,3408,1491,1520,4928,2017-07-01,2017-12-01,2021-08-15,10.1038/bjc.2016.82,27031854,https://www.ncbi.nlm.nih.gov/pubmed/27031854,2016-03-31,journal publication,TRUE,TRUE,doi,Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study,British journal of cancer,2016-Apr-12,2016-03-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,0,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0007-0920,1532-1827",British Journal of Cancer,Springer Science and Business Media LLC,2016-03-31,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-sa', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00079105,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years,No lead center,Other,Interventional,Biological,Phase 2,175,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2004-03-08,2004-01-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-67,2459,2459,526,526,2985,2017-07-01,2017-12-01,2021-08-15,10.1182/blood-2011-12-396556,22577177,https://www.ncbi.nlm.nih.gov/pubmed/22577177,2012-05-10,journal publication,TRUE,TRUE,doi,Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study,Blood,2012-Jun-21,2012-05-10,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-06-21,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-06-21,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00124813,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,"Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma",large,Other,Interventional,Drug,Phase 2,80,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-07-27,2002-08-01,2010-11-01,2010,2010-05-01,2010,NA,NA,NA,-1091,1923,1739,578,762,2501,2017-07-01,2017-12-01,2021-08-15,10.1007/s12288-011-0103-1,23730012,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332274/,2012-06-01,journal publication,TRUE,TRUE,doi,Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma,Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,2012-Jun,2011-08-18,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2587,3940,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0971-4502,0974-0449",Indian Journal of Hematology and Blood Transfusion,Springer Science and Business Media LLC,2011-08-18,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2012-08-18,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00145132,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Beta-CIT-SPECT and Neurophysiology in Depression,large,Other,Interventional,Procedure,Phase 4,30,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2005-09-01,2005-06-01,2009-12-01,2009,2009-12-01,2009,NA,NA,NA,-92,1552,1552,1861,1861,3413,2017-07-01,2017-12-01,2021-08-15,10.1016/j.euroneuro.2014.12.010,25819144,https://www.ncbi.nlm.nih.gov/pubmed/25819144,2015-01-05,journal publication,TRUE,TRUE,doi,Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study,European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2015-Jun,2015-01-05,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,0924-977X,European Neuropsychopharmacology,Elsevier BV,2015-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00167583,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB),large,Other,Interventional,Drug,Phase 3,37,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-09,2004-11-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-312,3370,3370,548,548,3918,2017-07-01,2017-12-01,2021-08-15,10.1136/annrheumdis-2016-eular.2780,NA,http://ard.bmj.com/content/75/Suppl_2/1091.2,2016-06-01,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,14,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0003-4967,1468-2060",Annals of the Rheumatic Diseases,BMJ,2016-06-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT00167583,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB),large,Other,Interventional,Drug,Phase 3,37,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-09,2004-11-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-312,3370,3370,548,548,3918,2017-07-01,2017-12-01,2021-08-15,10.1136/annrheumdis-2016-eular.2780,NA,http://ard.bmj.com/content/75/Suppl_2/1091.2,2016-06-01,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,14,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0003-4967,1468-2060",Annals of the Rheumatic Diseases,BMJ,2016-06-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00170573,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer,large,Other,Interventional,Drug,Phase 2,82,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2005-09-09,2001-10-01,2010-08-01,2010,2009-04-01,2009,NA,NA,NA,-1439,1787,1300,-1522,-1035,265,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdl079,16600975,https://academic.oup.com/annonc/article/17/6/957/197163/Biweekly-pegylated-liposomal-doxorubicin-in,2006-06-01,journal publication,TRUE,TRUE,doi,Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial,Annals of oncology : official journal of the European Society for Medical Oncology,2006-Jun,2006-04-06,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2679,4032,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2006-06-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2007-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00170677,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer,large,Other,Interventional,Drug,Phase 2,194,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2005-09-13,2005-09-01,2013-01-01,2013,2013-01-01,2013,NA,NA,NA,-12,2667,2667,-1341,-1341,1326,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2009.27.15_suppl.5553,NA,http://ascopubs.org/doi/abs/10.1200/jco.2009.27.15_suppl.5553,2009-05-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2009-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2010-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00170690,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Preference Study With Elderly Patients Recurrent Ovarian Cancer,large,Other,Interventional,Drug,Phase 3,123,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-08-01,2012-04-01,2012,2011-12-01,2011,NA,NA,NA,-407,2393,2271,1801,1923,4194,2017-07-01,2017-12-01,2021-08-15,10.1186/s40661-017-0040-2,28286660,https://gynoncrp.biomedcentral.com/articles/10.1186/s40661-017-0040-2,2017-03-07,journal publication,TRUE,TRUE,doi,Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial,Gynecologic oncology research and practice,2017,2017-03-07,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,0,0,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,2053-6844,Gynecologic Oncology Research and Practice,Springer Science and Business Media LLC,2017-03-07,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -837,7 +837,7 @@ NCT00324779,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Erl NCT00326079,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz,A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2,No lead center,Industry,Interventional,Device,Phase 4,61,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2006-05-12,2004-08-01,2013-05-01,2013,2013-05-01,2013,NA,NA,NA,-649,2546,2546,-464,-464,2082,2017-07-01,2017-12-01,2021-08-15,10.1136/bjophthalmol-2011-300218,22275344,http://bjo.bmj.com/content/96/5/645.short,2012-01-23,journal publication,TRUE,TRUE,doi,Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study,The British journal of ophthalmology,2012-May,2012-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0007-1161,1468-2079",British Journal of Ophthalmology,BMJ,2012-01-23,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00337519,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin Dresden,NA,Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia,large,Other,Interventional,Procedure,Phase 2,82,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2006-06-15,2003-01-01,2009-04-01,2009,2009-04-01,2009,NA,NA,NA,-1261,1021,1021,1036,1036,2057,2017-07-01,2017-12-01,2021-08-15,10.1016/j.bbmt.2011.12.041,NA,http://www.bbmt.org/article/S1083-8791(11)00601-X/fulltext,2012-02-01,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3166,4519,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,1083-8791,Biology of Blood and Marrow Transplantation,Elsevier BV,2012-02-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00344253,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis",large,Other,Interventional,Drug,Phase 3,19,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2006-06-22,2006-03-01,2012-01-01,2012,2011-03-01,2011,NA,NA,NA,-113,2019,1713,533,839,2552,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajo.2013.05.002,23786783,https://www.ncbi.nlm.nih.gov/pubmed/23786783,2013-06-17,journal publication,TRUE,TRUE,doi,Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial,American journal of ophthalmology,2013-Sep,2013-06-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,2,2,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-9394,American Journal of Ophthalmology,Elsevier BV,2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00349089,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,large,Other,Interventional,Drug,Phase 2,132,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-04,2006-09-26,2014-04-14,2014,2014-04-14,2014,NA,NA,NA,84,2841,2841,-515,-515,2326,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mds578,23161898,https://www.ncbi.nlm.nih.gov/pubmed/23161898,2012-11-15,journal publication,TRUE,TRUE,doi,Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study,Annals of oncology : official journal of the European Society for Medical Oncology,2013-Apr,2012-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,11,7,1327,2680,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00349089,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,Göttingen,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,large,Other,Interventional,Drug,Phase 2,132,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-04,2006-09-26,2014-04-14,2014,2014-04-14,2014,NA,NA,NA,84,2841,2841,-515,-515,2326,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mds578,23161898,https://www.ncbi.nlm.nih.gov/pubmed/23161898,2012-11-15,journal publication,TRUE,TRUE,doi,Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study,Annals of oncology : official journal of the European Society for Medical Oncology,2013-Apr,2012-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,11,7,1327,2680,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00368121,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,Münster Würzburg,EMMA-1 (Erbitux for Multiple Myeloma),large,Other,Interventional,Drug,Phase 2,13,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2006-08-23,2006-08-01,2012-06-01,2012,2012-06-01,2012,NA,NA,NA,-22,2109,2109,423,423,2532,2017-07-01,2017-12-01,2021-08-15,10.3109/10428194.2013.809074,23713484,https://www.ncbi.nlm.nih.gov/pubmed/23713484,2013-07-29,journal publication,TRUE,TRUE,doi,Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial,Leukemia & lymphoma,2014-Mar,2013-07-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2013-07-29,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2014-07-29,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00369018,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.,large,Industry,Interventional,Drug,Phase 1/Phase 2,96,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2006-08-28,2006-08-01,2009-07-01,2009,2009-07-01,2009,NA,NA,NA,-27,1038,1038,1077,1077,2115,2017-07-01,2017-12-01,2021-08-15,10.1002/lsm.22041,22693121,https://www.ncbi.nlm.nih.gov/pubmed/22693121,2012-06-12,journal publication,TRUE,TRUE,doi,"Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate--a double-blind, dose-finding study",Lasers in surgery and medicine,2012-Aug,2012-06-12,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,3075,4428,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0196-8092,Lasers in Surgery and Medicine,Wiley,2012-06-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00372216,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Frankfurt Giessen Leipzig Mannheim Rostock,CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction,No lead center,Other,Interventional,Drug,Phase 3,337,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-09-04,2006-10-01,2010-01-01,2010,2009-10-01,2009,NA,NA,NA,27,1215,1123,719,811,1934,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-011-0393-1,22186968,NA,2011-12-21,journal publication,TRUE,TRUE,doi,Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial,Clinical research in cardiology : official journal of the German Cardiac Society,2012-Apr,2011-12-21,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2011-12-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2012-12-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -857,7 +857,7 @@ NCT00427180,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hamb NCT00431561,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,Berlin Dresden Giessen Schleswig-Holstein Leipzig Magdeburg Mainz Münster Tübingen,Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma,small,Industry,Interventional,Drug,Phase 2,141,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2007-02-05,2003-04-01,2009-03-01,2009,2009-03-01,2009,NA,NA,NA,-1406,755,755,605,605,1360,2017-07-01,2017-12-01,2021-08-15,10.1093/neuonc/noq142,20980335,https://www.ncbi.nlm.nih.gov/pubmed/20980335,2010-10-27,journal publication,TRUE,TRUE,doi,Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study,Neuro-oncology,2011-Jan,2010-10-27,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,3197,4550,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"1522-8517,1523-5866",Neuro-Oncology,Oxford University Press (OUP),2010-10-27,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00431912,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mannheim,A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma,No lead center,Industry,Interventional,Drug,Phase 2,25,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2007-02-05,2007-02-01,2011-09-01,2011,2011-01-01,2011,NA,NA,NA,-4,1669,1426,1765,2008,3434,2017-07-01,2017-12-01,2021-08-15,10.1001/jamadermatol.2016.0401,27007550,https://www.ncbi.nlm.nih.gov/pubmed/27007550,2016-07-01,journal publication,TRUE,TRUE,doi,Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial,JAMA dermatology,2016-07-01,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,2168-6068,JAMA Dermatology,American Medical Association (AMA),2016-07-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-01-01,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT00434161,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma,large,Industry,Interventional,Drug,Phase 3,281,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,TRUE,2007-02-08,2006-12-01,2012-05-01,2012,2009-03-01,2009,2010-03-02,-791,366,-69,1909,752,230,1387,2139,2017-07-01,2017-12-01,2021-08-15,10.1038/bmt.2012.257,23241739,https://www.ncbi.nlm.nih.gov/pubmed/23241739,2012-12-17,journal publication,TRUE,TRUE,doi,"In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden",Bone marrow transplantation,2013-Jul,2012-12-17,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0268-3369,1476-5365",Bone Marrow Transplantation,Springer Science and Business Media LLC,2012-12-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2013-12-17,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00437307,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse,large,Other,Interventional,Drug,Phase 3,550,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2007-02-19,2007-03-01,2015-06-01,2015,2013-07-01,2013,NA,NA,NA,10,3024,2324,513,1213,3537,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdw418,27789470,https://www.ncbi.nlm.nih.gov/pubmed/27789470,2016-10-26,journal publication,TRUE,TRUE,doi,Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR),Annals of oncology : official journal of the European Society for Medical Oncology,2016-12,2016-10-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,914,2267,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-12-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00437307,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse,large,Other,Interventional,Drug,Phase 3,550,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2007-02-19,2007-03-01,2015-06-01,2015,2013-07-01,2013,NA,NA,NA,10,3024,2324,513,1213,3537,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdw418,27789470,https://www.ncbi.nlm.nih.gov/pubmed/27789470,2016-10-26,journal publication,TRUE,TRUE,doi,Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR),Annals of oncology : official journal of the European Society for Medical Oncology,2016-12,2016-10-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,914,2267,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-12-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00450684,ClinicalTrials.gov,TRUE,1,Dissertation,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Berlin Erlangen Freiburg Halle-Wittenberg Hamburg TU-München Münster Homburg Tübingen,Cardiac Resynchronization Therapy in Congenital Heart Defects,No lead center,Other,Interventional,Device,Phase 2/Phase 3,55,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2007-03-21,2007-05-01,2013-09-01,2013,2012-02-01,2012,NA,NA,NA,41,2356,1778,852,1430,3208,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://scidok.sulb.uni-saarland.de/volltexte/2017/6827/pdf/Dissertation_ohne_Lebenslauf.pdf,2016-01-01,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00451958,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mannheim Regensburg,A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy,No lead center,Industry,Interventional,Drug,Phase 3,386,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2007-03-23,2007-03-01,2011-12-01,2011,2011-10-01,2011,2012-10-10,314,375,-22,1714,1653,-282,-221,1432,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1742-1241.2011.02637.x,21342376,https://www.ncbi.nlm.nih.gov/pubmed/21342376,2011-02-22,journal publication,TRUE,TRUE,doi,Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer,International journal of clinical practice,2011-May,2011-02-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2192,3545,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,1368-5031,International Journal of Clinical Practice,Wiley,2011-02-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2012-02-22,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00453895,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,Berlin,Sunitinib in Refractory Adrenocortical Carcinoma,small,Other,Interventional,Drug,Phase 2,39,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-03-28,2007-07-01,2012-02-01,2012,2011-08-01,2011,2015-09-06,1313,1497,95,1771,1587,176,360,1947,2017-07-01,2017-12-01,2021-08-15,10.1210/jc.2012-1419,22837187,NA,2012-07-26,journal publication,TRUE,TRUE,doi,"Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial",The Journal of clinical endocrinology and metabolism,2012-Oct,2012-07-26,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2130,3483,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,bronze,bronze,"0021-972X,1945-7197",The Journal of Clinical Endocrinology & Metabolism,The Endocrine Society,2012-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2013-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -888,7 +888,7 @@ NCT00555906,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT00557531,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg,Safety and Feasibility of the Injectable BL-1040 Implant,No lead center,Industry,Interventional,Device,Phase 1/Phase 2,30,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2007-11-12,2008-03-01,2014-01-01,2014,2010-01-01,2010,NA,NA,NA,110,2242,781,300,1761,2542,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.114.001478,25351198,https://www.ncbi.nlm.nih.gov/pubmed/25351198,2014-10-28,journal publication,TRUE,TRUE,doi,Intracoronary delivery of injectable bioabsorbable scaffold (IK-5001) to treat left ventricular remodeling after ST-elevation myocardial infarction: a first-in-man study,Circulation. Cardiovascular interventions,2014-Dec,2014-10-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2014-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00558506,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis,large,Other,Interventional,Drug,Phase 2,30,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2007-11-14,2008-01-01,2009-12-01,2009,2009-10-01,2009,NA,NA,NA,48,748,687,471,532,1219,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://ard.bmj.com/content/70/6/1108.short,2011-03-17,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,16,16,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00560430,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,Berlin,Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients,large,Other,Interventional,Drug,Phase 3,56,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2007-11-16,2007-11-01,2009-10-01,2009,2009-09-01,2009,NA,NA,NA,-15,685,655,713,743,1398,2017-07-01,2017-12-01,2021-08-15,10.1161/hypertensionaha.111.173542,21876071,http://hyper.ahajournals.org/content/58/4/725.short,2011-09-14,journal publication,TRUE,TRUE,doi,High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome,"Hypertension (Dallas, Tex. : 1979)",2011-Oct,2011-08-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2983,4336,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0194-911X,1524-4563",Hypertension,Ovid Technologies (Wolters Kluwer Health),2011-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2012-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00561990,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum Bochum,NA,Nimotuzumab in Adults With Pancreatic Cancer,small,Industry,Interventional,Drug,Phase 2/Phase 3,188,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2007-11-20,2007-09-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-80,2234,1869,1369,1734,3603,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdx343,28961832,https://www.ncbi.nlm.nih.gov/pubmed/28961832,2017-10-01,journal publication,TRUE,TRUE,doi,"Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study",Annals of oncology : official journal of the European Society for Medical Oncology,2017-Oct-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,1,1,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2018-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00561990,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum,Schleswig-Holstein Mannheim,Nimotuzumab in Adults With Pancreatic Cancer,small,Industry,Interventional,Drug,Phase 2/Phase 3,188,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2007-11-20,2007-09-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-80,2234,1869,1369,1734,3603,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdx343,28961832,https://www.ncbi.nlm.nih.gov/pubmed/28961832,2017-10-01,journal publication,TRUE,TRUE,doi,"Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study",Annals of oncology : official journal of the European Society for Medical Oncology,2017-Oct-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,1,1,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2018-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00562107,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Leipzig Schleswig-Holstein Mainz Ulm,Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication,No lead center,Industry,Interventional,Device,Phase 4,650,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2007-11-20,2007-12-01,2013-04-01,2013,2011-03-01,2011,NA,NA,NA,11,1959,1197,518,1280,2477,2017-07-01,2017-12-01,2021-08-15,10.1093/eurheartj/ehu336,25179761,https://www.ncbi.nlm.nih.gov/pubmed/25179761,2014-09-01,journal publication,TRUE,TRUE,doi,Long-term clinical effects of ventricular pacing reduction with a changeover mode to minimize ventricular pacing in a general pacemaker population,European heart journal,2015-Jan-14,2014-09-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2014-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00564239,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Psychological Prevention of Internalizing Disorders,small,Other,Interventional,Behavioral,NA,77,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2007-11-26,2007-11-01,2009-05-01,2009,2009-05-01,2009,NA,NA,NA,-25,522,522,697,697,1219,2017-07-01,2017-12-01,2021-08-15,10.1026/0942-5403/a000046,NA,https://econtent.hogrefe.com/doi/abs/10.1026/0942-5403/a000046,2011-03-29,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3136,4489,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0942-5403,2190-6246",Kindheit und Entwicklung,Hogrefe Publishing Group,2011-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00567801,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,Bonn Frankfurt Giessen Hamburg Schleswig-Holstein Mainz Rostock,CRAIL - Controlled Reperfusion of the Acutely Ischemic Limb,large,Other,Interventional,Procedure,Phase 3,250,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2007-12-04,2002-09-01,2010-09-01,2010,2009-09-01,2009,NA,NA,NA,-1920,1002,637,1084,1449,2086,2017-07-01,2017-12-01,2021-08-15,10.1161/circinterventions.112.000371,23881815,http://circinterventions.ahajournals.org/content/6/4/417.short,2013-08-20,journal publication,TRUE,TRUE,doi,"Controlled reperfusion versus conventional treatment of the acutely ischemic limb: results of a randomized, open-label, multicenter trial",Circulation. Cardiovascular interventions,2013-Aug,2013-07-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2013-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -924,11 +924,11 @@ NCT00708942,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hann NCT00709852,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Dresden Erlangen Hamburg Hannover Schleswig-Holstein Köln Leipzig LMU-München TU-München Homburg,Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging,No lead center,Industry,Interventional,Drug,Phase 3,402,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2008-07-01,2008-06-01,2009-04-01,2009,2009-04-01,2009,2011-08-19,870,870,-30,274,274,2197,2197,2471,2017-07-01,2017-12-01,2021-08-15,10.4137/mri.s19794,25922578,https://www.ncbi.nlm.nih.gov/pubmed/25922578,2015-04-07,journal publication,TRUE,TRUE,doi,"Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study",Magnetic resonance insights,2015,2015-04-07,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,3166,4519,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,green,green,"1178-623X,1178-623X",Magnetic Resonance Insights,SAGE Publications,2015-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00710190,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Duisburg-Essen Hannover,Device Based Therapy in Hypertension Trial,No lead center,Industry,Interventional,Device,NA,46,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-07-01,2003-07-01,2011-10-01,2011,2011-10-01,2011,NA,NA,NA,-1827,1187,1187,-368,-368,819,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2010.03.089,20883933,http://www.sciencedirect.com/science/article/pii/S0735109710027221,2010-09-28,journal publication,TRUE,TRUE,doi,Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study,Journal of the American College of Cardiology,2010-Oct-05,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2010-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2011-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00710294,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Hannover,Device Based Therapy in Hypertension Extension Trial,No lead center,Industry,Interventional,Device,NA,50,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-07-02,2005-08-01,2011-10-01,2011,2011-10-01,2011,NA,NA,NA,-1066,1186,1186,-361,-361,825,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2010.03.089,20883933,https://www.ncbi.nlm.nih.gov/pubmed/20883933,2010-10-05,journal publication,TRUE,TRUE,doi,Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study,Journal of the American College of Cardiology,2010-Oct-05,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2010-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2011-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00711230,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients,large,Industry,Interventional,Biological,Phase 2,36,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-04,2008-04-01,2015-01-01,2015,2011-12-01,2011,NA,NA,NA,-94,2372,1245,-106,1021,2266,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.researchgate.net/publication/264848719_DermaVir_for_initial_treatment_of_HIV-infected_subjects_demonstrates_preliminary_safety_immunogenicity_and_HIV-RNA_reduction_versus_placebo_immunization_A-240-0111-_12561,2014-09-17,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,20,20,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00711230,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients,large,Industry,Interventional,Biological,Phase 2,36,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-04,2008-04-01,2015-01-01,2015,2011-12-01,2011,NA,NA,NA,-94,2372,1245,-106,1021,2266,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.researchgate.net/publication/264848719_DermaVir_for_initial_treatment_of_HIV-infected_subjects_demonstrates_preliminary_safety_immunogenicity_and_HIV-RNA_reduction_versus_placebo_immunization_A-240-0111-_12561,2014-09-17,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,20,20,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00717340,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,"A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer",large,Industry,Interventional,Drug,Phase 1,18,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2008-07-16,2009-02-01,2011-02-01,2011,2011-01-01,2011,NA,NA,NA,200,930,899,899,930,1829,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-013-2632-9,23868188,https://www.ncbi.nlm.nih.gov/pubmed/23868188,2013-07-19,journal publication,TRUE,TRUE,doi,A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer,Breast cancer research and treatment,2013-Jul,2013-07-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2495,3848,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2013-07-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00718939,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover Köln,NA,Rheos® Diastolic Heart Failure Trial,large,Industry,Interventional,Device,NA,6,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-17,2008-07-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-16,1445,1445,-635,-635,810,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jacc.2010.03.089,20883933,http://www.sciencedirect.com/science/article/pii/S0735109710027221,2010-10-05,journal publication,TRUE,TRUE,doi,Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study,Journal of the American College of Cardiology,2010-Oct-05,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2010-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2011-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00720850,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,Düsseldorf Duisburg-Essen Hamburg Hannover Ulm Würzburg,Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML),large,Other,Interventional,Drug,Phase 2,10,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-07-17,2008-04-01,2011-01-01,2011,2011-01-01,2011,NA,NA,NA,-107,898,898,609,609,1507,2017-07-01,2017-12-01,2021-08-15,10.3324/haematol.2012.067629,22952334,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436225/,2012-09-01,journal publication,TRUE,TRUE,doi,Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial,Haematologica,2012-Sep,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"0390-6078,1592-8721",Haematologica,Ferrata Storti Foundation (Haematologica),2012-09-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00727207,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy,large,Other,Interventional,Drug,Phase 2,35,Terminated,NA,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2008-07-31,2008-05-01,2014-09-01,2014,2011-05-01,2011,NA,NA,NA,-91,2223,1004,211,1430,2434,2017-07-01,2017-12-01,2021-08-15,10.3109/10428194.2015.1028055,25754578,https://www.ncbi.nlm.nih.gov/pubmed/25754578,2015-03-31,journal publication,TRUE,TRUE,doi,Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study,Leukemia & lymphoma,2015,2015-03-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2015-03-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-11-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00727207,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy,large,Other,Interventional,Drug,Phase 2,35,Terminated,NA,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2008-07-31,2008-05-01,2014-09-01,2014,2011-05-01,2011,NA,NA,NA,-91,2223,1004,211,1430,2434,2017-07-01,2017-12-01,2021-08-15,10.3109/10428194.2015.1028055,25754578,https://www.ncbi.nlm.nih.gov/pubmed/25754578,2015-03-31,journal publication,TRUE,TRUE,doi,Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study,Leukemia & lymphoma,2015,2015-03-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2015-03-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-11-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00730249,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Berlin Bochum Freiburg Hamburg Homburg Würzburg,Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA,No lead center,Industry,Interventional,Drug,Phase 3,150,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-06,2008-09-01,NA,NA,2010-01-01,2010,NA,NA,NA,26,NA,513,NA,347,860,2017-07-01,2017-12-01,2021-08-15,10.3109/15622975.2010.540257,21155632,http://www.tandfonline.com/doi/abs/10.3109/15622975.2010.540257,2010-12-14,journal publication,TRUE,TRUE,doi,"Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate",The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,2012-Jan,2010-12-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,green,green,"1562-2975,1814-1412",The World Journal of Biological Psychiatry,Informa UK Limited,2010-12-14,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00735137,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Randomized Study of Pessary Versus Standard Management in Women With Increased Chance of Premature Birth,No lead center,Other,Interventional,Device,Phase 3,2109,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-13,2008-08-01,2012-02-01,2012,2012-02-01,2012,NA,NA,NA,-12,1267,1267,1304,1304,2571,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajog.2015.08.051,26321037,http://www.sciencedirect.com/science/article/pii/S0002937815009333,2015-08-28,journal publication,TRUE,TRUE,doi,Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial,American journal of obstetrics and gynecology,2016-Jan,2015-08-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,1,0,0,1,0,0,2130,3483,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0002-9378,American Journal of Obstetrics and Gynecology,Elsevier BV,2016-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00736476,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Magdeburg,Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults,No lead center,Industry,Interventional,Biological,Phase 1,63,Completed,Single,Randomized,TRUE,FALSE,TRUE,TRUE,2008-08-13,2008-10-01,2010-04-01,2010,2010-03-01,2010,2016-09-30,2374,2405,49,596,565,2760,2791,3356,2017-07-01,2017-12-01,2021-08-15,10.1053/j.gastro.2017.10.014,29066327,NA,2017-10-21,journal publication,TRUE,TRUE,doi,Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection,Gastroenterology,2018-02,2017-10-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,2801,4154,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,closed,closed,0016-5085,Gastroenterology,Elsevier BV,2018-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -941,14 +941,14 @@ NCT00761059,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köl NCT00763464,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Coronary Artery Disease (CAD) in Postmenopausal Women,small,Other,Interventional,Procedure,NA,100,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2008-09-29,2006-10-01,2011-06-01,2011,2011-04-01,2011,NA,NA,NA,-729,975,914,1249,1310,2224,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-014-0780-5,25367244,NA,2014-11-01,journal publication,TRUE,TRUE,doi,Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study,Clinical research in cardiology : official journal of the German Cardiac Society,2015-Mar,2014-11-01,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2014-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00765830,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Frankfurt Hannover Heidelberg Jena LMU-München Würzburg,Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension),No lead center,Industry,Interventional,Drug,Phase 3,349,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-02,2008-09-01,2011-04-01,2011,2011-04-01,2011,NA,NA,NA,-31,911,911,464,464,1375,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1463-1326.2012.01634.x,22690943,https://www.ncbi.nlm.nih.gov/pubmed/22690943,2012-07-08,journal publication,TRUE,TRUE,doi,"One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment","Diabetes, obesity & metabolism",2012-Nov,2012-07-08,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2436,3789,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1462-8902,"Diabetes, Obesity and Metabolism",Wiley,2012-07-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2013-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00766155,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer,small,Other,Interventional,Drug,Phase 3,1094,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-02,2008-08-01,NA,NA,2011-09-01,2011,NA,NA,NA,-62,NA,1064,NA,1187,2251,2017-07-01,2017-12-01,2021-08-15,10.1016/s0167-8140(15)30355-8,NA,http://www.thegreenjournal.com/article/S0167-8140(15)30355-8/abstract,2014-12-01,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,0167-8140,Radiotherapy and Oncology,Elsevier BV,2014-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00770783,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Bonn Bonn,NA,Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression,large,Other,Interventional,Device,Phase 3,30,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-09,2005-02-01,2014-05-01,2014,2013-09-01,2013,NA,NA,NA,-1346,2030,1788,-1293,-1051,737,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jpsychires.2010.09.008,20951997,https://www.ncbi.nlm.nih.gov/pubmed/20951997,2010-10-16,journal publication,TRUE,TRUE,doi,"Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression",Journal of psychiatric research,2011-May,2010-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3956,Journal of Psychiatric Research,Elsevier BV,2011-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00770783,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression,large,Other,Interventional,Device,Phase 3,30,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-09,2005-02-01,2014-05-01,2014,2013-09-01,2013,NA,NA,NA,-1346,2030,1788,-1293,-1051,737,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jpsychires.2010.09.008,20951997,https://www.ncbi.nlm.nih.gov/pubmed/20951997,2010-10-16,journal publication,TRUE,TRUE,doi,"Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression",Journal of psychiatric research,2011-May,2010-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3956,Journal of Psychiatric Research,Elsevier BV,2011-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00776763,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab,No lead center,Other,Interventional,Drug,Phase 2,150,Completed,Single,Non-Randomized,FALSE,FALSE,TRUE,FALSE,2008-10-17,2008-10-01,2010-12-01,2010,2009-10-01,2009,NA,NA,NA,-16,775,349,-609,-183,166,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://iovs.arvojournals.org/article.aspx?articleid=2363769,2009-04-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00778648,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms,large,Other,Interventional,Dietary Supplement,NA,543,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,TRUE,2008-10-21,2008-09-01,2009-07-01,2009,2009-07-01,2009,2010-09-09,435,435,-50,253,253,418,418,671,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/reduction-of-common-cold-symptoms-by-encapsulated-juice-powder-concentrate-of-fruits-and-vegetables-a-randomised-double-blind-placebo-controlled-trial/4E3A02A6D1E0EF0A17D0043394E843C4,2010-08-23,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,3075,4428,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00779597,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg TU-München,NA,Improvement of Self Management for Oncologic Patients With Pain,large,Other,Interventional,Behavioral,NA,208,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-10-22,2008-10-01,2010-01-01,2010,2009-12-01,2009,NA,NA,NA,-21,436,405,1473,1504,1909,2017-07-01,2017-12-01,2021-08-15,10.1016/j.pain.2014.01.006,24434732,https://www.ncbi.nlm.nih.gov/pubmed/24434732,2014-01-13,journal publication,TRUE,TRUE,doi,Improvement of pain-related self-management for cancer patients through a modular transitional nursing intervention: a cluster-randomized multicenter trial,Pain,2014-Apr,2014-01-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0304-3959,Pain,Ovid Technologies (Wolters Kluwer Health),2014-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00783653,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Hamburg,NA,Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years,large,Other,Interventional,Drug,Phase 1/Phase 2,22,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-10-31,2008-08-01,NA,NA,2013-07-01,2013,NA,NA,NA,-91,NA,1704,NA,636,2340,2017-07-01,2017-12-01,2021-08-15,10.1111/bjh.13353,25818407,NA,2015-03-29,journal publication,TRUE,TRUE,doi,A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations,British journal of haematology,2015-Jun,2015-03-29,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,bronze,bronze,0007-1048,British Journal of Haematology,Wiley,2015-03-29,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-28,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00784446,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,Mainz Mannheim Ulm,First-line Therapy of Stage IV Colorectal Cancer,large,Other,Interventional,Drug,Phase 1/Phase 2,51,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-11-03,2008-04-01,2012-12-01,2012,2010-08-01,2010,NA,NA,NA,-216,1489,636,262,1115,1751,2017-07-01,2017-12-01,2021-08-15,10.1038/bjc.2013.409,23963139,https://www.ncbi.nlm.nih.gov/pubmed/?term=10.1038%2Fbjc.2013.409,2013-08-20,journal publication,TRUE,TRUE,doi,Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205,British journal of cancer,2013-Sep-17,2013-08-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0007-0920,1532-1827",British Journal of Cancer,Springer Science and Business Media LLC,2013-08-20,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-sa', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00785421,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Chemotherapy With or Without Enoxaparin in Pancreatic Cancer,No lead center,Other,Interventional,Drug,Phase 2/Phase 3,312,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2008-11-04,2004-04-01,2009-06-01,2009,2009-01-01,2009,NA,NA,NA,-1678,209,58,2177,2328,2386,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.55.1481,25987694,http://ascopubs.org/doi/full/10.1200/JCO.2014.55.1481,2015-05-18,journal publication,TRUE,TRUE,doi,Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2015-Jun-20,2015-05-18,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,3105,4458,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2015-06-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-06-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT00787293,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients,small,Industry,Interventional,Device,Phase 2,30,Suspended,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-11-05,2008-10-01,2015-11-01,2015,2010-11-01,2010,NA,NA,NA,-35,2552,726,-990,836,1562,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ahj.2013.01.010,23622913,https://www.ncbi.nlm.nih.gov/pubmed/23622913,2013-02-14,journal publication,TRUE,TRUE,doi,Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial,American heart journal,2013-May,2013-02-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,10,10,761,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-8703,American Heart Journal,Elsevier BV,2013-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00787293,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,Bochum Duisburg-Essen Freiburg,Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients,small,Industry,Interventional,Device,Phase 2,30,Suspended,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-11-05,2008-10-01,2015-11-01,2015,2010-11-01,2010,NA,NA,NA,-35,2552,726,-990,836,1562,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ahj.2013.01.010,23622913,https://www.ncbi.nlm.nih.gov/pubmed/23622913,2013-02-14,journal publication,TRUE,TRUE,doi,Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial,American heart journal,2013-May,2013-02-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,10,10,761,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-8703,American Heart Journal,Elsevier BV,2013-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00795548,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,Berlin Dresden Frankfurt Hamburg Heidelberg,Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation,small,Other,Interventional,Drug,Phase 2,30,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2008-11-20,2008-11-01,2011-08-01,2011,2010-10-01,2010,NA,NA,NA,-19,984,680,532,836,1516,2017-07-01,2017-12-01,2021-08-15,10.1038/leu.2013.7,23314834,https://www.ncbi.nlm.nih.gov/pubmed/23314834,2013-01-14,journal publication,TRUE,TRUE,doi,Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation,Leukemia,2013-Jun,2013-01-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2013-01-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00795964,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Influence of Tidal Volume on Postoperative Pulmonary Function,small,Other,Interventional,Other,NA,101,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2008-11-20,2008-09-01,2010-09-01,2010,2010-09-01,2010,NA,NA,NA,-80,650,650,639,639,1289,2017-07-01,2017-12-01,2021-08-15,10.1093/bja/aes140,22661750,NA,2012-06-01,journal publication,TRUE,TRUE,doi,Ventilation with low tidal volumes during upper abdominal surgery does not improve postoperative lung function,British journal of anaesthesia,2012-Aug,2012-06-01,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0007-0912,British Journal of Anaesthesia,Elsevier BV,2012-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00796354,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Halle-Wittenberg,Constipation Associated With Irritable Bowel Syndrome (IBS-C),No lead center,Industry,Interventional,Drug,Phase 3,210,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2008-11-21,2008-11-01,2010-02-01,2010,2010-02-01,2010,NA,NA,NA,-20,437,437,1254,1254,1691,2017-07-01,2017-12-01,2021-08-15,10.1038/ajg.2013.197,23835436,NA,2013-07-09,journal publication,TRUE,TRUE,doi,Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome,The American journal of gastroenterology,2013-Sep,2013-07-09,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2860,4213,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0002-9270,American Journal of Gastroenterology,Ovid Technologies (Wolters Kluwer Health),2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -981,8 +981,8 @@ NCT00849667,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT00851279,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leipzig,Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia,No lead center,Industry,Interventional,Device,Phase 4,53,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2009-02-24,2009-06-01,2013-04-01,2013,2012-10-01,2012,2013-12-02,245,427,97,1497,1315,1065,1247,2562,2017-07-01,2017-12-01,2021-08-15,10.1111/jce.12910,26969220,https://www.ncbi.nlm.nih.gov/pubmed/26969220,2016-03-01,journal publication,TRUE,TRUE,doi,Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial,Journal of cardiovascular electrophysiology,2016-Mar,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,bronze,bronze,1045-3873,Journal of Cardiovascular Electrophysiology,Wiley,2016-03-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00852670,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg Mainz Münster,ACT-128800 in Psoriasis,No lead center,Industry,Interventional,Drug,Phase 2,66,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-02-26,2008-10-01,2009-09-01,2009,2009-07-01,2009,NA,NA,NA,-148,187,125,504,566,691,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2008-001443-19/results,2011-01-18,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3013,4366,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00854516,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease,small,Industry,Interventional,Procedure,NA,15,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2009-02-27,2009-02-01,2010-01-01,2010,2009-10-01,2009,NA,NA,NA,-26,308,216,1599,1691,1907,2017-07-01,2017-12-01,2021-08-15,10.1177/0268355514529507,24843079,NA,2014-05-19,journal publication,TRUE,TRUE,doi,Compression therapy of leg ulcers with PAOD,Phlebology,2014-May,2014-05-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0268-3555,1758-1125",Phlebology: The Journal of Venous Disease,SAGE Publications,2014-05-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT00860730,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,PERCEVAL Pivotal Trial,large,Industry,Interventional,Device,NA,150,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-11,2009-01-01,2015-10-01,2015,2009-10-01,2009,NA,NA,NA,-69,2395,204,-209,1982,2186,2017-07-01,2017-12-01,2021-08-15,10.1093/ejcts/ezv040,25750010,https://www.ncbi.nlm.nih.gov/pubmed/25750010,2015-03-06,journal publication,TRUE,TRUE,doi,European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2016-Jan,2015-03-06,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,792,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1010-7940,1873-734X",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2015-03-06,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00862511,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA),large,Other,Interventional,Device,NA,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-16,2009-03-01,2017-01-01,2017,2012-12-01,2012,NA,NA,NA,-15,2848,1356,-245,1247,2603,2017-07-01,2017-12-01,2021-08-15,10.3928/01477447-20160509-10,27219721,https://www.ncbi.nlm.nih.gov/pubmed/?term=Midterm+Results+After+Coated+and+Uncoated+TKA%3A+A+Randomized+Controlled+Study,2016-05-01,journal publication,TRUE,TRUE,doi,Midterm Results After Coated and Uncoated TKA: A Randomized Controlled Study,Orthopedics,2016-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,334,1687,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0147-7447,1938-2367",Orthopedics,"SLACK, Inc.",2016-05-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT00860730,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,Bochum,PERCEVAL Pivotal Trial,large,Industry,Interventional,Device,NA,150,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-11,2009-01-01,2015-10-01,2015,2009-10-01,2009,NA,NA,NA,-69,2395,204,-209,1982,2186,2017-07-01,2017-12-01,2021-08-15,10.1093/ejcts/ezv040,25750010,https://www.ncbi.nlm.nih.gov/pubmed/25750010,2015-03-06,journal publication,TRUE,TRUE,doi,European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2016-Jan,2015-03-06,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,792,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1010-7940,1873-734X",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2015-03-06,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00862511,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA),large,Other,Interventional,Device,NA,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-16,2009-03-01,2017-01-01,2017,2012-12-01,2012,NA,NA,NA,-15,2848,1356,-245,1247,2603,2017-07-01,2017-12-01,2021-08-15,10.3928/01477447-20160509-10,27219721,https://www.ncbi.nlm.nih.gov/pubmed/?term=Midterm+Results+After+Coated+and+Uncoated+TKA%3A+A+Randomized+Controlled+Study,2016-05-01,journal publication,TRUE,TRUE,doi,Midterm Results After Coated and Uncoated TKA: A Randomized Controlled Study,Orthopedics,2016-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,334,1687,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0147-7447,1938-2367",Orthopedics,"SLACK, Inc.",2016-05-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT00866073,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,Aachen Düsseldorf Hannover Ulm,Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia,large,Other,Interventional,Drug,Phase 2,238,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-19,2003-04-01,2009-03-01,2009,2009-02-01,2009,NA,NA,NA,-2179,-18,-46,-105,-77,-123,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/112/11/2965?sso-checked=true,2008-11-16,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3197,4550,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00867750,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma,large,Industry,Interventional,Device,Phase 2,28,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-03-13,2006-03-01,2011-06-01,2011,2011-06-01,2011,NA,NA,NA,-1108,810,810,1326,1326,2136,2017-07-01,2017-12-01,2021-08-15,10.1111/liv.12750,25443863,https://www.ncbi.nlm.nih.gov/pubmed/25443863,2015-01-17,journal publication,TRUE,TRUE,doi,Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma,Liver international : official journal of the International Association for the Study of the Liver,2015-Jun,2015-01-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1478-3223,Liver International,Wiley,2015-01-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-01-17,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00868166,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Halle-Wittenberg Hannover Ulm,Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS,No lead center,Industry,Interventional,Drug,Phase 3,512,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-03-23,2009-04-30,2011-09-30,2011,2011-09-30,2011,2014-11-24,1151,1151,38,921,921,844,844,1765,2017-07-01,2017-12-01,2021-08-15,10.1111/ene.12344,24447620,http://onlinelibrary.wiley.com/doi/10.1111/ene.12344/full,2014-01-21,journal publication,TRUE,TRUE,doi,A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis,European journal of neurology,2014-Mar,2014-01-21,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2254,3607,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,closed,closed,1351-5101,European Journal of Neurology,Wiley,2014-01-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -1033,12 +1033,12 @@ NCT00976859,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Fran NCT00979966,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Berlin Düsseldorf Frankfurt Halle-Wittenberg Jena Schleswig-Holstein,Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib,No lead center,Other,Interventional,Drug,Phase 2,22,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-09-09,2009-07-01,NA,NA,2012-07-01,2012,NA,NA,NA,-70,NA,1026,NA,1184,2210,2017-07-01,2017-12-01,2021-08-15,10.1016/s0959-8049(16)31435-6,NA,http://www.sciencedirect.com/science/article/pii/S0959804916314356?via%3Dihub,2015-09-28,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,0959-8049,European Journal of Cancer,Elsevier BV,2015-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00989352,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg LMU-München,Heidelberg Köln Ulm,Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma,large,Other,Interventional,Drug,Phase 2,56,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-10-02,2009-09-01,2011-09-01,2011,2011-06-01,2011,NA,NA,NA,-31,699,607,1902,1994,2601,2017-07-01,2017-12-01,2021-08-15,10.1038/leu.2016.334,27843136,https://www.ncbi.nlm.nih.gov/pubmed/27843136,2016-11-15,journal publication,TRUE,TRUE,doi,High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study),Leukemia,2017-04,2016-11-15,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,hybrid,hybrid,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2016-11-15,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00993980,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Qigong and Exercise Therapy for Low Back Pain in Adults,large,Other,Interventional,Procedure,NA,127,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-13,2009-10-01,2011-01-01,2011,2010-03-01,2010,NA,NA,NA,-12,445,139,1251,1557,1696,2017-07-01,2017-12-01,2021-08-15,10.1002/ejp.529,24902673,http://onlinelibrary.wiley.com/doi/10.1002/ejp.529/abstract,2014-06-05,journal publication,TRUE,TRUE,doi,Qigong versus exercise therapy for chronic low back pain in adults--a randomized controlled non-inferiority trial,"European journal of pain (London, England)",2015-Jan,2014-06-05,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1090-3801,European Journal of Pain,Wiley,2014-06-05,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-06-05,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01002703,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,"Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma",large,Other,Interventional,Drug,Phase 1/Phase 2,50,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-10-23,2009-09-01,2014-10-01,2014,2012-10-01,2012,NA,NA,NA,-52,1804,1074,-498,232,1306,2017-07-01,2017-12-01,2021-08-15,10.1111/bjh.12361,23692564,https://www.ncbi.nlm.nih.gov/pubmed/23692564,2013-05-21,journal publication,TRUE,TRUE,doi,"Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077",British journal of haematology,2013-Jul,2013-05-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0007-1048,British Journal of Haematology,Wiley,2013-05-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01010243,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial,small,Other,Interventional,Drug,Phase 1/Phase 2,54,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-11-06,2009-10-01,2016-10-01,2016,2013-10-01,2013,NA,NA,NA,-36,2521,1425,-1415,-319,1106,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/120/21/5029?sso-checked=true,2012-11-16,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,426,1779,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01002703,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma",large,Other,Interventional,Drug,Phase 1/Phase 2,50,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-10-23,2009-09-01,2014-10-01,2014,2012-10-01,2012,NA,NA,NA,-52,1804,1074,-498,232,1306,2017-07-01,2017-12-01,2021-08-15,10.1111/bjh.12361,23692564,https://www.ncbi.nlm.nih.gov/pubmed/23692564,2013-05-21,journal publication,TRUE,TRUE,doi,"Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077",British journal of haematology,2013-Jul,2013-05-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0007-1048,British Journal of Haematology,Wiley,2013-05-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01010243,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,Schleswig-Holstein LMU-München,Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial,small,Other,Interventional,Drug,Phase 1/Phase 2,54,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-11-06,2009-10-01,2016-10-01,2016,2013-10-01,2013,NA,NA,NA,-36,2521,1425,-1415,-319,1106,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/120/21/5029?sso-checked=true,2012-11-16,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,426,1779,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01013259,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis,large,Other,Interventional,Drug,Phase 2,34,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2009-11-10,2009-02-01,2009-10-01,2009,2009-09-01,2009,NA,NA,NA,-282,-40,-70,1507,1537,1467,2017-07-01,2017-12-01,2021-08-15,10.1159/000356328,24247760,https://www.ncbi.nlm.nih.gov/pubmed/?term=Tolerability+and+Clinical+Outcome+of+Coseasonal+Treatment+with+Escherichia+coli+Strain+Nissle+1917+in+Grass+Pollen-Allergic+Subjects,2013-11-16,journal publication,TRUE,TRUE,doi,Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects,International archives of allergy and immunology,2014,2013-11-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2983,4336,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1423-0097,1018-2438",International Archives of Allergy and Immunology,S. Karger AG,2014-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01014767,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Regensburg,Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors,No lead center,Other,Interventional,Drug,Phase 3,27,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-11-13,2009-11-01,2014-01-01,2014,2013-10-01,2013,2017-02-03,1129,1221,-12,1510,1418,677,769,2187,2017-07-01,2017-12-01,2021-08-15,10.1093/neuonc/nov229.01,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639153/#__ffn_sectitle,2015-11-09,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,bronze,green,"1522-8517,1523-5866",Neuro-Oncology,Oxford University Press (OUP),2015-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01016873,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg Tübingen,INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD,No lead center,Industry,Interventional,Device,Phase 2,230,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2009-11-19,2009-11-01,2014-04-01,2014,2012-05-01,2012,2014-11-13,226,926,-18,1594,894,-212,488,1382,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ophtha.2013.02.016,23490327,http://www.sciencedirect.com/science/article/pii/S0161642013001504,2013-09-01,journal publication,TRUE,TRUE,doi,Stereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID study,Ophthalmology,2013-Sep,2013-03-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,0161-6420,Ophthalmology,Elsevier BV,2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01019434,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma,large,Other,Interventional,Drug,Phase 2,111,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-11-24,2009-10-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-54,1558,1468,794,884,2352,2017-07-01,2017-12-01,2021-08-15,10.1158/1078-0432.ccr-15-3153,27143690,http://clincancerres.aacrjournals.org/content/clincanres/early/2016/07/29/1078-0432.CCR-15-3153.full.pdf,2016-05-03,journal publication,TRUE,TRUE,doi,Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082),Clinical cancer research : an official journal of the American Association for Cancer Research,2016-Oct-01,2016-05-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2016-05-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2017-05-03,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01019434,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,Freiburg,Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma,large,Other,Interventional,Drug,Phase 2,111,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-11-24,2009-10-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-54,1558,1468,794,884,2352,2017-07-01,2017-12-01,2021-08-15,10.1158/1078-0432.ccr-15-3153,27143690,http://clincancerres.aacrjournals.org/content/clincanres/early/2016/07/29/1078-0432.CCR-15-3153.full.pdf,2016-05-03,journal publication,TRUE,TRUE,doi,Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082),Clinical cancer research : an official journal of the American Association for Cancer Research,2016-Oct-01,2016-05-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2016-05-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2017-05-03,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01022177,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus,large,Other,Interventional,Procedure,Phase 2,40,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-11-26,2009-10-01,2012-05-01,2012,2010-10-01,2010,NA,NA,NA,-56,887,309,-761,-183,126,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://iovs.arvojournals.org/article.aspx?articleid=2373309,2010-04-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01030185,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Frankfurt Regensburg,Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance,No lead center,Industry,Interventional,Device,Phase 2/Phase 3,40,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-12-10,2010-02-01,2013-06-01,2013,2011-11-01,2011,NA,NA,NA,53,1269,691,-141,437,1128,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jhep.2012.12.020,23318604,https://www.ncbi.nlm.nih.gov/pubmed/23318604,2013-01-11,journal publication,TRUE,TRUE,doi,Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study,Journal of hepatology,2013-May,2013-01-11,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1644,2997,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0168-8278,Journal of Hepatology,Elsevier BV,2013-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01032681,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz Mannheim,"EMD 521873 in Advanced Solid Tumors, MTD Finding",No lead center,Industry,Interventional,Biological,Phase 1,66,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-12-11,2006-12-01,2012-01-01,2012,2011-02-01,2011,NA,NA,NA,-1106,751,417,232,566,983,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ejca.2012.07.015,22918078,https://www.ncbi.nlm.nih.gov/pubmed/22918078,2012-08-20,journal publication,TRUE,TRUE,doi,A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours,"European journal of cancer (Oxford, England : 1990)",2013-Jan,2012-08-20,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0959-8049,European Journal of Cancer,Elsevier BV,2013-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -1047,7 +1047,7 @@ NCT01037231,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT01038804,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Erlangen Schleswig-Holstein,A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer,No lead center,Industry,Interventional,Drug,Phase 2,101,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-22,2009-12-01,2013-06-01,2013,2012-06-01,2012,NA,NA,NA,-21,1257,892,577,942,1834,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-014-3238-6,25547219,NA,2014-12-30,journal publication,TRUE,TRUE,doi,"Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer",Breast cancer research and treatment,2015-Jan,2014-12-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1644,2997,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2014-12-30,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01039103,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,TU-München,Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS),No lead center,Industry,Interventional,Drug,Phase 2,15,Terminated,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-20,2009-12-01,2011-11-01,2011,2011-11-01,2011,NA,NA,NA,-19,681,681,1232,1232,1913,2017-07-01,2017-12-01,2021-08-15,10.1016/j.nano.2015.02.021,25791806,https://www.ncbi.nlm.nih.gov/pubmed/?term=Prednisolone-containing+liposomes+accumulate+in+human+atherosclerotic+macrophages+upon+intravenous+administration,2015-03-17,journal publication,TRUE,TRUE,doi,Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration,"Nanomedicine : nanotechnology, biology, and medicine",2015-Jul,2015-03-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,1549-9634,"Nanomedicine: Nanotechnology, Biology and Medicine",Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01043419,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Sympathetic Neural Outflow During Xenon Anesthesia in Humans,small,Industry,Interventional,Drug,Phase 1,8,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-01-05,2010-01-01,2010-03-01,2010,2010-03-01,2010,NA,NA,NA,-4,55,55,917,917,972,2017-07-01,2017-12-01,2021-08-15,10.1093/bja/aes303,22945969,https://academic.oup.com/bja/article/109/6/887/365640/Cardiovascular-stability-and-unchanged-muscle,2012-09-03,journal publication,TRUE,TRUE,doi,Cardiovascular stability and unchanged muscle sympathetic activity during xenon anaesthesia: role of norepinephrine uptake inhibition,British journal of anaesthesia,2012-Dec,2012-09-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,3,1,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0007-0912,British Journal of Anaesthesia,Elsevier BV,2012-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01049100,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Surgical Staging in Cervical Cancer Prior to Chemoradiation,large,Other,Interventional,Procedure,NA,250,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-13,2009-04-01,2017-04-01,2017,2013-04-01,2013,NA,NA,NA,-287,2635,1174,-687,774,1948,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajog.2015.05.026,25986030,https://www.ncbi.nlm.nih.gov/pubmed/?term=Perioperative+morbidity+and+rate+of+upstaging+after+laparoscopic+staging+for+patients+with+locally+advanced+cervical+cancer%3A+results+of+a+prospective+randomized+trial,2015-05-15,journal publication,TRUE,TRUE,doi,Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial,American journal of obstetrics and gynecology,2015-Oct,2015-05-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,244,1597,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-9378,American Journal of Obstetrics and Gynecology,Elsevier BV,2015-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01049100,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Surgical Staging in Cervical Cancer Prior to Chemoradiation,large,Other,Interventional,Procedure,NA,250,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-13,2009-04-01,2017-04-01,2017,2013-04-01,2013,NA,NA,NA,-287,2635,1174,-687,774,1948,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ajog.2015.05.026,25986030,https://www.ncbi.nlm.nih.gov/pubmed/?term=Perioperative+morbidity+and+rate+of+upstaging+after+laparoscopic+staging+for+patients+with+locally+advanced+cervical+cancer%3A+results+of+a+prospective+randomized+trial,2015-05-15,journal publication,TRUE,TRUE,doi,Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial,American journal of obstetrics and gynecology,2015-Oct,2015-05-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,244,1597,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-9378,American Journal of Obstetrics and Gynecology,Elsevier BV,2015-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01049399,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Dresden Hannover Tübingen,"Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy",No lead center,Industry,Interventional,Drug,NA,146,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-13,2009-12-01,2011-11-01,2011,2011-09-01,2011,NA,NA,NA,-43,657,596,836,897,1493,2017-07-01,2017-12-01,2021-08-15,10.1002/mds.25824,24532007,https://www.ncbi.nlm.nih.gov/pubmed/24532007,2014-02-14,journal publication,TRUE,TRUE,doi,A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy,Movement disorders : official journal of the Movement Disorder Society,2014-Apr,2014-02-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0885-3185,Movement Disorders,Wiley,2014-02-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01049971,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors,large,Other,Interventional,Device,NA,109,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2010-01-14,2007-12-01,2011-01-01,2011,2011-01-01,2011,NA,NA,NA,-775,352,352,476,476,828,2017-07-01,2017-12-01,2021-08-15,10.1007/s00423-012-0954-4,22526415,https://link.springer.com/article/10.1007/s00423-012-0954-4,2012-04-21,journal publication,TRUE,TRUE,doi,Reduction of wound infections in laparoscopic-assisted colorectal resections by plastic wound ring drapes (REDWIL)?--A randomized controlled trial,Langenbeck's archives of surgery,2012-Oct,2012-04-21,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1435-2443,1435-2451",Langenbeck's Archives of Surgery,Springer Science and Business Media LLC,2012-04-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2013-04-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01051518,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Clinical Evaluation of Percutaneous Implantation of the Medtronic CoreValve Aortic Valve Prosthesis (18Fr-Study),large,Industry,Interventional,Device,NA,126,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2010-01-15,2006-05-01,2013-06-01,2013,2009-02-01,2009,2017-10-27,1609,3190,-1355,1233,-348,1227,2808,2460,2017-07-01,2017-12-01,2021-08-15,10.4244/eijy15m10_10,27159659,https://www.ncbi.nlm.nih.gov/pubmed/27159659,2016-10-10,journal publication,TRUE,TRUE,doi,Four-year experience with the CoreValve transcatheter heart valve,EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,2016-Oct-10,2016-10-10,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1644,2997,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,closed,closed,1969-6213,EuroIntervention,Europa Digital & Publishing,2016-10-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA @@ -1072,13 +1072,13 @@ NCT01094678,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT01095926,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,Duisburg-Essen Frankfurt Freiburg Schleswig-Holstein,Pharmacokinetic Study of Doxorubicin in Children With Cancer,large,Other,Interventional,Drug,Phase 2,101,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-03-22,2010-05-01,2013-05-01,2013,2013-02-01,2013,NA,NA,NA,40,1136,1047,914,1003,2050,2017-07-01,2017-12-01,2021-08-15,10.1007/s40262-015-0272-4,25925711,https://www.ncbi.nlm.nih.gov/pubmed/?term=Age-Dependent+Pharmacokinetics+of+Doxorubicin+in+Children+with+Cancer,2015-11-01,journal publication,TRUE,TRUE,doi,Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer,Clinical pharmacokinetics,2015-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0312-5963,1179-1926",Clinical Pharmacokinetics,Springer Science and Business Media LLC,2015-04-30,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01097434,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography,large,Other,Interventional,Device,Phase 4,48,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-03-31,2010-04-01,2011-05-01,2011,2011-05-01,2011,NA,NA,NA,1,396,396,998,998,1394,2017-07-01,2017-12-01,2021-08-15,10.1007/s10554-014-0376-1,24452729,https://www.ncbi.nlm.nih.gov/pubmed/24452729,2014-01-23,journal publication,TRUE,TRUE,doi,Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography,The international journal of cardiovascular imaging,2014-Mar,2014-01-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1569-5794,1573-0743",The International Journal of Cardiovascular Imaging,Springer Science and Business Media LLC,2014-01-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01101399,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg,Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy,No lead center,Industry,Interventional,Drug,Phase 3,19,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-03-30,2010-05-01,2013-11-01,2013,2012-11-01,2012,NA,NA,NA,32,1312,947,370,735,1682,2017-07-01,2017-12-01,2021-08-15,10.1007/s12032-014-0302-3,25373320,NA,2014-11-06,journal publication,TRUE,TRUE,doi,Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy,"Medical oncology (Northwood, London, England)",2014-Dec,2014-11-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"1357-0560,1559-131X",Medical Oncology,Springer Science and Business Media LLC,2014-11-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01105143,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Effects of Negative Energy Balance on Muscle Mass Regulation,large,Other,Interventional,Behavioral,NA,81,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2012-03-01,2017-05-01,2017,2015-05-01,2015,NA,NA,NA,687,2574,1843,-61,670,2513,2017-07-01,2017-12-01,2021-08-15,10.1093/cercor/bhw008,26838769,https://www.ncbi.nlm.nih.gov/pubmed/?term=Caloric+Restriction+in+Older+Adults%E2%80%94Differential+Effects+of+Weight+Loss+and+Reduced+Weight+on+Brain+Structure+and+Function,2017-03-01,journal publication,TRUE,TRUE,doi,Caloric Restriction in Older Adults-Differential Effects of Weight Loss and Reduced Weight on Brain Structure and Function,"Cerebral cortex (New York, N.Y. : 1991)",2017-Mar-01,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,214,1567,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1047-3211,1460-2199",Cerebral Cortex,Oxford University Press (OUP),2016-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01105143,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effects of Negative Energy Balance on Muscle Mass Regulation,large,Other,Interventional,Behavioral,NA,81,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2012-03-01,2017-05-01,2017,2015-05-01,2015,NA,NA,NA,687,2574,1843,-61,670,2513,2017-07-01,2017-12-01,2021-08-15,10.1093/cercor/bhw008,26838769,https://www.ncbi.nlm.nih.gov/pubmed/?term=Caloric+Restriction+in+Older+Adults%E2%80%94Differential+Effects+of+Weight+Loss+and+Reduced+Weight+on+Brain+Structure+and+Function,2017-03-01,journal publication,TRUE,TRUE,doi,Caloric Restriction in Older Adults-Differential Effects of Weight Loss and Reduced Weight on Brain Structure and Function,"Cerebral cortex (New York, N.Y. : 1991)",2017-Mar-01,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,214,1567,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1047-3211,1460-2199",Cerebral Cortex,Oxford University Press (OUP),2016-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01105728,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,"Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study",large,Other,Interventional,Procedure,Phase 1,38,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-04-15,2010-04-01,2012-01-01,2012,2012-01-01,2012,NA,NA,NA,-14,626,626,353,353,979,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0032-1325760,23254401,https://www.ncbi.nlm.nih.gov/pubmed/23254401,2012-12-19,journal publication,TRUE,TRUE,doi,EndoResect study: endoscopic full-thickness resection of gastric subepithelial tumors,Endoscopy,2013,2012-12-19,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0013-726X,1438-8812",Endoscopy,Georg Thieme Verlag KG,2012-12-19,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01114165,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients,large,Other,Interventional,Other,Phase 4,150,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-23,2010-05-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,8,862,862,860,860,1722,2017-07-01,2017-12-01,2021-08-15,10.1007/s00430-014-0385-7,25573349,https://www.ncbi.nlm.nih.gov/pubmed/25573349,2015-01-09,journal publication,TRUE,TRUE,doi,Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study,Medical microbiology and immunology,2015-Oct,2015-01-09,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0300-8584,1432-1831",Medical Microbiology and Immunology,Springer Science and Business Media LLC,2015-01-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-01-09,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01115192,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Blephacura Versus Baby Shampoo to Treat Blepharitis,large,Other,Interventional,Procedure,NA,144,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-05-03,2010-05-01,2010-12-31,2010,2010-12-31,2010,NA,NA,NA,-2,242,242,758,758,1000,2017-07-01,2017-12-01,2021-08-15,10.1007/s00347-012-2725-6,23354353,https://link.springer.com/article/10.1007/s00347-012-2725-6,2013-01-27,journal publication,TRUE,TRUE,doi,[Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution],Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,2013-Feb,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2527,3880,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0941-293X,1433-0423",Der Ophthalmologe,Springer Science and Business Media LLC,2013-01-27,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01116466,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Clinical Study to Evaluate the Implantation of the ActiGait Drop Foot Stimulator System,small,Industry,Interventional,Device,NA,5,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2010-04-23,2009-08-01,2010-03-01,2010,2010-03-01,2010,2013-07-22,1239,1239,-265,-53,-53,1037,1037,984,2017-07-01,2017-12-01,2021-08-15,10.3233/rnn-120283,23756541,https://www.ncbi.nlm.nih.gov/pubmed/23756541,2013-01-01,journal publication,TRUE,TRUE,doi,Towards physiological ankle movements with the ActiGait implantable drop foot stimulator in chronic stroke,Restorative neurology and neuroscience,2013,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,closed,closed,0922-6028,Restorative Neurology and Neuroscience,IOS Press,2013-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01117519,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Impact of Fluid Management Within a Goal-directed Hemodynamic Protocol on Acid-base Balance in Elective Trauma Surgery,large,Other,Interventional,Drug,Phase 4,40,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-05-03,2010-05-01,2011-11-01,2011,2011-06-01,2011,NA,NA,NA,-2,547,394,832,985,1379,2017-07-01,2017-12-01,2021-08-15,10.1177/0300060513509548,24514432,https://www.ncbi.nlm.nih.gov/pubmed/24514432,2014-02-10,journal publication,TRUE,TRUE,doi,Influence of goal-directed therapy with balanced crystalloid-colloid or unbalanced crystalloid solution on base excess,The Journal of international medical research,2014-Apr,2014-02-10,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"0300-0605,1473-2300",Journal of International Medical Research,SAGE Publications,2014-02-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01117597,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects,large,Other,Interventional,Radiation,NA,32,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-05-04,2010-04-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-33,1581,1216,211,576,1792,2017-07-01,2017-12-01,2021-08-15,10.1016/j.envres.2015.03.021,25839715,https://www.ncbi.nlm.nih.gov/pubmed/25839715,2015-03-31,journal publication,TRUE,TRUE,doi,"Do signals of a hand-held TETRA transmitter affect cognitive performance, well-being, mood or somatic complaints in healthy young men? Results of a randomized double-blind cross-over provocation study",Environmental research,2015-Jul,2015-03-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0013-9351,Environmental Research,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2017-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01117597,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects,large,Other,Interventional,Radiation,NA,32,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-05-04,2010-04-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-33,1581,1216,211,576,1792,2017-07-01,2017-12-01,2021-08-15,10.1016/j.envres.2015.03.021,25839715,https://www.ncbi.nlm.nih.gov/pubmed/25839715,2015-03-31,journal publication,TRUE,TRUE,doi,"Do signals of a hand-held TETRA transmitter affect cognitive performance, well-being, mood or somatic complaints in healthy young men? Results of a randomized double-blind cross-over provocation study",Environmental research,2015-Jul,2015-03-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0013-9351,Environmental Research,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2017-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01117818,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Hamburg TU-München,"Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease",No lead center,Industry,Interventional,Biological,Phase 2,335,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-04-19,2010-09-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,135,1322,1322,799,799,2121,2017-07-01,2017-12-01,2021-08-15,10.14283/jpad.2015.67,26866015,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746013/,2016-02-08,journal publication,TRUE,TRUE,doi,Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite Scales,The journal of prevention of Alzheimer's disease,2015-Jun,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,2274-5807,The Journal of Prevention of Alzheimer's Disease,SERDI,2015-01-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01121666,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Heidelberg,Multi-centre Study to Compare Efficacy and Safety of AFOLIA and Gonal-f in Women for Assisted Reproductive Treatment,No lead center,Industry,Interventional,Drug,Phase 3,460,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2010-05-10,2010-06-01,2013-03-01,2013,2011-12-01,2011,2016-02-17,1083,1539,22,1026,570,-59,397,967,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://insights.ovid.com/human-reproduction/hurep/2013/06/001/108-phase-iii-assessor-blinded-randomised-multi/137/00004683,2013-01-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01122433,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Airway Management Study to Evaluate the C-MAC Video Laryngoscope as an Alternative to the Direct Laryngoscopy,large,Other,Interventional,Device,NA,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-05-05,2010-04-01,2010-09-01,2010,2010-09-01,2010,NA,NA,NA,-34,119,119,358,358,477,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1365-2044.2011.06872.x,21883131,https://www.ncbi.nlm.nih.gov/pubmed/21883131,2011-08-25,journal publication,TRUE,TRUE,doi,Performance of the C-MAC video laryngoscope in patients after a limited glottic view using Macintosh laryngoscopy,Anaesthesia,2011-Dec,2011-08-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0003-2409,Anaesthesia,Wiley,2011-08-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2012-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -1090,7 +1090,7 @@ NCT01125813,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn NCT01130493,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Ulm,A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066,No lead center,Industry,Interventional,Drug,Phase 3,110,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-05-24,2010-05-01,2012-01-01,2012,2012-01-01,2012,2016-08-03,1676,1676,-23,587,587,957,957,1544,2017-07-01,2017-12-01,2021-08-15,10.1016/j.parkreldis.2014.08.004,25306200,https://www.ncbi.nlm.nih.gov/pubmed/25306200,2014-08-15,journal publication,TRUE,TRUE,doi,Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients,Parkinsonism & related disorders,2014-Dec,2014-08-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2161,3514,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,hybrid,hybrid,1353-8020,Parkinsonism & Related Disorders,Elsevier BV,2014-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01133327,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heidelberg Tübingen,Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study,No lead center,Industry,Interventional,Device,NA,100,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-05-27,2010-06-01,2012-06-01,2012,2011-06-01,2011,NA,NA,NA,5,736,370,875,1241,1611,2017-07-01,2017-12-01,2021-08-15,10.1007/s00270-014-1000-4,25338828,https://www.ncbi.nlm.nih.gov/pubmed/?term=Carotid+Stenting+with+Distal+Protection+in+High-Surgical-Risk+Patients%3A+One-Year+Results+of+the+ASTI+Trial,2014-10-24,journal publication,TRUE,TRUE,doi,Carotid stenting with distal protection in high-surgical-risk patients: one-year results of the ASTI trial,Cardiovascular and interventional radiology,2015-Apr,2014-10-24,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,6,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0174-1551,1432-086X",CardioVascular and Interventional Radiology,Springer Science and Business Media LLC,2014-10-24,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01137305,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Soft Skills and Surgical Performance,small,Other,Interventional,Other,NA,50,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-06-02,2008-06-01,2009-05-01,2009,2009-01-01,2009,NA,NA,NA,-731,-397,-517,607,727,210,2017-07-01,2017-12-01,2021-08-15,10.1007/s00268-010-0933-2,21190109,https://www.ncbi.nlm.nih.gov/pubmed/21190109,2010-12-29,journal publication,TRUE,TRUE,doi,Do soft skills predict surgical performance?: a single-center randomized controlled trial evaluating predictors of skill acquisition in virtual reality laparoscopy,World journal of surgery,2011-Mar,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,3136,4489,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0364-2313,1432-2323",World Journal of Surgery,Springer Science and Business Media LLC,2010-12-29,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2011-12-29,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01137734,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitation,large,Industry,Interventional,Device,Phase 2,30,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-05-24,2010-03-01,2014-01-01,2014,2012-02-01,2012,NA,NA,NA,-84,1318,618,-282,418,1036,2017-07-01,2017-12-01,2021-08-15,10.1093/ejcts/ezt128,23530026,https://www.ncbi.nlm.nih.gov/pubmed/23530026,2013-03-25,journal publication,TRUE,TRUE,doi,Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2013-Nov,2013-03-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1873-734X,1010-7940",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2013-03-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-03-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01137734,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitation,large,Industry,Interventional,Device,Phase 2,30,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-05-24,2010-03-01,2014-01-01,2014,2012-02-01,2012,NA,NA,NA,-84,1318,618,-282,418,1036,2017-07-01,2017-12-01,2021-08-15,10.1093/ejcts/ezt128,23530026,https://www.ncbi.nlm.nih.gov/pubmed/23530026,2013-03-25,journal publication,TRUE,TRUE,doi,Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2013-Nov,2013-03-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1873-734X,1010-7940",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2013-03-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-03-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01137968,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz TU-München,Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC),No lead center,Industry,Interventional,Drug,Phase 2,116,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-06-03,2010-05-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-33,1186,1186,457,457,1643,2017-07-01,2017-12-01,2021-08-15,10.1093/annonc/mdu550,25467017,https://www.ncbi.nlm.nih.gov/pubmed/25467017,2014-12-02,journal publication,TRUE,TRUE,doi,A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer,Annals of oncology : official journal of the European Society for Medical Oncology,2015-Feb,2014-12-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01145092,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Effects of Six Months of Moderate Resistance- Versus Endurance-Training on Muscle ATP Synthesis in First-Degree Relatives of Patients With Type 2 Diabetes,small,Other,Interventional,Behavioral,NA,16,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-06-14,2006-02-01,2009-03-01,2009,2009-03-01,2009,NA,NA,NA,-1594,-470,-470,1025,1025,555,2017-07-01,2017-12-01,2021-08-15,10.2337/dc11-1426,22190678,NA,2011-12-21,journal publication,TRUE,TRUE,doi,A single nucleotide polymorphism associates with the response of muscle ATP synthesis to long-term exercise training in relatives of type 2 diabetic humans,Diabetes care,2012-Feb,2011-12-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,3197,4550,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0149-5992,1935-5548",Diabetes Care,American Diabetes Association,2012-01-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01145248,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,Heidelberg,Comparison of Biliary Forceps Biopsy and Brush Cytology,large,Other,Interventional,Device,NA,43,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-06-14,2006-01-01,2009-07-01,2009,2009-07-01,2009,NA,NA,NA,-1625,-348,-348,556,556,208,2017-07-01,2017-12-01,2021-08-15,10.1007/s10620-010-1535-4,21221795,https://www.ncbi.nlm.nih.gov/pubmed/21221795,2011-01-08,journal publication,TRUE,TRUE,doi,A novel method of forceps biopsy improves the diagnosis of proximal biliary malignancies,Digestive diseases and sciences,2011-Feb,2011-01-08,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,3075,4428,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0163-2116,1573-2568",Digestive Diseases and Sciences,Springer Science and Business Media LLC,2011-01-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2012-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -1100,7 +1100,7 @@ NCT01153139,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Tüb NCT01153750,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,Schleswig-Holstein Mainz,Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct,large,Other,Interventional,Drug,Phase 2,44,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-04-01,2007-04-01,2010-03-01,2010,2010-03-01,2010,NA,NA,NA,-1096,-31,-31,-181,-181,-212,2017-07-01,2017-12-01,2021-08-15,10.1016/s1359-6349(09)71339-4,NA,http://ac.els-cdn.com/S1359634909713394/1-s2.0-S1359634909713394-main.pdf?_tid=57c51abe-7d12-11e7-a70d-00000aacb360&acdnat=1502290520_8276f3bfb83e04d844afb2ba91f08d7b,2009-09-01,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1359-6349,European Journal of Cancer Supplements,Elsevier BV,2009-09-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01158599,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg Rostock,This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population,No lead center,Industry,Interventional,Biological,Phase 4,200,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-07-07,2010-06-01,2011-10-01,2011,2011-06-01,2011,NA,NA,NA,-36,451,329,1759,1881,2210,2017-07-01,2017-12-01,2021-08-15,10.1016/j.vaccine.2016.07.029,27460550,https://www.ncbi.nlm.nih.gov/pubmed/27460550,2016-07-25,journal publication,TRUE,TRUE,doi,"Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study",Vaccine,2016-08-31,2016-07-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0264-410X,Vaccine,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01159366,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Jena Leipzig,NA,Incidence of Occluded Culprit Arteries and Impact of Coronary Collaterals on Outcome in Patients With NSTEMI,large,Other,Interventional,Procedure,Phase 4,602,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-07-08,2006-07-01,2010-01-01,2010,2009-12-01,2009,NA,NA,NA,-1468,-188,-219,350,381,162,2017-07-01,2017-12-01,2021-08-15,10.1007/s00392-010-0269-9,21165625,https://link.springer.com/article/10.1007/s00392-010-0269-9,2010-12-17,journal publication,TRUE,TRUE,doi,Incidence and distribution of occluded culprit arteries and impact of coronary collaterals on outcome in patients with non-ST-segment elevation myocardial infarction and early invasive treatment strategy,Clinical research in cardiology : official journal of the German Cardiac Society,2011-May,2010-12-17,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2891,4244,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2010-12-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2012-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01160419,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer,large,Other,Interventional,Drug,Phase 2,49,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-10-22,2009-12-01,2014-05-01,2014,2011-05-01,2011,NA,NA,NA,40,1652,556,300,1396,1952,2017-07-01,2017-12-01,2021-08-15,10.1002/ijc.29403,25530271,https://www.ncbi.nlm.nih.gov/pubmed/25530271,2015-02-25,journal publication,TRUE,TRUE,doi,NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors,International journal of cancer,2015-Aug-01,2015-02-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2015-02-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-02-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01160419,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer,large,Other,Interventional,Drug,Phase 2,49,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-10-22,2009-12-01,2014-05-01,2014,2011-05-01,2011,NA,NA,NA,40,1652,556,300,1396,1952,2017-07-01,2017-12-01,2021-08-15,10.1002/ijc.29403,25530271,https://www.ncbi.nlm.nih.gov/pubmed/25530271,2015-02-25,journal publication,TRUE,TRUE,doi,NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors,International journal of cancer,2015-Aug-01,2015-02-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2015-02-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-02-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01168791,ClinicalTrials.gov,TRUE,1,Registry linked,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln Tübingen,Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma,No lead center,Industry,Interventional,Drug,Phase 3,447,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-07-21,2010-07-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-20,954,954,1350,1350,2304,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2016.67.6684,27621408,https://www.ncbi.nlm.nih.gov/pubmed/27621408,2016-11-10,journal publication,TRUE,TRUE,doi,"PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2016-11-10,2016-09-30,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,0,0,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-11-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-11-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01170936,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses,large,Other,Interventional,Drug,Phase 2,10,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-07-26,2010-07-01,2011-12-01,2011,2011-09-01,2011,NA,NA,NA,-25,493,402,540,631,1033,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jaci.2013.04.008,23711544,https://www.ncbi.nlm.nih.gov/pubmed/23711544,2013-05-24,journal publication,TRUE,TRUE,doi,Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study,The Journal of allergy and clinical immunology,2013-Sep,2013-05-24,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01171274,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Effects of Hatha Yoga on Chronic Neck Pain,large,Other,Interventional,Behavioral,NA,58,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-23,2010-08-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,9,131,131,821,821,952,2017-07-01,2017-12-01,2021-08-15,10.1097/ajp.0b013e318251026c,23249655,https://www.ncbi.nlm.nih.gov/pubmed/?term=Randomized-controlled+Trial+Comparing+Yoga+and+Home-based+Exercise+for+Chronic+Neck+Pain,2013-03-01,journal publication,TRUE,TRUE,doi,Randomized-controlled trial comparing yoga and home-based exercise for chronic neck pain,The Clinical journal of pain,2013-Mar,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0749-8047,The Clinical Journal of Pain,Ovid Technologies (Wolters Kluwer Health),2013-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -1111,12 +1111,12 @@ NCT01174498,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT01174992,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Duisburg-Essen Giessen Schleswig-Holstein Marburg,A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair,No lead center,Industry,Interventional,Biological,Phase 2/Phase 3,139,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-08-03,2010-07-01,2011-10-01,2011,2011-09-01,2011,NA,NA,NA,-33,424,394,1046,1076,1470,2017-07-01,2017-12-01,2021-08-15,10.3109/02688697.2014.948808,25112563,NA,2014-08-12,journal publication,TRUE,TRUE,doi,"A multicentre, prospective, randomized, controlled study to evaluate the use of a fibrin sealant as an adjunct to sutured dural repair",British journal of neurosurgery,2015-Feb,2014-08-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0268-8697,1360-046X",British Journal of Neurosurgery,Informa UK Limited,2014-08-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-01-02,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01176721,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Göttingen LMU-München,Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia,No lead center,Industry,Interventional,Device,Phase 2,20,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-08-05,2010-03-01,2012-02-01,2012,2011-07-01,2011,NA,NA,NA,-157,545,330,1271,1486,1816,2017-07-01,2017-12-01,2021-08-15,10.1007/s00406-015-0618-9,26210303,https://www.ncbi.nlm.nih.gov/pubmed/26210303,2015-07-26,journal publication,TRUE,TRUE,doi,Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study,European archives of psychiatry and clinical neuroscience,2015-Oct,2015-07-26,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2130,3483,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0940-1334,1433-8491",European Archives of Psychiatry and Clinical Neuroscience,Springer Science and Business Media LLC,2015-07-26,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-07-26,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01180205,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,"Telmisartan, Amlodipine and Flow Mediated Dilation",large,Other,Interventional,Drug,Phase 4,576,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-04,2010-08-01,2011-10-01,2011,2011-10-01,2011,NA,NA,NA,-3,423,423,2174,2174,2597,2017-07-01,2017-12-01,2021-08-15,10.1373/clinchem.2017.275289,28904053,https://www.ncbi.nlm.nih.gov/pubmed/28904053,2017-09-13,journal publication,TRUE,TRUE,doi,Cardiovascular Biomarkers in Hypertensive Patients with Medical Treatment-Results from the Randomized TEAMSTA Protect I Trial,Clinical chemistry,2017-Dec,2017-09-13,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,bronze,"0009-9147,1530-8561",Clinical Chemistry,Oxford University Press (OUP),2017-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01180322,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine,large,Other,Interventional,Drug,Phase 2,277,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-02,2010-11-01,2016-10-02,2016,2012-06-01,2012,NA,NA,NA,91,2253,669,-1401,183,852,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/120/21/412?sso-checked=true,2012-12-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,425,1778,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01181401,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,InductionChemo-Radio-Antibody-Treatment,large,Other,Interventional,Drug,Phase 2,94,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-12,2010-08-01,2015-08-01,2015,2015-04-01,2015,NA,NA,NA,-11,1815,1693,427,549,2242,2017-07-01,2017-12-01,2021-08-15,10.1007/s00106-016-0243-6,27624903,NA,2016-10-01,abstract,TRUE,TRUE,doi,[Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting],HNO,2016-Oct,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,8,8,853,2206,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0017-6192,1433-0458",HNO,Springer Science and Business Media LLC,2016-09-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-09-13,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01180322,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,Berlin Bochum Bonn Düsseldorf Duisburg-Essen Frankfurt Giessen Göttingen Hamburg Hannover Mainz Tübingen,Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine,large,Other,Interventional,Drug,Phase 2,277,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-02,2010-11-01,2016-10-02,2016,2012-06-01,2012,NA,NA,NA,91,2253,669,-1401,183,852,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/120/21/412?sso-checked=true,2012-12-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,425,1778,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01181401,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,Giessen Hamburg Hannover Marburg Regensburg,InductionChemo-Radio-Antibody-Treatment,large,Other,Interventional,Drug,Phase 2,94,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-12,2010-08-01,2015-08-01,2015,2015-04-01,2015,NA,NA,NA,-11,1815,1693,427,549,2242,2017-07-01,2017-12-01,2021-08-15,10.1007/s00106-016-0243-6,27624903,NA,2016-10-01,abstract,TRUE,TRUE,doi,[Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting],HNO,2016-Oct,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,8,8,853,2206,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0017-6192,1433-0458",HNO,Springer Science and Business Media LLC,2016-09-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-09-13,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01185613,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leipzig,Clinical Evaluation of Therapy™ Cool Flex Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation,No lead center,Industry,Interventional,Device,Phase 2,50,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-08-18,2010-06-01,2011-09-01,2011,2011-09-01,2011,NA,NA,NA,-78,379,379,991,991,1370,2017-07-01,2017-12-01,2021-08-15,10.1093/europace/euu064,24843051,https://www.ncbi.nlm.nih.gov/pubmed/?term=Safety+and+efficacy+of+multipolar+pulmonary+vein+Mccready,2014-05-19,journal publication,TRUE,TRUE,doi,Safety and efficacy of multipolar pulmonary vein ablation catheter vs. irrigated radiofrequency ablation for paroxysmal atrial fibrillation: a randomized multicentre trial,"Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2014-Aug,2014-05-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2014-05-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-05-19,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01186263,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy,small,Other,Interventional,Drug,Phase 2,24,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-23,2010-07-01,2013-08-01,2013,2011-07-01,2011,NA,NA,NA,-22,1105,343,922,1684,2027,2017-07-01,2017-12-01,2021-08-15,10.2967/jnumed.115.169987,26912438,NA,2016-02-09,journal publication,TRUE,TRUE,doi,Pharmacokinetics of 99mTc-MAA- and 99mTc-HSA-Microspheres Used in Preradioembolization Dosimetry: Influence on the Liver-Lung Shunt,"Journal of nuclear medicine : official publication, Society of Nuclear Medicine",2016-Jun,2016-02-09,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0161-5505,2159-662X",Journal of Nuclear Medicine,Society of Nuclear Medicine,2016-02-09,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01186861,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Schleswig-Holstein Homburg,"Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy",No lead center,Industry,Interventional,Drug,Phase 2,205,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-19,2011-03-04,2015-03-11,2015,2013-07-01,2013,NA,NA,NA,197,1665,1047,876,1494,2541,2017-07-01,2017-12-01,2021-08-15,10.1038/bjc.2017.226,28772281,https://www.ncbi.nlm.nih.gov/pubmed/28772281,2017-08-03,journal publication,TRUE,TRUE,doi,Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer,British journal of cancer,2017-Sep-05,2017-08-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,996,2349,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0007-0920,1532-1827",British Journal of Cancer,Springer Science and Business Media LLC,2017-08-03,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-sa', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01187303,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL),large,Other,Interventional,Drug,Phase 2,28,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-08-19,2011-05-01,2015-09-01,2015,2013-11-01,2013,NA,NA,NA,255,1839,1170,80,749,1919,2017-07-01,2017-12-01,2021-08-15,10.1038/leu.2015.321,26585412,https://www.ncbi.nlm.nih.gov/pubmed/26585412,2015-11-20,journal publication,TRUE,TRUE,doi,Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group,Leukemia,2016-06,2015-11-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2015-11-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01187303,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL),large,Other,Interventional,Drug,Phase 2,28,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-08-19,2011-05-01,2015-09-01,2015,2013-11-01,2013,NA,NA,NA,255,1839,1170,80,749,1919,2017-07-01,2017-12-01,2021-08-15,10.1038/leu.2015.321,26585412,https://www.ncbi.nlm.nih.gov/pubmed/26585412,2015-11-20,journal publication,TRUE,TRUE,doi,Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group,Leukemia,2016-06,2015-11-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2015-11-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01187888,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy",large,Other,Interventional,Drug,Phase 3,44,Terminated,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-08-20,2010-01-01,2012-06-01,2012,2012-06-01,2012,NA,NA,NA,-231,651,651,1455,1455,2106,2017-07-01,2017-12-01,2021-08-15,10.1007/s00415-016-8169-1,27230855,https://www.ncbi.nlm.nih.gov/pubmed/27230855,2016-05-26,journal publication,TRUE,TRUE,doi,"PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy",Journal of neurology,2016-Aug,2016-05-26,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0340-5354,1432-1459",Journal of Neurology,Springer Science and Business Media LLC,2016-05-26,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01188902,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women,large,Other,Interventional,Dietary Supplement,NA,60,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-25,2010-08-01,2012-08-01,2012,2012-04-01,2012,NA,NA,NA,-24,707,585,468,590,1175,2017-07-01,2017-12-01,2021-08-15,10.1016/j.metabol.2013.11.005,24360749,https://www.ncbi.nlm.nih.gov/pubmed/24360749,2013-11-12,journal publication,TRUE,TRUE,doi,Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial,Metabolism: clinical and experimental,2014-Mar,2013-11-12,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1948,3301,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0026-0495,Metabolism,Elsevier BV,2014-03-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01189253,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Hamburg Hannover Mannheim LMU-München,Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma,No lead center,Other,Interventional,Drug,Phase 2/Phase 3,133,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-25,2011-05-01,2015-06-01,2015,2013-06-01,2013,NA,NA,NA,249,1741,1011,-39,691,1702,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ejca.2015.03.023,25912752,https://www.ncbi.nlm.nih.gov/pubmed/25912752,2015-04-23,journal publication,TRUE,TRUE,doi,A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial,"European journal of cancer (Oxford, England : 1990)",2015-Jul,2015-04-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,914,2267,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0959-8049,European Journal of Cancer,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -1142,7 +1142,7 @@ NCT01221610,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT01223352,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Giessen,Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension,No lead center,Industry,Interventional,Drug,Phase 3,64,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2010-10-12,2011-03-08,2013-08-19,2013,2013-04-03,2013,2017-03-02,1291,1429,147,1042,904,1312,1450,2354,2017-07-01,2017-12-01,2021-08-15,10.1111/bcp.13267,28213957,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510076/,2017-03-23,journal publication,TRUE,TRUE,doi,A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3,British journal of clinical pharmacology,2017-08,2017-03-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1565,2918,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,hybrid,hybrid,0306-5251,British Journal of Clinical Pharmacology,Wiley,2017-03-23,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01225380,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Duisburg-Essen Frankfurt Freiburg Hannover Heidelberg Leipzig Mainz LMU-München,"A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C",No lead center,Industry,Interventional,Drug,Phase 2,324,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-10-18,2010-10-01,2013-09-01,2013,2013-01-01,2013,NA,NA,NA,-17,1049,806,-469,-226,580,2017-07-01,2017-12-01,2021-08-15,10.1002/hep.27836,25847509,https://www.ncbi.nlm.nih.gov/pubmed/25847509,2012-05-20,journal publication,TRUE,TRUE,doi,Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failed,"Hepatology (Baltimore, Md.)",2015-Jul,2015-05-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,6,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0270-9139,1527-3350",Hepatology,Wiley,2015-05-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-05-20,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01228799,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Trabeculectomy Versus Canaloplasty,small,Other,Interventional,Procedure,NA,64,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-20,2010-06-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-141,773,773,853,853,1626,2017-07-01,2017-12-01,2021-08-15,10.1111/aos.12722,25847610,http://onlinelibrary.wiley.com/doi/10.1111/aos.12722/full,2015-04-03,journal publication,TRUE,TRUE,doi,Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial,Acta ophthalmologica,2015-Dec,2015-04-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1755-375X,1755-3768",Acta Ophthalmologica,Wiley,2015-04-03,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01229306,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation,large,Other,Interventional,Procedure,NA,108,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-26,2010-07-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,-117,1163,979,413,597,1576,2017-07-01,2017-12-01,2021-08-15,10.1093/europace/euu389,25694536,https://www.ncbi.nlm.nih.gov/pubmed/25694536,2015-02-18,journal publication,TRUE,TRUE,doi,"Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial","Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2015-Sep,2015-02-18,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2015-02-18,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-02-18,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01229306,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation,large,Other,Interventional,Procedure,NA,108,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-26,2010-07-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,-117,1163,979,413,597,1576,2017-07-01,2017-12-01,2021-08-15,10.1093/europace/euu389,25694536,https://www.ncbi.nlm.nih.gov/pubmed/25694536,2015-02-18,journal publication,TRUE,TRUE,doi,"Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial","Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2015-Sep,2015-02-18,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2015-02-18,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-02-18,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01230723,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography,large,Other,Interventional,Device,Phase 4,30,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-10-28,2010-10-01,2012-07-01,2012,2011-12-01,2011,NA,NA,NA,-27,612,399,270,483,882,2017-07-01,2017-12-01,2021-08-15,10.1161/atvbaha.113.301227,23539216,https://www.ncbi.nlm.nih.gov/pubmed/23539216,2013-03-28,journal publication,TRUE,TRUE,doi,Tissue characterization after drug-eluting stent implantation using optical coherence tomography,"Arteriosclerosis, thrombosis, and vascular biology",2013-Jun,2013-03-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1079-5642,1524-4636","Arteriosclerosis, Thrombosis, and Vascular Biology",Ovid Technologies (Wolters Kluwer Health),2013-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01232283,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg Schleswig-Holstein Leipzig,Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.,No lead center,Industry,Interventional,Drug,Phase 3,413,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-10-29,2010-11-22,2016-11-30,2016,2012-03-15,2012,2014-10-22,-770,951,24,2224,503,-389,1332,1835,2017-07-01,2017-12-01,2021-08-15,10.1111/bjd.14164,26357944,https://www.ncbi.nlm.nih.gov/pubmed/26357944,2015-11-07,journal publication,TRUE,TRUE,doi,"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)",The British journal of dermatology,2015-Dec,2015-11-07,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,366,1719,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0007-0963,1365-2133",British Journal of Dermatology,Wiley,2015-11-07,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01233180,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Effects of Gua Sha and Thermotherapy on Chronic Neck Pain,large,Other,Interventional,Other,NA,50,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-11-02,2010-09-01,2011-02-01,2011,2011-02-01,2011,NA,NA,NA,-62,91,91,-4,-4,87,2017-07-01,2017-12-01,2021-08-15,10.1111/j.1526-4637.2011.01053.x,21276190,http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2011.01053.x/full,2011-01-28,journal publication,TRUE,TRUE,doi,"Effectiveness of traditional Chinese ""gua sha"" therapy in patients with chronic neck pain: a randomized controlled trial","Pain medicine (Malden, Mass.)",2011-Mar,2011-01-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2495,3848,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1526-2375,1526-4637",Pain Medicine,Oxford University Press (OUP),2011-03-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2012-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -1156,7 +1156,7 @@ NCT01240083,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Rege NCT01242345,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,TU-München,Capnography During Upper GI Endoscopy,small,Other,Interventional,Device,Phase 3,170,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2010-11-16,2010-06-01,2011-11-01,2011,2011-11-01,2011,NA,NA,NA,-168,350,350,1888,1888,2238,2017-07-01,2017-12-01,2021-08-15,10.1016/j.dld.2016.08.124,27671621,https://www.ncbi.nlm.nih.gov/pubmed/27671621,2017-01-01,journal publication,TRUE,TRUE,doi,"Clinical value of the Integrated Pulmonary Index® during sedation for interventional upper GI-endoscopy: A randomized, prospective tri-center study",Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,2017-Jan,2016-09-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,1590-8658,Digestive and Liver Disease,Elsevier BV,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01245985,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors,large,Other,Interventional,Radiation,Phase 2,8,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-11-22,2010-11-01,2013-11-01,2013,2012-11-01,2012,NA,NA,NA,-21,1075,710,197,562,1272,2017-07-01,2017-12-01,2021-08-15,10.1007/s00066-014-0677-2,24838408,https://link-1springer-1com-1001260vm0165.han.mh-hannover.de/article/10.1007/s00066-014-0677-2,2014-05-17,abstract,TRUE,TRUE,doi,"[Abstracts of the 20th Annual Meeting of the German Society for Radiation Oncology (DEGRO), 3-4 July, 2014, Dusseldorf, Germany]",Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],2014-Jul,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0179-7158,1439-099X",Strahlentherapie und Onkologie,Springer Science and Business Media LLC,2014-05-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-05-17,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01247051,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Comparison of Two Different Heart-lung Machine Filling Methods: Precoating Versus Colloidal Fluids,large,Other,Interventional,Procedure,NA,90,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-23,2011-01-01,2011-08-01,2011,2011-08-01,2011,NA,NA,NA,39,251,251,298,298,549,2017-07-01,2017-12-01,2021-08-15,10.1177/0267659112447654,22635965,NA,2012-05-25,journal publication,TRUE,TRUE,doi,"Pre-filling of the extracorporeal circuit with autologous blood is safe, but not effective in optimizing biocompatibility in high-risk patients",Perfusion,2012-Sep,2012-05-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0267-6591,1477-111X",Perfusion,SAGE Publications,2012-05-25,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT01249638,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC,large,Other,Interventional,Drug,Phase 3,516,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-29,2010-12-01,2016-12-01,2016,2013-12-01,2013,NA,NA,NA,2,2194,1098,-1927,-831,267,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2407-11-367,21861888,https://www.ncbi.nlm.nih.gov/pubmed/21861888,2011-08-23,journal publication,TRUE,TRUE,doi,"A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial",BMC cancer,2011-Aug-23,2011-08-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,2,2,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2011-08-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01249638,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC,large,Other,Interventional,Drug,Phase 3,516,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-29,2010-12-01,2016-12-01,2016,2013-12-01,2013,NA,NA,NA,2,2194,1098,-1927,-831,267,2017-07-01,2017-12-01,2021-08-15,10.1186/1471-2407-11-367,21861888,https://www.ncbi.nlm.nih.gov/pubmed/21861888,2011-08-23,journal publication,TRUE,TRUE,doi,"A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial",BMC cancer,2011-Aug-23,2011-08-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,2,2,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2011-08-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01252940,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Hamburg Köln,Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF,No lead center,Industry,Interventional,Drug,Phase 3,482,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-01,2010-11-01,2014-10-01,2014,2012-01-01,2012,2013-03-08,-572,432,-30,1400,396,-246,758,1154,2017-07-01,2017-12-01,2021-08-15,10.1097/qad.0000000000000087,24670520,http://journals.lww.com/aidsonline/Abstract/2014/01280/Simplification_to.6.aspx,2014-01-28,journal publication,TRUE,TRUE,doi,Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants,"AIDS (London, England)",2014-Jan-28,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,0269-9370,AIDS,Ovid Technologies (Wolters Kluwer Health),2014-01-28,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01253096,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,Hannover,Intratumoral Application of L19IL2 in Patients With Malignant Melanoma,large,Industry,Interventional,Drug,Phase 2,25,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-12-02,2010-04-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-245,1004,1004,215,215,1219,2017-07-01,2017-12-01,2021-08-15,10.1158/2326-6066.cir-13-0206,24906352,https://www.ncbi.nlm.nih.gov/pubmed/24906352,2014-04-04,journal publication,TRUE,TRUE,doi,Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses,Cancer immunology research,2014-Jul,2014-04-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"2326-6066,2326-6074",Cancer Immunology Research,American Association for Cancer Research (AACR),2014-04-04,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2015-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01255722,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Mannheim Ulm,Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography,No lead center,Industry,Interventional,Drug,Phase 4,468,Completed,Double,Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-03,2010-11-01,2012-09-01,2012,2012-09-01,2012,2015-08-27,1090,1090,-32,638,638,1375,1375,2013,2017-07-01,2017-12-01,2021-08-15,10.1007/s00330-016-4437-9,27271922,https://www.ncbi.nlm.nih.gov/pubmed/27271922,2016-06-07,journal publication,TRUE,TRUE,doi,Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial,European radiology,2017-Feb,2016-06-07,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,hybrid,hybrid,"0938-7994,1432-1084",European Radiology,Springer Science and Business Media LLC,2016-06-07,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -1165,15 +1165,15 @@ NCT01256996,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Heid NCT01262521,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Dietary Nitrate and Cardiovascular Health,small,Other,Interventional,Dietary Supplement,NA,20,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-12-16,2010-11-01,2012-12-01,2012,2012-10-01,2012,NA,NA,NA,-45,716,655,-267,-206,449,2017-07-01,2017-12-01,2021-08-15,10.1016/j.freeradbiomed.2012.02.051,22406434,https://www.ncbi.nlm.nih.gov/pubmed/22406434,2012-03-09,journal publication,TRUE,TRUE,doi,Dietary inorganic nitrate mobilizes circulating angiogenic cells,Free radical biology & medicine,2012-May-01,2012-03-09,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0891-5849,Free Radical Biology and Medicine,Elsevier BV,2012-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01262677,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn,Once-A-Day Pregabalin For Partial Seizures,No lead center,Industry,Interventional,Drug,Phase 3,325,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2010-12-16,2011-02-17,2012-08-01,2012,2012-07-31,2012,2017-10-16,1902,1903,63,594,593,692,693,1286,2017-07-01,2017-12-01,2021-08-15,10.1111/epi.12690,24962242,http://onlinelibrary.wiley.com/doi/10.1111/epi.12690/full,2014-06-24,journal publication,TRUE,TRUE,doi,"Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial",Epilepsia,2014-08,2014-06-24,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1948,3301,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,bronze,bronze,0013-9580,Epilepsia,Wiley,2014-06-24,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-06-24,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01264640,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma,small,Other,Interventional,Drug,NA,25,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2010-12-21,2010-07-01,2011-03-01,2011,2011-02-01,2011,NA,NA,NA,-173,70,42,152,180,222,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jneuroim.2011.06.015,21803431,https://www.ncbi.nlm.nih.gov/pubmed/21803431,2011-07-31,journal publication,TRUE,TRUE,doi,Differential effect of clopidogrel and aspirin on the release of BDNF from platelets,Journal of neuroimmunology,2011-Sep-15,2011-07-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0165-5728,Journal of Neuroimmunology,Elsevier BV,2011-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01269151,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Schleswig-Holstein,NA,Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD,small,Other,Interventional,Drug,NA,20,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-01-03,2010-10-01,2014-04-01,2014,2013-03-01,2013,NA,NA,NA,-94,1184,788,1101,1497,2285,2017-07-01,2017-12-01,2021-08-15,10.2147/opth.s123513,28435212,https://www.ncbi.nlm.nih.gov/pubmed/28435212,2017-04-06,journal publication,TRUE,TRUE,doi,Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study,"Clinical ophthalmology (Auckland, N.Z.)",2017,2017-04-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1177-5483,Clinical Ophthalmology,Informa UK Limited,2017-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01269151,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD,small,Other,Interventional,Drug,NA,20,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-01-03,2010-10-01,2014-04-01,2014,2013-03-01,2013,NA,NA,NA,-94,1184,788,1101,1497,2285,2017-07-01,2017-12-01,2021-08-15,10.2147/opth.s123513,28435212,https://www.ncbi.nlm.nih.gov/pubmed/28435212,2017-04-06,journal publication,TRUE,TRUE,doi,Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study,"Clinical ophthalmology (Auckland, N.Z.)",2017,2017-04-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1177-5483,Clinical Ophthalmology,Informa UK Limited,2017-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01271595,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,AUTO-ACUSAR - Effects of Acupuncture on the Autonomic Nervous System in Seasonal Allergic Rhinitis Patients,large,Other,Interventional,Other,NA,60,Completed,Single,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-12-23,2009-08-01,2011-05-01,2011,2010-04-01,2010,NA,NA,NA,-509,129,-266,1419,1814,1548,2017-07-01,2017-12-01,2021-08-15,10.1159/000381086,26021958,https://www.karger.com/Article/FullText/381086,2015-03-20,journal publication,TRUE,TRUE,doi,Autonomic Function in Seasonal Allergic Rhinitis and Acupuncture - an Experimental Pilot Study within a Randomized Trial,Forschende Komplementarmedizin (2006),2015,2015-03-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"2504-2092,2504-2106",Complementary Medicine Research,S. Karger AG,2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2016-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01271790,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Duisburg-Essen Frankfurt Freiburg Hannover Heidelberg Leipzig Mainz,"A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C",No lead center,Industry,Interventional,Drug,Phase 2,245,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2011-01-05,2010-10-01,2013-09-01,2013,2013-01-01,2013,NA,NA,NA,-96,970,727,269,512,1239,2017-07-01,2017-12-01,2021-08-15,10.1002/hep.27053,24501005,http://onlinelibrary.wiley.com/doi/10.1002/hep.27053/full,2014-05-28,journal publication,TRUE,TRUE,doi,"All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection","Hepatology (Baltimore, Md.)",2014-Jul,2014-05-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0270-9139,Hepatology,Wiley,2014-05-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-05-28,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01272674,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Adiponectin and Circulating Progenitor Cells (CPC) Function,large,Other,Interventional,Other,Phase 1,20,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-01-07,2011-01-01,2011-03-01,2011,2011-03-01,2011,NA,NA,NA,-6,53,53,464,464,517,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ijcard.2012.05.056,22682478,https://www.ncbi.nlm.nih.gov/pubmed/22682478,2012-06-07,journal publication,TRUE,TRUE,doi,Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor,International journal of cardiology,2013-Sep-01,2012-06-07,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0167-5273,International Journal of Cardiology,Elsevier BV,2013-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01275508,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut,large,Other,Interventional,Drug,Phase 1/Phase 2,25,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-07,2011-01-01,2012-04-01,2012,2012-04-01,2012,NA,NA,NA,-6,450,450,693,693,1143,2017-07-01,2017-12-01,2021-08-15,10.1038/nm.3462,24562382,NA,2014-02-23,journal publication,TRUE,TRUE,doi,In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease,Nature medicine,2014-Mar,2014-02-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,8,8,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"1078-8956,1546-170X",Nature Medicine,Springer Science and Business Media LLC,2014-02-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-02-23,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01277406,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,4SC-201 (Resminostat) in Advanced Colorectal Carcinoma,large,Industry,Interventional,Drug,Phase 1/Phase 2,17,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-01-10,2011-01-01,2015-02-01,2015,2013-02-01,2013,NA,NA,NA,-9,1483,753,-641,89,842,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2013.31.15_suppl.3625,NA,http://ascopubs.org/doi/abs/10.1200/jco.2013.31.15_suppl.3625,2013-05-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1034,2387,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01277406,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,Tübingen,4SC-201 (Resminostat) in Advanced Colorectal Carcinoma,large,Industry,Interventional,Drug,Phase 1/Phase 2,17,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-01-10,2011-01-01,2015-02-01,2015,2013-02-01,2013,NA,NA,NA,-9,1483,753,-641,89,842,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2013.31.15_suppl.3625,NA,http://ascopubs.org/doi/abs/10.1200/jco.2013.31.15_suppl.3625,2013-05-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1034,2387,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01280032,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,Kypho-IORT: Intraoperative Radiotherapy During Kyphoplasty for Spinal Metastases,small,Other,Interventional,Radiation,Phase 2,18,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-19,2011-01-01,2013-07-01,2013,2013-07-01,2013,NA,NA,NA,-18,894,894,-997,-997,-103,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ijrobp.2010.07.1985,20934272,http://www.sciencedirect.com/science/article/pii/S0360301610030324,2010-10-08,journal publication,TRUE,TRUE,doi,Development of a novel method for intraoperative radiotherapy during kyphoplasty for spinal metastases (Kypho-IORT),"International journal of radiation oncology, biology, physics",2011-Nov-15,2010-10-08,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0360-3016,International Journal of Radiation Oncology*Biology*Physics,Elsevier BV,2011-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2012-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01282827,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,Berlin,Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve),small,Other,Interventional,Device,NA,40,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2011-01-21,2006-11-01,2010-03-01,2010,2010-03-01,2010,NA,NA,NA,-1542,-326,-326,306,306,-20,2017-07-01,2017-12-01,2021-08-15,10.3233/rnn-2011-0624,22124039,NA,2011-01-01,journal publication,TRUE,TRUE,doi,Non-invasive alternating current stimulation improves vision in optic neuropathy,Restorative neurology and neuroscience,2011,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0922-6028,Restorative Neurology and Neuroscience,IOS Press,2011-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01283776,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-25,2011-03-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,35,1223,1041,288,470,1511,2017-07-01,2017-12-01,2021-08-15,10.1111/ejh.12541,25703164,https://www.ncbi.nlm.nih.gov/pubmed/25703164,2015-03-16,journal publication,TRUE,TRUE,doi,OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation,European journal of haematology,2016-Jan,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0902-4441,European Journal of Haematology,Wiley,2015-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01283776,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-25,2011-03-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,35,1223,1041,288,470,1511,2017-07-01,2017-12-01,2021-08-15,10.1111/ejh.12541,25703164,https://www.ncbi.nlm.nih.gov/pubmed/25703164,2015-03-16,journal publication,TRUE,TRUE,doi,OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation,European journal of haematology,2016-Jan,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0902-4441,European Journal of Haematology,Wiley,2015-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01291199,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome,large,Other,Interventional,Drug,Phase 2/Phase 3,57,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-02-01,2006-11-01,2010-04-01,2010,2009-08-01,2009,NA,NA,NA,-1553,-306,-549,2092,2335,1786,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://circ.ahajournals.org/content/124/Suppl_21/A13048,2015-12-23,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,2801,4154,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01293266,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation,small,Other,Interventional,Drug,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-02-09,2009-06-01,2010-08-01,2010,2010-08-01,2010,NA,NA,NA,-618,-192,-192,961,961,769,2017-07-01,2017-12-01,2021-08-15,NA,23511362,http://www.minervamedica.it/en/journals/minerva-anestesiologica/article.php?cod=R02Y2013N06A0626,2013-03-19,journal publication,TRUE,TRUE,pmid,Effect of propofol and sevoflurane on acid-base balance during pediatric heart catheterization,Minerva anestesiologica,2013-Jun,2013-03-19,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2679,4032,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01294241,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10),large,Industry,Interventional,Drug,Phase 2,10,Completed,Single,Non-Randomized,FALSE,FALSE,TRUE,TRUE,2010-10-27,2010-11-01,2011-06-01,2011,2011-06-01,2011,2016-10-22,1970,1970,5,217,217,2182,2182,2399,2017-07-01,2017-12-01,2021-08-15,10.1155/2017/5068969,28611842,https://www.hindawi.com/journals/drp/2017/5068969/,2017-05-22,journal publication,TRUE,TRUE,doi,Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study,Dermatology research and practice,2017,2017-05-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,0,0,2375,3728,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,gold,gold,"1687-6105,1687-6113",Dermatology Research and Practice,Hindawi Limited,2017-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -1196,7 +1196,7 @@ NCT01333397,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT01339819,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,large,Other,Interventional,Drug,Phase 4,70,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-04-15,2011-04-01,2012-09-01,2012,2012-05-01,2012,NA,NA,NA,-14,505,382,1033,1156,1538,2017-07-01,2017-12-01,2021-08-15,10.1155/2015/798486,26229963,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502273/,2015-07-01,journal publication,TRUE,TRUE,doi,Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials),BioMed research international,2015,2015-07-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"2314-6133,2314-6141",BioMed Research International,Hindawi Limited,2015-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01345630,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Frankfurt Hamburg Köln LMU-München,Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1,No lead center,Industry,Interventional,Drug,Phase 3,813,Terminated,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2011-04-27,2011-09-01,2014-01-01,2014,2013-08-01,2013,2014-08-14,225,378,127,980,827,865,1018,1845,2017-07-01,2017-12-01,2021-08-15,10.1097/qad.0000000000001058,26854810,NA,2016-05-15,journal publication,TRUE,TRUE,doi,Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment,"AIDS (London, England)",2016-05-15,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,green,green,0269-9370,AIDS,Ovid Technologies (Wolters Kluwer Health),2016-05-15,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01350986,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Guided Self-Help for Parents of Children With Externalizing Problem Behavior,large,Other,Interventional,Behavioral,NA,146,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-06,2011-05-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-5,665,665,297,297,962,2017-07-01,2017-12-01,2021-08-15,10.1111/jcpp.12177,NA,http://onlinelibrary.wiley.com/doi/10.1111/jcpp.12177/full,2013-12-23,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0021-9630,Journal of Child Psychology and Psychiatry,Wiley,2013-12-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01352988,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Münster Münster,NA,Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-29,2011-07-01,2014-02-01,2014,2013-10-01,2013,NA,NA,NA,63,1009,886,822,945,1831,2017-07-01,2017-12-01,2021-08-15,10.1177/0961203316644335,27147621,https://www.ncbi.nlm.nih.gov/pubmed/27147621,2016-05-03,journal publication,TRUE,TRUE,doi,"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study",Lupus,2016-Oct,2016-05-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0961-2033,1477-0962",Lupus,SAGE Publications,2016-07-11,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT01352988,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-29,2011-07-01,2014-02-01,2014,2013-10-01,2013,NA,NA,NA,63,1009,886,822,945,1831,2017-07-01,2017-12-01,2021-08-15,10.1177/0961203316644335,27147621,https://www.ncbi.nlm.nih.gov/pubmed/27147621,2016-05-03,journal publication,TRUE,TRUE,doi,"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study",Lupus,2016-Oct,2016-05-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0961-2033,1477-0962",Lupus,SAGE Publications,2016-07-11,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01357980,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Schleswig-Holstein,Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis,No lead center,Industry,Interventional,Drug,Phase 2,47,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2011-05-17,2011-05-01,2013-03-01,2013,2013-03-01,2013,2014-03-27,391,391,-16,654,654,1433,1433,2087,2017-07-01,2017-12-01,2021-08-15,10.1002/nau.22954,26756554,http://onlinelibrary.wiley.com/doi/10.1002/nau.22954/full,2017-02-01,journal publication,TRUE,TRUE,doi,Efficacy and safety of two administration modes of an intra-detrusor injection of 750 units dysport® (abobotulinumtoxinA) in patients suffering from refractory neurogenic detrusor overactivity (NDO): A randomised placebo-controlled phase IIa study,Neurourology and urodynamics,2017-02,2016-01-12,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,0733-2467,Neurourology and Urodynamics,Wiley,2016-01-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-01-12,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01363362,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma,large,Other,Interventional,Procedure,NA,150,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-05-27,2010-12-01,2011-08-01,2011,2011-08-01,2011,NA,NA,NA,-177,66,66,2010,2010,2076,2017-07-01,2017-12-01,2021-08-15,10.1111/aos.13360,28139066,http://onlinelibrary.wiley.com/doi/10.1111/aos.13360/full,2017-01-31,journal publication,TRUE,TRUE,doi,Effect of selective laser trabeculoplasty on ocular haemodynamics in primary open-angle glaucoma,Acta ophthalmologica,2017-Jun,2017-01-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2314,3667,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,bronze,1755-375X,Acta Ophthalmologica,Wiley,2017-01-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01370551,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients,small,Industry,Interventional,Drug,Phase 1,16,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2011-05-10,2011-04-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-39,418,418,648,648,1066,2017-07-01,2017-12-01,2021-08-15,10.1007/s10549-014-2930-x,24718774,https://www.ncbi.nlm.nih.gov/pubmed/24718774,2014-04-10,journal publication,TRUE,TRUE,doi,"Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study",Breast cancer research and treatment,2014-Jun,2014-04-10,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2014-04-10,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -1213,11 +1213,11 @@ NCT01411566,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köl NCT01418066,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome,large,Other,Interventional,Drug,NA,32,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-15,2011-08-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-14,474,474,1223,1223,1697,2017-07-01,2017-12-01,2021-08-15,10.1016/j.ctim.2016.04.002,27261998,http://www.sciencedirect.com/science/article/pii/S0965229916300528,2016-04-07,journal publication,TRUE,TRUE,doi,Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: A randomised controlled crossover trial,Complementary therapies in medicine,2016-Jun,2016-04-07,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0965-2299,Complementary Therapies in Medicine,Elsevier BV,2016-06-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01419249,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln LMU-München,First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study,No lead center,Industry,Interventional,Other,Phase 4,458,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2011-08-16,2011-09-01,2012-10-01,2012,2012-10-01,2012,2013-11-26,421,421,16,412,412,1450,1450,1862,2017-07-01,2017-12-01,2021-08-15,10.1530/eje-16-0357,27651465,https://www.ncbi.nlm.nih.gov/pubmed/27651465,2016-09-20,journal publication,TRUE,TRUE,doi,Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study,European journal of endocrinology,2016-Dec,2016-09-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1887,3240,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,hybrid,hybrid,"0804-4643,1479-683X",European Journal of Endocrinology,Bioscientifica,2016-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01420211,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®,small,Other,Interventional,Drug,Phase 1/Phase 2,45,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-08-16,2006-10-01,2010-07-01,2010,2010-07-01,2010,NA,NA,NA,-1780,-411,-411,736,736,325,2017-07-01,2017-12-01,2021-08-15,10.1148/radiol.12112061,22771883,NA,2012-07-06,journal publication,TRUE,TRUE,doi,Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging,Radiology,2012-Sep,2012-07-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2710,4063,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0033-8419,1527-1315",Radiology,Radiological Society of North America (RSNA),2012-09-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01433523,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Rostock Rostock,NA,House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma,small,Industry,Interventional,Drug,Phase 3,834,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-26,2011-08-01,2014-02-01,2014,2013-04-01,2013,NA,NA,NA,-25,890,584,815,1121,1705,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2016.3964,27115376,https://www.ncbi.nlm.nih.gov/pubmed/27115376,2016-04-26,journal publication,TRUE,TRUE,doi,Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial,JAMA,2016-Apr-26,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,1,1,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0098-7484,JAMA,American Medical Association (AMA),2016-04-26,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2016-10-26,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT01433523,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma,small,Industry,Interventional,Drug,Phase 3,834,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-26,2011-08-01,2014-02-01,2014,2013-04-01,2013,NA,NA,NA,-25,890,584,815,1121,1705,2017-07-01,2017-12-01,2021-08-15,10.1001/jama.2016.3964,27115376,https://www.ncbi.nlm.nih.gov/pubmed/27115376,2016-04-26,journal publication,TRUE,TRUE,doi,Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial,JAMA,2016-Apr-26,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,1,1,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0098-7484,JAMA,American Medical Association (AMA),2016-04-26,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2016-10-26,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01435226,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Frankfurt Freiburg Hamburg Hannover Heidelberg Leipzig Mainz Würzburg,"GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection",No lead center,Industry,Interventional,Drug,Phase 2,170,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-09-13,2011-09-01,2013-07-01,2013,2013-01-01,2013,NA,NA,NA,-12,657,476,340,521,997,2017-07-01,2017-12-01,2021-08-15,10.1093/infdis/jiu325,24907384,https://academic.oup.com/jid/article/210/12/1881/2908616/Interferon-Induced-Protein10-Kinetics-in-Treatment,2014-06-06,journal publication,TRUE,TRUE,doi,Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response,The Journal of infectious diseases,2014-Dec-15,2014-06-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0022-1899,1537-6613",The Journal of Infectious Diseases,Oxford University Press (OUP),2014-06-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01436162,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Münster,Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder,No lead center,Industry,Interventional,Drug,Phase 3,1105,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2011-09-15,2011-10-19,2013-12-10,2013,2013-12-10,2013,2014-10-31,325,325,34,817,817,938,938,1755,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jad.2016.07.006,27474961,NA,2016-07-05,journal publication,TRUE,TRUE,doi,"Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies",Journal of affective disorders,2016-Dec,2016-07-05,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,1,1,1452,2805,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,hybrid,hybrid,0165-0327,Journal of Affective Disorders,Elsevier BV,2016-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01438463,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Erlangen,PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis,No lead center,Industry,Interventional,Biological,Phase 2,290,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-09-20,2011-09-01,2013-05-01,2013,2013-05-01,2013,NA,NA,NA,-19,589,589,-973,-973,-384,2017-07-01,2017-12-01,2021-08-15,10.2500/ajra.2010.24.3508,21244725,https://www.ncbi.nlm.nih.gov/pubmed/?term=Efficacy+and+safety+of+a+glutaraldehyde-modified+house+dust+mite+extract+in+allergic+rhinitis,2010-09-01,journal publication,TRUE,TRUE,doi,Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis,American journal of rhinology & allergy,2010 Sep-Oct,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1945-8924,1945-8932",American Journal of Rhinology & Allergy,SAGE Publications,2010-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT01439958,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS),large,Industry,Interventional,Drug,Phase 3,14,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-22,2012-02-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,132,1166,648,-53,465,1113,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004304-38/results,2014-10-09,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01439958,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS),large,Industry,Interventional,Drug,Phase 3,14,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-22,2012-02-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,132,1166,648,-53,465,1113,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-004304-38/results,2014-10-09,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01441791,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,Bonn Düsseldorf Leipzig Mainz,PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery,large,Other,Interventional,Procedure,NA,900,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2011-09-23,2011-02-01,2013-04-01,2013,2013-01-01,2013,NA,NA,NA,-234,556,466,1583,1673,2139,2017-07-01,2017-12-01,2021-08-15,10.1097/eja.0000000000000626,28306591,https://www.ncbi.nlm.nih.gov/pubmed/28306591,2017-08-01,journal publication,TRUE,TRUE,doi,Ventilation with high versus low peep levels during general anaesthesia for open abdominal surgery does not affect postoperative spirometry: A randomised clinical trial,European journal of anaesthesiology,2017-08,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,0,0,0,2,7,3,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0265-0215,European Journal of Anaesthesiology,Ovid Technologies (Wolters Kluwer Health),2017-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01441986,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf,"Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects",No lead center,Industry,Interventional,Drug,Phase 2,20,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-22,2011-09-01,2012-05-01,2012,2012-05-01,2012,NA,NA,NA,-21,222,222,1049,1049,1271,2017-07-01,2017-12-01,2021-08-15,10.1038/nm.3822,25774850,NA,2015-03-16,journal publication,TRUE,TRUE,doi,Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment,Nature medicine,2015-Apr,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1078-8956,1546-170X",Nature Medicine,Springer Science and Business Media LLC,2015-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01448265,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Real-Time Assessment of Cryoballoon Pulmonary Vein Isolation Using a Novel Circular Mapping Catheter,large,Other,Interventional,Procedure,Phase 4,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-30,2011-09-01,2013-07-01,2013,2013-07-01,2013,NA,NA,NA,-29,640,640,973,973,1613,2017-07-01,2017-12-01,2021-08-15,10.4022/jafib.1341,27909474,https://www.ncbi.nlm.nih.gov/pubmed/27909474,2016-02-29,journal publication,TRUE,TRUE,doi,"Efficacy, High Procedural Safety And Rapid Optimization Of Cryoballoon Atrial Fibrillation Ablation In The Hands Of A New Operator",Journal of atrial fibrillation,2016 Feb-Mar,2016-02-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,unresolved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1255,11 +1255,11 @@ NCT01587157,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-M NCT01595997,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Münster,Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris,No lead center,Industry,Interventional,Drug,Phase 1/Phase 2,20,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2012-05-09,2012-02-01,2012-10-01,2012,2012-08-01,2012,NA,NA,NA,-98,145,84,1230,1291,1375,2017-07-01,2017-12-01,2021-08-15,10.1111/exd.12927,26738450,https://www.ncbi.nlm.nih.gov/pubmed/?term=The+single-chain+anti-TNF-%CE%B1+antibody+DLX105+induces+clinical+and+biomarker+responses+upon+local+administration+in+patients+with+chronic+plaque-type+psoriasis,2016-02-13,journal publication,TRUE,TRUE,doi,The single-chain anti-TNF-α antibody DLX105 induces clinical and biomarker responses upon local administration in patients with chronic plaque-type psoriasis,Experimental dermatology,2016-06,2016-02-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0906-6705,Experimental Dermatology,Wiley,2016-02-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01596777,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy Subjects,small,Other,Interventional,Drug,Phase 1,15,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-07,2010-01-01,2010-05-01,2010,2010-03-01,2010,NA,NA,NA,-857,-737,-798,1998,2059,1261,2017-07-01,2017-12-01,2021-08-15,10.1002/jcph.624,26313157,NA,2015-10-20,journal publication,TRUE,TRUE,doi,Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects,Journal of clinical pharmacology,2016-Feb,2015-10-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2771,4124,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,0091-2700,The Journal of Clinical Pharmacology,Wiley,2015-10-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-20,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01601769,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Tissue Sparing Therapy of Female Precancerous Genital Lesions With VITOM,large,Other,Interventional,Device,NA,300,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-14,2011-04-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-409,48,48,544,544,592,2017-07-01,2017-12-01,2021-08-15,10.1007/s00404-013-3134-z,24370959,https://link.springer.com/article/10.1007/s00404-013-3134-z,2013-12-27,journal publication,TRUE,TRUE,doi,A multicentric randomized study comparing two techniques of magnification assisted loop excision of high-grade cervical intraepithelial neoplasia: video exoscopy and colposcopy,Archives of gynecology and obstetrics,2014-Jun,2013-12-27,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0932-0067,1432-0711",Archives of Gynecology and Obstetrics,Springer Science and Business Media LLC,2013-12-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-12-27,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01605487,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,"Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria",large,Other,Interventional,Drug,Phase 2,24,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-11,2012-06-01,2014-10-01,2014,2013-09-01,2013,NA,NA,NA,21,873,478,457,852,1330,2017-07-01,2017-12-01,2021-08-15,10.2340/00015555-2150,26038847,http://www.ingentaconnect.com/content/mjl/adv/2016/00000096/00000001/art00009#,2016-01-01,journal publication,TRUE,TRUE,doi,Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria,Acta dermato-venereologica,2016-Jan,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,0001-5555,Acta Dermato Venereologica,Medical Journals Sweden AB,2016-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01605487,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria",large,Other,Interventional,Drug,Phase 2,24,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-11,2012-06-01,2014-10-01,2014,2013-09-01,2013,NA,NA,NA,21,873,478,457,852,1330,2017-07-01,2017-12-01,2021-08-15,10.2340/00015555-2150,26038847,http://www.ingentaconnect.com/content/mjl/adv/2016/00000096/00000001/art00009#,2016-01-01,journal publication,TRUE,TRUE,doi,Rupatadine 20 mg and 40 mg are Effective in Reducing the Symptoms of Chronic Cold Urticaria,Acta dermato-venereologica,2016-Jan,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,0001-5555,Acta Dermato Venereologica,Medical Journals Sweden AB,2016-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01606462,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Oxytocin and Social Cognition,large,Other,Interventional,Drug,Phase 1,153,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-23,2011-06-01,2013-06-01,2013,2013-06-01,2013,NA,NA,NA,-357,374,374,-228,-228,146,2017-07-01,2017-12-01,2021-08-15,10.1073/pnas.1208852109,23074247,https://www.ncbi.nlm.nih.gov/pubmed/?term=Oxytocin+facilitates+protective+responses+to+aversive+social+stimuli+in+males,2012-10-16,journal publication,TRUE,TRUE,doi,Oxytocin facilitates protective responses to aversive social stimuli in males,Proceedings of the National Academy of Sciences of the United States of America,2012-Oct-30,2012-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1644,2997,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0027-8424,1091-6490",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,2012-10-16,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,6,2013-04-29,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01607775,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,In-house Produced PMMA- Versus PEEK-cages,small,Other,Interventional,Device,Phase 1/Phase 2,88,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-05-22,2009-02-01,2012-02-01,2012,2012-02-01,2012,NA,NA,NA,-1206,-111,-111,1051,1051,940,2017-07-01,2017-12-01,2021-08-15,10.1007/s00586-014-3725-9,25524227,https://link.springer.com/article/10.1007/s00586-014-3725-9,2014-12-18,journal publication,TRUE,TRUE,doi,Influence of cervical bone mineral density on cage subsidence in patients following stand-alone anterior cervical discectomy and fusion,"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society",2015-Dec,2014-12-19,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2130,3483,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0940-6719,1432-0932",European Spine Journal,Springer Science and Business Media LLC,2014-12-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-12-19,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01607970,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Oxytocin Modulation of Startle Reactivity to Social Stimuli and Moral Decision Making,large,Other,Interventional,Drug,Phase 1,80,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-23,2011-08-01,2012-05-01,2012,2012-05-01,2012,NA,NA,NA,-296,-22,-22,168,168,146,2017-07-01,2017-12-01,2021-08-15,10.1073/pnas.1208852109,23074247,https://www.ncbi.nlm.nih.gov/pubmed/?term=Oxytocin+facilitates+protective+responses+to+aversive+social+stimuli+in+males,2012-10-16,journal publication,TRUE,TRUE,doi,Oxytocin facilitates protective responses to aversive social stimuli in males,Proceedings of the National Academy of Sciences of the United States of America,2012-Oct-30,2012-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0027-8424,1091-6490",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,2012-10-16,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,6,2013-04-29,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01609946,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Realtime-Elastography (RTE) and Thyroid Nodules,large,Other,Interventional,Device,NA,602,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-30,2012-06-01,2014-12-01,2014,2013-12-01,2013,NA,NA,NA,2,915,550,498,863,1413,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0042-104647,27070127,https://www.ncbi.nlm.nih.gov/pubmed/27070127,2016-04-12,journal publication,TRUE,TRUE,doi,Evaluation of Strain Elastography for Differentiation of Thyroid Nodules: Results of a Prospective DEGUM Multicenter Study,"Ultraschall in der Medizin (Stuttgart, Germany : 1980)",2016-Jun,2016-04-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0172-4614,1438-8782",Ultraschall in der Medizin - European Journal of Ultrasound,Georg Thieme Verlag KG,2016-04-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2017-04-12,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01609946,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,Leipzig Ulm,Realtime-Elastography (RTE) and Thyroid Nodules,large,Other,Interventional,Device,NA,602,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-30,2012-06-01,2014-12-01,2014,2013-12-01,2013,NA,NA,NA,2,915,550,498,863,1413,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0042-104647,27070127,https://www.ncbi.nlm.nih.gov/pubmed/27070127,2016-04-12,journal publication,TRUE,TRUE,doi,Evaluation of Strain Elastography for Differentiation of Thyroid Nodules: Results of a Prospective DEGUM Multicenter Study,"Ultraschall in der Medizin (Stuttgart, Germany : 1980)",2016-Jun,2016-04-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0172-4614,1438-8782",Ultraschall in der Medizin - European Journal of Ultrasound,Georg Thieme Verlag KG,2016-04-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2017-04-12,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01612754,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,Dresden,Prospective Trial on Noise Reduction in Surgical Operating Theaters,large,Other,Interventional,Behavioral,NA,16,Completed,Single,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2012-06-04,2010-09-01,2012-04-01,2012,2011-11-01,2011,NA,NA,NA,-642,-64,-216,760,912,696,2017-07-01,2017-12-01,2021-08-15,10.1097/sla.0000000000000253,24394594,http://journals.lww.com/annalsofsurgery/Abstract/2014/05000/A_Noise_Reduction_Program_in_a_Pediatric_Operation.28.aspx,2014-05-01,journal publication,TRUE,TRUE,doi,A noise-reduction program in a pediatric operation theatre is associated with surgeon's benefits and a reduced rate of complications: a prospective controlled clinical trial,Annals of surgery,2014-May,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2014-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01613287,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,Greifswald Köln,Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension,large,Industry,Interventional,Device,NA,12,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-29,2012-06-01,2013-11-01,2013,2013-08-01,2013,NA,NA,NA,3,521,429,1373,1465,1894,2017-07-01,2017-12-01,2021-08-15,10.1159/000478744,28787715,https://www.ncbi.nlm.nih.gov/pubmed/28787715,2017-08-05,journal publication,TRUE,TRUE,doi,Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension,Respiration; international review of thoracic diseases,2017,2017-08-05,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0025-7931,1423-0356",Respiration,S. Karger AG,2017-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01616966,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Laryngeal Injuries After Removal of the Tracheal Tube: A Comparison Between Sevoflurane and Propofol,small,Other,Interventional,Drug,NA,65,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-06-07,2010-08-01,2011-10-01,2011,2011-10-01,2011,NA,NA,NA,-676,-250,-250,501,501,251,2017-07-01,2017-12-01,2021-08-15,10.1155/2013/723168,23533393,https://www.ncbi.nlm.nih.gov/pubmed/?term=Anesthesia+with+Propofol+versus+Sevoflurane%3A+Does+the+Longer+Neuromuscular+Block+under+Sevoflurane+Anesthesia+Reduce+Laryngeal+Injuries%3F,2013-02-13,journal publication,TRUE,TRUE,doi,Anesthesia with Propofol versus Sevoflurane: Does the Longer Neuromuscular Block under Sevoflurane Anesthesia Reduce Laryngeal Injuries?,Anesthesiology research and practice,2013,2013-02-27,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"1687-6962,1687-6970",Anesthesiology Research and Practice,Hindawi Limited,2013-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -1270,8 +1270,8 @@ NCT01634958,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mann NCT01635608,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Greifswald,NA,"Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water",small,Other,Interventional,Drug,Phase 1,12,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-04,2011-04-01,NA,NA,2011-07-01,2011,NA,NA,NA,-460,NA,-369,NA,733,364,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://d-nb.info/1037829050/34,2013-07-03,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01638793,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Capnographic Monitoring of Propofol-sedation During Colonoscopy,large,Other,Interventional,Device,NA,528,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-07-11,2012-06-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-40,417,417,101,101,518,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0033-1359149,24338242,NA,2013-12-11,journal publication,TRUE,TRUE,doi,Capnographic monitoring of propofol-based sedation during colonoscopy,Endoscopy,2014-Mar,2013-12-11,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0013-726X,1438-8812",Endoscopy,Georg Thieme Verlag KG,2013-12-11,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01638832,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease,large,Other,Interventional,Device,NA,572,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-07-05,2012-06-01,2013-12-01,2013,2013-09-01,2013,NA,NA,NA,-34,514,423,1425,1516,1939,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0186720,29073252,NA,2017-10-26,journal publication,TRUE,TRUE,doi,Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study,PloS one,2017,2017-10-26,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-10-26,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01644032,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Telemedically Supported Analgesia in the Emergency Medical Service,small,Other,Interventional,Other,NA,106,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,175,967,1321,2017-07-01,2017-12-01,2021-08-15,10.1002/ejp.843,26914284,http://onlinelibrary.wiley.com/doi/10.1002/ejp.843/full,2016-02-23,journal publication,TRUE,TRUE,doi,"Analgesia by telemedically supported paramedics compared with physician-administered analgesia: A prospective, interventional, multicentre trial","European journal of pain (London, England)",2016-08,2016-02-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1090-3801,European Journal of Pain,Wiley,2016-02-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01655290,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI,large,Other,Interventional,Other,Phase 2,20,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-07-30,2012-08-01,2014-06-01,2014,2013-05-01,2013,NA,NA,NA,2,671,275,128,524,799,2017-07-01,2017-12-01,2021-08-15,10.1097/rli.0000000000000076,24872002,https://www.ncbi.nlm.nih.gov/pubmed/24872002,2014-10-07,journal publication,TRUE,TRUE,doi,Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T,Investigative radiology,2014-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0020-9996,Investigative Radiology,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01644032,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Telemedically Supported Analgesia in the Emergency Medical Service,small,Other,Interventional,Other,NA,106,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,175,967,1321,2017-07-01,2017-12-01,2021-08-15,10.1002/ejp.843,26914284,http://onlinelibrary.wiley.com/doi/10.1002/ejp.843/full,2016-02-23,journal publication,TRUE,TRUE,doi,"Analgesia by telemedically supported paramedics compared with physician-administered analgesia: A prospective, interventional, multicentre trial","European journal of pain (London, England)",2016-08,2016-02-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1090-3801,European Journal of Pain,Wiley,2016-02-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01655290,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI,large,Other,Interventional,Other,Phase 2,20,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-07-30,2012-08-01,2014-06-01,2014,2013-05-01,2013,NA,NA,NA,2,671,275,128,524,799,2017-07-01,2017-12-01,2021-08-15,10.1097/rli.0000000000000076,24872002,https://www.ncbi.nlm.nih.gov/pubmed/24872002,2014-10-07,journal publication,TRUE,TRUE,doi,Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T,Investigative radiology,2014-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0020-9996,Investigative Radiology,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01655979,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Berlin Köln,Medium-term Bedrest Whey Protein (MEP),No lead center,Other,Interventional,Dietary Supplement,NA,10,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-23,2011-08-01,NA,NA,2012-04-01,2012,NA,NA,NA,-357,NA,-113,NA,591,478,2017-07-01,2017-12-01,2021-08-15,10.1016/j.actaastro.2013.11.001,NA,https://www.sciencedirect.com/science/article/pii/S0094576513003937,2013-11-13,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,0094-5765,Acta Astronautica,Elsevier BV,2014-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01656720,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Halle-Wittenberg Heidelberg,"A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period",No lead center,Industry,Interventional,Drug,Phase 2,417,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-01,2012-02-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-182,761,487,590,864,1351,2017-07-01,2017-12-01,2021-08-15,10.1007/s00384-016-2585-7,27075314,NA,2016-04-13,journal publication,TRUE,TRUE,doi,Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response,International journal of colorectal disease,2016-Jun,2016-04-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0179-1958,1432-1262",International Journal of Colorectal Disease,Springer Science and Business Media LLC,2016-04-13,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01660464,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD),large,Other,Interventional,Behavioral,NA,50,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-08-06,2012-01-01,2013-11-01,2013,2013-11-01,2013,NA,NA,NA,-218,452,452,-240,-240,212,2017-07-01,2017-12-01,2021-08-15,10.1007/s00787-013-0397-7,23463180,https://link.springer.com/article/10.1007/s00787-013-0397-7,2013-03-06,journal publication,TRUE,TRUE,doi,Effectiveness of telephone-assisted parent-administered behavioural family intervention for preschool children with externalizing problem behaviour: a randomized controlled trial,European child & adolescent psychiatry,2013-Sep,2013-03-06,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1018-8827,1435-165X",European Child & Adolescent Psychiatry,Springer Science and Business Media LLC,2013-03-06,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -1280,7 +1280,7 @@ NCT01663311,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Rege NCT01664832,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Ulm,NA,Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?,large,Other,Interventional,Device,NA,18,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-08-02,2012-07-01,NA,NA,2013-09-01,2013,NA,NA,NA,-32,NA,395,NA,654,1049,2017-07-01,2017-12-01,2021-08-15,10.1159/000431074,26107742,https://www.ncbi.nlm.nih.gov/pubmed/26107742,2015-06-17,journal publication,TRUE,TRUE,doi,Effects of Synchronization during Noninvasive Intermittent Mandatory Ventilation in Preterm Infants with Respiratory Distress Syndrome Immediately after Extubation,Neonatology,2015,2015-06-17,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,"1661-7800,1661-7819",Neonatology,S. Karger AG,2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2016-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01669382,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,Giessen,Angio-Seal® vs. Exo-Seal® for Closure of Arterial Puncture Sites,large,Other,Interventional,Device,Phase 3,304,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-09,2012-01-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-221,23,23,1015,1015,1038,2017-07-01,2017-12-01,2021-08-15,10.1007/s00059-015-4306-3,26070467,NA,2015-06-13,journal publication,TRUE,TRUE,doi,"Comparison of Exo-Seal(®) and Angio-Seal (®) for arterial puncture site closure: A randomized, multicenter, single-blind trial",Herz,2015-Aug,2015-06-13,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0340-9937,1615-6692",Herz,Springer Science and Business Media LLC,2015-06-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-06-13,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01669863,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS),large,Other,Interventional,Device,Phase 1/Phase 2,6,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2012-08-15,2012-08-01,2013-04-01,2013,2013-04-01,2013,2015-03-17,715,715,-14,229,229,128,128,357,2017-07-01,2017-12-01,2021-08-15,10.1007/s00134-013-3052-3,23921981,https://www.ncbi.nlm.nih.gov/pubmed/23921981,2013-08-07,journal publication,TRUE,TRUE,doi,Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome,Intensive care medicine,2013-Nov,2013-08-07,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0342-4642,1432-1238",Intensive Care Medicine,Springer Science and Business Media LLC,2013-08-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2014-08-07,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01673763,ClinicalTrials.gov,TRUE,1,Dissertation,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Post-ERCP Pancreatitis Prevention by Stent Insertion,large,Other,Interventional,Device,NA,169,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2011-10-17,2010-07-01,2017-08-01,2017,2016-06-01,2016,NA,NA,NA,-473,2115,1689,-35,391,2080,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://mediatum.ub.tum.de/?id=1304952,2017-06-27,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,122,1475,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01673763,ClinicalTrials.gov,TRUE,1,Dissertation,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Post-ERCP Pancreatitis Prevention by Stent Insertion,large,Other,Interventional,Device,NA,169,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2011-10-17,2010-07-01,2017-08-01,2017,2016-06-01,2016,NA,NA,NA,-473,2115,1689,-35,391,2080,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://mediatum.ub.tum.de/?id=1304952,2017-06-27,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,122,1475,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01676246,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,"Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine",small,Other,Interventional,Drug,Phase 1,36,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-08-28,2008-05-01,2009-06-01,2009,2009-05-01,2009,NA,NA,NA,-1580,-1184,-1215,2099,2130,915,2017-07-01,2017-12-01,2021-08-15,10.1111/bcp.12522,25264565,NA,2015-03-01,journal publication,TRUE,TRUE,doi,"Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1",British journal of clinical pharmacology,2015-Mar,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,3105,4458,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,green,0306-5251,British Journal of Clinical Pharmacology,Wiley,2015-02-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-02-20,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01692041,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Effect of an add-on Treatment With Ivy Leaves Dry Extract on Lung Function in Bronchial Asthma,large,Other,Interventional,Drug,Phase 2,30,Unknown status,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-03,2012-04-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-32,577,577,188,188,765,2017-07-01,2017-12-01,2021-08-15,10.1016/j.phymed.2014.05.006,24916707,http://www.sciencedirect.com/science/article/pii/S094471131400227X?via%3Dihub,2014-06-07,journal publication,TRUE,TRUE,doi,Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma,Phytomedicine : international journal of phytotherapy and phytopharmacology,2014-Sep-15,2014-06-07,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0944-7113,Phytomedicine,Elsevier BV,2014-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01693497,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Comparison of Cognitive Processing Therapy (CPT) and Dialogical Exposure Therapy (DET) for Posttraumatic Stress Disorder,large,Other,Interventional,Behavioral,NA,150,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-09-18,2002-09-01,2012-04-01,2012,2011-09-01,2011,NA,NA,NA,-3670,-170,-383,1335,1548,1165,2017-07-01,2017-12-01,2021-08-15,10.1159/000440726,26610167,https://www.ncbi.nlm.nih.gov/pubmed/26610167?dopt=Abstract,2015-11-27,journal publication,TRUE,TRUE,doi,A Randomized Controlled Clinical Trial of Dialogical Exposure Therapy versus Cognitive Processing Therapy for Adult Outpatients Suffering from PTSD after Type I Trauma in Adulthood,Psychotherapy and psychosomatics,2016,2015-11-27,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0033-3190,1423-0348",Psychotherapy and Psychosomatics,S. Karger AG,2015-11-27,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -1302,16 +1302,16 @@ NCT01767545,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU- NCT01788800,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Physical Activity and Cognitive Behavioural Therapy in Panic Disorder,large,Other,Interventional,Behavioral,NA,46,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-04,2009-01-01,2013-05-01,2013,2013-01-01,2013,NA,NA,NA,-1495,86,-34,446,566,532,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.sciencedirect.com/science/article/pii/S0022395614002052,2014-07-21,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01793558,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Incidence and Prevention of Hypothermia in Newborns Bonding During Caesarean Section,small,Other,Interventional,Procedure,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-02-12,2013-02-01,2013-04-01,2013,2013-04-01,2013,NA,NA,NA,-11,48,48,395,395,443,2017-07-01,2017-12-01,2021-08-15,10.1213/ane.0000000000000160,24681658,https://www.ncbi.nlm.nih.gov/pubmed/24681658,2014-05-01,journal publication,TRUE,TRUE,doi,The incidence and prevention of hypothermia in newborn bonding after cesarean delivery: a randomized controlled trial,Anesthesia and analgesia,2014-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-2999,Anesthesia & Analgesia,Ovid Technologies (Wolters Kluwer Health),2014-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01798160,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).,large,Other,Interventional,Procedure,Phase 4,24,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-16,2010-02-01,2013-05-01,2013,2013-05-01,2013,NA,NA,NA,-1111,74,74,555,555,629,2017-07-01,2017-12-01,2021-08-15,10.1007/s00270-014-1012-0,25373796,https://www.ncbi.nlm.nih.gov/pubmed/25373796,2014-11-07,journal publication,TRUE,TRUE,doi,Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma,Cardiovascular and interventional radiology,2015-Apr,2014-11-07,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0174-1551,1432-086X",CardioVascular and Interventional Radiology,Springer Science and Business Media LLC,2014-11-07,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01801280,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS,large,Other,Interventional,Drug,Phase 4,20,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,TRUE,2013-02-13,2012-01-01,2014-03-01,2014,2013-03-01,2013,2014-12-17,291,656,-409,381,16,500,865,881,2017-07-01,2017-12-01,2021-08-15,10.1111/bcp.12664,25913040,http://onlinelibrary.wiley.com/doi/10.1111/bcp.12664/full,2015-07-14,journal publication,TRUE,TRUE,doi,No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study,British journal of clinical pharmacology,2015-Nov,2015-07-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0306-5251,British Journal of Clinical Pharmacology,Wiley,2015-07-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-07-14,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01801280,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS,large,Other,Interventional,Drug,Phase 4,20,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,TRUE,2013-02-13,2012-01-01,2014-03-01,2014,2013-03-01,2013,2014-12-17,291,656,-409,381,16,500,865,881,2017-07-01,2017-12-01,2021-08-15,10.1111/bcp.12664,25913040,http://onlinelibrary.wiley.com/doi/10.1111/bcp.12664/full,2015-07-14,journal publication,TRUE,TRUE,doi,No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study,British journal of clinical pharmacology,2015-Nov,2015-07-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0306-5251,British Journal of Clinical Pharmacology,Wiley,2015-07-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-07-14,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01811615,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,FALSE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Efficacy of New Alcohol Free Mouthrinses,small,Other,Interventional,Other,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-01-18,2010-02-01,NA,NA,2011-02-01,2011,NA,NA,NA,-1082,NA,-717,NA,1377,660,2017-07-01,2017-12-01,2021-08-15,10.1111/idh.12111,25382448,https://www.ncbi.nlm.nih.gov/pubmed/25382448,2014-11-09,journal publication,TRUE,TRUE,doi,Randomized controlled trial on the efficacy of new alcohol-free chlorhexidine mouthrinses after 8 weeks,International journal of dental hygiene,2015-May,2014-11-09,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,closed,closed,1601-5029,International Journal of Dental Hygiene,Wiley,2014-11-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-11-09,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01811914,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg Marburg,NA,Focused TTE for Hemodynamic Instable High Risk Patients,small,Other,Interventional,Other,NA,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-03-13,2013-03-01,2014-03-01,2014,2013-11-01,2013,NA,NA,NA,-12,353,233,977,1097,1330,2017-07-01,2017-12-01,2021-08-15,10.1053/j.jvca.2016.11.002,28089598,https://www.ncbi.nlm.nih.gov/pubmed/28089598,2016-11-02,journal publication,TRUE,TRUE,doi,Impact of Focused Intraoperative Transthoracic Echocardiography by Anesthesiologists on Management in Hemodynamically Unstable High-Risk Noncardiac Surgery Patients,Journal of cardiothoracic and vascular anesthesia,2017-Apr,2016-11-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1053-0770,Journal of Cardiothoracic and Vascular Anesthesia,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01811914,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Focused TTE for Hemodynamic Instable High Risk Patients,small,Other,Interventional,Other,NA,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-03-13,2013-03-01,2014-03-01,2014,2013-11-01,2013,NA,NA,NA,-12,353,233,977,1097,1330,2017-07-01,2017-12-01,2021-08-15,10.1053/j.jvca.2016.11.002,28089598,https://www.ncbi.nlm.nih.gov/pubmed/28089598,2016-11-02,journal publication,TRUE,TRUE,doi,Impact of Focused Intraoperative Transthoracic Echocardiography by Anesthesiologists on Management in Hemodynamically Unstable High-Risk Noncardiac Surgery Patients,Journal of cardiothoracic and vascular anesthesia,2017-Apr,2016-11-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1053-0770,Journal of Cardiothoracic and Vascular Anesthesia,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01820702,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn,"Short Term Bed Rest Study: Evaluation of the Use of Artificial Gravity, Induced by Short-arm Centrifugation",No lead center,Other,Interventional,Other,NA,10,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-12-11,2010-11-01,2011-05-01,2011,2011-05-01,2011,NA,NA,NA,-771,-590,-590,1305,1305,715,2017-07-01,2017-12-01,2021-08-15,10.1007/s00421-014-3045-0,25425257,https://www.ncbi.nlm.nih.gov/pubmed/25425257,2014-11-26,journal publication,TRUE,TRUE,doi,Musculoskeletal effects of 5 days of bed rest with and without locomotion replacement training,European journal of applied physiology,2015-Apr,2014-11-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1439-6319,1439-6327",European Journal of Applied Physiology,Springer Science and Business Media LLC,2014-11-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01831947,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Göttingen,Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.,No lead center,Other,Interventional,Biological,Phase 4,40,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-04-11,2010-04-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-1106,-41,-41,1420,1420,1379,2017-07-01,2017-12-01,2021-08-15,10.1007/s00417-017-3589-x,28102456,NA,2017-01-19,journal publication,TRUE,TRUE,doi,Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial,Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,2017-May,2017-01-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0721-832X,1435-702X",Graefe's Archive for Clinical and Experimental Ophthalmology,Springer Science and Business Media LLC,2017-01-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01834547,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players,large,Other,Interventional,Drug,Phase 1,40,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-25,2011-05-01,2013-04-01,2013,2013-04-01,2013,NA,NA,NA,-24,677,677,1392,1392,2069,2017-07-01,2017-12-01,2021-08-15,10.1016/j.euroneuro.2017.01.006,28119083,https://www.ncbi.nlm.nih.gov/pubmed/28119083,2017-01-22,journal publication,TRUE,TRUE,doi,"Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial",European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2017-03,2017-01-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0924-977X,European Neuropsychopharmacology,Elsevier BV,2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01834573,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Impact of Physical Exercise on Quality of Life in Patients With Inflammatory Bowel Disease - a Pilot Study.,large,Other,Interventional,Behavioral,NA,36,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-04-14,2013-04-01,2013-11-01,2013,2013-09-01,2013,NA,NA,NA,-13,201,140,508,569,709,2017-07-01,2017-12-01,2021-08-15,10.1159/000371795,25823689,https://www.ncbi.nlm.nih.gov/pubmed/25823689,2015-03-24,journal publication,TRUE,TRUE,doi,The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial,Digestion,2015,2015-03-24,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0012-2823,1421-9867",Digestion,S. Karger AG,2015-03-24,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2016-03-24,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01837901,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa,large,Industry,Interventional,Device,NA,88,Completed,Single,Randomized,TRUE,FALSE,FALSE,TRUE,2013-04-09,2011-07-01,2014-02-01,2014,2013-08-01,2013,2021-02-23,2579,2763,-648,298,114,1065,1249,1363,2017-07-01,2017-12-01,2021-08-15,10.1167/iovs.16-19906,28114587,https://www.ncbi.nlm.nih.gov/pubmed/28114587,2017-01-01,journal publication,TRUE,TRUE,doi,"Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year",Investigative ophthalmology & visual science,2017-01-01,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,1399,2752,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,gold,gold,1552-5783,Investigative Opthalmology & Visual Science,Association for Research in Vision and Ophthalmology (ARVO),2017-01-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01837901,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa,large,Industry,Interventional,Device,NA,88,Completed,Single,Randomized,TRUE,FALSE,FALSE,TRUE,2013-04-09,2011-07-01,2014-02-01,2014,2013-08-01,2013,2021-02-23,2579,2763,-648,298,114,1065,1249,1363,2017-07-01,2017-12-01,2021-08-15,10.1167/iovs.16-19906,28114587,https://www.ncbi.nlm.nih.gov/pubmed/28114587,2017-01-01,journal publication,TRUE,TRUE,doi,"Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year",Investigative ophthalmology & visual science,2017-01-01,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,1399,2752,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,gold,gold,1552-5783,Investigative Opthalmology & Visual Science,Association for Research in Vision and Ophthalmology (ARVO),2017-01-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01841567,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Post Market Clinical Follow-up Study,No lead center,Industry,Interventional,Device,Phase 4,60,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2013-04-23,2013-04-01,2013-09-01,2013,2013-09-01,2013,2014-04-16,227,227,-22,131,131,821,821,952,2017-07-01,2017-12-01,2021-08-15,NA,26790803,https://www.ncbi.nlm.nih.gov/pubmed/26790803,2015-12-01,journal publication,TRUE,TRUE,pmid,Is the use of modern versus conventional wound dressings warranted after primary knee and hip arthroplasty? Results of a Prospective Comparative Study,Acta orthopaedica Belgica,2015-Dec,NA,FALSE,FALSE,TRUE,FALSE,FALSE,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01845142,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Immunologic Action of a Single Dose Cholecalciferol,large,Other,Interventional,Drug,Phase 4,40,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-04-24,2013-02-01,2014-04-01,2014,2013-05-01,2013,NA,NA,NA,-82,342,7,1028,1363,1370,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0169620,28114352,https://www.ncbi.nlm.nih.gov/pubmed/?term=Pharmacokinetic+Evaluation+of+a+Single+Intramuscular+High+Dose+versus+an+Oral+Long-Term+Supplementation+of+Cholecalciferol,2017-01-23,journal publication,TRUE,TRUE,doi,Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol,PloS one,2017,2017-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01845142,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Immunologic Action of a Single Dose Cholecalciferol,large,Other,Interventional,Drug,Phase 4,40,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-04-24,2013-02-01,2014-04-01,2014,2013-05-01,2013,NA,NA,NA,-82,342,7,1028,1363,1370,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0169620,28114352,https://www.ncbi.nlm.nih.gov/pubmed/?term=Pharmacokinetic+Evaluation+of+a+Single+Intramuscular+High+Dose+versus+an+Oral+Long-Term+Supplementation+of+Cholecalciferol,2017-01-23,journal publication,TRUE,TRUE,doi,Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol,PloS one,2017,2017-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01859416,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Effects of Oral Nutritional Supplements in Nursing Home Residents,large,Other,Interventional,Dietary Supplement,NA,87,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-05-17,2009-03-01,2010-09-01,2010,2010-07-01,2010,NA,NA,NA,-1538,-989,-1051,1065,1127,76,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jamda.2013.05.011,23810109,http://www.sciencedirect.com/science/article/pii/S152586101300282X?via%3Dihub,2013-08-01,journal publication,TRUE,TRUE,doi,"Effects of a low-volume, nutrient- and energy-dense oral nutritional supplement on nutritional and functional status: a randomized, controlled trial in nursing home residents",Journal of the American Medical Directors Association,2013-Aug,2013-06-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1525-8610,Journal of the American Medical Directors Association,Elsevier BV,2013-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01880697,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Rostock,Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above,No lead center,Industry,Interventional,Biological,Phase 3,126,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2013-06-12,2013-08-01,2013-09-01,2013,2013-09-01,2013,2013-11-07,67,67,50,81,81,416,416,497,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2013-000621-30/results,2014-10-22,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01880970,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Giessen Marburg,Effect of Starter Formula on Infection Prevention,No lead center,Industry,Interventional,Other,NA,477,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2013-06-17,2008-10-01,2013-10-01,2013,2013-10-01,2013,NA,NA,NA,-1720,106,106,1177,1177,1283,2017-07-01,2017-12-01,2021-08-15,10.1038/pr.2016.270,28002391,https://www.ncbi.nlm.nih.gov/pubmed/28002391,2016-12-21,journal publication,TRUE,TRUE,doi,Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial,Pediatric research,2017-Apr,2016-12-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0031-3998,1530-0447",Pediatric Research,Springer Science and Business Media LLC,2016-12-21,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -1319,10 +1319,10 @@ NCT01900067,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Gies NCT01903538,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Interference With Cognitive Control by Transcranial Direct Current Stimulation,large,Other,Interventional,Device,NA,28,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-13,2011-07-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-743,-377,-377,1005,1005,628,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0122578,25837520,https://www.ncbi.nlm.nih.gov/pubmed/25837520,2015-04-02,journal publication,TRUE,TRUE,doi,Keep calm and carry on: improved frustration tolerance and processing speed by transcranial direct current stimulation (tDCS),PloS one,2015,2015-04-02,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-04-02,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01905254,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Transient Elastography in Autoimmune Hepatitis,large,Other,Interventional,Device,NA,34,Completed,Single,NA,NA,FALSE,FALSE,TRUE,2013-07-01,2007-08-01,2013-01-01,2013,2010-08-01,2010,2014-12-07,705,1589,-2161,-181,-1065,1241,2125,1060,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jhep.2016.05.023,27238753,NA,2016-05-26,journal publication,TRUE,TRUE,doi,Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis,Journal of hepatology,2016-10,2016-05-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,0168-8278,Journal of Hepatology,Elsevier BV,2016-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01908244,ClinicalTrials.gov,TRUE,1,Dissertation,FALSE,FALSE,TRUE,TRUE,FALSE,NA,Tübingen,Short-term Effects of Live Music in Preterm Infants,No lead center,Other,Interventional,Other,NA,21,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2013-07-23,2013-07-01,NA,NA,2013-10-01,2013,NA,NA,NA,-22,NA,70,NA,842,912,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://publikationen.uni-tuebingen.de/xmlui/handle/10900/68041,2016-01-21,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,4,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01908270,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen Duisburg-Essen,NA,Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer,large,Other,Interventional,Behavioral,NA,40,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-07-23,2013-08-01,2014-02-01,2014,2013-11-01,2013,NA,NA,NA,9,193,101,396,488,589,2017-07-01,2017-12-01,2021-08-15,10.1002/cncr.29330,25739642,http://onlinelibrary.wiley.com/doi/10.1002/cncr.29330/full,2015-03-04,journal publication,TRUE,TRUE,doi,Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial,Cancer,2015-Jul-01,2015-03-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2015-03-04,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01908270,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer,large,Other,Interventional,Behavioral,NA,40,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-07-23,2013-08-01,2014-02-01,2014,2013-11-01,2013,NA,NA,NA,9,193,101,396,488,589,2017-07-01,2017-12-01,2021-08-15,10.1002/cncr.29330,25739642,http://onlinelibrary.wiley.com/doi/10.1002/cncr.29330/full,2015-03-04,journal publication,TRUE,TRUE,doi,Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial,Cancer,2015-Jul-01,2015-03-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2015-03-04,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01921777,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Effects of Traumeel®S Tablets on Recovery and Inflammatory Immune Response After Repeated Bouts of Exercise,small,Other,Interventional,Drug,Phase 1,95,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-06,2010-01-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-1313,117,117,1178,1178,1295,2017-07-01,2017-12-01,2021-08-15,10.1007/s00421-017-3554-8,28224232,NA,2017-02-21,journal publication,TRUE,TRUE,doi,Effects of Traumeel (Tr14) on recovery and inflammatory immune response after repeated bouts of exercise: a double-blind RCT,European journal of applied physiology,2017-Mar,2017-02-21,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1439-6319,1439-6327",European Journal of Applied Physiology,Springer Science and Business Media LLC,2017-02-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-02-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01923961,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration,small,Other,Interventional,Drug,NA,8,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,TRUE,2013-08-10,2013-08-01,2015-08-10,2015,2015-03-30,2015,2017-07-30,720,853,-9,730,597,317,450,1047,2017-07-01,2017-12-01,2021-08-15,10.1111/apha.12730,27259463,NA,2016-06-22,journal publication,TRUE,TRUE,doi,Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal,"Acta physiologica (Oxford, England)",2017-02,2016-06-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,844,2197,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,1748-1708,Acta Physiologica,Wiley,2016-06-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-06-22,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01927991,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg Marburg,NA,Internet-based Self-help for Tinnitus: The Role of Support,small,Other,Interventional,Behavioral,NA,112,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-17,2012-09-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,-350,257,106,731,882,988,2017-07-01,2017-12-01,2021-08-15,10.1016/j.invent.2016.04.001,30135798,http://www.sciencedirect.com/science/article/pii/S2214782915300245,2016-05-01,journal publication,TRUE,TRUE,doi,Treating tinnitus distress via the Internet: A mixed methods approach of what makes patients seek help and stay motivated during Internet-based cognitive behavior therapy,Internet interventions,2016-May,2016-05-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2214-7829,Internet Interventions,Elsevier BV,2016-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01927991,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Internet-based Self-help for Tinnitus: The Role of Support,small,Other,Interventional,Behavioral,NA,112,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-17,2012-09-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,-350,257,106,731,882,988,2017-07-01,2017-12-01,2021-08-15,10.1016/j.invent.2016.04.001,30135798,http://www.sciencedirect.com/science/article/pii/S2214782915300245,2016-05-01,journal publication,TRUE,TRUE,doi,Treating tinnitus distress via the Internet: A mixed methods approach of what makes patients seek help and stay motivated during Internet-based cognitive behavior therapy,Internet interventions,2016-May,2016-05-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2214-7829,Internet Interventions,Elsevier BV,2016-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01933191,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Exercise Treatment of Dental Anxiety,large,Other,Interventional,Behavioral,NA,30,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-26,2011-08-01,2013-10-01,2013,2013-09-01,2013,NA,NA,NA,-725,67,37,1333,1363,1400,2017-07-01,2017-12-01,2021-08-15,10.1002/da.22659,28556577,http://onlinelibrary.wiley.com/doi/10.1002/da.22659/full,2017-05-26,journal publication,TRUE,TRUE,doi,Clinical and neurobiological effects of aerobic exercise in dental phobia: A randomized controlled trial,Depression and anxiety,2017-11,2017-05-26,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1091-4269,Depression and Anxiety,Wiley,2017-05-26,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-05-26,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01939639,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,The Influence of Oxytocin on the Processing of Social Contact,large,Other,Interventional,Drug,Phase 1,40,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-27,2013-03-01,2013-08-01,2013,2013-06-01,2013,NA,NA,NA,-179,-26,-87,365,426,339,2017-07-01,2017-12-01,2021-08-15,10.1038/npp.2014.78,24694924,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104346/,2014-08-01,journal publication,TRUE,TRUE,doi,An oxytocin-induced facilitation of neural and emotional responses to social touch correlates inversely with autism traits,Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,2014-Aug,2014-04-02,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0893-133X,1740-634X",Neuropsychopharmacology,Springer Science and Business Media LLC,2014-04-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01981915,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Optimum Insufflation Capacity in NMD,large,Other,Interventional,Procedure,NA,40,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2013-10-11,2011-01-01,2013-03-01,2013,2013-02-01,2013,NA,NA,NA,-1014,-224,-252,640,668,416,2017-07-01,2017-12-01,2021-08-15,10.1513/annalsats.201406-264oc,25384211,https://www.ncbi.nlm.nih.gov/pubmed/25384211,2014-12-01,journal publication,TRUE,TRUE,doi,Optimum insufflation capacity and peak cough flow in neuromuscular disorders,Annals of the American Thoracic Society,2014-Dec,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"2329-6933,2325-6621",Annals of the American Thoracic Society,American Thoracic Society,2014-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA @@ -1331,7 +1331,7 @@ NCT02001636,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT02039648,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,The Influence of Rumex Acetosa L on the Intraoral Colonization With Porphyromonas Gingivalis,small,Other,Interventional,Other,Early Phase 1,35,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2014-01-16,2012-03-01,2013-04-01,2013,2013-04-01,2013,NA,NA,NA,-686,-290,-290,722,722,432,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0120130,25803708,NA,2015-03-24,journal publication,TRUE,TRUE,doi,Extract from Rumex acetosa L. for prophylaxis of periodontitis: inhibition of bacterial in vitro adhesion and of gingipains of Porphyromonas gingivalis by epicatechin-3-O-(4β→8)-epicatechin-3-O-gallate (procyanidin-B2-Di-gallate),PloS one,2015,2015-03-24,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2015-03-24,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02112396,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Community Reinforcement and Family Training (CRAFT) for Treatment-resistant Individuals With Alcohol Use Disorders,small,Other,Interventional,Behavioral,NA,89,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-04-01,2008-08-01,2011-06-01,2011,2011-03-01,2011,NA,NA,NA,-2069,-1035,-1127,1784,1876,749,2017-07-01,2017-12-01,2021-08-15,10.1016/j.drugalcdep.2016.04.015,27141840,https://www.ncbi.nlm.nih.gov/pubmed/27141840,2016-04-19,journal publication,TRUE,TRUE,doi,Efficacy of the Community Reinforcement and Family Training for concerned significant others of treatment-refusing individuals with alcohol dependence: A randomized controlled trial,Drug and alcohol dependence,2016-Jun-01,2016-04-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0376-8716,Drug and Alcohol Dependence,Elsevier BV,2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02125669,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Greifswald,Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas,No lead center,Other,Interventional,Procedure,NA,100,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2014-04-13,2012-11-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-528,-224,-224,505,505,281,2017-07-01,2017-12-01,2021-08-15,10.1111/bjd.13266,25040296,NA,2015-01-19,journal publication,TRUE,TRUE,doi,The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial,The British journal of dermatology,2015-Mar,2015-01-19,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0007-0963,British Journal of Dermatology,Wiley,2015-01-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT02149927,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers,large,Other,Interventional,Drug,Early Phase 1,20,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-22,2013-06-01,2014-01-01,2014,2013-12-01,2013,NA,NA,NA,-325,-111,-142,1035,1066,924,2017-07-01,2017-12-01,2021-08-15,10.1097/aln.0000000000001322,27617689,https://www.ncbi.nlm.nih.gov/pubmed/27617689,2016-11-01,journal publication,TRUE,TRUE,doi,Neural Correlates of Sevoflurane-induced Unconsciousness Identified by Simultaneous Functional Magnetic Resonance Imaging and Electroencephalography,Anesthesiology,2016-11,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0003-3022,Anesthesiology,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",journal,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT02149927,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers,large,Other,Interventional,Drug,Early Phase 1,20,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-22,2013-06-01,2014-01-01,2014,2013-12-01,2013,NA,NA,NA,-325,-111,-142,1035,1066,924,2017-07-01,2017-12-01,2021-08-15,10.1097/aln.0000000000001322,27617689,https://www.ncbi.nlm.nih.gov/pubmed/27617689,2016-11-01,journal publication,TRUE,TRUE,doi,Neural Correlates of Sevoflurane-induced Unconsciousness Identified by Simultaneous Functional Magnetic Resonance Imaging and Electroencephalography,Anesthesiology,2016-11,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0003-3022,Anesthesiology,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",journal,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02154607,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Impact of Continuous Defocused CO2 Laser Vaporisation on the Histological Malignant Transformation of Erosive Oral Lichen Planus in Patients,large,Other,Interventional,Device,NA,263,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2014-03-27,2004-01-01,2013-12-01,2013,2011-11-01,2011,NA,NA,NA,-3738,-116,-877,584,1345,468,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jcms.2015.06.044,26210304,https://www.ncbi.nlm.nih.gov/pubmed/26210304,2015-07-08,journal publication,TRUE,TRUE,doi,Clinical trial analyzing the impact of continuous defocused CO2 laser vaporisation on the malignant transformation of erosive oral lichen planus,Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery,2015-Oct,2015-07-08,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1010-5182,Journal of Cranio-Maxillofacial Surgery,Elsevier BV,2015-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02197546,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Acupuncture for Pain During Injection of Local Anaesthetic,small,Other,Interventional,Other,NA,49,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-07-21,2010-07-01,2011-11-01,2011,2011-06-01,2011,NA,NA,NA,-1481,-993,-1146,1522,1675,529,2017-07-01,2017-12-01,2021-08-15,10.1097/ajp.0000000000000222,25724021,NA,2016-01-01,journal publication,TRUE,TRUE,doi,Acupuncture Reduces Pain and Autonomic Distress During Injection of Local Anesthetic in Children: A Pragmatic Crossover Investigation,The Clinical journal of pain,2016-Jan,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0749-8047,The Clinical Journal of Pain,Ovid Technologies (Wolters Kluwer Health),2016-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02199106,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,Münster Tübingen Würzburg,Effectiveness of Neuronavigated Continuous Theta Burst Stimulation of the Left Heschl's Gyrus in Chronic Tinnitus,small,Other,Interventional,Device,NA,23,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2014-07-22,2009-01-01,2011-05-01,2011,2011-03-01,2011,NA,NA,NA,-2028,-1178,-1239,1786,1847,608,2017-07-01,2017-12-01,2021-08-15,10.3233/rnn-150518,26890094,NA,2016-03-21,journal publication,TRUE,TRUE,doi,Neuronavigated left temporal continuous theta burst stimulation in chronic tinnitus,Restorative neurology and neuroscience,2016,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0922-6028,1878-3627",Restorative Neurology and Neuroscience,IOS Press,2016-03-21,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA @@ -1339,14 +1339,14 @@ NCT02267499,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA, NCT02297646,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Influencing Factors on Training Efficacy in Healthy Adults,small,Other,Interventional,Behavioral,Early Phase 1,23,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-09-10,2012-08-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-405,82,82,1305,1305,1387,2017-07-01,2017-12-01,2021-08-15,10.1080/02640414.2017.1346276,28657863,https://www.ncbi.nlm.nih.gov/pubmed/28657863,2017-06-28,journal publication,TRUE,TRUE,doi,Carbohydrate intake and training efficacy - a randomized cross-over study,Journal of sports sciences,2018-Apr,2017-06-28,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0264-0414,1466-447X",Journal of Sports Sciences,Informa UK Limited,2017-06-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2019-04-18,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02340351,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Auricular Acupuncture vs. Progressive Muscle Relaxation in Patients With Anxiety Disorders or Major Depressive Disorder.,large,Other,Interventional,Device,NA,136,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-01-13,2007-07-01,2013-08-01,2013,2009-03-01,2009,NA,NA,NA,-2753,-530,-2144,995,2609,465,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jams.2016.03.008,27555224,NA,2016-04-22,journal publication,TRUE,TRUE,doi,Auricular Acupuncture Versus Progressive Muscle Relaxation in Patients with Anxiety Disorders or Major Depressive Disorder: A Prospective Parallel Group Clinical Trial,Journal of acupuncture and meridian studies,2016-Aug,2016-04-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2005-2901,Journal of Acupuncture and Meridian Studies,Medical Association of Pharmacopuncture Institute,2016-08-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02359266,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Vitamin D Improves Depression in Liver Patients,small,Other,Interventional,Dietary Supplement,NA,111,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-02-04,2011-12-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-1161,-430,-430,592,592,162,2017-07-01,2017-12-01,2021-08-15,10.1016/j.clnu.2015.07.004,26212170,https://www.ncbi.nlm.nih.gov/pubmed/26212170,2015-07-16,journal publication,TRUE,TRUE,doi,Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease,"Clinical nutrition (Edinburgh, Scotland)",2016-08,2015-07-16,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0261-5614,Clinical Nutrition,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT02425163,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg Magdeburg,NA,Shear Wave Elastography of Prostate Cancer,small,Other,Interventional,Device,Phase 2,73,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-02-10,2012-03-01,2015-01-01,2015,2013-03-01,2013,NA,NA,NA,-1076,-40,-711,729,1400,689,2017-07-01,2017-12-01,2021-08-15,10.15557/jou.2016.0035,28138406,NA,2016-12-30,journal publication,TRUE,TRUE,doi,"Inability of shear-wave elastography to distinguish malignant from benign prostate tissue - a comparison of biopsy, whole-mount sectioning and shear-wave elastography",Journal of ultrasonography,2016-Dec,2016-12-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"2084-8404,2451-070X",Journal of Ultrasonography,Medical Communications Sp. z.o.o.,2016-12-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT02425163,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Shear Wave Elastography of Prostate Cancer,small,Other,Interventional,Device,Phase 2,73,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-02-10,2012-03-01,2015-01-01,2015,2013-03-01,2013,NA,NA,NA,-1076,-40,-711,729,1400,689,2017-07-01,2017-12-01,2021-08-15,10.15557/jou.2016.0035,28138406,NA,2016-12-30,journal publication,TRUE,TRUE,doi,"Inability of shear-wave elastography to distinguish malignant from benign prostate tissue - a comparison of biopsy, whole-mount sectioning and shear-wave elastography",Journal of ultrasonography,2016-Dec,2016-12-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"2084-8404,2451-070X",Journal of Ultrasonography,Medical Communications Sp. z.o.o.,2016-12-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02480608,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004),large,Other,Interventional,Drug,Phase 1/Phase 2,113,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-06-10,2004-04-01,2013-05-01,2013,2011-08-01,2011,NA,NA,NA,-4087,-770,-1409,1645,2284,875,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://ash.confex.com/ash/2017/webprogram/Paper99881.html,2017-11-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02487368,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain,large,Other,Interventional,Device,NA,166,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2015-06-29,2009-10-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-2097,-1671,-1671,2035,2035,364,2017-07-01,2017-12-01,2021-08-15,10.1016/j.eujim.2016.06.015,NA,http://www.sciencedirect.com/science/article/pii/S1876382016301172,2016-06-27,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,1876-3820,European Journal of Integrative Medicine,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02515019,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Bispectral Index Guided Sevoflurane Titration,large,Other,Interventional,Device,NA,60,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-28,2011-04-01,2012-01-01,2012,2011-09-01,2011,NA,NA,NA,-1579,-1304,-1426,974,1096,-330,2017-07-01,2017-12-01,2021-08-15,10.1097/eja.0000000000000106,24927118,https://insights.ovid.com/pubmed?pmid=24927118,2014-09-01,journal publication,TRUE,TRUE,doi,"Bispectral index guided titration of sevoflurane in on-pump cardiac surgery reduces plasma sevoflurane concentration and vasopressor requirements: a prospective, controlled, sequential two-arm clinical study",European journal of anaesthesiology,2014-Sep,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0265-0215,European Journal of Anaesthesiology,Ovid Technologies (Wolters Kluwer Health),2014-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02529358,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,Marburg,Text Message Based Maintenance Intervention,large,Other,Interventional,Behavioral,NA,180,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2015-03-18,2012-02-01,2013-10-01,2013,2013-10-01,2013,NA,NA,NA,-1141,-533,-533,1489,1489,956,2017-07-01,2017-12-01,2021-08-15,10.1016/j.jad.2017.10.047,29132073,NA,2017-10-29,journal publication,TRUE,TRUE,doi,Evaluation of a text-message-based maintenance intervention for Major Depressive Disorder after inpatient cognitive behavioral therapy,Journal of affective disorders,2018-02,2017-10-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0165-0327,Journal of Affective Disorders,Elsevier BV,2018-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02548208,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Single Focused Shock Wave in the Release od Delayed Onset Muscle Soreness (DOMS),large,Other,Interventional,Device,NA,46,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-09-09,2011-01-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-1712,-1378,-1378,1842,1842,464,2017-07-01,2017-12-01,2021-08-15,10.1016/j.apmr.2016.11.013,27993588,NA,2016-12-16,journal publication,TRUE,TRUE,doi,Effect of a Single Administration of Focused Extracorporeal Shock Wave in the Relief of Delayed-Onset Muscle Soreness: Results of a Partially Blinded Randomized Controlled Trial,Archives of physical medicine and rehabilitation,2017-05,2016-12-16,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,0003-9993,Archives of Physical Medicine and Rehabilitation,Elsevier BV,2017-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02557113,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Creation of a Small Cavity Reduces the Rate of Cement Leakage During Vertebral Body Augmentation,large,Other,Interventional,Procedure,NA,36,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-09-20,2011-01-01,2013-01-01,2013,2012-09-01,2012,NA,NA,NA,-1723,-992,-1114,1163,1285,171,2017-07-01,2017-12-01,2021-08-15,10.1002/jor.23215,26919407,NA,2016-03-09,journal publication,TRUE,TRUE,doi,Small cavity creation in the vertebral body reduces the rate of cement leakage during vertebroplasty,Journal of orthopaedic research : official publication of the Orthopaedic Research Society,2017-01,2016-03-09,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0736-0266,Journal of Orthopaedic Research,Wiley,2016-03-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT02585882,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke Witten/Herdecke,NA,Preventive Effect of Salt Fluoridation,small,Other,Interventional,Other,NA,441,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-10-22,2012-03-01,2015-10-01,2015,2013-08-01,2013,NA,NA,NA,-1330,-21,-812,776,1567,755,2017-07-01,2017-12-01,2021-08-15,10.1159/000479892,29136625,https://www.ncbi.nlm.nih.gov/pubmed/29136625,2017-11-15,journal publication,TRUE,TRUE,doi,"Caries-Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia: A Prospective, Controlled, Interventional Study",Caries research,2017,2017-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,792,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT02585882,ClinicalTrials.gov,TRUE,1,Hand search,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Preventive Effect of Salt Fluoridation,small,Other,Interventional,Other,NA,441,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-10-22,2012-03-01,2015-10-01,2015,2013-08-01,2013,NA,NA,NA,-1330,-21,-812,776,1567,755,2017-07-01,2017-12-01,2021-08-15,10.1159/000479892,29136625,https://www.ncbi.nlm.nih.gov/pubmed/29136625,2017-11-15,journal publication,TRUE,TRUE,doi,"Caries-Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia: A Prospective, Controlled, Interventional Study",Caries research,2017,2017-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,792,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02643602,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Does Bicarbonate in Addition to Theophylline Reduce CIN?,large,Other,Interventional,Other,NA,152,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2015-12-23,2005-12-01,2012-12-01,2012,2012-06-01,2012,NA,NA,NA,-3674,-1117,-1300,1247,1430,130,2017-07-01,2017-12-01,2021-08-15,10.1097/md.0000000000003720,27227933,https://www.ncbi.nlm.nih.gov/pubmed/27227933,2016-05-01,journal publication,TRUE,TRUE,doi,Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial,Medicine,2016-May,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,0025-7974,Medicine,Ovid Technologies (Wolters Kluwer Health),2016-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02651766,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,The Effects of Cupping Massage in Patients With Chronic Neck Pain - A Randomized Controlled Trial,large,Other,Interventional,Procedure,NA,50,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2016-01-07,2009-05-01,2011-02-01,2011,2011-02-01,2011,NA,NA,NA,-2442,-1801,-1801,2206,2206,405,2017-07-01,2017-12-01,2021-08-15,10.1159/000454872,28219058,https://www.ncbi.nlm.nih.gov/pubmed/28219058,2017-02-15,journal publication,TRUE,TRUE,doi,The Effects of Cupping Massage in Patients with Chronic Neck Pain - A Randomised Controlled Trial,Complementary medicine research,2017,2017-02-15,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,4,2495,3848,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,bronze,bronze,"2504-2092,2504-2106",Complementary Medicine Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02711202,ClinicalTrials.gov,TRUE,1,Hand search,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation,No lead center,Other,Interventional,Drug,NA,20,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2016-03-09,2007-01-01,2009-03-01,2009,2009-03-01,2009,NA,NA,NA,-3355,-2565,-2565,2875,2875,310,2017-07-01,2017-12-01,2021-08-15,10.1371/journal.pone.0169624,28085915,http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0169624,2017-01-13,journal publication,TRUE,TRUE,doi,Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial,PloS one,2017,2017-01-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,0,0,3197,4550,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -1538,7 +1538,7 @@ NCT00151892,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Frei NCT00156338,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Effect of Intraoperative Fluid Management on Morbidity,large,Other,Interventional,Procedure,NA,108,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-08,2005-07-01,2010-12-01,2010,2009-12-01,2009,NA,NA,NA,-69,1910,1545,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00160966,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,Heidelberg,Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy,small,Other,Interventional,Drug,Phase 4,108,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-08,2004-09-01,2010-03-01,2010,2010-03-01,2010,NA,NA,NA,-372,1635,1635,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,46,46,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00167596,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Rostock,Near Infrared Spectroscopy (NIRS) in Severe Sepsis,No lead center,Other,Interventional,Device,Phase 2/Phase 3,103,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-09,2005-07-01,2009-12-01,2009,2009-05-01,2009,NA,NA,NA,-70,1544,1330,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00170274,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Mannheim Schleswig-Holstein Mannheim,NA,APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias,small,Industry,Interventional,Device,NA,156,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-12,2000-08-01,2014-10-01,2014,2011-06-01,2011,NA,NA,NA,-1868,3306,2088,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00170274,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Mannheim,NA,APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias,small,Industry,Interventional,Device,NA,156,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-12,2000-08-01,2014-10-01,2014,2011-06-01,2011,NA,NA,NA,-1868,3306,2088,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00176046,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study",large,Other,Interventional,Drug,Phase 4,114,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-10,1999-05-01,2009-07-01,2009,2009-06-01,2009,NA,NA,NA,-2324,1390,1360,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3075,4428,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00176410,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Statin Therapy in Asymptomatic Aortic Stenosis,large,Other,Interventional,Drug,Phase 2,100,Unknown status,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-13,2003-01-01,2009-12-01,2009,2009-09-01,2009,NA,NA,NA,-986,1540,1449,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00188136,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML),large,Other,Interventional,Drug,Phase 2,32,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2005-09-12,2002-08-01,2010-12-01,2010,2010-07-01,2010,NA,NA,NA,-1138,1906,1753,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1561,13 +1561,13 @@ NCT00323661,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aach NCT00325221,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Erlangen Würzburg,Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM),No lead center,Industry,Interventional,Device,NA,148,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-05-11,2006-08-01,2012-10-01,2012,2012-01-01,2012,NA,NA,NA,82,2335,2061,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00331721,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST,large,Industry,Interventional,Drug,Phase 2,24,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2006-05-30,2006-05-01,2009-05-01,2009,2009-05-01,2009,NA,NA,NA,-29,1067,1067,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3136,4489,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00368264,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,Düsseldorf Erlangen,TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ),large,Other,Interventional,Drug,Phase 2/Phase 3,1,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2006-08-23,2006-09-01,2009-06-01,2009,2009-06-01,2009,NA,NA,NA,9,1013,1013,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,3105,4458,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00390702,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System,large,Industry,Interventional,Device,NA,103,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2006-10-19,2006-10-01,2017-05-01,2017,2012-08-01,2012,NA,NA,NA,-18,3847,2113,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,214,1567,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00390702,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,Giessen LMU-München,Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System,large,Industry,Interventional,Device,NA,103,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2006-10-19,2006-10-01,2017-05-01,2017,2012-08-01,2012,NA,NA,NA,-18,3847,2113,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,214,1567,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00391534,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy,large,Industry,Interventional,Drug,Phase 3,100,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-10-23,2006-10-01,2009-11-01,2009,2009-11-01,2009,NA,NA,NA,-22,1105,1105,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2952,4305,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00405873,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003,large,Industry,Interventional,Drug,Phase 2,73,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2006-11-29,2007-03-01,2010-03-01,2010,2010-03-01,2010,NA,NA,NA,92,1188,1188,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00409799,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Göttingen Hannover Schleswig-Holstein Münster,Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting,No lead center,Industry,Interventional,Drug,Phase 2,208,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2006-12-08,2006-11-01,2011-09-01,2011,2011-09-01,2011,NA,NA,NA,-37,1728,1728,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00412451,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,LMU-München,A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME),No lead center,Industry,Interventional,Drug,Phase 2,51,Completed,Triple,Randomized,TRUE,TRUE,TRUE,TRUE,2006-12-14,2006-12-01,2010-03-01,2010,2010-01-01,2010,2013-07-04,1221,1280,-13,1173,1114,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2832,4185,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00422201,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Würzburg,"Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion",No lead center,Industry,Interventional,Drug,Phase 2,18,Terminated,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-01-12,2007-05-15,2012-04-04,2012,2012-04-04,2012,2013-08-08,491,491,123,1909,1909,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,6,6,2067,3420,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00425425,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,"Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer",large,Other,Interventional,Biological,Phase 1/Phase 2,43,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2007-01-19,2006-07-01,2015-05-01,2015,2010-05-01,2010,NA,NA,NA,-202,3024,1198,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,945,2298,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00425425,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,Berlin Marburg,"Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer",large,Other,Interventional,Biological,Phase 1/Phase 2,43,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2007-01-19,2006-07-01,2015-05-01,2015,2010-05-01,2010,NA,NA,NA,-202,3024,1198,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,945,2298,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00433459,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,Giessen Marburg,Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma,small,Other,Interventional,Drug,Phase 3,2134,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2007-02-08,2007-01-01,2013-01-01,2013,2013-01-01,2013,NA,NA,NA,-38,2154,2154,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00434616,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia",large,Other,Interventional,Procedure,Phase 2/Phase 3,90,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2007-02-09,2007-04-01,2011-07-01,2011,2011-04-01,2011,NA,NA,NA,51,1603,1512,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,14,14,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00436098,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Pediatric Exercise With Congenital Heart Defects (Kinderturnen Mit Angeborenem Herzfehler),large,Other,Interventional,Behavioral,NA,60,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2007-02-15,2007-02-01,2010-05-01,2010,2009-11-01,2009,NA,NA,NA,-14,1171,990,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2771,4124,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1594,7 +1594,7 @@ NCT00540631,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,M NCT00542828,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hannover,Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic Syndrome,No lead center,Industry,Interventional,Biological,Phase 2,16,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2007-10-10,2007-10-01,2009-07-01,2009,2009-05-01,2009,2010-04-07,280,341,-9,630,569,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,3075,4428,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00544583,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Continuous Versus Interrupted Abdominal Wall Closure After Emergency Midline Laparotomy,large,Other,Interventional,Procedure,Phase 2/Phase 3,80,Unknown status,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2007-10-15,2007-11-01,2012-04-01,2012,2011-04-01,2011,NA,NA,NA,17,1630,1264,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00545441,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,A Randomized Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas,small,Industry,Interventional,Device,NA,86,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2007-10-16,2008-06-01,2013-04-01,2013,2013-04-01,2013,2014-10-24,571,571,229,1994,1994,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00546845,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study,large,Other,Interventional,Device,Phase 4,180,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2007-10-17,2007-09-01,2014-06-01,2014,2012-03-01,2012,NA,NA,NA,-46,2419,1597,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00546845,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study,large,Other,Interventional,Device,Phase 4,180,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2007-10-17,2007-09-01,2014-06-01,2014,2012-03-01,2012,NA,NA,NA,-46,2419,1597,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00546975,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effect of Oral Nutritional Supplements With Specialized Nutrients on Functional Recovery and Morbidity After Gastrointestinal Surgery,large,Other,Interventional,Dietary Supplement,NA,NA,Terminated,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2007-10-18,2007-10-01,2009-09-01,2009,2009-09-01,2009,NA,NA,NA,-17,684,684,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3013,4366,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00558662,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum Bonn Duisburg-Essen,NA,Randomized Clinical Trial (RCT) to Compare the Efficacy of Coban 2 Versus SSB in the Treatment of Venous Leg Ulcers,large,Industry,Interventional,Device,NA,234,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2007-11-13,2007-11-01,2011-09-01,2011,2009-04-01,2009,NA,NA,NA,-12,1388,505,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00559286,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,Heidelberg,Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels,small,Other,Interventional,Drug,Phase 4,40,Terminated,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2007-11-15,2007-12-01,2009-01-01,2009,2009-01-01,2009,NA,NA,NA,16,413,413,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,3256,4609,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1668,7 +1668,7 @@ NCT00776906,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leip NCT00777127,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,Berlin Düsseldorf Frankfurt Schleswig-Holstein Mainz Münster Regensburg,Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses,small,Industry,Interventional,Drug,Phase 4,258,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-10-21,2008-12-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,41,1472,1472,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00779714,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,Aachen Berlin Bochum Duisburg-Essen Frankfurt Hannover Jena Schleswig-Holstein Magdeburg Mainz Mannheim Marburg LMU-München Münster Homburg Tübingen,Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC,small,Other,Interventional,Drug,Phase 3,360,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-10-22,2008-10-01,2013-04-01,2013,2012-10-01,2012,NA,NA,NA,-21,1622,1440,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2015.33.15_suppl.e20080,NA,http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e20080,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,8,8,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00781053,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Frankfurt Köln,Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study,No lead center,Industry,Interventional,Drug,Phase 2,38,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-10-24,2008-07-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-115,768,768,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00781807,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Rehabilitation and Outcome for Patients on LVAD Support,large,Other,Interventional,Other,NA,80,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-10-28,2008-11-01,2014-04-01,2014,2013-10-01,2013,NA,NA,NA,4,1981,1799,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00781807,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Rehabilitation and Outcome for Patients on LVAD Support,large,Other,Interventional,Other,NA,80,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-10-28,2008-11-01,2014-04-01,2014,2013-10-01,2013,NA,NA,NA,4,1981,1799,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00782080,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,Berlin,Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD,large,Other,Interventional,Drug,Phase 3,155,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-29,2008-07-01,2010-06-01,2010,2010-03-01,2010,NA,NA,NA,-120,580,488,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00782405,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,TU-München,NA,"Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine",large,Other,Interventional,Drug,Phase 3,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-10-24,2008-10-01,NA,NA,2011-04-01,2011,NA,NA,NA,-23,NA,889,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00786552,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer,small,Other,Interventional,Drug,Phase 2,47,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2008-11-05,2008-11-01,2013-11-01,2013,2012-11-01,2012,NA,NA,NA,-4,1822,1457,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1676,7 +1676,7 @@ NCT00787683,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Götting NCT00794482,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Duisburg-Essen,Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.,No lead center,Industry,Interventional,Drug,Phase 3,1200,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2008-11-19,2008-03-01,2009-06-01,2009,2009-06-01,2009,NA,NA,NA,-263,194,194,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,3105,4458,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00802347,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Hamburg Heidelberg Mannheim Tübingen,I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation,No lead center,Industry,Interventional,Drug,Phase 1/Phase 2,374,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-12-02,2008-12-01,2014-05-01,2014,2013-11-01,2013,NA,NA,NA,-1,1976,1795,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00806468,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease,large,Other,Interventional,Drug,Phase 4,1,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-09,2009-02-01,2011-02-01,2011,2010-12-01,2010,NA,NA,NA,54,784,722,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2495,3848,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00808600,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Empowerment of Lung and Heart-lung Transplant Patients,large,Other,Interventional,Behavioral,NA,132,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-15,2009-10-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,290,1843,1659,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,32,32,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00808600,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Empowerment of Lung and Heart-lung Transplant Patients,large,Other,Interventional,Behavioral,NA,132,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-15,2009-10-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,290,1843,1659,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,32,32,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00810095,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Percutaneous Recanalization in Ischemic Stroke Management (PRIISM): A Feasibility Clinical Study,large,Industry,Interventional,Device,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2008-12-15,2009-03-01,2011-04-01,2011,2011-04-01,2011,2012-03-21,355,355,76,837,837,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2436,3789,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00810433,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Göttingen Mannheim LMU-München,A Clinical Study of the GO-LIF® Approach for Lumbar Spinal Fixation,No lead center,Industry,Interventional,Procedure,NA,10,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-12-16,2009-02-01,2011-07-01,2011,2011-07-01,2011,NA,NA,NA,47,927,927,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00812019,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Giessen Marburg,Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old),No lead center,Industry,Interventional,Biological,Phase 1,753,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-12-18,2008-11-01,2010-11-01,2010,2009-03-01,2009,NA,NA,NA,-47,683,73,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,2587,3940,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1688,7 +1688,7 @@ NCT00823173,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübinge NCT00823225,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Urokinase Therapy in Patients With Diabetic Foot Syndrome,large,Industry,Interventional,Procedure,Phase 3,5,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-01-14,2008-06-01,2009-06-01,2009,2009-06-01,2009,NA,NA,NA,-227,138,138,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,3105,4458,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00826475,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Randomized Trial to Evaluate the Effectiveness of a Mindfulness Based Intervention (MBSR) for Patients Suffering From Migraine,large,Other,Interventional,Behavioral,NA,62,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-01-20,2009-01-01,2010-07-01,2010,2010-04-01,2010,NA,NA,NA,-19,527,436,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2710,4063,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00827008,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,"Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus",No lead center,Industry,Interventional,Drug,Phase 3,821,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2009-01-21,2009-01-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-20,1044,1044,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00827619,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg Magdeburg,NA,Zilver® Flex™ Vascular Stent Study,small,Industry,Interventional,Device,NA,110,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-01-22,2009-02-01,2015-11-01,2015,2011-11-01,2011,NA,NA,NA,10,2474,1013,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,761,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00827619,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Zilver® Flex™ Vascular Stent Study,small,Industry,Interventional,Device,NA,110,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-01-22,2009-02-01,2015-11-01,2015,2011-11-01,2011,NA,NA,NA,10,2474,1013,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,761,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00829192,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Schleswig-Holstein,Phase II AK Study in Organ Transplant Patients,No lead center,Industry,Interventional,Drug,Phase 2,200,Unknown status,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2009-01-23,2007-11-01,2012-08-01,2012,2012-07-01,2012,NA,NA,NA,-449,1286,1255,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1948,3301,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00840775,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Heidelberg,PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems),No lead center,Industry,Interventional,Device,Phase 4,278,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-02-09,2009-04-01,2011-06-01,2011,2011-01-01,2011,NA,NA,NA,51,842,691,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2375,3728,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00842959,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX,large,Industry,Interventional,Device,Phase 4,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-11,2009-02-01,2011-01-01,2011,2011-01-01,2011,NA,NA,NA,-10,689,689,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1697,7 +1697,7 @@ NCT00850499,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berl NCT00852020,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients",large,Industry,Interventional,Dietary Supplement,NA,60,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2009-02-13,2009-04-01,2011-04-01,2011,2011-04-01,2011,NA,NA,NA,47,777,777,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2436,3789,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00852059,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA),large,Other,Interventional,Drug,Phase 4,32,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-25,2009-03-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,4,1740,1740,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00853866,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,Tübingen,Enhancement of Motor Function With Reboxetine and Transcranial Direct Current Stimulation,large,Other,Interventional,Drug,Phase 4,12,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2009-02-27,2009-01-01,2010-06-01,2010,2009-11-01,2009,NA,NA,NA,-57,459,247,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,13,13,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00854256,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Trabeculectomy Versus Canaloplasty to Treat Glaucoma,large,Other,Interventional,Procedure,NA,60,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-02,2009-04-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,30,1886,1735,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00854256,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Trabeculectomy Versus Canaloplasty to Treat Glaucoma,large,Other,Interventional,Procedure,NA,60,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-02,2009-04-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,30,1886,1735,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00854802,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Düsseldorf Frankfurt Freiburg Hannover Heidelberg Mainz,A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients,No lead center,Industry,Interventional,Drug,NA,290,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-03-02,2009-01-01,2010-09-01,2010,2010-09-01,2010,NA,NA,NA,-60,548,548,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,24,24,2648,4001,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00854893,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Enhance of Language Learning With Neurostimulation,large,Other,Interventional,Device,NA,70,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-02,2009-10-01,2010-07-01,2010,2010-01-01,2010,NA,NA,NA,213,486,305,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2710,4063,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00856505,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 1/Phase 2,38,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-03-04,2008-03-01,2011-03-01,2011,2010-03-01,2010,NA,NA,NA,-368,727,362,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2467,3820,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1764,7 +1764,7 @@ NCT00990314,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Heid NCT00992394,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Erlangen Frankfurt Freiburg Hamburg,Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept,No lead center,Industry,Interventional,Drug,Phase 4,174,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-10-08,2010-01-01,2013-04-01,2013,2013-04-01,2013,2014-04-03,367,367,85,1271,1271,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00992576,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Jena,Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain,No lead center,Industry,Interventional,Drug,Phase 2/Phase 3,600,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2009-10-06,2010-01-01,2012-01-01,2012,2011-11-01,2011,NA,NA,NA,87,817,756,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00993967,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bonn Freiburg Hamburg Tübingen,Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension),No lead center,Industry,Interventional,Drug,Phase 3,200,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2009-10-13,2007-06-01,2012-06-01,2012,2012-06-01,2012,2016-10-14,1596,1596,-865,962,962,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2009,3362,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00996229,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Münster Berlin,NA,Effects of Dietary Interventions on the Aging Brain,large,Other,Interventional,Behavioral,Phase 3,300,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-14,2009-11-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,18,1571,1509,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00996229,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Münster,NA,Effects of Dietary Interventions on the Aging Brain,large,Other,Interventional,Behavioral,Phase 3,300,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-14,2009-11-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,18,1571,1509,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01001468,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Düsseldorf Frankfurt Schleswig-Holstein Mainz,Study to Assess VB-201 in Patients With Psoriasis,No lead center,Industry,Interventional,Drug,Phase 2,185,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-10-20,2009-12-01,2011-07-01,2011,2011-07-01,2011,NA,NA,NA,42,619,619,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01004198,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Frankfurt,Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients,No lead center,Industry,Interventional,Drug,Phase 2,51,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-10-28,2009-12-01,2010-06-01,2010,2010-06-01,2010,NA,NA,NA,34,216,216,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,20,20,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01010711,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Influence of a Dietary Supplement as Treatment of Migraine in Children and Adolescents,large,Industry,Interventional,Dietary Supplement,NA,76,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-11-09,2009-11-01,2011-04-01,2011,2010-12-01,2010,NA,NA,NA,-8,508,387,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2436,3789,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1792,7 +1792,7 @@ NCT01054391,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Schlesw NCT01057160,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Rizatriptan 10 MG RPD in the Treatment of Acute Migraine,large,Other,Interventional,Drug,Phase 4,195,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-01-26,2008-05-01,2010-06-01,2010,2010-06-01,2010,NA,NA,NA,-635,126,126,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01058369,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Exjade-Early-Trial,large,Other,Interventional,Drug,Phase 2,2,Terminated,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,TRUE,2010-01-27,2010-04-01,2013-01-01,2013,2013-01-01,2013,2020-09-11,2810,2810,64,1070,1070,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01058759,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Taxotere-Enoxaparin-(ENOXA)-Study,large,Other,Interventional,Drug,Phase 3,14,Terminated,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-01-28,2009-11-01,2011-02-01,2011,2011-02-01,2011,NA,NA,NA,-88,369,369,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2495,3848,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01060423,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer,small,Other,Interventional,Drug,Phase 2,8,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-27,2010-02-01,2015-05-01,2015,2012-12-01,2012,NA,NA,NA,5,1920,1039,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,945,2298,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01060423,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,Dresden Frankfurt Hamburg Magdeburg Regensburg Tübingen Würzburg,TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer,small,Other,Interventional,Drug,Phase 2,8,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-27,2010-02-01,2015-05-01,2015,2012-12-01,2012,NA,NA,NA,5,1920,1039,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,945,2298,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01060878,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bochum Bonn Dresden Freiburg Schleswig-Holstein Marburg TU-München Tübingen Würzburg,Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD),No lead center,Industry,Interventional,Drug,Phase 2,425,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-02-01,2010-11-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,273,1034,1034,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01061190,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Beta Blockers In Acute Ischemic Stroke,large,Other,Interventional,Drug,Phase 2/Phase 3,20,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-02-01,2010-01-01,2013-04-01,2013,2011-10-01,2011,NA,NA,NA,-31,1155,607,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01064583,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Cocoa Flavanols and Painfree Walking Distance,small,Other,Interventional,Other,Phase 1/Phase 2,62,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2010-02-05,2009-10-01,2012-12-01,2012,2012-11-01,2012,NA,NA,NA,-127,1030,1000,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1838,13 +1838,13 @@ NCT01140451,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köl NCT01140555,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Erlangen,A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device,No lead center,Industry,Interventional,Device,NA,2,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-06-08,2010-04-01,2010-07-01,2010,2010-06-01,2010,NA,NA,NA,-68,23,-7,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2710,4063,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01141075,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düsseldorf,Ataluren for Nonsense Mutation Methylmalonic Acidemia,No lead center,Industry,Interventional,Drug,Phase 2,11,Terminated,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2010-06-07,2010-07-19,2011-11-03,2011,2011-11-03,2011,2020-05-28,3129,3129,42,514,514,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,4,4,2220,3573,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01144429,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,Bonn Dresden Mainz Münster,Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma,large,Industry,Interventional,Biological,Phase 2,344,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-06-10,2010-06-01,2011-05-01,2011,2011-02-01,2011,NA,NA,NA,-9,325,236,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01148264,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis,small,Other,Interventional,Drug,Phase 2,23,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-06-21,2010-07-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,10,1563,1198,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01148264,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis,small,Other,Interventional,Drug,Phase 2,23,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-06-21,2010-07-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,10,1563,1198,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1157,2510,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01156220,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,FALSE,TRUE,TRUE,Hamburg,NA,Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers,large,Other,Interventional,Drug,Phase 4,0,Withdrawn,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-01,2012-01-01,2012-06-01,2012,2012-06-01,2012,NA,NA,NA,549,701,701,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01166321,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,FALSE,TRUE,TRUE,Heidelberg,NA,Carbon Ion Radiotherapy for Atypical Meningiomas,large,Other,Interventional,Radiation,NA,40,Recruiting,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-07-20,2012-06-01,2023-08-01,2023,2023-08-01,2023,NA,NA,NA,682,4760,4760,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,-2069,-716,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01166542,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg,Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers,No lead center,Industry,Interventional,Biological,Phase 3,167,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-07-13,2010-06-01,2014-05-01,2014,2012-04-01,2012,NA,NA,NA,-42,1388,628,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01168557,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Stress Echo and Electric Impedance Tomography (EIT) Pilot Study,small,Other,Interventional,Device,NA,8,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-07-22,2010-07-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-21,772,772,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01170624,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Schleswig-Holstein,Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD) Function,No lead center,Industry,Interventional,Device,Phase 4,388,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-06-16,2009-09-01,2011-09-01,2011,2011-09-01,2011,NA,NA,NA,-288,442,442,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01175694,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen Erlangen,NA,Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-08-04,2010-01-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-215,1611,667,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01175694,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-08-04,2010-01-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-215,1611,667,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01178437,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy,large,Industry,Interventional,Device,NA,7,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-07-29,2009-08-01,2011-01-01,2011,2010-09-01,2010,NA,NA,NA,-362,156,34,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2526,3879,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01178905,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Tübingen,NA,Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants,large,Other,Interventional,Procedure,NA,NA,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2010-07-26,2010-08-01,NA,NA,2012-10-01,2012,NA,NA,NA,6,NA,798,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01186783,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine,small,Other,Interventional,Drug,Phase 2,70,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-08-17,2010-05-01,2012-05-01,2012,2011-11-01,2011,NA,NA,NA,-108,623,441,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,71,71,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1860,7 +1860,7 @@ NCT01225835,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Düs NCT01226238,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Online Self-help for Depressed Patients Awaiting Psychotherapy,small,Other,Interventional,Other,NA,230,Terminated,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-20,2010-10-01,NA,NA,2011-06-01,2011,NA,NA,NA,-19,NA,224,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01227304,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,SMOOCH - Small Volume Challenges to Predict Volume Responsiveness: Prospective Interventional Study,large,Other,Interventional,Device,NA,100,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2010-10-21,2010-07-01,2010-12-01,2010,2010-12-01,2010,NA,NA,NA,-112,41,41,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01228162,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hannover,Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation,No lead center,Other,Interventional,Procedure,Phase 4,120,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-25,2010-09-01,2013-06-01,2013,2013-06-01,2013,NA,NA,NA,-54,950,950,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1644,2997,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01229033,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF,large,Other,Interventional,Procedure,NA,186,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-10-26,2010-01-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-298,1163,798,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01229033,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF,large,Other,Interventional,Procedure,NA,186,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-10-26,2010-01-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-298,1163,798,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01229475,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Stepwise Approach Versus Linear Ablation in Patients With Recurrence of Persistent Atrial Fibrillation,large,Other,Interventional,Procedure,NA,130,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-26,2010-10-01,2013-12-01,2013,2013-10-01,2013,NA,NA,NA,-25,1132,1071,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01230138,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden,Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis,No lead center,Industry,Interventional,Drug,Phase 2,252,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-09-24,2010-09-01,2012-05-01,2012,2012-01-01,2012,NA,NA,NA,-23,585,464,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01231854,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.,large,Other,Interventional,Drug,Phase 4,15,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-29,2010-11-01,2013-03-01,2013,2012-03-01,2012,NA,NA,NA,3,854,489,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1872,7 +1872,7 @@ NCT01246024,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübinge NCT01248910,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg,Health Benefits of Alpine Skiing for the Elderly,No lead center,Other,Interventional,Behavioral,NA,NA,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2010-11-24,2008-12-01,2010-11-01,2010,2010-11-01,2010,NA,NA,NA,-723,-23,-23,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2587,3940,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01251809,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,Berlin Bonn Dresden Erlangen Duisburg-Essen Göttingen Hannover Heidelberg Schleswig-Holstein Leipzig Mainz TU-München Münster Regensburg Rostock Ulm Würzburg,Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia,large,Industry,Interventional,Drug,Phase 1/Phase 2,56,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-11-26,2011-01-01,2013-05-01,2013,2012-10-01,2012,NA,NA,NA,36,887,675,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01258023,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hannover,Seasonal Flu Vaccine in Adult Transplant Recipients,No lead center,Other,Interventional,Biological,Phase 2,122,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-11-18,2010-11-01,2012-04-01,2012,2012-02-01,2012,NA,NA,NA,-17,500,440,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01258153,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic,large,Industry,Interventional,Drug,Phase 2,115,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-09,2010-11-01,2014-03-01,2014,2013-12-01,2013,2015-05-04,429,519,-38,1178,1088,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01258153,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic,large,Industry,Interventional,Drug,Phase 2,115,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-09,2010-11-01,2014-03-01,2014,2013-12-01,2013,2015-05-04,429,519,-38,1178,1088,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01259518,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas,large,Industry,Interventional,Drug,Phase 1,48,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-11-24,2009-11-01,2012-01-01,2012,2011-09-01,2011,NA,NA,NA,-388,403,281,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01260558,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography,large,Other,Interventional,Device,Phase 4,20,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-12-14,2010-12-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-13,718,718,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01262196,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Berlin Frankfurt,Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients,No lead center,Industry,Interventional,Drug,Phase 2,348,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-12-15,2011-05-01,2012-11-01,2012,2012-10-01,2012,NA,NA,NA,137,687,656,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,24,24,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1898,19 +1898,19 @@ NCT01326208,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA, NCT01327703,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Erlangen Jena LMU-München Tübingen,Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency,No lead center,Industry,Interventional,Drug,Phase 4,87,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-03-28,2011-04-01,2012-05-01,2012,2012-05-01,2012,2014-03-05,673,673,4,400,400,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01329601,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI,small,Other,Interventional,Behavioral,Phase 4,24,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-04-01,2011-01-01,2011-12-01,2011,2011-10-01,2011,NA,NA,NA,-90,244,183,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01332773,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer,large,Other,Interventional,Procedure,Phase 3,124,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-04-07,2010-03-01,2011-07-01,2011,2011-07-01,2011,NA,NA,NA,-402,85,85,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2345,3698,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01338922,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,FALSE,Schleswig-Holstein Schleswig-Holstein,NA,Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM),No lead center,Other,Interventional,Other,NA,211,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-07,2011-04-01,2016-08-01,2016,2015-07-01,2015,NA,NA,NA,-6,1943,1546,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,487,1840,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01338922,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,FALSE,Schleswig-Holstein,Berlin Bochum Schleswig-Holstein Leipzig Rostock,Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM),No lead center,Other,Interventional,Other,NA,211,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-07,2011-04-01,2016-08-01,2016,2015-07-01,2015,NA,NA,NA,-6,1943,1546,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,487,1840,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01341158,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,"NAM-Trial: Multiferon in Malignant Melanoma",large,Other,Interventional,Drug,Phase 2,42,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2011-04-19,2011-04-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-18,682,682,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01341340,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,The ABSORB BTK (Below The Knee) Clinical Investigation,large,Industry,Interventional,Device,NA,2,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-15,2011-11-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,200,566,566,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01342601,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents,small,Industry,Interventional,Device,NA,72,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-21,2011-04-01,2011-09-01,2011,2011-09-01,2011,NA,NA,NA,-20,133,133,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01345526,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream,small,Other,Interventional,Device,Phase 2,124,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-21,2011-04-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,-20,2051,2051,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01348269,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome,small,Other,Interventional,Drug,Phase 3,63,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-02,2011-05-01,2015-08-26,2015,2015-08-26,2015,NA,NA,NA,-1,1577,1577,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,828,2181,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01348269,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome,small,Other,Interventional,Drug,Phase 3,63,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-02,2011-05-01,2015-08-26,2015,2015-08-26,2015,NA,NA,NA,-1,1577,1577,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,828,2181,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01348425,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Zilver PTX Drug-Eluting Peripheral Stent Study,small,Industry,Interventional,Device,NA,45,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-04-29,2011-05-01,2012-09-01,2012,2011-10-01,2011,2013-07-25,327,663,2,491,155,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01349790,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia,large,Industry,Interventional,Drug,Phase 3,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2011-05-05,2011-10-01,2013-07-01,2013,2013-07-01,2013,2017-03-22,1360,1360,149,788,788,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,1614,2967,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01351272,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD),small,Other,Interventional,Drug,Phase 3,41,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2011-04-29,2011-05-01,2013-03-01,2013,2012-12-01,2012,NA,NA,NA,2,672,582,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01352741,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin,small,Industry,Interventional,Drug,Phase 4,622,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2011-04-12,2011-03-01,2012-01-01,2012,2012-01-01,2012,2016-05-10,1591,1591,-42,264,264,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,4,4,2161,3514,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01353586,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Leipzig,REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial Fibrillation,No lead center,Industry,Interventional,Device,Phase 2,186,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2011-05-12,2011-03-01,2013-09-01,2013,2013-09-01,2013,2015-09-20,749,749,-72,843,843,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01357460,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency,large,Other,Interventional,Device,Phase 2/Phase 3,25,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-05-16,2011-05-01,2012-05-01,2012,2012-05-01,2012,NA,NA,NA,-15,351,351,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01362361,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,"TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)",small,Other,Interventional,Drug,Phase 2,54,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-25,2011-06-01,2016-12-01,2016,2016-06-01,2016,NA,NA,NA,7,2017,1834,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2012.30.15_suppl.tps3636,NA,http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.tps3636,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01362361,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,Greifswald Mannheim LMU-München Ulm,"TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)",small,Other,Interventional,Drug,Phase 2,54,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-25,2011-06-01,2016-12-01,2016,2016-06-01,2016,NA,NA,NA,7,2017,1834,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2012.30.15_suppl.tps3636,NA,http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.tps3636,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,365,1718,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01363895,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Interventional Strategies in Treatment of Atrial Fibrillation: Percutaneous Closure of the Left Atrial Appendage Versus Catheter Ablation,large,Other,Interventional,Procedure,NA,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-25,2010-11-01,2013-11-01,2013,2012-11-01,2012,NA,NA,NA,-24,1072,707,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01363921,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Effect of HCO1100 on Cardiovascular Function,small,Industry,Interventional,Device,NA,10,Terminated,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-05-26,2011-04-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-55,829,829,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01365780,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Hyperbaric Oxygen Therapy in Distal Radius Fractures: Can it Shorten Recovery Time and Increase Fracture Healing?,small,Other,Interventional,Procedure,NA,100,Suspended,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-06-01,2011-09-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,92,519,519,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1919,18 +1919,18 @@ NCT01374789,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,D NCT01377558,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,Hannover,Effects of Different Types of Exercise Interventions in Patients With Type 2 Diabetes,small,Other,Interventional,Other,NA,100,Unknown status,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2011-06-09,2011-04-01,2012-06-01,2012,2011-11-01,2011,NA,NA,NA,-69,358,145,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2009,3362,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01378624,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hannover,Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging,No lead center,Other,Interventional,Other,NA,15,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-06-17,2011-06-01,2012-10-01,2012,2012-10-01,2012,NA,NA,NA,-16,472,472,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1887,3240,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01382914,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Determination of a Threshold for Mouth Rinse Induced Discoloration of Teeth,large,Other,Interventional,Other,NA,16,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-06-24,2011-04-01,2011-05-01,2011,2011-05-01,2011,NA,NA,NA,-84,-54,-54,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,6,6,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01384994,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients,large,Other,Interventional,Drug,Phase 2,111,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-02,2011-08-01,2014-08-01,2014,2013-08-01,2013,NA,NA,NA,91,1187,822,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1218,2571,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01384994,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients,large,Other,Interventional,Drug,Phase 2,111,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-02,2011-08-01,2014-08-01,2014,2013-08-01,2013,NA,NA,NA,91,1187,822,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1218,2571,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01385735,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,"Emotion, Mood and Executive Function in Parkinson's Disease (PD)",small,Other,Interventional,Drug,Phase 4,70,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-06-28,2011-10-01,2013-04-01,2013,2012-10-01,2012,NA,NA,NA,95,643,461,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,10,10,1705,3058,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01387555,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg Hannover Mainz TU-München,A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib,No lead center,Industry,Interventional,Biological,Phase 2,129,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2011-06-27,2008-12-01,2011-12-01,2011,2011-12-01,2011,NA,NA,NA,-938,157,157,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2192,3545,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01388998,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Fluid Management Study to Evaluate Changes in Intravascular Volume After Applying Various Pressure Levels on the Caval Vein,large,Other,Interventional,Other,NA,24,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-05,2011-01-01,2012-01-01,2012,2012-01-01,2012,NA,NA,NA,-185,180,180,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01391078,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry,large,Other,Interventional,Device,NA,12,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-06-14,2011-06-01,2012-02-01,2012,2012-01-01,2012,NA,NA,NA,-13,232,201,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2130,3483,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01393275,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes,small,Other,Interventional,Other,NA,68,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2011-07-12,2010-02-01,2011-10-01,2011,2010-11-01,2010,NA,NA,NA,-526,81,-253,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2253,3606,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01397149,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG),large,Other,Interventional,Drug,Phase 1/Phase 2,4,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-06-30,2011-10-01,2014-11-01,2014,2013-11-01,2013,NA,NA,NA,93,1220,855,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1126,2479,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01397149,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,Dresden Schleswig-Holstein Köln,Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG),large,Other,Interventional,Drug,Phase 1/Phase 2,4,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-06-30,2011-10-01,2014-11-01,2014,2013-11-01,2013,NA,NA,NA,93,1220,855,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1126,2479,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01400360,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Frankfurt,Düsseldorf Jena Mannheim Ulm,Invasive Diagnostic and Therapeutic Management of Cerebral Vasospasm After Aneurysmatic Subarachnoid Hemorrhage,large,Other,Interventional,Other,NA,92,Unknown status,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2011-07-21,2009-08-01,NA,NA,2011-08-01,2011,NA,NA,NA,-719,NA,11,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01403064,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg Köln Homburg,Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects,No lead center,Industry,Interventional,Biological,Phase 2,76,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2011-07-25,2011-07-01,2014-03-01,2014,2013-04-01,2013,2021-02-22,2550,2884,-24,950,616,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01403116,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Halle-Wittenberg Münster,Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men,No lead center,Industry,Interventional,Drug,Phase 3,325,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2011-07-25,2011-07-01,2013-09-01,2013,2013-09-01,2013,2017-08-22,1451,1451,-24,769,769,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01404234,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Bochum Duisburg-Essen Frankfurt,Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways,No lead center,Industry,Interventional,Drug,Phase 3,61,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2011-07-26,2011-12-01,2013-04-01,2013,2013-04-01,2013,2014-03-31,364,364,128,615,615,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1705,3058,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01405235,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen Erlangen,NA,Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma,large,Other,Interventional,Drug,Phase 3,312,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-27,2006-09-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-1790,1254,310,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01405235,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma,large,Other,Interventional,Drug,Phase 3,312,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-27,2006-09-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-1790,1254,310,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1065,2418,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01409733,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,Tübingen,TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients,large,Other,Interventional,Device,Phase 1/Phase 2,20,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-08-03,2010-06-01,2012-12-01,2012,2012-09-01,2012,NA,NA,NA,-428,486,395,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01409850,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Comparison Study of Two Splints Used for Treatment of Acute Temporomandibular Pain.,large,Other,Interventional,Device,NA,36,Terminated,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-03,2010-07-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-398,486,486,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01410903,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Immunoadsorption in Patients With Severe Systemic Sclerosis,large,Other,Interventional,Device,NA,1,Terminated,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-08-04,2011-04-01,2012-08-01,2012,2012-07-01,2012,NA,NA,NA,-125,363,332,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1948,3301,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1940,18 +1940,18 @@ NCT01418820,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdebur NCT01422720,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Bonn Mainz Ulm,Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients,No lead center,Industry,Interventional,Drug,Phase 3,72,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2011-07-29,2010-04-01,2013-09-01,2013,2013-09-01,2013,2014-05-09,250,250,-484,765,765,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01427985,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation,large,Other,Interventional,Drug,Phase 4,24,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-31,2011-06-01,2012-07-01,2012,2012-07-01,2012,NA,NA,NA,-91,305,305,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01431118,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Iron Metabolism in Dragon Boat Athletes,small,Other,Interventional,Other,NA,40,Completed,Single,Non-Randomized,FALSE,TRUE,FALSE,FALSE,2011-08-31,2011-04-01,2012-04-01,2012,2012-04-01,2012,NA,NA,NA,-152,214,214,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01431222,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery,large,Other,Interventional,Device,Phase 4,100,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-07,2011-09-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-6,1090,725,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01431222,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery,large,Other,Interventional,Device,Phase 4,100,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-07,2011-09-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-6,1090,725,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01434914,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds,large,Industry,Interventional,Drug,Phase 4,9,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-13,2011-10-01,2013-07-01,2013,2013-07-01,2013,NA,NA,NA,18,657,657,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,4,2,1614,2967,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01435746,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Transfusion Requirements After Orthotopic Liver Transplantation,small,Other,Interventional,Behavioral,Phase 2,60,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-14,2011-11-01,2013-11-01,2013,2012-11-01,2012,NA,NA,NA,48,779,414,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01447758,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,Berlin Bonn Duisburg-Essen Hannover Münster,"Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.",large,Industry,Interventional,Drug,Phase 1,58,Terminated,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-07-13,2011-09-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,50,597,597,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01448798,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.,large,Other,Interventional,Procedure,NA,50,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-06,2011-10-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-5,818,453,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01448798,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.,large,Other,Interventional,Procedure,NA,50,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-06,2011-10-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-5,818,453,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1430,2783,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01449890,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Randomized Trial of Depression Follow-up Care by Email,large,Other,Interventional,Behavioral,NA,92,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-06,2012-09-01,2013-11-01,2013,2013-09-01,2013,NA,NA,NA,331,757,696,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01457833,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema,large,Other,Interventional,Device,Phase 2/Phase 3,50,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-19,2011-08-01,2012-05-01,2012,2012-05-01,2012,NA,NA,NA,-79,195,195,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01458015,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain,small,Other,Interventional,Drug,Phase 4,5,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-05,2011-10-01,2013-11-01,2013,2013-11-01,2013,NA,NA,NA,57,819,819,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01462721,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Schleswig-Holstein,The eSVS® Mesh Randomized Post-Market Study,No lead center,Industry,Interventional,Device,NA,12,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-26,2011-10-01,2013-02-01,2013,2013-02-01,2013,NA,NA,NA,-25,464,464,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1764,3117,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01468194,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Change in Peripheral Oxygen Saturation by Using Different Breathing Procedures in High Altitude,small,Other,Interventional,Other,NA,30,Completed,Single,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-10-09,2011-07-01,2011-11-01,2011,2011-10-01,2011,NA,NA,NA,-100,23,-8,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2222,3575,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01468220,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Berlin,NA,Normobaric Hypoxic Training and Metabolic Syndrome,large,Other,Interventional,Other,NA,27,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-15,2012-01-01,2018-06-01,2018,2017-07-01,2017,NA,NA,NA,108,2451,2116,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,-182,1171,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01473966,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Coffee Against Obstipation in Intensive Care Treatment,large,Other,Interventional,Dietary Supplement,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-10,2011-11-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-9,934,752,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01473966,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Coffee Against Obstipation in Intensive Care Treatment,large,Other,Interventional,Dietary Supplement,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-10,2011-11-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-9,934,752,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01475396,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,The Effect of Physical Activity on the Brain,large,Other,Interventional,Behavioral,Phase 3,120,Unknown status,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-11-07,2006-03-01,2012-12-01,2012,2012-03-01,2012,NA,NA,NA,-2077,390,115,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01484249,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Carotid Filtration During Endovascular Aortic Valve Implantation,large,Industry,Interventional,Device,NA,38,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2011-11-24,2010-02-01,2011-05-01,2011,2011-05-01,2011,NA,NA,NA,-661,-207,-207,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01497002,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Leipzig,NA,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a,large,Other,Interventional,Drug,Phase 3,1222,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-12-21,2005-04-01,2018-07-18,2018,2018-07-18,2018,NA,NA,NA,-2455,2401,2401,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,-229,1124,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1970,7 +1970,7 @@ NCT01551407,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-Mün NCT01552837,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology,small,Other,Interventional,Drug,NA,33,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2012-03-02,2007-12-01,2010-12-01,2010,2010-02-01,2010,NA,NA,NA,-1553,-457,-760,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,6,6,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01553032,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE),large,Other,Interventional,Drug,Phase 4,500,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2011-05-31,2011-05-01,2013-10-01,2013,2013-08-01,2013,NA,NA,NA,-30,854,793,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01562925,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,"Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury",large,Other,Interventional,Dietary Supplement,Phase 3,260,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-03-22,2012-03-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-21,163,163,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01567241,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Clinical Hypnosis During Insemination or Embryotransfer,large,Other,Interventional,Other,NA,282,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-03-22,2012-03-01,2014-03-01,2014,2013-08-01,2013,NA,NA,NA,-21,709,497,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01567241,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Clinical Hypnosis During Insemination or Embryotransfer,large,Other,Interventional,Other,NA,282,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-03-22,2012-03-01,2014-03-01,2014,2013-08-01,2013,NA,NA,NA,-21,709,497,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01571895,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Freiburg Schleswig-Holstein Marburg,NA,Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid,large,Industry,Interventional,Drug,Phase 2,4,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-04-04,2011-07-01,NA,NA,2012-07-01,2012,NA,NA,NA,-278,NA,88,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01580176,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Continuous GlucoseMonitor for Measurement of Blood Glucose Level,large,Other,Interventional,Device,NA,100,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-04-17,2012-03-01,2013-03-01,2013,2012-12-01,2012,NA,NA,NA,-47,318,228,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01581450,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Hyperalgesia and Pain,large,Industry,Interventional,Drug,Phase 1,20,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-11-30,2012-01-01,2012-04-01,2012,2012-04-01,2012,NA,NA,NA,32,123,123,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2070,3423,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -1985,19 +1985,19 @@ NCT01594736,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-Münc NCT01596764,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,"Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.",small,Other,Interventional,Drug,Phase 1,16,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-07,2011-05-01,2012-01-01,2012,2011-07-01,2011,NA,NA,NA,-372,-127,-311,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2161,3514,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01601756,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Joint Line Reconstruction in Navigated Total Knee Arthroplasty Revision,large,Other,Interventional,Device,NA,40,Unknown status,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-14,2011-09-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-256,201,201,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01607684,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis,small,Other,Interventional,Device,Phase 2,50,Completed,Single,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2012-05-20,2012-01-01,2012-09-01,2012,2012-09-01,2012,NA,NA,NA,-140,104,104,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1917,3270,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01611207,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke Witten/Herdecke,NA,Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine,small,Other,Interventional,Device,NA,12,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-03-28,2012-06-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,65,795,613,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01611207,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,Frankfurt Halle-Wittenberg Jena Schleswig-Holstein Mainz LMU-München Münster,Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine,small,Other,Interventional,Device,NA,12,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-03-28,2012-06-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,65,795,613,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01622088,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Hannover Jena Ulm,Phase 3 Extension Study of Dexpramipexole in ALS,No lead center,Industry,Interventional,Drug,Phase 3,616,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-03,2012-06-01,2013-02-01,2013,2013-02-01,2013,NA,NA,NA,29,274,274,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1764,3117,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01622829,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Activity on Prescription to Promote Physical Activity in Hospitalized Patients,large,Other,Interventional,Procedure,NA,120,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-06-15,2012-02-01,2013-09-01,2013,2012-12-01,2012,NA,NA,NA,-135,443,169,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01631175,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Indication-based Identification and Psychosocial Treatment of Orthopedic Cancer Patients,large,Other,Interventional,Behavioral,Phase 3,100,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-06-20,2011-01-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-536,529,529,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01635114,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Effect of resVida on Liver Fat Content,large,Other,Interventional,Dietary Supplement,NA,112,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-03,2012-06-01,2015-09-01,2015,2013-12-01,2013,NA,NA,NA,-32,1155,516,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01635114,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Effect of resVida on Liver Fat Content,large,Other,Interventional,Dietary Supplement,NA,112,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-03,2012-06-01,2015-09-01,2015,2013-12-01,2013,NA,NA,NA,-32,1155,516,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01637025,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Frankfurt Magdeburg Mainz Marburg Homburg,Oxidized Cellulose hEmostAsis evaluatioN,No lead center,Industry,Interventional,Device,NA,111,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-07-06,2012-05-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,-66,118,118,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01638585,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,Leipzig,Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia,large,Other,Interventional,Drug,Phase 3,34,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-05-14,2011-06-01,2012-11-01,2012,2012-11-01,2012,NA,NA,NA,-348,171,171,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1856,3209,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01639261,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT,small,Other,Interventional,Drug,Phase 2,10,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-09,2012-07-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-8,784,510,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01639261,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT,small,Other,Interventional,Drug,Phase 2,10,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-09,2012-07-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-8,784,510,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1187,2540,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01640327,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Rostock,"Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above",No lead center,Industry,Interventional,Biological,Phase 3,126,Completed,None (Open Label),NA,NA,FALSE,TRUE,TRUE,2012-07-06,2012-07-01,2012-08-01,2012,2012-08-01,2012,2013-07-11,344,344,-5,26,26,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1948,3301,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01644019,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Prehospital Telemedical Support in Acute Stroke,small,Other,Interventional,Procedure,NA,28,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01644045,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation,small,Other,Interventional,Device,NA,17,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01644019,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Prehospital Telemedical Support in Acute Stroke,small,Other,Interventional,Procedure,NA,28,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01644045,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation,small,Other,Interventional,Device,NA,17,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01648660,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Jena Leipzig,NA,Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2),large,Other,Interventional,Dietary Supplement,NA,80,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-07-19,2009-05-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,-1175,135,135,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01657305,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12),small,Industry,Interventional,Drug,Phase 3,107,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2012-07-29,2012-08-01,2014-09-01,2014,2013-08-01,2013,2015-09-24,388,784,3,764,368,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,1187,2540,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01657305,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,Düsseldorf Duisburg-Essen Frankfurt Freiburg Mainz,Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12),small,Industry,Interventional,Drug,Phase 3,107,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2012-07-29,2012-08-01,2014-09-01,2014,2013-08-01,2013,2015-09-24,388,784,3,764,368,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,1187,2540,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01661569,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden,A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace,No lead center,Other,Interventional,Other,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-07,2012-08-01,2013-01-01,2013,2013-01-01,2013,NA,NA,NA,-6,147,147,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01666639,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Behavioral Exercise Therapy and Multidisciplinary Rehabilitation for Chronic Non-specific Low Back Pain,large,Other,Interventional,Behavioral,NA,351,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-06-18,2011-03-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-475,531,531,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01669408,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Prehospital COOLing 1 (PreCOOL 1),large,Other,Interventional,Drug,Phase 2,40,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-14,2012-09-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,18,383,383,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2005,7 +2005,7 @@ NCT01682070,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berl NCT01693146,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Homburg,STIT-2: Evaluation of Safety and Efficacy of Short-time TNI® Treatment in Patients With COPD and Hypercapnia,No lead center,Other,Interventional,Device,Phase 1,30,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2012-09-14,2011-12-01,2013-12-01,2013,2013-12-01,2013,NA,NA,NA,-288,443,443,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01701180,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Neural Correlates of Empathogenic and Affiliative Actions of Oxytocin,large,Other,Interventional,Drug,Early Phase 1,23,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-10-02,2012-08-01,2013-08-01,2013,2013-08-01,2013,NA,NA,NA,-62,303,303,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1583,2936,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01701843,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Cromoglicate in Mastocytosis,large,Industry,Interventional,Drug,Phase 2,7,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2012-07-11,2012-10-01,2013-02-01,2013,2013-02-01,2013,NA,NA,NA,82,205,205,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1764,3117,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01702597,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,WBV and Acute Lateral Ankle Sprain,large,Other,Interventional,Device,NA,60,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-10-03,2012-10-01,2014-04-01,2014,2013-04-01,2013,NA,NA,NA,-2,545,180,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01702597,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,WBV and Acute Lateral Ankle Sprain,large,Other,Interventional,Device,NA,60,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-10-03,2012-10-01,2014-04-01,2014,2013-04-01,2013,NA,NA,NA,-2,545,180,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01708577,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,UMIC Validation Study,small,Other,Interventional,Device,NA,12,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2012-09-28,2011-07-01,2012-05-01,2012,2012-03-01,2012,NA,NA,NA,-455,-150,-211,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2040,3393,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01713374,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System,large,Other,Interventional,Procedure,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-10-18,2012-10-01,2014-03-01,2014,2013-03-01,2013,NA,NA,NA,-17,499,134,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01715337,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) Patients,No lead center,Other,Interventional,Other,NA,20,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-10-24,2010-02-01,2014-04-01,2014,2013-03-01,2013,NA,NA,NA,-996,524,128,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1340,2693,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2017,16 +2017,16 @@ NCT01740544,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,N NCT01749306,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg,A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing,No lead center,Industry,Interventional,Biological,Phase 3,1,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-12-11,2012-12-01,2013-11-01,2013,2013-11-01,2013,NA,NA,NA,-10,325,325,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1491,2844,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01775397,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin Duisburg-Essen Halle-Wittenberg,"A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System",No lead center,Industry,Interventional,Drug,Phase 4,12,Terminated,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2013-01-08,2012-11-29,2013-04-15,2013,2013-04-15,2013,NA,NA,NA,-40,97,97,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1691,3044,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01788917,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Effects of Supplementation With Linseed Oil on Blood Lipids in Vegetarians,small,Other,Interventional,Dietary Supplement,NA,10,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-02-06,2009-09-01,2009-12-01,2009,2009-11-01,2009,NA,NA,NA,-1254,-1163,-1193,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2922,4275,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01803217,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing,large,Other,Interventional,Other,NA,70,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-28,2007-11-01,2016-06-01,2016,2011-12-01,2011,NA,NA,NA,-1946,1189,-455,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,548,1901,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01803217,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing,large,Other,Interventional,Other,NA,70,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-28,2007-11-01,2016-06-01,2016,2011-12-01,2011,NA,NA,NA,-1946,1189,-455,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,548,1901,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01808950,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Berlin,Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma,No lead center,Industry,Interventional,Drug,Phase 1/Phase 2,4,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,TRUE,2013-03-05,2013-02-01,2013-08-01,2013,2013-08-01,2013,2015-12-03,854,854,-32,149,149,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1583,2936,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01835340,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Schleswig-Holstein,NA,Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures,small,Other,Interventional,Device,NA,22,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-04-15,2012-10-01,2017-12-09,2017,2017-12-09,2017,NA,NA,NA,-196,1699,1699,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,-8,1345,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01835340,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures,small,Other,Interventional,Device,NA,22,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-04-15,2012-10-01,2017-12-09,2017,2017-12-09,2017,NA,NA,NA,-196,1699,1699,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,-8,1345,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01885117,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Hamburg,"Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above",No lead center,Industry,Interventional,Biological,Phase 3,125,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,TRUE,2013-06-19,2013-08-01,2013-09-01,2013,2013-09-01,2013,2013-10-31,60,60,43,74,74,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01888783,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Two Measures of Tactile Acuity in CRPS Type I Patients,small,Other,Interventional,Other,NA,150,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2013-06-25,2012-09-01,2013-09-01,2013,2013-09-01,2013,NA,NA,NA,-297,68,68,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01913899,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum Bochum,NA,Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain,small,Other,Interventional,Other,NA,70,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-30,2013-04-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-120,214,124,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01913899,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain,small,Other,Interventional,Other,NA,70,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-30,2013-04-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-120,214,124,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1371,2724,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01919632,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,"MOVING - MOtiVation, INtervention and Vascular chanGe",large,Other,Interventional,Behavioral,NA,330,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-07-05,2009-10-01,2013-05-01,2013,2013-05-01,2013,NA,NA,NA,-1373,-65,-65,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01924962,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries,large,Other,Interventional,Device,NA,205,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-15,2008-05-28,2017-06-16,2017,2016-08-14,2016,NA,NA,NA,-1905,1401,1095,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,168,1521,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01924962,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries,large,Other,Interventional,Device,NA,205,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-15,2008-05-28,2017-06-16,2017,2016-08-14,2016,NA,NA,NA,-1905,1401,1095,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,168,1521,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02040324,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Laryngeal Mask Airway in Lower Abdominal Surgery,large,Other,Interventional,Device,NA,100,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2014-01-15,2009-11-01,2012-03-01,2012,2011-03-01,2011,NA,NA,NA,-1536,-685,-1051,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02094287,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Placebo Effect in the Treatment of Atopic Dermatitis,large,Other,Interventional,Drug,NA,166,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2014-03-17,2010-09-01,2015-02-01,2015,2013-11-01,2013,NA,NA,NA,-1293,321,-136,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1034,2387,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02094287,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,Hamburg,Placebo Effect in the Treatment of Atopic Dermatitis,large,Other,Interventional,Drug,NA,166,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2014-03-17,2010-09-01,2015-02-01,2015,2013-11-01,2013,NA,NA,NA,-1293,321,-136,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1034,2387,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02136160,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,LMU-München,NA,Population-based Intervention to Promote Health in Elementary Schools,large,Other,Interventional,Behavioral,NA,249,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2014-05-05,2013-03-01,NA,NA,2013-05-01,2013,NA,NA,NA,-430,NA,-369,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02157090,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Clinical Assessment of the Effectiveness and Safety of Herpes Patch SOS in the Treatment of Herpes Simplex Labialis in Comparison to a Competitor's Product.,large,Other,Interventional,Other,NA,NA,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2010-10-28,2009-08-01,2010-06-01,2010,2010-01-01,2010,NA,NA,NA,-453,-149,-300,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2740,4093,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02157181,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,Bochum Frankfurt Freiburg Hannover,Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab,small,Other,Interventional,Drug,Phase 2,89,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2014-05-21,2004-06-01,2013-01-01,2013,2012-09-01,2012,NA,NA,NA,-3641,-505,-627,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1795,3148,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2034,10 +2034,10 @@ NCT02177474,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Götting NCT02188212,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Nobel Procera Crown Shaded Zirconia and NobelProceraTM Full Contour Crown IPS e.Max CAD,small,Industry,Interventional,Device,NA,53,Terminated,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-07-03,2010-03-01,2014-07-01,2014,2013-11-01,2013,NA,NA,NA,-1585,-2,-244,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1249,2602,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02197312,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen,NobelProceraTM Bridge Shaded Zirconia,No lead center,Industry,Interventional,Device,NA,25,Terminated,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-07-03,2010-06-18,2013-11-23,2013,2013-11-23,2013,NA,NA,NA,-1476,-222,-222,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1469,2822,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02234609,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Effectiveness of Modified Class IV Atraumatic Restorative Treatment,small,Other,Interventional,Device,NA,69,Completed,Single,NA,NA,FALSE,FALSE,FALSE,2014-08-25,2012-09-01,2013-10-01,2013,2013-10-01,2013,NA,NA,NA,-723,-328,-328,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1522,2875,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02493283,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration,small,Other,Interventional,Drug,Phase 1,23,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-06-30,2011-09-01,2015-03-01,2015,2012-06-01,2012,NA,NA,NA,-1398,-121,-1124,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1006,2359,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02507167,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8,small,Other,Interventional,Dietary Supplement,Phase 1,19,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-22,2012-11-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,-993,-233,-751,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02493283,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration,small,Other,Interventional,Drug,Phase 1,23,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-06-30,2011-09-01,2015-03-01,2015,2012-06-01,2012,NA,NA,NA,-1398,-121,-1124,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1006,2359,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02507167,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8,small,Other,Interventional,Dietary Supplement,Phase 1,19,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-22,2012-11-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,-993,-233,-751,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1096,2449,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02514941,ClinicalTrials.gov,TRUE,1,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Greifswald,NA,"Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation",small,Other,Interventional,Drug,Phase 1,12,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-07-29,2007-06-01,NA,NA,2010-03-01,2010,NA,NA,NA,-2980,NA,-1976,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02535741,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee,large,Industry,Interventional,Device,NA,168,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2015-08-21,2006-10-01,2016-05-01,2016,2013-05-01,2013,2015-09-29,-215,881,-3246,254,-842,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,579,1932,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02535741,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee,large,Industry,Interventional,Device,NA,168,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2015-08-21,2006-10-01,2016-05-01,2016,2013-05-01,2013,2015-09-29,-215,881,-3246,254,-842,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,579,1932,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02690740,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Köln,Titrated Quantitative Conjunctival Provocation Test (tqCPT),No lead center,Other,Interventional,Other,NA,23,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2016-02-09,2012-12-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-1165,-1075,-1075,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02794896,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,Heidelberg,Anesthetic Depth Effects Upon Immune Competent Cells,small,Other,Interventional,Drug,NA,16,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2016-05-12,2009-03-01,2013-03-01,2013,2012-03-01,2012,NA,NA,NA,-2629,-1168,-1533,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03065036,ClinicalTrials.gov,TRUE,1,No publ,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Mainz,Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG,No lead center,Industry,Interventional,Drug,Phase 1/Phase 2,120,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2012-02-29,2010-03-01,2014-02-01,2014,2013-11-01,2013,NA,NA,NA,-730,703,611,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1399,2752,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2056,10 +2056,10 @@ NCT00785122,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,N NCT00832507,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Giessen LMU-München,Study of Cicletanine for Pulmonary Arterial Hypertension (PAH),No lead center,Industry,Interventional,Drug,Phase 2,162,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-01-29,2009-01-01,2012-03-01,2012,2011-10-01,2011,NA,NA,NA,-28,1127,975,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://erj.ersjournals.com/content/40/Suppl_56/3274,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00839059,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,Bonn Düsseldorf Frankfurt Hamburg Hannover,Lenalidomide In Patients With Acute Myeloid Leukemia,large,Other,Interventional,Drug,Phase 1,14,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-01-20,2009-01-01,2011-05-01,2011,2011-05-01,2011,NA,NA,NA,-19,831,831,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/116/21/3297,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2406,3759,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00927654,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Aachen Düsseldorf Frankfurt,Iloprost in High Risk Cardiac Surgical Patients,No lead center,Other,Interventional,Drug,Phase 3,253,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-06-17,2009-06-01,2012-03-01,2012,2012-03-01,2012,NA,NA,NA,-16,988,988,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://circ.ahajournals.org/content/134/Suppl_1/A13135.short,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2101,3454,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00977132,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf Düsseldorf,NA,Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome,small,Other,Interventional,Drug,Phase 2,23,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-09-14,2009-10-01,2014-05-01,2014,2013-05-01,2013,NA,NA,NA,17,1690,1325,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01047059,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Molecular Imaging With Erlotinib and Bevacizumab,large,Other,Interventional,Drug,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-01-10,2010-01-01,2016-05-01,2016,2012-10-01,2012,NA,NA,NA,-9,2303,995,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.32.15_suppl.e19049,NA,http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.e19049,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,579,1932,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00977132,ClinicalTrials.gov,TRUE,1,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,Dresden Freiburg Göttingen Ulm,Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome,small,Other,Interventional,Drug,Phase 2,23,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-09-14,2009-10-01,2014-05-01,2014,2013-05-01,2013,NA,NA,NA,17,1690,1325,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1310,2663,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01047059,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Molecular Imaging With Erlotinib and Bevacizumab,large,Other,Interventional,Drug,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-01-10,2010-01-01,2016-05-01,2016,2012-10-01,2012,NA,NA,NA,-9,2303,995,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2014.32.15_suppl.e19049,NA,http://ascopubs.org/doi/abs/10.1200/jco.2014.32.15_suppl.e19049,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,579,1932,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01053832,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Ventricular Pace Suppression Study,small,Industry,Interventional,Device,NA,84,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-19,2010-01-01,2011-09-01,2011,2011-09-01,2011,NA,NA,NA,-18,590,590,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1093/eurheartj/ehu322,NA,https://academic.oup.com/eurheartj/article/35/suppl_1/1/541954,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2283,3636,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01111448,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Temsirolimus in Myelodysplastic Syndrome (MDS),large,Other,Interventional,Drug,Phase 2,20,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-04-23,2010-04-01,2014-06-01,2014,2013-06-01,2013,NA,NA,NA,-22,1500,1135,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/122/21/2808.short?sso-checked=true,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01111448,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,Düsseldorf Göttingen Leipzig Mannheim,Temsirolimus in Myelodysplastic Syndrome (MDS),large,Other,Interventional,Drug,Phase 2,20,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-04-23,2010-04-01,2014-06-01,2014,2013-06-01,2013,NA,NA,NA,-22,1500,1135,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/122/21/2808.short?sso-checked=true,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1279,2632,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01123811,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,Berlin Duisburg-Essen Hannover TU-München Ulm,Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer,large,Other,Interventional,Drug,Phase 2,45,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2010-05-07,2006-05-01,2010-05-01,2010,2010-05-01,2010,NA,NA,NA,-1467,-6,-6,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1200/jco.2009.27.15_suppl.4534,NA,http://ascopubs.org/doi/abs/10.1200/jco.2009.27.15_suppl.4534,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2771,4124,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01184586,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010),large,Other,Interventional,Device,Phase 2,60,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-17,2011-11-01,2012-12-01,2012,2012-12-01,2012,NA,NA,NA,441,837,837,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.3205/12dgh05,NA,http://www.egms.de/static/de/meetings/dgh2012/12dgh05.shtml,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,7,7,1826,3179,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01185951,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies,large,Other,Interventional,Drug,Phase 2,114,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-08-17,2007-01-01,2010-12-01,2010,2010-08-01,2010,NA,NA,NA,-1324,106,-16,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.3205/11dgch102,NA,http://www.egms.de/static/de/meetings/dgch2011/11dgch102.shtml,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,34,34,2557,3910,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2073,7 +2073,7 @@ NCT01306903,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Fr NCT01310816,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Duisburg-Essen Mannheim,A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma,No lead center,Industry,Interventional,Drug,Phase 2,105,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2011-03-03,2011-02-01,2013-12-01,2013,2013-11-01,2013,NA,NA,NA,-30,1004,974,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.google.de/url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8&ved=0ahUKEwi3_-_B_NjVAhUKbBoKHVbSDYIQFgg7MAM&url=https%3A%2F%2Fwww.ctos.org%2FCTOSPresentations%2F2013%2520Presentations%2FFriday%2520CTOS.nov1.2013%2F912_Wagner%25202013%2520CTOS%2520IPI-926.pptx&usg=AFQjCNE1iXl9s59FSMAl0BTebPdq_vbNKQ,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01444235,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen Heidelberg Jena,NA,Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery,large,Industry,Interventional,Drug,Phase 2,102,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2011-09-29,2011-03-01,2012-07-01,2012,2012-05-01,2012,NA,NA,NA,-212,276,215,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1186/1749-8090-10-s1-a73,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693888/pdf/1749-8090-10-S1-A73.pdf,NA,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1979,3332,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01476553,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,Heidelberg,Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer,small,Other,Interventional,Procedure,NA,30,Terminated,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-11-11,2011-02-01,2013-03-01,2013,2013-03-01,2013,NA,NA,NA,-283,476,476,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1159/000439392,NA,https://www.karger.com/Article/Pdf/439392,NA,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,15,15,1736,3089,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01534702,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML,large,Other,Interventional,Drug,Phase 1/Phase 2,60,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-02-14,2012-01-01,2015-09-01,2015,2013-04-01,2013,NA,NA,NA,-44,1295,412,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/128/22/4038,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01534702,ClinicalTrials.gov,TRUE,1,Abstract only,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,Düsseldorf Duisburg-Essen Freiburg Hamburg Ulm,Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML,large,Other,Interventional,Drug,Phase 1/Phase 2,60,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-02-14,2012-01-01,2015-09-01,2015,2013-04-01,2013,NA,NA,NA,-44,1295,412,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://www.bloodjournal.org/content/128/22/4038,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,822,2175,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01589211,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Brief Intervention Study for Quitting Smoking,large,Other,Interventional,Behavioral,NA,800,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-04-27,2011-12-01,2013-12-01,2013,2012-11-01,2012,NA,NA,NA,-148,583,188,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,10.1055/s-0035-1544777,NA,https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1544777,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,2814,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01684566,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Dresden Göttingen,A Comparative Investigation of Standard Of Care (SOC) and Episil® in Combination Versus SOC Alone on Oral Mucositis,No lead center,Industry,Interventional,Device,NA,116,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2012-09-11,2013-02-01,2013-09-01,2013,2013-09-01,2013,2015-11-12,802,802,143,355,355,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,https://www.episil.net/wp-content/uploads/2016/06/A4-EBMT-20161.pdf,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1552,2905,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01739244,ClinicalTrials.gov,TRUE,1,Abstract only,FALSE,TRUE,TRUE,TRUE,FALSE,NA,Freiburg Köln Mainz,Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma,No lead center,Industry,Interventional,Drug,Phase 2,80,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2012-11-12,2012-07-01,2013-05-01,2013,2013-05-01,2013,NA,NA,NA,-134,170,170,NA,NA,NA,2017-07-01,2017-12-01,2021-08-15,NA,NA,http://iovs.arvojournals.org/article.aspx?articleid=2271257,NA,abstract,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1675,3028,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2142,23 +2142,23 @@ NCT01351246,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT02848352,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,The Role of Expectations in Experimentally Induced Sadness,small,Other,Interventional,Other,NA,128,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-06-29,2016-06-01,2016-10-01,2016,2016-10-01,2016,NA,NA,NA,-28,94,94,1330,1330,1424,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jad.2020.05.056,32664033,https://www.sciencedirect.com/science/article/abs/pii/S0165032720302500,2020-05-23,journal publication,TRUE,TRUE,doi,Expectation-induced placebo effect on acute sadness in women with major depression: An experimental investigation,Journal of affective disorders,2020-09-01,2020-05-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,0165-0327,Journal of Affective Disorders,Elsevier BV,2020-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2021-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01352702,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation,large,Other,Interventional,Drug,Phase 4,46,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-11,2011-05-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-10,1086,1086,426,426,1512,2020-07-01,2020-09-01,2021-08-15,10.1155/2015/798486,26229963,https://pubmed.ncbi.nlm.nih.gov/26229963/,2015-07-01,journal publication,TRUE,TRUE,doi,Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials),BioMed research international,2015,2015-07-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,"2314-6133,2314-6141",BioMed Research International,Hindawi Limited,2015-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01266837,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)",large,Industry,Interventional,Drug,Phase 4,64,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-12-23,2011-03-01,2017-10-31,2017,2017-09-26,2017,NA,NA,NA,68,2504,2469,1083,1118,3587,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.33349,33070307,https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.33349,2020-10-18,journal publication,TRUE,TRUE,doi,Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial,International journal of cancer,2021-04-01,2020-10-26,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1036,1384,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0020-7136,1097-0215",International Journal of Cancer,Wiley,2020-10-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01258153,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic,large,Industry,Interventional,Drug,Phase 2,115,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-09,2010-11-01,2014-03-01,2014,2013-12-01,2013,2015-05-04,429,519,-38,1178,1088,396,486,1574,2020-07-01,2020-09-01,2021-08-15,10.1016/s0016-5085(15)31431-1,NA,https://www.gastrojournal.org/article/S0016-5085(15)31431-1/pdf,2015-04-01,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0016-5085,Gastroenterology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01258153,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic,large,Industry,Interventional,Drug,Phase 2,115,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,TRUE,2010-12-09,2010-11-01,2014-03-01,2014,2013-12-01,2013,2015-05-04,429,519,-38,1178,1088,396,486,1574,2020-07-01,2020-09-01,2021-08-15,10.1016/s0016-5085(15)31431-1,NA,https://www.gastrojournal.org/article/S0016-5085(15)31431-1/pdf,2015-04-01,abstract,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0016-5085,Gastroenterology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02207582,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Prefrontal Transcranial Random Noise Stimulation in Patients With Depression,small,Other,Interventional,Device,NA,44,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2014-07-31,2014-07-01,2016-12-06,2016,2016-10-14,2016,NA,NA,NA,-30,859,806,1410,1463,2269,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jpsychires.2020.10.011,33086145,https://www.sciencedirect.com/science/article/pii/S0022395620310141,2020-10-16,journal publication,TRUE,TRUE,doi,Bifrontal high-frequency transcranial random noise stimulation is not effective as an add-on treatment in depression,Journal of psychiatric research,2021-01,2020-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1365,1713,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,0022-3956,Journal of Psychiatric Research,Elsevier BV,2021-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2022-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03039387,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients,large,Other,Interventional,Device,NA,44,Unknown status,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2016-10-28,2016-09-01,2017-04-01,2017,2017-04-01,2017,NA,NA,NA,-57,155,155,760,760,915,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.nature.com/articles/s41598-019-43234-2,2019-05-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02076646,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,A Phase I/II Dose Escalation Study of the Tumor-targeting Human L19-IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Dacarbazine for Patients With Metastatic Melanoma,large,Industry,Interventional,Drug,Phase 1/Phase 2,96,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2014-02-24,2013-10-01,2017-06-01,2017,2017-04-01,2017,NA,NA,NA,-146,1193,1132,824,885,2017,2020-07-01,2020-09-01,2021-08-15,10.1007/s00262-019-02383-z,NA,https://link.springer.com/article/10.1007/s00262-019-02383-z#citeas,2019-09-03,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,3,0,0,0,1188,1536,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"0340-7004,1432-0851","Cancer Immunology, Immunotherapy",Springer Science and Business Media LLC,2019-09-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02710617,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System,large,Other,Interventional,Device,NA,109,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2016-03-11,2016-03-01,2016-05-01,2016,2016-04-01,2016,NA,NA,NA,-10,51,21,957,987,1008,2020-07-01,2020-09-01,2021-08-15,10.1177/1932296818821105,30547683,https://journals.sagepub.com/doi/10.1177/1932296818821105,2018-12-14,journal publication,TRUE,TRUE,doi,"Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197",Journal of diabetes science and technology,2019-03,2018-12-14,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1932-2968,1932-2968",Journal of Diabetes Science and Technology,SAGE Publications,2018-12-14,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT03423576,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Ulm Würzburg,NA,Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF),large,Other,Interventional,Behavioral,NA,318,Completed,NA,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2018-01-23,2011-08-01,2016-12-31,2016,2016-02-28,2016,NA,NA,NA,-2367,-388,-695,700,1007,312,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Berichte/Abschlussbericht_VEMSE-190416.pdf,2018-12-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,12,1340,1688,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01966146,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Examination of Valve Insufficiency Before and After MitraClip or TAVI Procedure by 3D Echocardiography Compared to MRI,large,Other,Interventional,Device,NA,200,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-07-17,2013-05-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-77,441,441,1380,1380,1821,2020-07-01,2020-09-01,2021-08-15,10.1109/tbme.2018.2855661,30004869,https://pubmed.ncbi.nlm.nih.gov/30004869/,2018-07-12,journal publication,TRUE,TRUE,doi,Capacitive ECG Monitoring in Cardiac Patients During Simulated Driving,IEEE transactions on bio-medical engineering,2019-03,2018-07-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0018-9294,1558-2531",IEEE Transactions on Biomedical Engineering,Institute of Electrical and Electronics Engineers (IEEE),2019-03-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses'}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT01644032,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Telemedically Supported Analgesia in the Emergency Medical Service,large,Other,Interventional,Other,NA,106,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,1270,2062,2416,2020-07-01,2020-09-01,2021-08-15,10.3389/fnins.2019.00042,30853880,https://pubmed.ncbi.nlm.nih.gov/30853880/,2019-02-22,journal publication,TRUE,TRUE,doi,Serotonergic Contributions to Human Brain Aggression Networks,Frontiers in neuroscience,2019,2019-02-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1662-453X,Frontiers in Neuroscience,Frontiers Media SA,2019-02-22,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01644032,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Telemedically Supported Analgesia in the Emergency Medical Service,large,Other,Interventional,Other,NA,106,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,1270,2062,2416,2020-07-01,2020-09-01,2021-08-15,10.3389/fnins.2019.00042,30853880,https://pubmed.ncbi.nlm.nih.gov/30853880/,2019-02-22,journal publication,TRUE,TRUE,doi,Serotonergic Contributions to Human Brain Aggression Networks,Frontiers in neuroscience,2019,2019-02-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1662-453X,Frontiers in Neuroscience,Frontiers Media SA,2019-02-22,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT03105024,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Self-efficacy Enhancement and Exposure Therapy,small,Other,Interventional,Other,NA,71,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2017-03-27,2017-03-22,2017-11-29,2017,2017-11-29,2017,NA,NA,NA,-5,247,247,566,566,813,2020-07-01,2020-09-01,2021-08-15,10.3389/fpsyg.2019.01191,31275188,https://pubmed.ncbi.nlm.nih.gov/31275188/,2019-06-18,journal publication,TRUE,TRUE,doi,Low Perceived Self-Efficacy Impedes Discriminative Fear Learning,Frontiers in psychology,2019,2019-06-18,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1007,1355,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,1664-1078,Frontiers in Psychology,Frontiers Media SA,2019-06-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00749723,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bonn Duisburg-Essen,NA,Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children,large,Other,Interventional,Drug,Phase 2/Phase 3,174,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-09-05,2006-02-01,2016-01-31,2016,2015-01-31,2015,NA,NA,NA,-947,2704,2339,1453,1818,4157,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0227693,31971950,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977734/,2020-01-23,journal publication,TRUE,TRUE,doi,Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment,PloS one,2020,2020-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1675,2023,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2020-01-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02110043,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS,large,Other,Interventional,Device,NA,21,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2014-02-13,2014-03-01,2017-10-01,2017,2017-08-01,2017,NA,NA,NA,16,1326,1265,947,1008,2273,2020-07-01,2020-09-01,2021-08-15,10.3233/jad-191234,32280093,https://pubmed.ncbi.nlm.nih.gov/32280093/,2020-05-05,journal publication,TRUE,TRUE,doi,Impact of 3-Day Combined Anodal Transcranial Direct Current Stimulation-Visuospatial Training on Object-Location Memory in Healthy Older Adults and Patients with Mild Cognitive Impairment,Journal of Alzheimer's disease : JAD,2020,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,green,"1387-2877,1875-8908",Journal of Alzheimer's Disease,IOS Press,2020-05-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01865604,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Impact of tDCS on Cerebral Autoregulation,large,Other,Interventional,Device,NA,60,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-12-18,2012-04-01,2014-03-01,2014,2014-03-01,2014,NA,NA,NA,-261,438,438,314,314,752,2020-07-01,2020-09-01,2021-08-15,10.1212/wnl.0000000000001230,25576632,https://pubmed.ncbi.nlm.nih.gov/25576632/,2015-01-09,journal publication,TRUE,TRUE,doi,Impact of tDCS on cerebral autoregulation in aging and in patients with cerebrovascular diseases,Neurology,2015-Feb-10,2015-01-09,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0028-3878,1526-632X",Neurology,Ovid Technologies (Wolters Kluwer Health),2015-01-09,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-02-10,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01791790,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Elderly Healthy Subjects,large,Other,Interventional,Device,NA,32,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-02-13,2013-01-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,-43,1387,1387,-217,-217,1170,2020-07-01,2020-09-01,2021-08-15,10.1016/j.brs.2016.04.016,27247261,https://pubmed.ncbi.nlm.nih.gov/27247261/,2016-04-28,journal publication,TRUE,TRUE,doi,Boosting Slow Oscillatory Activity Using tDCS during Early Nocturnal Slow Wave Sleep Does Not Improve Memory Consolidation in Healthy Older Adults,Brain stimulation,2016 Sep-Oct,2016-04-28,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1935-861X,Brain Stimulation,Elsevier BV,2016-09-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01219244,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI),large,Other,Interventional,Behavioral,Phase 2/Phase 3,330,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-12,2010-08-01,2016-12-01,2016,2016-07-01,2016,NA,NA,NA,-72,2242,2089,-427,-274,1815,2020-07-01,2020-09-01,2021-08-15,10.1016/j.neuroimage.2015.09.050,26433119,https://pubmed.ncbi.nlm.nih.gov/26433119/,2015-10-01,journal publication,TRUE,TRUE,doi,"Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment",NeuroImage,2016-05-01,2015-10-01,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1053-8119,NeuroImage,Elsevier BV,2016-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE -NCT01105143,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Effects of Negative Energy Balance on Muscle Mass Regulation,large,Other,Interventional,Behavioral,NA,81,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2012-03-01,2017-05-01,2017,2015-05-01,2015,NA,NA,NA,687,2574,1843,1157,1888,3731,2020-07-01,2020-09-01,2021-08-15,10.4049/jimmunol.2000108,32482712,https://pubmed.ncbi.nlm.nih.gov/32482712/,2020-07-01,journal publication,TRUE,TRUE,doi,"Association between Subcutaneous Adipose Tissue Inflammation, Insulin Resistance, and Calorie Restriction in Obese Females","Journal of immunology (Baltimore, Md. : 1950)",2020-07-01,2020-06-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0022-1767,1550-6606",The Journal of Immunology,The American Association of Immunologists,2020-06-01,no_embargo_info,FALSE,NA,NA,[],NA,NA,NA,[],journal,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,NA -NCT00850629,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Hormonal Regulation of Body Weight Maintenance,large,Other,Interventional,Behavioral,NA,286,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2010-01-01,2016-01-01,2016,2015-12-01,2015,NA,NA,NA,318,2509,2478,161,192,2670,2020-07-01,2020-09-01,2021-08-15,10.1186/s40608-016-0110-8,27298729,https://pubmed.ncbi.nlm.nih.gov/27298729/,2016-06-10,journal publication,TRUE,TRUE,doi,Hormonal regulatory mechanisms in obese children and adolescents after previous weight reduction with a lifestyle intervention: maintain - paediatric part - a RCT from 2009-15,BMC obesity,2016,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,2052-9538,BMC Obesity,Springer Science and Business Media LLC,2016-06-10,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT00437307,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse,large,Other,Interventional,Drug,Phase 3,550,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2007-02-19,2007-03-01,2015-06-01,2015,2013-07-01,2013,NA,NA,NA,10,3024,2324,147,847,3171,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdw418,27789470,https://pubmed.ncbi.nlm.nih.gov/27789470/,2015-10-26,journal publication,TRUE,TRUE,doi,Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR),Annals of oncology : official journal of the European Society for Medical Oncology,2016-12,2016-10-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-12-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01105143,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effects of Negative Energy Balance on Muscle Mass Regulation,large,Other,Interventional,Behavioral,NA,81,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2012-03-01,2017-05-01,2017,2015-05-01,2015,NA,NA,NA,687,2574,1843,1157,1888,3731,2020-07-01,2020-09-01,2021-08-15,10.4049/jimmunol.2000108,32482712,https://pubmed.ncbi.nlm.nih.gov/32482712/,2020-07-01,journal publication,TRUE,TRUE,doi,"Association between Subcutaneous Adipose Tissue Inflammation, Insulin Resistance, and Calorie Restriction in Obese Females","Journal of immunology (Baltimore, Md. : 1950)",2020-07-01,2020-06-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0022-1767,1550-6606",The Journal of Immunology,The American Association of Immunologists,2020-06-01,no_embargo_info,FALSE,NA,NA,[],NA,NA,NA,[],journal,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,NA +NCT00850629,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Hormonal Regulation of Body Weight Maintenance,large,Other,Interventional,Behavioral,NA,286,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2010-01-01,2016-01-01,2016,2015-12-01,2015,NA,NA,NA,318,2509,2478,161,192,2670,2020-07-01,2020-09-01,2021-08-15,10.1186/s40608-016-0110-8,27298729,https://pubmed.ncbi.nlm.nih.gov/27298729/,2016-06-10,journal publication,TRUE,TRUE,doi,Hormonal regulatory mechanisms in obese children and adolescents after previous weight reduction with a lifestyle intervention: maintain - paediatric part - a RCT from 2009-15,BMC obesity,2016,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,2052-9538,BMC Obesity,Springer Science and Business Media LLC,2016-06-10,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT00437307,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse,large,Other,Interventional,Drug,Phase 3,550,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2007-02-19,2007-03-01,2015-06-01,2015,2013-07-01,2013,NA,NA,NA,10,3024,2324,147,847,3171,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdw418,27789470,https://pubmed.ncbi.nlm.nih.gov/27789470/,2015-10-26,journal publication,TRUE,TRUE,doi,Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR),Annals of oncology : official journal of the European Society for Medical Oncology,2016-12,2016-10-26,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-12-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02721836,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Yoga for Patients With Irritable Bowel Syndrome,large,Other,Interventional,Behavioral,NA,59,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2016-03-17,2016-04-01,2017-05-01,2017,2016-12-01,2016,NA,NA,NA,15,410,259,179,330,589,2020-07-01,2020-09-01,2021-08-15,10.1111/apt.14400,29076171,https://pubmed.ncbi.nlm.nih.gov/29076171/,2017-10-27,journal publication,TRUE,TRUE,doi,Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome,Alimentary pharmacology & therapeutics,2018-01,2017-10-27,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0269-2813,Alimentary Pharmacology & Therapeutics,Wiley,2017-10-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01515852,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,General Anesthesia vs. Local Anesthesia in Stereotaxy,large,Other,Interventional,Procedure,NA,80,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-01-23,2012-01-01,2014-01-01,2014,2014-01-01,2014,NA,NA,NA,-22,709,709,996,996,1705,2020-07-01,2020-09-01,2021-08-15,10.1016/j.wneu.2016.09.064,27671885,https://pubmed.ncbi.nlm.nih.gov/27671885/,2016-09-23,journal publication,TRUE,TRUE,doi,General Anesthesia Versus Local Anesthesia in Stereotactic Biopsies of Brain Lesions: A Prospective Randomized Study,World neurosurgery,2017-Jan,2016-09-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1878-8750,World Neurosurgery,Elsevier BV,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02372318,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Mannheim,NA,Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity,small,Other,Interventional,Drug,Early Phase 1,23,Terminated,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2015-02-06,2015-04-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,54,450,450,1293,1293,1743,2020-07-01,2020-09-01,2021-08-15,10.1016/j.euroneuro.2019.10.014,31740271,https://pubmed.ncbi.nlm.nih.gov/31740271/,2019-11-15,journal publication,TRUE,TRUE,doi,"The effects of nalmefene on emotion processing in alcohol use disorder - A randomized, controlled fMRI study",European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2019-12,2019-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0924-977X,European Neuropsychopharmacology,Elsevier BV,2019-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2020-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2173,10 +2173,10 @@ NCT02071615,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01984788,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE,large,Industry,Interventional,Drug,Phase 2,24,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2013-11-05,2013-11-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-4,177,177,854,854,1031,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.jacionline.org/article/S0091-6749(16)30270-6/pdf,2016-09-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01963793,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Topical Aprepitant in Prurigo Patients,large,Industry,Interventional,Drug,Phase 2,20,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,TRUE,2013-09-18,2013-10-01,2014-07-01,2014,2014-07-01,2014,2018-08-17,1508,1508,13,286,286,1291,1291,1577,2020-07-01,2020-09-01,2021-08-15,10.2340/00015555-2780,28853492,https://pubmed.ncbi.nlm.nih.gov/28853492/,2018-01-12,journal publication,TRUE,TRUE,doi,"Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant",Acta dermato-venereologica,2018-Jan-12,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2254,2602,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,gold,gold,0001-5555,Acta Dermato Venereologica,Medical Journals Sweden AB,2018-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01914965,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin Ulm Bochum Münster,NA,Apathy Cure Through Bupropion in Huntington's Disease,large,Other,Interventional,Drug,Phase 2,40,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2013-07-31,2012-06-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-425,274,274,1055,1055,1329,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0173872,28323838,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360242/,2017-03-21,journal publication,TRUE,TRUE,doi,"Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial",PloS one,2017,2017-03-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-03-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01845142,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Immunologic Action of a Single Dose Cholecalciferol,large,Other,Interventional,Drug,Phase 4,40,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-04-24,2013-02-01,2014-04-01,2014,2013-05-01,2013,NA,NA,NA,-82,342,7,1028,1363,1370,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0169620,28114352,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256876/,2017-01-23,journal publication,TRUE,TRUE,doi,Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol,PloS one,2017,2017-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01845142,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Immunologic Action of a Single Dose Cholecalciferol,large,Other,Interventional,Drug,Phase 4,40,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-04-24,2013-02-01,2014-04-01,2014,2013-05-01,2013,NA,NA,NA,-82,342,7,1028,1363,1370,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0169620,28114352,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256876/,2017-01-23,journal publication,TRUE,TRUE,doi,Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol,PloS one,2017,2017-01-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-23,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01600573,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ),large,Other,Interventional,Drug,Phase 1/Phase 2,68,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-05-09,2012-05-01,2017-03-01,2017,2017-03-01,2017,NA,NA,NA,-8,1757,1757,457,457,2214,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2018.36.15_suppl.e17553,NA,https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e17553,2018-06-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2018-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2019-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01221779,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Chronic Aphasia - Improved by Intensive Training and Electrical Brain Stimulation,large,Other,Interventional,Behavioral,Phase 2,40,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-13,2011-01-01,2014-12-01,2014,2014-08-01,2014,NA,NA,NA,80,1510,1388,442,564,1952,2020-07-01,2020-09-01,2021-08-15,10.1093/brain/aww002,26912641,https://pubmed.ncbi.nlm.nih.gov/26912641/,2016-02-16,journal publication,TRUE,TRUE,doi,Electrical stimulation of the motor cortex enhances treatment outcome in post-stroke aphasia,Brain : a journal of neurology,2016-Apr,2016-02-16,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0006-8950,1460-2156",Brain,Oxford University Press (OUP),2016-02-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-02-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01049100,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Surgical Staging in Cervical Cancer Prior to Chemoradiation,large,Other,Interventional,Procedure,NA,250,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-13,2009-04-01,2017-04-01,2017,2013-04-01,2013,NA,NA,NA,-287,2635,1174,-529,932,2106,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ijrobp.2015.10.027,26853333,https://pubmed.ncbi.nlm.nih.gov/26853333/,2015-10-20,journal publication,TRUE,TRUE,doi,Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group,"International journal of radiation oncology, biology, physics",2016-Feb-01,2015-10-20,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0360-3016,International Journal of Radiation Oncology*Biology*Physics,Elsevier BV,2016-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01049100,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Surgical Staging in Cervical Cancer Prior to Chemoradiation,large,Other,Interventional,Procedure,NA,250,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-13,2009-04-01,2017-04-01,2017,2013-04-01,2013,NA,NA,NA,-287,2635,1174,-529,932,2106,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ijrobp.2015.10.027,26853333,https://pubmed.ncbi.nlm.nih.gov/26853333/,2015-10-20,journal publication,TRUE,TRUE,doi,Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group,"International journal of radiation oncology, biology, physics",2016-Feb-01,2015-10-20,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0360-3016,International Journal of Radiation Oncology*Biology*Physics,Elsevier BV,2016-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02404844,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,"Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer",large,Other,Interventional,Drug,Phase 2,48,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-02-20,2014-12-01,2017-10-19,2017,2017-09-19,2017,NA,NA,NA,-81,972,942,924,954,1896,2020-07-01,2020-09-01,2021-08-15,10.1002/cam4.3092,32352244,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333856/,2020-04-30,journal publication,TRUE,TRUE,doi,"Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression",Cancer medicine,2020-07,2020-04-30,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,4,4,1048,1396,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,"2045-7634,2045-7634",Cancer Medicine,Wiley,2020-04-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02099968,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Comprehensive Lifestyle Modification for Patients With Hypertension and Metabolic Syndrome: a Multicenter Randomized Controlled Trial,large,Other,Interventional,Behavioral,NA,145,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2014-03-26,2014-04-01,2015-12-01,2015,2015-03-01,2015,NA,NA,NA,6,615,340,1547,1822,2162,2020-07-01,2020-09-01,2021-08-15,10.1101/2020.02.23.20027029,NA,https://www.medrxiv.org/content/10.1101/2020.02.23.20027029v1,2020-02-25,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,NA,NA,Cold Spring Harbor Laboratory,2020-02-25,unresolved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01455675,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients,small,Other,Interventional,Drug,Phase 3,164,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-10-18,2011-10-01,2017-06-27,2017,2017-06-27,2017,NA,NA,NA,-17,2079,2079,654,654,2733,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-000801-39/results,2019-04-12,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1162,1510,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2208,12 +2208,12 @@ NCT01884376,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE, NCT01839084,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,PaNeX: Partial Nephrectomy Under Xenon,large,Other,Interventional,Drug,Phase 3,46,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-04-09,2013-07-01,2016-02-01,2016,2016-02-01,2016,NA,NA,NA,83,1028,1028,1254,1254,2282,2020-07-01,2020-09-01,2021-08-15,10.1186/s12871-019-0799-2,31288740,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617591/,2019-07-09,journal publication,TRUE,TRUE,doi,Better haemodynamic stability under xenon anaesthesia than under isoflurane anaesthesia during partial nephrectomy - a secondary analysis of a randomised controlled trial,BMC anesthesiology,2019-07-09,2019-07-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,2,2,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2253,BMC Anesthesiology,Springer Science and Business Media LLC,2019-07-09,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01712464,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Modulation of Reinforcement Learning,large,Other,Interventional,Drug,NA,60,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2012-10-15,2013-10-18,2016-08-07,2016,2016-08-07,2016,NA,NA,NA,368,1392,1392,817,817,2209,2020-07-01,2020-09-01,2021-08-15,10.1038/s41386-018-0258-7,30390065,https://pubmed.ncbi.nlm.nih.gov/30390065/,2018-11-02,journal publication,TRUE,TRUE,doi,Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial,Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,2019-03,2018-11-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1486,1834,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"0893-133X,1740-634X",Neuropsychopharmacology,Springer Science and Business Media LLC,2018-11-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-11-02,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01647854,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Operation of a Mobile Telemedicine System in the EMS,large,Other,Interventional,Procedure,NA,425,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-16,2012-08-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,16,1019,1019,33,33,1052,2020-07-01,2020-09-01,2021-08-15,10.1007/s00101-015-0039-1,26036316,https://link.springer.com/article/10.1007%2Fs00101-015-0039-1,2015-06-03,journal publication,TRUE,TRUE,doi,[Potential and effectiveness of a telemedical rescue assistance system. Prospective observational study on implementation in emergency medicine],Der Anaesthesist,2015-Jun,2015-06-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0003-2417,1432-055X",Der Anaesthesist,Springer Science and Business Media LLC,2015-06-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01644006,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome,large,Other,Interventional,Procedure,NA,39,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,457,1249,1603,2020-07-01,2020-09-01,2021-08-15,10.2196/jmir.6358,27908843,https://pubmed.ncbi.nlm.nih.gov/27908843/,2016-12-01,journal publication,TRUE,TRUE,doi,"Treatment of Acute Coronary Syndrome by Telemedically Supported Paramedics Compared With Physician-Based Treatment: A Prospective, Interventional, Multicenter Trial",Journal of medical Internet research,2016-12-01,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1438-8871,Journal of Medical Internet Research,JMIR Publications Inc.,2016-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01644006,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Telemedical Support in Prehospital Emergency Care of Acute Coronary Syndrome,large,Other,Interventional,Procedure,NA,39,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,457,1249,1603,2020-07-01,2020-09-01,2021-08-15,10.2196/jmir.6358,27908843,https://pubmed.ncbi.nlm.nih.gov/27908843/,2016-12-01,journal publication,TRUE,TRUE,doi,"Treatment of Acute Coronary Syndrome by Telemedically Supported Paramedics Compared With Physician-Based Treatment: A Prospective, Interventional, Multicenter Trial",Journal of medical Internet research,2016-12-01,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1438-8871,Journal of Medical Internet Research,JMIR Publications Inc.,2016-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01199276,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Hip Fracture Surgery in Elderly Patients,large,Industry,Interventional,Drug,Phase 2,256,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2010-09-09,2010-09-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-8,1483,1483,1147,1147,2630,2020-07-01,2020-09-01,2021-08-15,10.1016/j.bja.2017.11.015,29397119,https://pubmed.ncbi.nlm.nih.gov/29397119/,2017-11-21,journal publication,TRUE,TRUE,doi,"The hip fracture surgery in elderly patients (HIPELD) study to evaluate xenon anaesthesia for the prevention of postoperative delirium: a multicentre, randomized clinical trial",British journal of anaesthesia,2018-Jan,2017-11-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,2,2,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0007-0912,British Journal of Anaesthesia,Elsevier BV,2018-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00785109,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification,large,Other,Interventional,Dietary Supplement,Phase 3,99,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-11-04,2010-01-01,2015-08-01,2015,2015-08-01,2015,NA,NA,NA,423,2461,2461,661,661,3122,2020-07-01,2020-09-01,2021-08-15,10.1161/circulationaha.116.027011,28533322,https://www.ahajournals.org/doi/full/10.1161/circulationaha.116.027011,2017-05-23,journal publication,TRUE,TRUE,doi,Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study,Circulation,2017-05-23,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0009-7322,1524-4539",Circulation,Ovid Technologies (Wolters Kluwer Health),2017-05-23,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00554502,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy,large,Other,Interventional,Drug,Phase 3,148,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2007-10-29,2008-02-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,95,2652,2652,305,305,2957,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1415463,26630142,https://pubmed.ncbi.nlm.nih.gov/26630142/,2015-12-03,journal publication,TRUE,TRUE,doi,Intensive Supportive Care plus Immunosuppression in IgA Nephropathy,The New England journal of medicine,2015-Dec-03,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-12-03,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-06-02,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01578525,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Medication Safety of Elderly Patients in Hospital and Ambulatory Setting,large,Other,Interventional,Other,NA,61,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-04-13,2012-04-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-12,718,718,1525,1525,2243,2020-07-01,2020-09-01,2021-08-15,10.1186/s12877-018-0814-3,29898670,https://pubmed.ncbi.nlm.nih.gov/29898670/,2018-06-04,journal publication,TRUE,TRUE,doi,Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial,BMC geriatrics,2018-06-04,2018-06-04,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2318,BMC Geriatrics,Springer Science and Business Media LLC,2018-06-04,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00787293,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients,large,Industry,Interventional,Device,Phase 2,30,Suspended,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-11-05,2008-10-01,2015-11-01,2015,2010-11-01,2010,NA,NA,NA,-35,2552,726,-990,836,1562,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ahj.2013.01.010,23622913,https://www.sciencedirect.com/science/article/abs/pii/S0002870313000677,2013-02-14,journal publication,TRUE,TRUE,doi,Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial,American heart journal,2013-May,2013-02-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,10,10,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-8703,American Heart Journal,Elsevier BV,2013-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00787293,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients,large,Industry,Interventional,Device,Phase 2,30,Suspended,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-11-05,2008-10-01,2015-11-01,2015,2010-11-01,2010,NA,NA,NA,-35,2552,726,-990,836,1562,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ahj.2013.01.010,23622913,https://www.sciencedirect.com/science/article/abs/pii/S0002870313000677,2013-02-14,journal publication,TRUE,TRUE,doi,Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial,American heart journal,2013-May,2013-02-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,10,10,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0002-8703,American Heart Journal,Elsevier BV,2013-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03860129,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Different Volatile Anaesthetics and the Depth of Long Term ICU Sedation,small,Other,Interventional,Drug,NA,30,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2018-09-24,2014-12-10,2017-05-31,2017,2017-05-05,2017,NA,NA,NA,-1384,-481,-507,868,894,387,2020-07-01,2020-09-01,2021-08-15,10.1186/s13613-019-0594-8,31620921,https://pubmed.ncbi.nlm.nih.gov/31620921/,2019-10-16,journal publication,TRUE,TRUE,doi,"Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial",Annals of intensive care,2019-Oct-16,2019-10-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,1189,1537,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,2110-5820,Annals of Intensive Care,Springer Science and Business Media LLC,2019-10-16,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT03587324,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Perioperative Aspirin Response in Patients Undergoing Vascular Surgery,small,Other,Interventional,Drug,NA,176,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2018-07-02,2013-02-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,-1977,-1219,-1219,1058,1058,-161,2020-07-01,2020-09-01,2021-08-15,10.1111/jth.13962,29383871,https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.13962,2018-01-22,journal publication,TRUE,TRUE,doi,Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non-cardiac surgery: an observational cohort study,Journal of thrombosis and haemostasis : JTH,2018-04,2018-02-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1538-7933,1538-7836",Journal of Thrombosis and Haemostasis,Wiley,2018-02-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-02-28,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02468427,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Objective Structured Assessment of Technical Skills (OSATS) Evaluation of Delivery by Vacuum Extraction,small,Other,Interventional,Other,NA,137,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2015-05-03,2015-03-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,-63,151,151,540,540,691,2020-07-01,2020-09-01,2021-08-15,10.1097/md.0000000000006355,28296771,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369926/,2017-03-24,journal publication,TRUE,TRUE,doi,A randomized comparison of video demonstration versus hands-on training of medical students for vacuum delivery using Objective Structured Assessment of Technical Skills (OSATS),Medicine,2017-Mar,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,0025-7974,Medicine,Ovid Technologies (Wolters Kluwer Health),2017-03-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2223,7 +2223,7 @@ NCT02330471,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02313493,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Efficacy and Feasibility of Baby Triple P - a Pilot Study,small,Other,Interventional,Behavioral,NA,78,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2014-12-07,2012-09-01,2015-11-01,2015,2015-07-01,2015,NA,NA,NA,-827,329,206,1458,1581,1787,2020-07-01,2020-09-01,2021-08-15,10.3389/fpsyg.2019.02425,31736826,https://pubmed.ncbi.nlm.nih.gov/31736826/,2019-10-29,journal publication,TRUE,TRUE,doi,The Relevance of Infant Outcome Measures: A Pilot-RCT Comparing Baby Triple P Positive Parenting Program With Care as Usual,Frontiers in psychology,2019,2019-10-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1664-1078,Frontiers in Psychology,Frontiers Media SA,2019-10-29,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01809379,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer,small,Other,Interventional,Drug,Phase 2,69,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-03-08,2013-02-01,2014-09-01,2014,2014-03-01,2014,NA,NA,NA,-35,542,358,170,354,712,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ygyno.2015.02.009,25701703,https://www.sciencedirect.com/science/article/abs/pii/S0090825815006496,2015-02-18,journal publication,TRUE,TRUE,doi,Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study,Gynecologic oncology,2015-May,2015-02-18,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0090-8258,Gynecologic Oncology,Elsevier BV,2015-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01470677,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Tachosil for the Prevention of Symptomatic Lymph Cysts,small,Other,Interventional,Drug,Phase 3,220,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-07-12,2011-11-01,2016-01-01,2016,2016-01-01,2016,NA,NA,NA,112,1634,1634,-489,-489,1145,2020-07-01,2020-09-01,2021-08-15,10.1186/1471-2407-14-635,25175029,https://pubmed.ncbi.nlm.nih.gov/25175029/,2014-08-30,journal publication,TRUE,TRUE,doi,A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial,BMC cancer,2014-Aug-30,2014-08-30,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,18,18,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2014-08-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00561990,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum Bochum,NA,Nimotuzumab in Adults With Pancreatic Cancer,small,Industry,Interventional,Drug,Phase 2/Phase 3,188,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2007-11-20,2007-09-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-80,2234,1869,1369,1734,3603,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdx343,28961832,https://pubmed.ncbi.nlm.nih.gov/28961832/,2017-10-01,journal publication,TRUE,TRUE,doi,"Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study",Annals of oncology : official journal of the European Society for Medical Oncology,2017-Oct-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,1,1,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2018-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00561990,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Nimotuzumab in Adults With Pancreatic Cancer,small,Industry,Interventional,Drug,Phase 2/Phase 3,188,Completed,NA,NA,NA,FALSE,FALSE,FALSE,2007-11-20,2007-09-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-80,2234,1869,1369,1734,3603,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdx343,28961832,https://pubmed.ncbi.nlm.nih.gov/28961832/,2017-10-01,journal publication,TRUE,TRUE,doi,"Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study",Annals of oncology : official journal of the European Society for Medical Oncology,2017-Oct-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,1,1,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0923-7534,Annals of Oncology,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2018-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT03829839,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity,small,Other,Interventional,Drug,Phase 1,120,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2019-02-01,2016-03-03,2017-08-16,2017,2017-08-16,2017,NA,NA,NA,-1065,-534,-534,996,996,462,2020-07-01,2020-09-01,2021-08-15,10.1073/pnas.1920147117,32385158,https://www.pnas.org/content/117/21/11781,2020-05-08,journal publication,TRUE,TRUE,doi,Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear,Proceedings of the National Academy of Sciences of the United States of America,2020-05-26,2020-05-08,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1112,1460,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,green,"0027-8424,1091-6490",Proceedings of the National Academy of Sciences,Proceedings of the National Academy of Sciences,2020-05-08,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,6,2020-11-26,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT03425929,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,"Oxytocin, Trauma Disclosure and Intrusions",small,Other,Interventional,Drug,Phase 1,70,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2018-01-28,2016-06-01,2017-03-18,2017,2017-03-18,2017,NA,NA,NA,-606,-316,-316,381,381,65,2020-07-01,2020-09-01,2021-08-15,10.1159/000496056,NA,https://static1.squarespace.com/static/5e99fa9f3fa9f76f9cb19251/t/5ea36d9755121234097ef539/1587768728156/Scheele+et+al+2019+Psychotherapy+and+Psychosomatics.pdf,2018-04-03,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1263,1611,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0033-3190,1423-0348",Psychotherapy and Psychosomatics,S. Karger AG,2019-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2020-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03265899,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Oxytocin and the Processing of Social Stress-Associated Chemosignals,small,Other,Interventional,Drug,Phase 1,60,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2017-08-18,2015-07-01,2016-11-30,2016,2016-11-30,2016,NA,NA,NA,-779,-261,-261,498,498,237,2020-07-01,2020-09-01,2021-08-15,10.1038/s41386-018-0063-3,29703998,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300531/,2018-04-12,journal publication,TRUE,TRUE,doi,Oxytocin reduces a chemosensory-induced stress bias in social perception,Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,2019-01,2018-04-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1371,1719,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"0893-133X,1740-634X",Neuropsychopharmacology,Springer Science and Business Media LLC,2018-04-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-04-12,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -2237,7 +2237,7 @@ NCT01914159,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01852149,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Mitralign Percutaneous Annuloplasty First in Man Study,small,Industry,Interventional,Device,NA,35,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-05-07,2009-08-01,2015-09-01,2015,2014-03-01,2014,NA,NA,NA,-1375,847,298,301,850,1148,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2016.03.591,27339489,https://pubmed.ncbi.nlm.nih.gov/27339489/,2016-06-28,journal publication,TRUE,TRUE,doi,Treatment of Chronic Functional Mitral Valve Regurgitation With a Percutaneous Annuloplasty System,Journal of the American College of Cardiology,2016-06-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01651780,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,"Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH",small,Industry,Interventional,Drug,Phase 3,803,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2012-07-24,2012-10-01,2015-06-01,2015,2015-06-01,2015,2017-01-09,588,588,69,1042,1042,136,136,1178,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2015.10.003,26477635,https://pubmed.ncbi.nlm.nih.gov/26477635/,2015-10-15,journal publication,TRUE,TRUE,doi,Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial,Journal of the American College of Cardiology,2015-Dec-29,2015-10-15,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1919,2267,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01149109,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients,small,Other,Interventional,Drug,Phase 3,141,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-06-14,2010-10-01,2017-04-06,2017,2017-04-06,2017,NA,NA,NA,109,2488,2488,679,679,3167,2020-07-01,2020-09-01,2021-08-15,10.1016/s0140-6736(18)31791-4,30782343,https://pubmed.ncbi.nlm.nih.gov/30782343/,2019-02-14,journal publication,TRUE,TRUE,doi,"Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial","Lancet (London, England)",2019-02-16,2019-02-14,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,2,2,1244,1592,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,0140-6736,The Lancet,Elsevier BV,2019-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2019-07-31,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00770783,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Bonn Bonn,NA,Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression,small,Other,Interventional,Device,Phase 3,30,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-09,2005-02-01,2014-05-01,2014,2013-09-01,2013,NA,NA,NA,-1346,2030,1788,208,450,2238,2020-07-01,2020-09-01,2021-08-15,10.1017/s0033291714002244,25420474,https://pubmed.ncbi.nlm.nih.gov/25420474/,2014-11-25,journal publication,TRUE,TRUE,doi,"Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects",Psychological medicine,2015-Apr,2014-11-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0033-2917,1469-8978",Psychological Medicine,Cambridge University Press (CUP),2014-11-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-05-24,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00770783,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Magnetic Seizure Therapy (MST) for Treatment Resistant Major Depression,small,Other,Interventional,Device,Phase 3,30,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-09,2005-02-01,2014-05-01,2014,2013-09-01,2013,NA,NA,NA,-1346,2030,1788,208,450,2238,2020-07-01,2020-09-01,2021-08-15,10.1017/s0033291714002244,25420474,https://pubmed.ncbi.nlm.nih.gov/25420474/,2014-11-25,journal publication,TRUE,TRUE,doi,"Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects",Psychological medicine,2015-Apr,2014-11-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0033-2917,1469-8978",Psychological Medicine,Cambridge University Press (CUP),2014-11-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-05-24,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02479412,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,"A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma",small,Industry,Interventional,Drug,Phase 2,54,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2015-06-17,2015-06-25,2016-02-08,2016,2016-02-08,2016,2017-01-27,354,354,8,236,236,1106,1106,1342,2020-07-01,2020-09-01,2021-08-15,10.1186/s12931-019-1000-7,30777086,https://pubmed.ncbi.nlm.nih.gov/30777086/,2019-02-18,journal publication,TRUE,TRUE,doi,"Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial",Respiratory research,2019-Feb-18,2019-02-18,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1667,2015,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,gold,gold,1465-993X,Respiratory Research,Springer Science and Business Media LLC,2019-02-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02034279,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn Frankfurt Heidelberg LMU-München Tübingen Ulm,NA,The INFECIR-2 Albumin Prevention Study,large,Other,Interventional,Drug,Phase 4,136,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-01-07,2014-05-01,2017-02-10,2017,2016-12-31,2016,NA,NA,NA,114,1130,1089,906,947,2036,2020-07-01,2020-09-01,2021-08-15,10.1016/j.cgh.2019.07.055,31394283,https://pubmed.ncbi.nlm.nih.gov/31394283/,2019-08-05,journal publication,TRUE,TRUE,doi,Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis,Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,2020-04,2019-08-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,5,5,1299,1647,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,green,green,1542-3565,Clinical Gastroenterology and Hepatology,Elsevier BV,2020-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2021-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02997137,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Bonn,NA,Impact of an Amino Acid Composition With Micronutrients on Wellbeing of Patients With Chronic Exhaustion Conditions,small,Industry,Interventional,Dietary Supplement,Phase 3,74,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2016-12-15,2014-10-01,2016-02-01,2016,2016-02-01,2016,NA,NA,NA,-806,-318,-318,818,818,500,2020-07-01,2020-09-01,2021-08-15,10.3390/nu10050551,29710825,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986431/,2018-04-29,journal publication,TRUE,TRUE,doi,Impact of a Specific Amino Acid Composition with Micronutrients on Well-Being in Subjects with Chronic Psychological Stress and Exhaustion Conditions: A Pilot Study,Nutrients,2018-Apr-29,2018-04-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2072-6643,Nutrients,MDPI AG,2018-04-29,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2290,7 +2290,7 @@ NCT01923493,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE, NCT01845129,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Impact of Transcranial Direct Current Stimulation of the Motor Cortex on Language Functions in Residual Aphasia,large,Other,Interventional,Device,NA,16,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-04-30,2013-04-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-29,336,336,955,955,1291,2020-07-01,2020-09-01,2021-08-15,10.1002/hbm.23469,27859982,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866985/,2016-11-11,journal publication,TRUE,TRUE,doi,Transcranial direct current stimulation effects on neural processing in post-stroke aphasia,Human brain mapping,2017-03,2016-11-11,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"1065-9471,1097-0193",Human Brain Mapping,Wiley,2016-11-11,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01840839,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Older Adults,large,Other,Interventional,Device,NA,18,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-04-18,2013-10-01,2015-08-01,2015,2015-05-01,2015,NA,NA,NA,166,835,743,336,428,1171,2020-07-01,2020-09-01,2021-08-15,10.1016/j.neuroimage.2016.06.057,27381076,https://pubmed.ncbi.nlm.nih.gov/27381076/,2016-07-02,journal publication,TRUE,TRUE,doi,Brain stimulation during an afternoon nap boosts slow oscillatory activity and memory consolidation in older adults,NeuroImage,2016-Nov-15,2016-07-02,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,16,16,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1053-8119,NeuroImage,Elsevier BV,2016-11-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01811589,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Guided Application of Ventricular Catheters,large,Industry,Interventional,Device,NA,144,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2013-03-13,2013-05-01,2015-01-01,2015,2015-01-01,2015,NA,NA,NA,49,659,659,1308,1308,1967,2020-07-01,2020-09-01,2021-08-15,10.1093/neuros/nyx420,28973670,https://pubmed.ncbi.nlm.nih.gov/28973670/,2018-08-01,journal publication,TRUE,TRUE,doi,"GAVCA Study: Randomized, Multicenter Trial to Evaluate the Quality of Ventricular Catheter Placement with a Mobile Health Assisted Guidance Technique",Neurosurgery,2018-08-01,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0148-396X,1524-4040",Neurosurgery,Ovid Technologies (Wolters Kluwer Health),2017-08-04,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01801280,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS,large,Other,Interventional,Drug,Phase 4,20,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,TRUE,2013-02-13,2012-01-01,2014-03-01,2014,2013-03-01,2013,2014-12-17,291,656,-409,381,16,419,784,800,2020-07-01,2020-09-01,2021-08-15,10.1111/bcp.12664,25913040,https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.12664,2015-04-24,journal publication,TRUE,TRUE,doi,No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study,British journal of clinical pharmacology,2015-Nov,2015-07-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0306-5251,British Journal of Clinical Pharmacology,Wiley,2015-07-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-07-14,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01801280,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS,large,Other,Interventional,Drug,Phase 4,20,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,TRUE,2013-02-13,2012-01-01,2014-03-01,2014,2013-03-01,2013,2014-12-17,291,656,-409,381,16,419,784,800,2020-07-01,2020-09-01,2021-08-15,10.1111/bcp.12664,25913040,https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.12664,2015-04-24,journal publication,TRUE,TRUE,doi,No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study,British journal of clinical pharmacology,2015-Nov,2015-07-14,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0306-5251,British Journal of Clinical Pharmacology,Wiley,2015-07-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-07-14,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01797887,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Ayurvedic Versus Conventional Counseling in Mothers With Burnout-Syndrome,large,Other,Interventional,Behavioral,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-02-21,2013-05-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,69,648,648,958,958,1606,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ctim.2017.07.005,28917376,https://pubmed.ncbi.nlm.nih.gov/28917376/,2017-07-16,journal publication,TRUE,TRUE,doi,Ayurvedic versus conventional dietary and lifestyle counseling for mothers with burnout-syndrome: A randomized controlled pilot study including a qualitative evaluation,Complementary therapies in medicine,2017-Oct,2017-07-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0965-2299,Complementary Therapies in Medicine,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01785082,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Fast-track LiveR: Study for the Early Identification of Low-risk Patients After Partial Liver Resection by the LiMAx-test,large,Industry,Interventional,Drug,Phase 3,149,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2013-01-25,2013-01-01,2015-09-01,2015,2015-09-01,2015,NA,NA,NA,-24,949,949,1017,1017,1966,2020-07-01,2020-09-01,2021-08-15,10.1002/bjs5.81,30263981,https://pubmed.ncbi.nlm.nih.gov/30263981/,2018-06-14,journal publication,TRUE,TRUE,doi,Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function,BJS open,2018-Sep,2018-06-14,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,2474-9842,BJS Open,Oxford University Press (OUP),2018-06-14,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01782391,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,FALSE,TRUE,TRUE,Berlin,NA,Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments,large,Other,Interventional,Device,NA,0,Withdrawn,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-06-05,2013-04-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,300,2005,2005,-128,-128,1877,2020-07-01,2020-09-01,2021-08-15,10.1523/jneurosci.0260-17.2017,28637840,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705731/,2017-07-26,journal publication,TRUE,TRUE,doi,Promoting Sleep Oscillations and Their Functional Coupling by Transcranial Stimulation Enhances Memory Consolidation in Mild Cognitive Impairment,The Journal of neuroscience : the official journal of the Society for Neuroscience,2017-07-26,2017-06-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"0270-6474,1529-2401",The Journal of Neuroscience,Society for Neuroscience,2017-06-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,6,2018-01-26,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2298,7 +2298,7 @@ NCT01782365,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01770080,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Efficacy of Euminz® for Tension-Type Headache,large,Other,Interventional,Drug,Phase 4,211,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-01-09,2013-02-01,2015-09-01,2015,2015-09-01,2015,NA,NA,NA,23,965,965,757,757,1722,2020-07-01,2020-09-01,2021-08-15,10.1055/s-0037-1607119,NA,https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0037-1607119,2017-09-27,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,NA,Phytotherapie 2017 „Von der Innovation zur Evidenz“,Georg Thieme Verlag KG,2017-09-01,unresolved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01693393,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Low Dose Cyclosporin A in Primary Sjögren Syndrome,large,Other,Interventional,Drug,Phase 2,30,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2012-09-14,2010-03-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-928,747,747,666,666,1413,2020-07-01,2020-09-01,2021-08-15,10.1007/s10067-016-3360-4,27470087,https://pubmed.ncbi.nlm.nih.gov/27470087/,2016-07-28,journal publication,TRUE,TRUE,doi,A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome,Clinical rheumatology,2016-Sep,2016-07-28,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0770-3198,1434-9949",Clinical Rheumatology,Springer Science and Business Media LLC,2016-07-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-07-28,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01647880,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study),large,Other,Interventional,Drug,Phase 2/Phase 3,15,Terminated,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2012-07-23,2013-07-01,2016-04-01,2016,2016-04-01,2016,NA,NA,NA,343,1348,1348,1432,1432,2780,2020-07-01,2020-09-01,2021-08-15,10.1186/s12883-020-01645-z,32126977,https://pubmed.ncbi.nlm.nih.gov/32126977/,2020-03-03,journal publication,TRUE,TRUE,doi,"Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial",BMC neurology,2020-Mar-03,2020-03-03,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,0,0,0,0,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2377,BMC Neurology,Springer Science and Business Media LLC,2020-03-03,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01605487,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,"Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria",large,Other,Interventional,Drug,Phase 2,24,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-11,2012-06-01,2014-10-01,2014,2013-09-01,2013,NA,NA,NA,21,873,478,1528,1923,2401,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://refubium.fu-berlin.de/handle/fub188/23549,2018-12-07,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01605487,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold Urticaria",large,Other,Interventional,Drug,Phase 2,24,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-11,2012-06-01,2014-10-01,2014,2013-09-01,2013,NA,NA,NA,21,873,478,1528,1923,2401,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://refubium.fu-berlin.de/handle/fub188/23549,2018-12-07,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01582724,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effectiveness of Additional Self-care Acupressure for Women With Menstrual Pain Compared to Usual Care Alone,large,Other,Interventional,Procedure,NA,220,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-04-18,2012-12-01,2015-03-01,2015,2014-09-01,2014,NA,NA,NA,227,1047,866,-689,-508,358,2020-07-01,2020-09-01,2021-08-15,10.1186/1745-6215-14-99,24499425,https://pubmed.ncbi.nlm.nih.gov/24499425/,2013-04-11,journal publication,TRUE,TRUE,doi,Effectiveness of additional self-care acupressure for women with menstrual pain compared to usual care alone: using stakeholder engagement to design a pragmatic randomized trial and study protocol,Trials,2013-Apr-11,2013-04-11,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1745-6215,Trials,Springer Science and Business Media LLC,2013-04-11,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01580592,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Cold Urticaria Treatment With Xolair,large,Other,Interventional,Drug,Phase 2,31,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2012-04-18,2012-04-01,2015-02-01,2015,2014-12-01,2014,2015-10-27,268,330,-17,1019,957,793,855,1812,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jaci.2017.01.043,28389393,https://pubmed.ncbi.nlm.nih.gov/28389393/,2017-04-04,journal publication,TRUE,TRUE,doi,Omalizumab is effective in cold urticaria-results of a randomized placebo-controlled trial,The Journal of allergy and clinical immunology,2017-09,2017-04-04,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,0,1,0,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,bronze,bronze,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2017-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-09-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01538355,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,FALSE,TRUE,TRUE,TRUE,Berlin,NA,A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis,large,Other,Interventional,Other,NA,48,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-02-15,2012-07-30,2020-06-23,2020,2013-02-28,2013,NA,NA,NA,166,3051,379,-629,2043,2422,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ebiom.2018.08.057,30292675,https://pubmed.ncbi.nlm.nih.gov/30292675/,2018-10-03,journal publication,TRUE,TRUE,doi,Ketogenic diets attenuate cyclooxygenase and lipoxygenase gene expression in multiple sclerosis,EBioMedicine,2018-Oct,2018-10-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,70,418,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,2352-3964,EBioMedicine,Elsevier BV,2018-10-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2310,16 +2310,16 @@ NCT01278537,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01266655,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Baclofen for the Treatment of Alcohol Dependence,large,Other,Interventional,Drug,Phase 2/Phase 3,56,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-23,2011-02-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,40,1225,1225,1594,1594,2819,2020-07-01,2020-09-01,2021-08-15,10.1016/j.euroneuro.2018.08.507,30217552,https://pubmed.ncbi.nlm.nih.gov/30217552/,2018-09-11,journal publication,TRUE,TRUE,doi,"Effects of high-dose baclofen on cue reactivity in alcohol dependence: A randomized, placebo-controlled pharmaco-fMRI study",European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2018-11,2018-09-11,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0924-977X,European Neuropsychopharmacology,Elsevier BV,2018-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01264549,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI),large,Other,Interventional,Device,NA,230,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2010-12-21,2010-12-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-20,1380,1380,936,936,2316,2020-07-01,2020-09-01,2021-08-15,10.3389/fneur.2017.00153,28484421,https://pubmed.ncbi.nlm.nih.gov/28484421/,2017-04-24,journal publication,TRUE,TRUE,doi,The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke,Frontiers in neurology,2017,2017-04-24,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1664-2295,Frontiers in Neurology,Frontiers Media SA,2017-04-24,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01225133,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Complex Āyurvedic Treatment in Osteoarthritis of the Knee Compared to Standard Care.,large,Other,Interventional,Other,Phase 3,150,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-10-06,2010-10-01,2015-03-01,2015,2014-07-01,2014,NA,NA,NA,-5,1607,1364,1074,1317,2681,2020-07-01,2020-09-01,2021-08-15,10.1016/j.joca.2018.01.022,29426006,https://pubmed.ncbi.nlm.nih.gov/29426006/,2018-02-07,journal publication,TRUE,TRUE,doi,Effectiveness of an Ayurveda treatment approach in knee osteoarthritis - a randomized controlled trial,Osteoarthritis and cartilage,2018-05,2018-02-07,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,1063-4584,Osteoarthritis and Cartilage,Elsevier BV,2018-05-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01181401,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,InductionChemo-Radio-Antibody-Treatment,large,Other,Interventional,Drug,Phase 2,94,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-12,2010-08-01,2015-08-01,2015,2015-04-01,2015,NA,NA,NA,-11,1815,1693,293,415,2108,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2016.34.15_suppl.6035,NA,https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.6035,2016-05-20,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,8,8,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01181401,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,InductionChemo-Radio-Antibody-Treatment,large,Other,Interventional,Drug,Phase 2,94,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-12,2010-08-01,2015-08-01,2015,2015-04-01,2015,NA,NA,NA,-11,1815,1693,293,415,2108,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2016.34.15_suppl.6035,NA,https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.6035,2016-05-20,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,8,8,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01143233,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up,large,Industry,Interventional,Other,NA,503,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2010-06-11,2010-04-01,2017-08-01,2017,2014-07-01,2014,NA,NA,NA,-71,2608,1481,273,1400,2881,2020-07-01,2020-09-01,2021-08-15,10.1097/mpg.0000000000001853,29216020,https://pubmed.ncbi.nlm.nih.gov/29216020/,2018-05-01,journal publication,TRUE,TRUE,doi,Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Noninferiority Trial,Journal of pediatric gastroenterology and nutrition,2018-05,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0277-2116,1536-4801",Journal of Pediatric Gastroenterology & Nutrition,Ovid Technologies (Wolters Kluwer Health),2018-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2019-05-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01117597,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects,large,Other,Interventional,Radiation,NA,32,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-05-04,2010-04-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-33,1581,1216,211,576,1792,2020-07-01,2020-09-01,2021-08-15,10.1016/j.envres.2015.03.021,25839715,https://pubmed.ncbi.nlm.nih.gov/25839715/,2015-03-31,journal publication,TRUE,TRUE,doi,"Do signals of a hand-held TETRA transmitter affect cognitive performance, well-being, mood or somatic complaints in healthy young men? Results of a randomized double-blind cross-over provocation study",Environmental research,2015-Jul,2015-03-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0013-9351,Environmental Research,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2017-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01117597,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects,large,Other,Interventional,Radiation,NA,32,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2010-05-04,2010-04-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-33,1581,1216,211,576,1792,2020-07-01,2020-09-01,2021-08-15,10.1016/j.envres.2015.03.021,25839715,https://pubmed.ncbi.nlm.nih.gov/25839715/,2015-03-31,journal publication,TRUE,TRUE,doi,"Do signals of a hand-held TETRA transmitter affect cognitive performance, well-being, mood or somatic complaints in healthy young men? Results of a randomized double-blind cross-over provocation study",Environmental research,2015-Jul,2015-03-31,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0013-9351,Environmental Research,Elsevier BV,2015-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2017-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01112579,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure,large,Industry,Interventional,Device,Phase 2,81,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2010-04-16,2010-04-01,2015-04-01,2015,2014-01-01,2014,2015-10-01,183,638,-15,1811,1356,618,1073,2429,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jchf.2015.10.006,26682789,https://pubmed.ncbi.nlm.nih.gov/26682789/,2016-12-09,journal publication,TRUE,TRUE,doi,Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study,JACC. Heart failure,2016-Feb,2015-12-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1980,2328,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,2213-1779,JACC: Heart Failure,Elsevier BV,2016-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01050686,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Need for Subcutaneous Wound Drains in Ileostomy Reversal,large,Other,Interventional,Procedure,NA,102,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-01-14,2010-03-01,2015-02-01,2015,2014-11-01,2014,NA,NA,NA,46,1844,1752,455,547,2299,2020-07-01,2020-09-01,2021-08-15,10.1007/s00423-016-1436-x,27138020,https://pubmed.ncbi.nlm.nih.gov/27138020/,2016-05-01,journal publication,TRUE,TRUE,doi,"Necessity of subcutaneous suction drains in ileostomy reversal (DRASTAR)-a randomized, controlled bi-centered trial",Langenbeck's archives of surgery,2016-Jun,2016-05-01,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1435-2443,1435-2451",Langenbeck's Archives of Surgery,Springer Science and Business Media LLC,2016-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01047891,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer,large,Other,Interventional,Drug,Phase 2,174,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-01-12,2010-01-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-11,1846,1846,1285,1285,3131,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(18)30372-3,30100379,https://pubmed.ncbi.nlm.nih.gov/30100379/,2018-08-09,journal publication,TRUE,TRUE,doi,"Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial",The Lancet. Oncology,2018-09,2018-08-09,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2018-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2019-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00942747,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma,large,Other,Interventional,Drug,Phase 2,37,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-07-20,2009-07-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-19,1777,1595,652,834,2429,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2015.64.9897,26976424,https://pubmed.ncbi.nlm.nih.gov/26976424/,2016-03-14,journal publication,TRUE,TRUE,doi,Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2016-05-20,2016-03-14,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,13,11,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,TRUE,TRUE,NA +NCT00942747,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma,large,Other,Interventional,Drug,Phase 2,37,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-07-20,2009-07-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-19,1777,1595,652,834,2429,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2015.64.9897,26976424,https://pubmed.ncbi.nlm.nih.gov/26976424/,2016-03-14,journal publication,TRUE,TRUE,doi,Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2016-05-20,2016-03-14,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,13,11,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2016-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-05-20,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT00865982,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer",large,Other,Interventional,Drug,Phase 2,50,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-19,2008-09-01,2015-09-01,2015,2014-09-01,2014,NA,NA,NA,-199,2357,1992,-1164,-799,1193,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mds129,22734012,https://pubmed.ncbi.nlm.nih.gov/22734012/,2012-06-24,journal publication,TRUE,TRUE,doi,"Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}",Annals of oncology : official journal of the European Society for Medical Oncology,2012-Nov,2012-06-24,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2012-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2013-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00841256,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children,large,Industry,Interventional,Biological,Phase 3,207,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-04-22,2008-02-01,2015-08-01,2015,2012-06-01,2012,NA,NA,NA,-81,2657,1501,-1067,89,1590,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jaci.2012.06.047,22939758,https://pubmed.ncbi.nlm.nih.gov/22939758/,2012-08-29,journal publication,TRUE,TRUE,doi,"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study",The Journal of allergy and clinical immunology,2012-Oct,2012-08-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2012-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00772655,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Zevalin® First Line in Follicular Lymphoma,large,Other,Interventional,Drug,Phase 2,60,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-10-14,2007-10-01,2015-06-01,2015,2010-06-01,2010,NA,NA,NA,-379,2421,595,-903,923,1518,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2011.41.1553,23233718,https://pubmed.ncbi.nlm.nih.gov/23233718/,2012-12-10,journal publication,TRUE,TRUE,doi,(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2013-Jan-20,2012-12-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-01-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-01-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00841256,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children,large,Industry,Interventional,Biological,Phase 3,207,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2008-04-22,2008-02-01,2015-08-01,2015,2012-06-01,2012,NA,NA,NA,-81,2657,1501,-1067,89,1590,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jaci.2012.06.047,22939758,https://pubmed.ncbi.nlm.nih.gov/22939758/,2012-08-29,journal publication,TRUE,TRUE,doi,"High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study",The Journal of allergy and clinical immunology,2012-Oct,2012-08-29,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0091-6749,Journal of Allergy and Clinical Immunology,Elsevier BV,2012-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00772655,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Zevalin® First Line in Follicular Lymphoma,large,Other,Interventional,Drug,Phase 2,60,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-10-14,2007-10-01,2015-06-01,2015,2010-06-01,2010,NA,NA,NA,-379,2421,595,-903,923,1518,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2011.41.1553,23233718,https://pubmed.ncbi.nlm.nih.gov/23233718/,2012-12-10,journal publication,TRUE,TRUE,doi,(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2013-Jan-20,2012-12-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2013-01-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-01-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00590447,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Risk Stratified Sequential Treatment for CD20-positive PTLD,large,Other,Interventional,Drug,Phase 2,152,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2007-12-28,2006-12-01,2015-07-01,2015,2014-12-01,2014,NA,NA,NA,-392,2742,2530,537,749,3279,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2016.69.3564,27992268,https://pubmed.ncbi.nlm.nih.gov/27992268/,2016-12-19,journal publication,TRUE,TRUE,doi,"Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2017-Feb-10,2016-12-19,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,2,2,1889,2237,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2017-02-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-02-10,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT00530738,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Safety and Efficacy of Longterm HPN With Two Lipid Emulsions,large,Industry,Interventional,Drug,Phase 4,42,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2007-09-14,2007-09-01,2014-01-01,2014,2014-01-01,2014,NA,NA,NA,-13,2301,2301,1794,1794,4095,2020-07-01,2020-09-01,2021-08-15,10.1186/s12937-018-0419-x,30501620,https://pubmed.ncbi.nlm.nih.gov/30501620/,2018-11-30,journal publication,TRUE,TRUE,doi,"Efficacy of a long-term home parenteral nutrition regimen containing fish oil-derived n-3 polyunsaturated fatty acids: a single-centre, randomized, double blind study",Nutrition journal,2018-11-30,2018-11-30,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1475-2891,Nutrition Journal,Springer Science and Business Media LLC,2018-11-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01703273,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Low-level Intervention for Adolescents With Extreme Obesity,large,Other,Interventional,Behavioral,NA,119,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-07,2012-07-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-37,846,846,982,982,1828,2020-07-01,2020-09-01,2021-08-15,10.1159/000475717,28787738,https://pubmed.ncbi.nlm.nih.gov/28787738/,2017-08-09,journal publication,TRUE,TRUE,doi,"A Structured, Manual-Based Low-Level Intervention vs. Treatment as Usual Evaluated in a Randomized Controlled Trial for Adolescents with Extreme Obesity - the STEREO Trial",Obesity facts,2017,2017-08-09,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,2,2,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"1662-4025,1662-4033",Obesity Facts,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2329,7 +2329,7 @@ NCT01471782,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01540383,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions,small,Other,Interventional,Behavioral,NA,156,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-02-06,2012-04-01,2015-01-01,2015,2015-01-01,2015,NA,NA,NA,55,1060,1060,835,835,1895,2020-07-01,2020-09-01,2021-08-15,10.1016/s0140-6736(17)30067-3,28256356,https://pubmed.ncbi.nlm.nih.gov/28256356/,2017-04-15,journal publication,TRUE,TRUE,doi,"Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting","Lancet (London, England)",2017-04-15,2017-03-01,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0140-6736,The Lancet,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT03584451,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Evaluation of the Effect of Rehabilitation Sport After Total Hip Arthroplasty (THA),small,Other,Interventional,Behavioral,NA,160,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2018-06-04,2015-02-01,2017-12-01,2017,2017-07-01,2017,NA,NA,NA,-1219,-185,-338,396,549,211,2020-07-01,2020-09-01,2021-08-15,10.3238/arztebl.2019.0001,30782304,https://www.aerzteblatt.de/archiv/204208/Sporttherapeutische-Massnahmen-nach-Huefttotalendoprothese,2019-01-01,journal publication,TRUE,TRUE,doi,Sports Therapy Interventions Following Total Hip Replacement,Deutsches Arzteblatt international,2019-01-07,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,1866-0452,Deutsches Aerzteblatt Online,Deutscher Arzte-Verlag GmbH,2019-01-07,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02834338,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Enhanced Perioperative Mobilization (EPM) Trial,small,Other,Interventional,Device,NA,110,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2016-06-15,2016-07-26,2017-07-20,2017,2017-07-20,2017,NA,NA,NA,41,400,400,445,445,845,2020-07-01,2020-09-01,2021-08-15,10.1007/s11605-018-3998-0,30298422,https://pubmed.ncbi.nlm.nih.gov/30298422/,2018-10-08,journal publication,TRUE,TRUE,doi,Use of Activity Tracking in Major Visceral Surgery-the Enhanced Perioperative Mobilization Trial: a Randomized Controlled Trial,Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,2019-06,2018-10-08,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1139,1487,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"1091-255X,1873-4626",Journal of Gastrointestinal Surgery,Springer Science and Business Media LLC,2018-10-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-10-08,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT02620553,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Primary Intervention With Mucosal Insulin,small,Other,Interventional,Drug,Phase 1/Phase 2,25,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-08,2007-09-01,2014-01-01,2014,2013-06-01,2013,NA,NA,NA,-2837,-523,-737,475,689,-48,2020-07-01,2020-09-01,2021-08-15,10.1001/jama.2015.2928,25898052,https://pubmed.ncbi.nlm.nih.gov/25898052/,2015-04-21,journal publication,TRUE,TRUE,doi,Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial,JAMA,2015-Apr-21,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,2,2,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2015-04-21,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2015-10-21,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT02620553,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Primary Intervention With Mucosal Insulin,small,Other,Interventional,Drug,Phase 1/Phase 2,25,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-08,2007-09-01,2014-01-01,2014,2013-06-01,2013,NA,NA,NA,-2837,-523,-737,475,689,-48,2020-07-01,2020-09-01,2021-08-15,10.1001/jama.2015.2928,25898052,https://pubmed.ncbi.nlm.nih.gov/25898052/,2015-04-21,journal publication,TRUE,TRUE,doi,Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial,JAMA,2015-Apr-21,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,0,0,2,2,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2015-04-21,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2015-10-21,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT02612220,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection,small,Other,Interventional,Procedure,NA,101,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2015-11-13,2015-12-03,2017-09-06,2017,2017-09-06,2017,NA,NA,NA,20,663,663,786,786,1449,2020-07-01,2020-09-01,2021-08-15,10.1016/j.hpb.2019.10.1529,31680010,https://pubmed.ncbi.nlm.nih.gov/31680010/,2019-11-01,journal publication,TRUE,TRUE,doi,Randomized clinical trial of BioFoam® Surgical Matrix to achieve hemostasis after liver resection,HPB : the official journal of the International Hepato Pancreato Biliary Association,2020-07,2019-11-01,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1091,1439,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1365-182X,HPB,Elsevier BV,2020-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2021-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02552589,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Effect of Toothpaste on the Reduction of Plaque and Inflammation,small,Other,Interventional,Other,NA,241,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2015-09-03,2015-09-01,2016-02-01,2016,2016-02-01,2016,NA,NA,NA,-2,151,151,1120,1120,1271,2020-07-01,2020-09-01,2021-08-15,10.1111/idh.12392,NA,https://onlinelibrary.wiley.com/doi/abs/10.1111/idh.12392,2019-02-25,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1601-5029,1601-5037",International Journal of Dental Hygiene,Wiley,2019-04-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2020-04-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02534285,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,the Impact of Noise on Requirements of Anesthetics During General Anesthesia,small,Other,Interventional,Device,NA,100,Completed,Triple,Randomized,TRUE,FALSE,TRUE,TRUE,2015-08-25,2015-08-01,2016-11-01,2016,2016-11-01,2016,2020-07-21,1358,1358,-24,434,434,1308,1308,1742,2020-07-01,2020-09-01,2021-08-15,10.19224/ai2020.196,NA,https://www.ai-online.info/archiv/2020/06-2020/laermabschirmung-senkt-nicht-den-desfluranbedarf-waehrend-allgemein-anaesthesien-fuehrt-aber-zu-einer-verminderung-von-bis-werten-60.html,2020-06-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1400,1748,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,unresolved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -2338,9 +2338,9 @@ NCT02138552,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT02137798,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Reduction of Fluoroscopy Exposure During Atrial Fibrillation Ablation,small,Other,Interventional,Device,NA,80,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-05-02,2014-03-01,2014-09-01,2014,2014-09-01,2014,NA,NA,NA,-62,122,122,260,260,382,2020-07-01,2020-09-01,2021-08-15,10.1016/j.hrthm.2015.05.018,26001508,https://pubmed.ncbi.nlm.nih.gov/26001508/,2015-05-19,journal publication,TRUE,TRUE,doi,"Reduction of radiation exposure during atrial fibrillation ablation using a novel fluoroscopy image integrated 3-dimensional electroanatomic mapping system: A prospective, randomized, single-blind, and controlled study",Heart rhythm,2015-Sep,2015-05-19,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1547-5271,Heart Rhythm,Elsevier BV,2015-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01954914,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Plerixafor as a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers,small,Other,Interventional,Drug,Phase 2,39,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2013-09-27,2013-12-01,2016-01-01,2016,2016-01-01,2016,NA,NA,NA,65,826,826,336,336,1162,2020-07-01,2020-09-01,2021-08-15,10.1182/blood.v128.22.3369.3369,NA,https://ashpublications.org/blood/article/128/22/3369/98213/Plerixafor-As-a-Salvage-Regimen-to-Mobilize,2016-12-02,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0006-4971,1528-0020",Blood,American Society of Hematology,2016-12-02,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2017-12-02,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT01442610,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease,small,Other,Interventional,Drug,Phase 4,30,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-23,2011-10-01,2015-09-01,2015,2015-03-01,2015,NA,NA,NA,8,1439,1255,132,316,1571,2020-07-01,2020-09-01,2021-08-15,10.1111/ene.13567,29322594,https://onlinelibrary.wiley.com/doi/abs/10.1111/ene.13567,2016-01-11,journal publication,TRUE,TRUE,doi,"Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial",European journal of neurology,2018-04,2018-02-27,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1351-5101,European Journal of Neurology,Wiley,2018-02-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-02-27,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01111448,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Temsirolimus in Myelodysplastic Syndrome (MDS),small,Other,Interventional,Drug,Phase 2,20,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-04-23,2010-04-01,2014-06-01,2014,2013-06-01,2013,NA,NA,NA,-22,1500,1135,-198,167,1302,2020-07-01,2020-09-01,2021-08-15,10.1182/blood.v122.21.2808.2808,NA,https://ashpublications.org/blood/article/122/21/2808/13453/Activity-Of-Single-Agent-Temsirolimus-and,2013-11-15,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-11-15,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-11-15,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT00893373,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age,small,Other,Interventional,Drug,Phase 2,276,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-05-04,2009-03-01,2014-09-01,2014,2011-11-01,2011,NA,NA,NA,-64,1946,911,431,1466,2377,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(15)00362-9,26549589,https://pubmed.ncbi.nlm.nih.gov/26549589/,2015-11-06,journal publication,TRUE,TRUE,doi,"Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial",The Lancet. Oncology,2015-Dec,2015-11-06,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-05-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00862511,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA),small,Other,Interventional,Device,NA,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-16,2009-03-01,2017-01-01,2017,2012-12-01,2012,NA,NA,NA,-15,2848,1356,-220,1272,2628,2020-07-01,2020-09-01,2021-08-15,10.3928/01477447-20160509-10,27219721,https://www.healio.com/orthopedics/journals/ortho/2016-5-39-3-supplemental/%7B690c5cdd-d69e-4f90-adcf-c896b76e81cf%7D/midterm-results-after-coated-and-uncoated-tka-a-randomized-controlled-study,2016-05-26,journal publication,TRUE,TRUE,doi,Midterm Results After Coated and Uncoated TKA: A Randomized Controlled Study,Orthopedics,2016-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1339,1687,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0147-7447,1938-2367",Orthopedics,"SLACK, Inc.",2016-05-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT01111448,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Temsirolimus in Myelodysplastic Syndrome (MDS),small,Other,Interventional,Drug,Phase 2,20,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-04-23,2010-04-01,2014-06-01,2014,2013-06-01,2013,NA,NA,NA,-22,1500,1135,-198,167,1302,2020-07-01,2020-09-01,2021-08-15,10.1182/blood.v122.21.2808.2808,NA,https://ashpublications.org/blood/article/122/21/2808/13453/Activity-Of-Single-Agent-Temsirolimus-and,2013-11-15,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-11-15,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-11-15,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00893373,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age,small,Other,Interventional,Drug,Phase 2,276,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-05-04,2009-03-01,2014-09-01,2014,2011-11-01,2011,NA,NA,NA,-64,1946,911,431,1466,2377,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(15)00362-9,26549589,https://pubmed.ncbi.nlm.nih.gov/26549589/,2015-11-06,journal publication,TRUE,TRUE,doi,"Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial",The Lancet. Oncology,2015-Dec,2015-11-06,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-05-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00862511,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Serum Metal Ion Concentration After Total Knee Arthroplasty (TKA),small,Other,Interventional,Device,NA,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-16,2009-03-01,2017-01-01,2017,2012-12-01,2012,NA,NA,NA,-15,2848,1356,-220,1272,2628,2020-07-01,2020-09-01,2021-08-15,10.3928/01477447-20160509-10,27219721,https://www.healio.com/orthopedics/journals/ortho/2016-5-39-3-supplemental/%7B690c5cdd-d69e-4f90-adcf-c896b76e81cf%7D/midterm-results-after-coated-and-uncoated-tka-a-randomized-controlled-study,2016-05-26,journal publication,TRUE,TRUE,doi,Midterm Results After Coated and Uncoated TKA: A Randomized Controlled Study,Orthopedics,2016-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1339,1687,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0147-7447,1938-2367",Orthopedics,"SLACK, Inc.",2016-05-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT02134470,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Diagnostic Relevance of Salivary Testosterone Concentrations in Doping Control.,small,Other,Interventional,Drug,NA,12,Unknown status,Single,NA,NA,FALSE,FALSE,FALSE,2014-05-06,2014-04-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-35,574,574,314,314,888,2020-07-01,2020-09-01,2021-08-15,10.1002/dta.2110,27723957,https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2110,2016-10-10,journal publication,TRUE,TRUE,doi,"Potential detection of low-dose transdermal testosterone administration in blood, urine, and saliva",Drug testing and analysis,2016-Nov,2016-11-09,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1942-7603,Drug Testing and Analysis,Wiley,2016-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02727140,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Yoga as a Supportive Therapy for Patients With Hypertension,large,Other,Interventional,Behavioral,NA,75,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2016-03-23,2016-05-01,2017-04-01,2017,2017-01-01,2017,NA,NA,NA,39,374,284,622,712,996,2020-07-01,2020-09-01,2021-08-15,10.3238/arztebl.2018.0833,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375068/,2018-12-14,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,1866-0452,Deutsches Aerzteblatt Online,Deutscher Arzte-Verlag GmbH,2018-12-14,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02420145,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Yoga for Abdominal Obesity,large,Other,Interventional,Behavioral,NA,60,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2015-04-09,2015-04-01,2015-08-01,2015,2015-08-01,2015,NA,NA,NA,-8,114,114,426,426,540,2020-07-01,2020-09-01,2021-08-15,10.3238/arztebl.2016.0645,27776622,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098025/,2016-09-30,journal publication,TRUE,TRUE,doi,Yoga in Women With Abdominal Obesityߞa Randomized Controlled Trial,Deutsches Arzteblatt international,2016-Sep-30,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,1866-0452,Deutsches Aerzteblatt Online,Deutscher Arzte-Verlag GmbH,2016-09-30,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -2350,7 +2350,7 @@ NCT02080299,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02043600,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Randomized-controlled Trial of Yoga for Ulcerative Colitis,large,Other,Interventional,Behavioral,NA,77,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2014-01-21,2014-02-01,2015-08-01,2015,2015-05-01,2015,NA,NA,NA,11,557,465,613,705,1170,2020-07-01,2020-09-01,2021-08-15,10.1111/apt.14062,28378342,https://pubmed.ncbi.nlm.nih.gov/28378342/,2017-04-05,journal publication,TRUE,TRUE,doi,Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis,Alimentary pharmacology & therapeutics,2017-06,2017-04-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0269-2813,Alimentary Pharmacology & Therapeutics,Wiley,2017-04-05,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02038244,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Integrative Medicine for Chronic Pain,large,Other,Interventional,Other,NA,300,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2014-01-09,2014-02-01,2015-03-01,2015,2014-09-01,2014,NA,NA,NA,23,416,235,495,676,911,2020-07-01,2020-09-01,2021-08-15,10.1097/md.0000000000004152,27399133,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058862/,2016-07-08,journal publication,TRUE,TRUE,doi,Integrative medicine for chronic pain: A cohort study using a process-outcome design in the context of a department for internal and integrative medicine,Medicine,2016-Jul,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,0025-7974,Medicine,Ovid Technologies (Wolters Kluwer Health),2016-07-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02027792,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Cabbage Leaf Wraps in Osteoarthritis of the Knee,large,Other,Interventional,Other,NA,81,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2014-01-03,2014-01-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,-2,210,210,823,823,1033,2020-07-01,2020-09-01,2021-08-15,10.1097/ajp.0000000000000352,26889617,https://pubmed.ncbi.nlm.nih.gov/26889617/,2016-11-01,journal publication,TRUE,TRUE,doi,Efficacy of Cabbage Leaf Wraps in the Treatment of Symptomatic Osteoarthritis of the Knee: A Randomized Controlled Trial,The Clinical journal of pain,2016-11,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0749-8047,The Clinical Journal of Pain,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01908270,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen Duisburg-Essen,NA,Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer,large,Other,Interventional,Behavioral,NA,40,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-07-23,2013-08-01,2014-02-01,2014,2013-11-01,2013,NA,NA,NA,9,193,101,396,488,589,2020-07-01,2020-09-01,2021-08-15,10.1002/cncr.29330,25739642,https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.29330,2015-03-04,journal publication,TRUE,TRUE,doi,Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial,Cancer,2015-Jul-01,2015-03-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2015-03-04,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01908270,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer,large,Other,Interventional,Behavioral,NA,40,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-07-23,2013-08-01,2014-02-01,2014,2013-11-01,2013,NA,NA,NA,9,193,101,396,488,589,2020-07-01,2020-09-01,2021-08-15,10.1002/cncr.29330,25739642,https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.29330,2015-03-04,journal publication,TRUE,TRUE,doi,Yoga and meditation for menopausal symptoms in breast cancer survivors-A randomized controlled trial,Cancer,2015-Jul-01,2015-03-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0008-543X,Cancer,Wiley,2015-03-04,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01735513,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Intraprocedural Intraaortic Embolic Protection With the EmbolX Device in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation,large,Other,Interventional,Device,NA,30,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2012-11-22,2012-07-01,2015-09-01,2015,2014-04-01,2014,NA,NA,NA,-144,1013,495,-31,487,982,2020-07-01,2020-09-01,2021-08-15,10.1016/j.athoracsur.2015.03.119,26234838,https://pubmed.ncbi.nlm.nih.gov/26234838/,2015-08-01,journal publication,TRUE,TRUE,doi,Intraaortic Protection From Embolization in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation,The Annals of thoracic surgery,2015-Aug,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4975,The Annals of Thoracic Surgery,Elsevier BV,2015-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01635634,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Cupping in Fibromyalgia,large,Other,Interventional,Other,NA,141,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-03,2012-06-01,2015-03-01,2015,2014-07-01,2014,NA,NA,NA,-32,971,728,627,870,1598,2020-07-01,2020-09-01,2021-08-15,10.1038/srep37316,27853272,https://pubmed.ncbi.nlm.nih.gov/27853272/,2016-11-17,journal publication,TRUE,TRUE,doi,Efficacy of cupping therapy in patients with the fibromyalgia syndrome-a randomised placebo controlled trial,Scientific reports,2016-11-17,2016-11-17,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2045-2322,Scientific Reports,Springer Science and Business Media LLC,2016-11-17,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01303952,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Duisburg-Essen,NA,Therapy of Chronic Cold Agglutinin Disease With Eculizumab,large,Other,Interventional,Drug,Phase 2,13,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2011-02-24,2011-01-01,2015-06-01,2015,2014-09-01,2014,NA,NA,NA,-54,1558,1285,1226,1499,2784,2020-07-01,2020-09-01,2021-08-15,10.1182/bloodadvances.2018024190,30291112,https://pubmed.ncbi.nlm.nih.gov/30291112/,2018-10-09,journal publication,TRUE,TRUE,doi,"Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial",Blood advances,2018-10-09,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,5,5,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"2473-9529,2473-9537",Blood Advances,American Society of Hematology,2018-10-05,no_embargo_info,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -2372,7 +2372,7 @@ NCT02149238,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01799005,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,FLAVIOLA Health Study,small,Other,Interventional,Dietary Supplement,NA,100,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-02-24,2013-02-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,-23,523,523,453,453,976,2020-07-01,2020-09-01,2021-08-15,10.1017/s0007114515002822,26348767,https://pubmed.ncbi.nlm.nih.gov/26348767/,2015-10-28,journal publication,TRUE,TRUE,doi,"Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study",The British journal of nutrition,2015-Oct-28,2015-09-09,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0007-1145,1475-2662",British Journal of Nutrition,Cambridge University Press (CUP),2015-09-09,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01655368,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Group Intervention for Improving Stigma Coping and Empowerment of People With Mental Illness (STEM),small,Other,Interventional,Behavioral,NA,486,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-06-14,2012-05-01,2015-06-01,2015,2015-06-01,2015,NA,NA,NA,-44,1082,1082,1565,1565,2647,2020-07-01,2020-09-01,2021-08-15,10.1007/s00406-019-01064-3,31520149,https://pubmed.ncbi.nlm.nih.gov/31520149/,2019-09-13,journal publication,TRUE,TRUE,doi,Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT,European archives of psychiatry and clinical neuroscience,2020-Aug,2019-09-13,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,39,25,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0940-1334,1433-8491",European Archives of Psychiatry and Clinical Neuroscience,Springer Science and Business Media LLC,2019-09-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2021-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01639781,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Age-dependent Effects of Flavanols on Vascular Status,small,Other,Interventional,Dietary Supplement,Phase 1,44,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-06-06,2011-11-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,-218,786,786,299,299,1085,2020-07-01,2020-09-01,2021-08-15,10.1007/s11357-015-9794-9,26013912,https://pubmed.ncbi.nlm.nih.gov/26013912/,2015-05-27,journal publication,TRUE,TRUE,doi,"Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial","Age (Dordrecht, Netherlands)",2015-Jun,2015-05-27,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0161-9152,1574-4647",AGE,Springer Science and Business Media LLC,2015-05-27,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT00847444,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf LMU-München Düsseldorf,NA,"Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention",small,Other,Interventional,Drug,Phase 3,3547,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2009-02-01,2016-09-01,2016,2011-09-01,2011,NA,NA,NA,-16,2753,926,131,1958,2884,2020-07-01,2020-09-01,2021-08-15,10.1016/j.clbc.2016.11.008,28190761,https://www.sciencedirect.com/science/article/abs/pii/S1526820916302579,2017-01-10,journal publication,TRUE,TRUE,doi,"Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer",Clinical breast cancer,2017-07,2017-01-10,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1526-8209,Clinical Breast Cancer,Elsevier BV,2017-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00847444,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf LMU-München,NA,"Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention",small,Other,Interventional,Drug,Phase 3,3547,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-02-17,2009-02-01,2016-09-01,2016,2011-09-01,2011,NA,NA,NA,-16,2753,926,131,1958,2884,2020-07-01,2020-09-01,2021-08-15,10.1016/j.clbc.2016.11.008,28190761,https://www.sciencedirect.com/science/article/abs/pii/S1526820916302579,2017-01-10,journal publication,TRUE,TRUE,doi,"Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer",Clinical breast cancer,2017-07,2017-01-10,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1526-8209,Clinical Breast Cancer,Elsevier BV,2017-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-07-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03268720,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Influence of the Immunosystem in Non-celiac Glutensensitivity,large,Other,Interventional,Other,NA,29,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2017-08-15,2014-04-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,-1232,-257,-257,489,489,232,2020-07-01,2020-09-01,2021-08-15,10.1016/j.clnu.2018.03.017,29653862,https://pubmed.ncbi.nlm.nih.gov/29653862/,2018-04-04,journal publication,TRUE,TRUE,doi,Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity,"Clinical nutrition (Edinburgh, Scotland)",2019-04,2018-04-04,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0261-5614,Clinical Nutrition,Elsevier BV,2019-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2020-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03012750,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Angiosome Perfusion After Tibial Bypass,large,Other,Interventional,Drug,Phase 2,40,Completed,NA,NA,NA,TRUE,FALSE,FALSE,2017-01-03,2015-02-01,2016-10-01,2016,2016-08-01,2016,NA,NA,NA,-702,-94,-155,459,520,365,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ejvs.2017.11.024,29305093,https://pubmed.ncbi.nlm.nih.gov/29305093/,2018-01-03,journal publication,TRUE,TRUE,doi,Pilot Assessment of the Angiosome Concept by Intra-operative Fluorescence Angiography After Tibial Bypass Surgery,European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,2018-02,2018-01-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1078-5884,European Journal of Vascular and Endovascular Surgery,Elsevier BV,2018-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02992236,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers,large,Industry,Interventional,Drug,Phase 1,16,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,TRUE,2016-12-07,2015-08-01,2016-11-01,2016,2016-05-01,2016,2019-03-21,870,1054,-494,-36,-220,849,1033,813,2020-07-01,2020-09-01,2021-08-15,10.1111/bcp.13870,30666700,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475696/,2019-02-28,journal publication,TRUE,TRUE,doi,Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers,British journal of clinical pharmacology,2019-05,2019-02-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1400,1748,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,bronze,green,"0306-5251,1365-2125",British Journal of Clinical Pharmacology,Wiley,2019-02-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2020-02-28,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -2419,9 +2419,9 @@ NCT01393067,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01279577,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease,large,Industry,Interventional,Drug,Phase 2,254,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-01-18,2010-11-01,2014-02-01,2014,2014-02-01,2014,NA,NA,NA,-78,1110,1110,977,977,2087,2020-07-01,2020-09-01,2021-08-15,10.1093/ecco-jcc/jjw184,27707789,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881737/,2016-10-05,journal publication,TRUE,TRUE,doi,"A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease",Journal of Crohn's & colitis,2017-Apr-01,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1873-9946,1876-4479",Journal of Crohn's and Colitis,Oxford University Press (OUP),2016-10-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01236807,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease,large,Other,Interventional,Procedure,NA,915,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-08,2010-12-01,2016-12-01,2016,2016-08-01,2016,NA,NA,NA,23,2215,2093,931,1053,3146,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1716734,31216398,https://pubmed.ncbi.nlm.nih.gov/31216398/,2019-06-20,journal publication,TRUE,TRUE,doi,Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease,The New England journal of medicine,2019-06-20,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2019-06-20,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2019-12-20,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01119469,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis,large,Other,Interventional,Behavioral,Phase 3,84,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-05-05,2010-06-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,27,1549,1549,136,136,1685,2020-07-01,2020-09-01,2021-08-15,10.1037/ccp0000013,25495359,https://pubmed.ncbi.nlm.nih.gov/25495359/,2014-12-15,journal publication,TRUE,TRUE,doi,Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): A randomized controlled trial,Journal of consulting and clinical psychology,2015-Aug,2014-12-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1939-2117,0022-006X",Journal of Consulting and Clinical Psychology,American Psychological Association (APA),2015-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,12,2016-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00849615,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,"Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction",large,Other,Interventional,Drug,Phase 2,252,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-02-23,2009-02-01,2016-01-01,2016,2012-01-01,2012,NA,NA,NA,-22,2503,1042,609,2070,3112,2020-07-01,2020-09-01,2021-08-15,10.1001/jamaoncol.2017.0515,28448662,https://pubmed.ncbi.nlm.nih.gov/28448662/,2017-09-01,journal publication,TRUE,TRUE,doi,Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial,JAMA oncology,2017-Sep-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,2374-2437,JAMA Oncology,American Medical Association (AMA),2017-09-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2018-03-01,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT02163863,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,BioMimics 3D Stent Clinical Investigation: The Mimics Study,large,Industry,Interventional,Device,NA,86,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-09,2010-02-01,2014-07-01,2014,2012-10-01,2012,NA,NA,NA,-1589,22,-616,701,1339,723,2020-07-01,2020-09-01,2021-08-15,10.1161/circinterventions.115.002930,27208046,https://pubmed.ncbi.nlm.nih.gov/27208046/,2016-06-01,journal publication,TRUE,TRUE,doi,Helical Centerline Stent Improves Patency: Two-Year Results From the Randomized Mimics Trial,Circulation. Cardiovascular interventions,2016-06,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01783639,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Leipzig Hamburg,NA,Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting,large,Industry,Interventional,Procedure,NA,120,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2013-01-13,2013-02-01,2015-04-01,2015,2013-12-01,2013,2015-06-08,68,554,19,808,322,709,1195,1517,2020-07-01,2020-09-01,2021-08-15,10.1161/circinterventions.116.004244,28283511,https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.116.004244,2017-03-10,journal publication,TRUE,TRUE,doi,Independent Modular Filter for Embolic Protection in Carotid Stenting,Circulation. Cardiovascular interventions,2017-Mar,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1980,2328,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00849615,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,"Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction",large,Other,Interventional,Drug,Phase 2,252,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-02-23,2009-02-01,2016-01-01,2016,2012-01-01,2012,NA,NA,NA,-22,2503,1042,609,2070,3112,2020-07-01,2020-09-01,2021-08-15,10.1001/jamaoncol.2017.0515,28448662,https://pubmed.ncbi.nlm.nih.gov/28448662/,2017-09-01,journal publication,TRUE,TRUE,doi,Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial,JAMA oncology,2017-Sep-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,2374-2437,JAMA Oncology,American Medical Association (AMA),2017-09-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2018-03-01,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT02163863,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,BioMimics 3D Stent Clinical Investigation: The Mimics Study,large,Industry,Interventional,Device,NA,86,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-06-09,2010-02-01,2014-07-01,2014,2012-10-01,2012,NA,NA,NA,-1589,22,-616,701,1339,723,2020-07-01,2020-09-01,2021-08-15,10.1161/circinterventions.115.002930,27208046,https://pubmed.ncbi.nlm.nih.gov/27208046/,2016-06-01,journal publication,TRUE,TRUE,doi,Helical Centerline Stent Improves Patency: Two-Year Results From the Randomized Mimics Trial,Circulation. Cardiovascular interventions,2016-06,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2016-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01783639,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Leipzig,NA,Safety and Performance Evaluation of WIRION™ EPD in Patients Undergoing Carotid Artery Stenting,large,Industry,Interventional,Procedure,NA,120,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2013-01-13,2013-02-01,2015-04-01,2015,2013-12-01,2013,2015-06-08,68,554,19,808,322,709,1195,1517,2020-07-01,2020-09-01,2021-08-15,10.1161/circinterventions.116.004244,28283511,https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.116.004244,2017-03-10,journal publication,TRUE,TRUE,doi,Independent Modular Filter for Embolic Protection in Carotid Stenting,Circulation. Cardiovascular interventions,2017-Mar,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1980,2328,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02142231,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt LMU-München,NA,AcuTA: Acupuncture in Test Anxiety,large,Other,Interventional,Device,NA,25,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2014-04-24,2014-04-01,2014-06-01,2014,2014-06-01,2014,NA,NA,NA,-23,38,38,1551,1551,1589,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0202659,30161153,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116988/,2018-08-30,journal publication,TRUE,TRUE,doi,Effects of single-point acupuncture (HT7) in the prevention of test anxiety: Results of a RCT,PloS one,2018,2018-08-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2018-08-30,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01466179,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt Würzburg,NA,Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL),large,Industry,Interventional,Biological,Phase 2,225,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2011-10-28,2011-12-01,2017-01-01,2017,2013-10-01,2013,2014-12-21,-742,446,34,1892,704,-747,441,1145,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(14)71170-2,25524800,https://pubmed.ncbi.nlm.nih.gov/25524800/,2014-12-16,journal publication,TRUE,TRUE,doi,"Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study",The Lancet. Oncology,2015-Jan,2014-12-16,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,5,5,1339,1687,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-06-30,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01067703,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt Schleswig-Holstein,NA,Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study),large,Other,Interventional,Procedure,Phase 3,1400,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-02-10,2010-12-01,2015-05-01,2015,2014-05-01,2014,NA,NA,NA,294,1906,1541,157,522,2063,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1413579,26436208,https://pubmed.ncbi.nlm.nih.gov/26436208/,2015-10-05,journal publication,TRUE,TRUE,doi,A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery,The New England journal of medicine,2015-Oct-08,2015-10-05,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-10-08,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-04-08,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2430,7 +2430,7 @@ NCT02503293,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT02369848,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg Leipzig,NA,Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2),large,Industry,Interventional,Device,NA,60,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2015-02-09,2015-06-01,2016-12-01,2016,2015-12-01,2015,2017-10-05,308,674,112,661,295,724,1090,1385,2020-07-01,2020-09-01,2021-08-15,10.1002/ccd.27943,30474206,https://onlinelibrary.wiley.com/doi/10.1002/ccd.27943,2018-11-25,journal publication,TRUE,TRUE,doi,"Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II",Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2019-02-01,2018-11-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"1522-1946,1522-726X",Catheterization and Cardiovascular Interventions,Wiley,2018-11-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2020-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02134457,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity,large,Other,Interventional,Biological,Phase 2,19,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2014-04-26,2014-08-01,2017-01-01,2017,2017-01-01,2017,NA,NA,NA,97,981,981,424,424,1405,2020-07-01,2020-09-01,2021-08-15,10.1001/jamapediatrics.2017.4838,29309486,https://pubmed.ncbi.nlm.nih.gov/29309486/,2018-03-01,journal publication,TRUE,TRUE,doi,Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial,JAMA pediatrics,2018-03-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,1,1,1339,1687,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,2168-6203,JAMA Pediatrics,American Medical Association (AMA),2018-03-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2018-08-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01967355,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis,large,Other,Interventional,Other,NA,6,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-07-26,2013-04-01,2014-05-08,2014,2014-05-08,2014,NA,NA,NA,-116,286,286,1434,1434,1720,2020-07-01,2020-09-01,2021-08-15,10.1016/j.preghy.2018.04.007,29858106,https://pubmed.ncbi.nlm.nih.gov/29858106/,2018-04-11,journal publication,TRUE,TRUE,doi,Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P.) apheresis: The Freiburg preeclampsia H.E.L.P.-Apheresis study,Pregnancy hypertension,2018-Apr,2018-04-11,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2308,2656,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,2210-7789,Pregnancy Hypertension,Elsevier BV,2018-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01924962,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries,large,Other,Interventional,Device,NA,205,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-15,2008-05-28,2017-06-16,2017,2016-08-14,2016,NA,NA,NA,-1905,1401,1095,479,785,1880,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2018.05.041,30219327,https://www.sciencedirect.com/science/article/pii/S1936879818312111,2018-10-08,journal publication,TRUE,TRUE,doi,A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC Trial,JACC. Cardiovascular interventions,2018-10-08,2018-09-12,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1173,1521,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2018-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01924962,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries,large,Other,Interventional,Device,NA,205,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-15,2008-05-28,2017-06-16,2017,2016-08-14,2016,NA,NA,NA,-1905,1401,1095,479,785,1880,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2018.05.041,30219327,https://www.sciencedirect.com/science/article/pii/S1936879818312111,2018-10-08,journal publication,TRUE,TRUE,doi,A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC Trial,JACC. Cardiovascular interventions,2018-10-08,2018-09-12,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1173,1521,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2018-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01867736,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries,large,Industry,Interventional,Device,NA,72,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2013-05-27,2012-07-01,2014-07-01,2014,2014-01-01,2014,NA,NA,NA,-330,400,219,457,638,857,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2015.07.011,26493253,https://www.sciencedirect.com/science/article/pii/S1936879815011395,2015-10-01,journal publication,TRUE,TRUE,doi,Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries),JACC. Cardiovascular interventions,2015-Oct,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2015-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01853384,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers,large,Industry,Interventional,Biological,Phase 3,252,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,TRUE,2013-05-08,2013-11-01,2015-02-01,2015,2014-12-01,2014,2016-09-19,596,658,177,634,572,1004,1066,1638,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jvsv.2017.06.017,29037354,https://pubmed.ncbi.nlm.nih.gov/29037354/,2017-11-01,journal publication,TRUE,TRUE,doi,Baseline factors affecting closure of venous leg ulcers,Journal of vascular surgery. Venous and lymphatic disorders,2017-11,NA,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,2,0,0,1,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,closed,closed,2213-333X,Journal of Vascular Surgery: Venous and Lymphatic Disorders,Elsevier BV,2017-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01789918,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg Duisburg-Essen Schleswig-Holstein Homburg,NA,TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE),large,Industry,Interventional,Device,NA,96,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-02-08,2013-01-09,2016-03-01,2016,2016-03-01,2016,NA,NA,NA,-30,1117,1117,1279,1279,2396,2020-07-01,2020-09-01,2021-08-15,10.1097/hjh.0000000000002120,31045964,https://pubmed.ncbi.nlm.nih.gov/31045964/,2019-09-01,journal publication,TRUE,TRUE,doi,Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study,Journal of hypertension,2019-09,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0263-6352,Journal of Hypertension,Ovid Technologies (Wolters Kluwer Health),2019-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2440,7 +2440,7 @@ NCT01011920,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT00867672,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia,large,Other,Interventional,Drug,Phase 2,204,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2009-03-23,2011-08-01,2016-02-01,2016,2015-02-01,2015,NA,NA,NA,861,2506,2141,1401,1766,3907,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.19.01053,31794324,https://pubmed.ncbi.nlm.nih.gov/31794324/,2019-12-03,journal publication,TRUE,TRUE,doi,"Valproate and Retinoic Acid in Combination With Decitabine in Elderly Nonfit Patients With Acute Myeloid Leukemia: Results of a Multicenter, Randomized, 2 × 2, Phase II Trial",Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2020-01-20,2019-12-03,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,2,2,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2020-01-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2021-01-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT00810472,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Functional Antigen Matching in Corneal Transplantation,large,Other,Interventional,Other,NA,650,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-17,2009-09-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,258,2326,2326,1078,1078,3404,2020-07-01,2020-09-01,2021-08-15,10.3238/arztebl.2018.0259,29735006,https://pubmed.ncbi.nlm.nih.gov/29735006/,2018-04-13,journal publication,TRUE,TRUE,doi,Rejection Prophylaxis in Corneal Transplant,Deutsches Arzteblatt international,2018-04-13,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,14,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,1866-0452,Deutsches Aerzteblatt Online,Deutscher Arzte-Verlag GmbH,2018-04-13,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00697333,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC,large,Other,Interventional,Procedure,Phase 2,200,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-06-11,2009-05-01,2017-05-01,2017,2016-11-01,2016,NA,NA,NA,324,3246,3065,1046,1227,4292,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(20)30013-9,32171429,https://pubmed.ncbi.nlm.nih.gov/32171429/,2020-03-12,journal publication,TRUE,TRUE,doi,"Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial",The Lancet. Oncology,2020-04,2020-03-12,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,14,14,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2020-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2020-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00970437,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Hamburg Freiburg Hamburg,NA,A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression,large,Other,Interventional,Behavioral,NA,268,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-09-01,2010-04-01,2014-12-01,2014,2013-10-01,2013,NA,NA,NA,212,1917,1491,821,1247,2738,2020-07-01,2020-09-01,2021-08-15,10.1001/jamapsychiatry.2016.3880,28146251,https://pubmed.ncbi.nlm.nih.gov/28146251/,2017-03-01,journal publication,TRUE,TRUE,doi,Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial,JAMA psychiatry,2017-Mar-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,2168-622X,JAMA Psychiatry,American Medical Association (AMA),2017-03-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-08-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT00970437,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Hamburg,NA,A Comparison of Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and System of Supportive Psychotherapy (SYSP) for Early Onset Chronic Depression,large,Other,Interventional,Behavioral,NA,268,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-09-01,2010-04-01,2014-12-01,2014,2013-10-01,2013,NA,NA,NA,212,1917,1491,821,1247,2738,2020-07-01,2020-09-01,2021-08-15,10.1001/jamapsychiatry.2016.3880,28146251,https://pubmed.ncbi.nlm.nih.gov/28146251/,2017-03-01,journal publication,TRUE,TRUE,doi,Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial,JAMA psychiatry,2017-Mar-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,2168-622X,JAMA Psychiatry,American Medical Association (AMA),2017-03-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-08-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT00941733,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg Leipzig,NA,Study of IN.PACT Amphirion™ Drug Eluting Balloon vs. Standard PTA for the Treatment of Below the Knee Critical Limb Ischemia,large,Industry,Interventional,Device,NA,358,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2009-07-16,2009-09-01,2017-11-30,2017,2013-08-01,2013,2014-08-29,-1189,393,47,3059,1477,-1143,439,1916,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2014.06.1198,25301459,https://pubmed.ncbi.nlm.nih.gov/25301459/,2014-10-14,journal publication,TRUE,TRUE,doi,Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial,Journal of the American College of Cardiology,2014-Oct-14,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1006,1354,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2014-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01135745,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg Schleswig-Holstein,NA,Deep Brain Stimulation for Obsessive Compulsive Disorder (OCD PMCF),large,Industry,Interventional,Device,Phase 4,32,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-05-05,2010-04-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,-34,1822,1822,1642,1642,3464,2020-07-01,2020-09-01,2021-08-15,10.1038/s41380-019-0562-6,31664175,https://www.nature.com/articles/s41380-019-0562-6,2019-10-29,journal publication,TRUE,TRUE,doi,A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive-compulsive disorder,Molecular psychiatry,2021-04,2019-10-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1359-4184,1476-5578",Molecular Psychiatry,Springer Science and Business Media LLC,2019-10-29,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT03753841,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,FEES to Determine Neurological Intensive Care Patients' Oral Diet,small,Other,Interventional,Other,NA,125,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2018-11-16,2014-01-14,2016-09-16,2016,2016-09-03,2016,NA,NA,NA,-1767,-791,-804,1295,1308,504,2020-07-01,2020-09-01,2021-08-15,10.1080/17549507.2020.1744727,32245331,https://pubmed.ncbi.nlm.nih.gov/32245331/,2020-04-03,journal publication,TRUE,TRUE,doi,Flexible endoscopic evaluation of swallowing (FEES) to determine neurological intensive care patients' oral diet,International journal of speech-language pathology,2021-Feb,2020-04-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1446,1794,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"1754-9507,1754-9515",International Journal of Speech-Language Pathology,Informa UK Limited,2020-04-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2021-04-03,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2457,7 +2457,7 @@ NCT02054299,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01776112,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Enhancing Synaptic Plasticity and Cognition in Schizophrenia,small,Other,Interventional,Other,NA,66,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2012-01-01,2011-01-01,2014-08-01,2014,2014-03-01,2014,NA,NA,NA,-365,943,790,-1642,-1489,-699,2020-07-01,2020-09-01,2021-08-15,10.1001/archgenpsychiatry.2009.193,20124113,https://pubmed.ncbi.nlm.nih.gov/20124113/,2010-02-01,journal publication,TRUE,TRUE,doi,Hippocampal plasticity in response to exercise in schizophrenia,Archives of general psychiatry,2010-Feb,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0003-990X,Archives of General Psychiatry,American Medical Association (AMA),2010-02-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2010-07-31,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01488955,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Immediate vs. Conditional Use of Antibiotics in Uncomplicated Urinary Tract Infection (UTI) - ICUTI,small,Other,Interventional,Drug,Phase 4,494,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-07,2012-02-01,2014-07-01,2014,2014-02-01,2014,NA,NA,NA,56,937,787,540,690,1477,2020-07-01,2020-09-01,2021-08-15,10.1136/bmj.h6544,26698878,https://pubmed.ncbi.nlm.nih.gov/26698878/,2015-12-23,journal publication,TRUE,TRUE,doi,Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial,BMJ (Clinical research ed.),2015-Dec-23,2015-12-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1756-1833,BMJ,BMJ,2015-12-23,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00725231,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP,small,Other,Interventional,Biological,Phase 3,274,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2008-07-25,2008-02-01,2014-03-01,2014,2014-03-01,2014,NA,NA,NA,-175,2045,2045,2259,2259,4304,2020-07-01,2020-09-01,2021-08-15,10.1038/s41375-020-0838-5,32382083,https://www.nature.com/articles/s41375-020-0838-5,2020-05-07,journal publication,TRUE,TRUE,doi,Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial,Leukemia,2021-01,2020-05-07,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,green,green,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2020-05-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2021-05-07,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00639743,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Göttingen Göttingen,NA,PEITHO Pulmonary Embolism Thrombolysis Study,small,Other,Interventional,Drug,Phase 3,1005,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-03-13,2007-11-16,2014-11-01,2014,2012-07-26,2012,NA,NA,NA,-118,2424,1596,878,1706,3302,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2016.12.039,28335835,https://pubmed.ncbi.nlm.nih.gov/28335835/,2017-03-28,journal publication,TRUE,TRUE,doi,Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism,Journal of the American College of Cardiology,2017-Mar-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00639743,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Göttingen,NA,PEITHO Pulmonary Embolism Thrombolysis Study,small,Other,Interventional,Drug,Phase 3,1005,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2008-03-13,2007-11-16,2014-11-01,2014,2012-07-26,2012,NA,NA,NA,-118,2424,1596,878,1706,3302,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2016.12.039,28335835,https://pubmed.ncbi.nlm.nih.gov/28335835/,2017-03-28,journal publication,TRUE,TRUE,doi,Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism,Journal of the American College of Cardiology,2017-Mar-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-03-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00865969,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen Halle-Wittenberg Mainz Marburg Ulm,NA,Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma,large,Industry,Interventional,Drug,Phase 2,129,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-19,2008-12-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-108,2022,2022,264,264,2286,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2014.59.2782,26101246,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087312/,2015-06-22,journal publication,TRUE,TRUE,doi,Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2015-Aug-10,2015-06-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2015-08-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-08-10,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT01855035,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Göttingen Mainz,NA,Finding Atrial Fibrillation in Stroke - Evaluation of Enhanced and Prolonged Holter Monitoring,large,Other,Interventional,Other,NA,402,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2013-05-07,2013-05-01,2017-11-01,2017,2017-09-01,2017,NA,NA,NA,-6,1639,1578,-266,-205,1373,2020-07-01,2020-09-01,2021-08-15,10.1016/s1474-4422(17)30002-9,28187920,https://pubmed.ncbi.nlm.nih.gov/28187920/,2017-02-08,journal publication,TRUE,TRUE,doi,Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial,The Lancet. Neurology,2017-Apr,2017-02-08,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,7,7,1035,1383,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1474-4422,The Lancet Neurology,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03093584,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Auricular Stimulation vs. Expressive Writing for Exam Anxiety,small,Other,Interventional,Device,NA,37,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2017-03-23,2014-04-01,2014-07-01,2014,2014-07-01,2014,NA,NA,NA,-1087,-996,-996,2249,2249,1253,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0238307,32853281,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451547/,2020-08-27,journal publication,TRUE,TRUE,doi,Auricular stimulation vs. expressive writing for exam anxiety in medical students - A randomized crossover investigation,PloS one,2020,2020-08-27,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2020-08-27,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2468,8 +2468,8 @@ NCT02670265,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02656966,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Auricular Acupuncture for Treatment of Preoperative Anxiety,small,Other,Interventional,Device,Phase 2,42,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2016-01-12,2015-12-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,-42,110,110,799,799,909,2020-07-01,2020-09-01,2021-08-15,10.1136/acupmed-2017-011456,29986900,https://pubmed.ncbi.nlm.nih.gov/29986900/,2018-07-09,journal publication,TRUE,TRUE,doi,Auricular acupuncture for treatment of preoperative anxiety in patients scheduled for ambulatory gynaecological surgery: a prospective controlled investigation with a non-randomised arm,Acupuncture in medicine : journal of the British Medical Acupuncture Society,2018-08,2018-07-09,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0964-5284,1759-9873",Acupuncture in Medicine,SAGE Publications,2018-08-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT02494830,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,"Single Dose Administration of Ketamine 10, 20, 40 and 80 mg and 5 mg Solution for Infusion in 15 Healthy Subjects",small,Other,Interventional,Drug,Phase 1,15,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-07,2014-08-01,2014-10-01,2014,2014-09-01,2014,NA,NA,NA,-340,-279,-309,1112,1142,833,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://epub.ub.uni-greifswald.de/frontdoor/deliver/index/docId/1997/file/diss_Hasan_Mahmoud.pdf,2017-10-17,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01803789,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Single Versus Double Kirschner Wires for Intramedullary Fixation of Metacarpal V Fractures,small,Other,Interventional,Device,NA,292,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2013-03-01,2013-05-01,2017-07-01,2017,2017-06-01,2017,NA,NA,NA,61,1583,1553,822,852,2405,2020-07-01,2020-09-01,2021-08-15,10.1302/0301-620x.101b10.bjj-2019-0410.r1,31564142,https://pubmed.ncbi.nlm.nih.gov/31564142/,2019-10-01,journal publication,TRUE,TRUE,doi,Single versus dual Kirschner wires for closed reduction and intramedullary nailing of displaced fractures of the fifth metacarpal neck (1-2 KiWi): a randomized controlled trial,The bone & joint journal,2019-10,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1158,1506,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"2049-4394,2049-4408",The Bone & Joint Journal,British Editorial Society of Bone & Joint Surgery,2019-10-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT01797458,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth,small,Other,Interventional,Procedure,NA,169,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2013-02-20,2011-05-01,2014-12-01,2014,2013-12-01,2013,2017-05-16,897,1262,-661,649,284,1115,1480,1764,2020-07-01,2020-09-01,2021-08-15,10.1159/000477855,29258064,https://pubmed.ncbi.nlm.nih.gov/29258064/,2017-12-20,journal publication,TRUE,TRUE,doi,Alternative Caries Management Options for Primary Molars: 2.5-Year Outcomes of a Randomised Clinical Trial,Caries research,2017,2017-12-20,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2101,2449,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,green,green,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01657305,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12),small,Industry,Interventional,Drug,Phase 3,107,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2012-07-29,2012-08-01,2014-09-01,2014,2013-08-01,2013,2015-09-24,388,784,3,764,368,950,1346,1714,2020-07-01,2020-09-01,2021-08-15,10.1016/j.burns.2017.03.005,28400148,https://www.sciencedirect.com/science/article/pii/S0305417917301493,2017-04-08,journal publication,TRUE,TRUE,doi,Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program,Burns : journal of the International Society for Burn Injuries,2017-Sep,2017-04-08,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,2,2,1,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,hybrid,hybrid,0305-4179,Burns,Elsevier BV,2017-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01797458,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,European Study on Three Different Approaches to Managing Class 2 Cavities in Primary Teeth,small,Other,Interventional,Procedure,NA,169,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2013-02-20,2011-05-01,2014-12-01,2014,2013-12-01,2013,2017-05-16,897,1262,-661,649,284,1115,1480,1764,2020-07-01,2020-09-01,2021-08-15,10.1159/000477855,29258064,https://pubmed.ncbi.nlm.nih.gov/29258064/,2017-12-20,journal publication,TRUE,TRUE,doi,Alternative Caries Management Options for Primary Molars: 2.5-Year Outcomes of a Randomised Clinical Trial,Caries research,2017,2017-12-20,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2101,2449,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,green,green,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01657305,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSH-12),small,Industry,Interventional,Drug,Phase 3,107,Completed,Single,Randomized,TRUE,TRUE,TRUE,TRUE,2012-07-29,2012-08-01,2014-09-01,2014,2013-08-01,2013,2015-09-24,388,784,3,764,368,950,1346,1714,2020-07-01,2020-09-01,2021-08-15,10.1016/j.burns.2017.03.005,28400148,https://www.sciencedirect.com/science/article/pii/S0305417917301493,2017-04-08,journal publication,TRUE,TRUE,doi,Accelerated re-epithelialization of partial-thickness skin wounds by a topical betulin gel: Results of a randomized phase III clinical trials program,Burns : journal of the International Society for Burn Injuries,2017-Sep,2017-04-08,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,2,2,1,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,hybrid,hybrid,0305-4179,Burns,Elsevier BV,2017-09-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01291693,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Testing Delivery Channels of Brief Motivational Alcohol Intervention,small,Other,Interventional,Behavioral,Phase 2/Phase 3,975,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-02-04,2011-02-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,-3,1366,1366,1066,1066,2432,2020-07-01,2020-09-01,2021-08-15,10.1037/hea0000556,28967769,https://pubmed.ncbi.nlm.nih.gov/28967769/,2017-10-02,journal publication,TRUE,TRUE,doi,In-person alcohol counseling versus computer-generated feedback: Results from a randomized controlled trial,"Health psychology : official journal of the Division of Health Psychology, American Psychological Association",2018-01,2017-10-02,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1930-7810,0278-6133",Health Psychology,American Psychological Association (APA),2018-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,12,2019-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02596594,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Intraumbilical Amino Acids and Glucose Supplementation Via Port by Severe IUGR in Human Fetuses,small,Other,Interventional,Device,NA,14,Completed,Single,Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-10-12,2010-01-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-2110,-559,-559,869,869,310,2020-07-01,2020-09-01,2021-08-15,10.1515/jpm-2016-0155,27533115,https://www.degruyter.com/view/journals/jpme/45/2/article-p227.xml,2016-08-17,journal publication,TRUE,TRUE,doi,The effect of intraumbilical fetal nutrition via a subcutaneously implanted port system on amino acid concentration by severe IUGR human fetuses,Journal of perinatal medicine,2017-Feb-01,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"1619-3997,0300-5577",Journal of Perinatal Medicine,Walter de Gruyter GmbH,2017-01-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-01-01,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02295462,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial,small,Other,Interventional,Other,NA,1158,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2014-11-12,2014-12-01,2017-02-01,2017,2017-02-01,2017,NA,NA,NA,19,812,812,755,755,1567,2020-07-01,2020-09-01,2021-08-15,10.1093/ageing/afz016,30806453,https://academic.oup.com/ageing/article/48/3/419/5365248,2019-02-26,journal publication,TRUE,TRUE,doi,Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): a cluster-randomised controlled trial,Age and ageing,2019-05-01,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1308,1656,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0002-0729,1468-2834",Age and Ageing,Oxford University Press (OUP),2019-02-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -2478,7 +2478,7 @@ NCT02251470,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT02084381,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,PERCI- Medium Cut Off (MCO),small,Industry,Interventional,Device,NA,50,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2014-02-07,2014-02-01,2015-02-01,2015,2014-07-01,2014,NA,NA,NA,-6,359,144,712,927,1071,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0169024,28085888,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234772/,2017-01-13,journal publication,TRUE,TRUE,doi,Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial,PloS one,2017,2017-01-13,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2017-01-13,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01651832,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Supportive Cancer Care Networkers (SCAN),small,Other,Interventional,Behavioral,NA,261,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2012-07-25,2012-07-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-24,1224,1224,-334,-334,890,2020-07-01,2020-09-01,2021-08-15,10.1016/j.zefq.2014.06.012,26028456,https://zefq-journal.com/article/S1865921714001330/abstract,2015-01-01,journal publication,TRUE,TRUE,doi,[Trans-sectoral care for patients with colorectal cancer: Design of a prospective randomized controlled multi-center trial (FKZ 01GY1143)],"Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen",2015,2014-08-28,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1865-9217,"Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen",Elsevier BV,2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01200121,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers,small,Other,Interventional,Drug,Phase 2,53,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2010-09-09,2010-02-01,2014-12-01,2014,2014-08-01,2014,NA,NA,NA,-220,1544,1422,562,684,2106,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ejca.2016.05.004,27314448,https://www.sciencedirect.com/science/article/abs/pii/S0959804916321268,2016-06-15,journal publication,TRUE,TRUE,doi,"Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108","European journal of cancer (Oxford, England : 1990)",2016-08,2016-06-15,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0959-8049,European Journal of Cancer,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01148264,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis,small,Other,Interventional,Drug,Phase 2,23,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-06-21,2010-07-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,10,1563,1198,624,989,2187,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://d-nb.info/1117028305/34,2016-06-16,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01148264,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis,small,Other,Interventional,Drug,Phase 2,23,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-06-21,2010-07-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,10,1563,1198,624,989,2187,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://d-nb.info/1117028305/34,2016-06-16,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01203228,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Hamburg Heidelberg Schleswig-Holstein Köln Leipzig Münster,NA,Dose-reduced Versus Standard Conditioning in MDS/sAML,large,Other,Interventional,Other,Phase 3,129,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-09-15,2004-05-01,2015-02-01,2015,2015-01-01,2015,NA,NA,NA,-2328,1600,1569,821,852,2421,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2016.70.7349,28463633,https://ascopubs.org/doi/full/10.1200/JCO.2016.70.7349,2017-05-02,journal publication,TRUE,TRUE,doi,Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial),Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2017-Jul-01,2017-05-02,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,2,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2017-07-01,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-07-01,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT02637778,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Modulation of Cardiovascular Risk Factors by the Diet,small,Other,Interventional,Dietary Supplement,NA,60,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2015-12-15,2016-02-01,2016-11-01,2016,2016-06-01,2016,NA,NA,NA,48,322,169,1217,1370,1539,2020-07-01,2020-09-01,2021-08-15,10.3390/nu12030676,32131476,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146433/,2020-03-02,journal publication,TRUE,TRUE,doi,Functional Biomarkers for the Selenium Status in a Human Nutritional Intervention Study,Nutrients,2020-Mar-02,2020-03-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,2072-6643,Nutrients,MDPI AG,2020-03-02,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01789567,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Leipzig TU-München,NA,Engager Direct Aortic Clinical Study,large,Industry,Interventional,Device,NA,20,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2013-02-06,2013-05-01,2015-06-01,2015,2014-07-01,2014,2016-09-06,463,798,84,845,510,-237,98,608,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2014.05.014,25129672,https://www.jacc.org/doi/full/10.1016/j.jcin.2014.05.014?utm_campaign=JACC%253A_Cardiovascular_Interventions_TrendMD_1&utm_medium=cpc&utm_source=TrendMD,2014-10-07,journal publication,TRUE,TRUE,doi,Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation,JACC. Cardiovascular interventions,2014-Oct,2014-08-13,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,1919,2267,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2014-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -2500,7 +2500,7 @@ NCT02044913,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT02005237,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain Connectivity,large,Other,Interventional,Behavioral,NA,68,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2013-12-03,2013-12-01,2016-11-01,2016,2016-05-01,2016,NA,NA,NA,-2,1064,880,771,955,1835,2020-07-01,2020-09-01,2021-08-15,10.7717/peerj.6037,30581662,https://peerj.com/articles/6037/,2018-12-12,journal publication,TRUE,TRUE,doi,Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial,PeerJ,2018,2018-12-12,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,2167-8359,PeerJ,PeerJ,2018-12-12,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01994928,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High-flow Nasal Cannula Oxygen.,large,Other,Interventional,Device,NA,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-11-20,2013-11-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,-19,346,346,584,584,930,2020-07-01,2020-09-01,2021-08-15,10.4187/respcare.04413,27274092,https://pubmed.ncbi.nlm.nih.gov/27274092/,2016-06-07,journal publication,TRUE,TRUE,doi,High-Flow Nasal Cannula Versus Bag-Valve-Mask for Preoxygenation Before Intubation in Subjects With Hypoxemic Respiratory Failure,Respiratory care,2016-Sep,2016-06-07,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0020-1324,1943-3654",Respiratory Care,Daedalus Enterprises,2016-06-07,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01900327,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Neoadjuvant Treatment in Resectable Pancreatic Cancer,large,Other,Interventional,Radiation,Phase 3,32,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2013-06-27,2014-02-01,2017-07-01,2017,2016-11-22,2016,NA,NA,NA,219,1465,1244,-1120,-899,345,2020-07-01,2020-09-01,2021-08-15,10.1186/1471-2407-14-411,24906700,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057592/,2014-06-07,journal publication,TRUE,TRUE,doi,"Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)",BMC cancer,2014-Jun-07,2014-06-07,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,2,2,4,0,1,1,1158,1506,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2014-06-07,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01879111,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback,large,Other,Interventional,Other,NA,4151,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-06-12,2011-10-01,2014-05-01,2014,2013-10-01,2013,NA,NA,NA,-620,323,111,1342,1554,1665,2020-07-01,2020-09-01,2021-08-15,10.1192/bjp.bp.116.184168,27908896,https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/depression-screening-with-patienttargeted-feedback-in-cardiology-depscreeninfo-randomised-clinical-trial/51576167758C2532B495D52DCE083DAA,2018-01-02,journal publication,TRUE,TRUE,doi,Depression screening with patient-targeted feedback in cardiology: DEPSCREEN-INFO randomised clinical trial,The British journal of psychiatry : the journal of mental science,2017-02,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,1,1,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2017-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-07-31,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01879111,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback,large,Other,Interventional,Other,NA,4151,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-06-12,2011-10-01,2014-05-01,2014,2013-10-01,2013,NA,NA,NA,-620,323,111,1342,1554,1665,2020-07-01,2020-09-01,2021-08-15,10.1192/bjp.bp.116.184168,27908896,https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/depression-screening-with-patienttargeted-feedback-in-cardiology-depscreeninfo-randomised-clinical-trial/51576167758C2532B495D52DCE083DAA,2018-01-02,journal publication,TRUE,TRUE,doi,Depression screening with patient-targeted feedback in cardiology: DEPSCREEN-INFO randomised clinical trial,The British journal of psychiatry : the journal of mental science,2017-02,2016-12-01,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,1,1,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2017-02-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2017-07-31,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01797484,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia,large,Other,Interventional,Drug,Phase 2/Phase 3,20,Completed,Single,Randomized,TRUE,FALSE,TRUE,TRUE,2013-02-20,2013-08-01,2015-06-01,2015,2015-06-01,2015,2016-04-25,329,329,162,831,831,1119,1119,1950,2020-07-01,2020-09-01,2021-08-15,10.1177/1074248418784290,29938533,https://journals.sagepub.com/doi/10.1177/1074248418784290,2018-06-24,journal publication,TRUE,TRUE,doi,Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial,Journal of cardiovascular pharmacology and therapeutics,2019-01,2018-06-24,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,19,19,1919,2267,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,closed,closed,"1074-2484,1940-4034",Journal of Cardiovascular Pharmacology and Therapeutics,SAGE Publications,2018-06-24,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01784367,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Extracorporeal Lung Assist to Avoid Intubation in Patients Failing NIV for Hypercapnic ARF,large,Other,Interventional,Device,NA,30,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-01-30,2012-12-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-60,791,791,481,481,1272,2020-07-01,2020-09-01,2021-08-15,10.1007/s00134-016-4452-y,27456703,https://pubmed.ncbi.nlm.nih.gov/27456703/,2016-07-25,journal publication,TRUE,TRUE,doi,The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study,Intensive care medicine,2016-Sep,2016-07-25,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0342-4642,1432-1238",Intensive Care Medicine,Springer Science and Business Media LLC,2016-07-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-07-25,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01770990,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Trial of Telephone-based Psychotherapy for Depression With and Without Adjunctive Supportive Mail,large,Other,Interventional,Behavioral,NA,59,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-01-08,2012-09-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-129,813,813,1799,1799,2612,2020-07-01,2020-09-01,2021-08-15,10.1089/tmj.2018.0311,31013466,https://www.liebertpub.com/doi/abs/10.1089/tmj.2018.0311,2020-03-04,journal publication,TRUE,TRUE,doi,Effectiveness of Telephone-Administered Cognitive-Behavioral Psychotherapy for Depression With Versus Without Additional Letters: A Randomized Controlled Trial,Telemedicine journal and e-health : the official journal of the American Telemedicine Association,2020-03,2019-04-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1530-5627,1556-3669",Telemedicine and e-Health,Mary Ann Liebert Inc,2020-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2021-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2508,7 +2508,7 @@ NCT01767181,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01731717,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Cluster Randomized Trial of Stepped Care Intervention vs. Treatment as Usual for Patients With Depression,large,Other,Interventional,Behavioral,NA,737,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-11-12,2012-09-01,2015-05-01,2015,2015-03-01,2015,NA,NA,NA,-72,900,839,1946,2007,2846,2020-07-01,2020-09-01,2021-08-15,10.1186/s12888-020-02829-0,32859177,https://pubmed.ncbi.nlm.nih.gov/32859177/,2020-08-28,journal publication,TRUE,TRUE,doi,Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial,BMC psychiatry,2020-08-28,2020-08-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,1471-244X,BMC Psychiatry,Springer Science and Business Media LLC,2020-08-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01726387,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,"Self-Management for Anxiety, Depression and Somatoform Disorders",large,Other,Interventional,Behavioral,NA,364,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-11-03,2013-03-01,2015-09-01,2015,2015-09-01,2015,NA,NA,NA,118,1032,1032,355,355,1387,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ijnurstu.2016.08.007,27611093,https://pubmed.ncbi.nlm.nih.gov/27611093/,2016-08-21,journal publication,TRUE,TRUE,doi,"Collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: Cluster-randomised controlled trial (findings of the SMADS study)",International journal of nursing studies,2016-Nov,2016-08-21,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,14,8,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0020-7489,International Journal of Nursing Studies,Elsevier BV,2016-11-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01683240,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones,large,Other,Interventional,Device,NA,59,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-07-06,2011-02-01,2016-02-01,2016,2016-02-01,2016,NA,NA,NA,-521,1305,1305,380,380,1685,2020-07-01,2020-09-01,2021-08-15,10.1016/s1499-3872(16)60170-4,28119264,https://www.sciencedirect.com/science/article/abs/pii/S1499387216601704,2017-02-15,journal publication,TRUE,TRUE,doi,Prospective evaluation of the short access cholangioscopy for stone clearance and evaluation of indeterminate strictures,Hepatobiliary & pancreatic diseases international : HBPD INT,2017-Feb,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,24,24,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1499-3872,Hepatobiliary & Pancreatic Diseases International,Elsevier BV,2017-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01663649,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders,large,Other,Interventional,Behavioral,NA,180,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-08,2012-06-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,-68,542,480,291,353,833,2020-07-01,2020-09-01,2021-08-15,10.1111/epi.12833,25410633,https://pubmed.ncbi.nlm.nih.gov/25410633/,2014-11-19,journal publication,TRUE,TRUE,doi,Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial,Epilepsia,2014-Dec,2014-11-19,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0013-9580,Epilepsia,Wiley,2014-11-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01663649,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders,large,Other,Interventional,Behavioral,NA,180,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-08-08,2012-06-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,-68,542,480,291,353,833,2020-07-01,2020-09-01,2021-08-15,10.1111/epi.12833,25410633,https://pubmed.ncbi.nlm.nih.gov/25410633/,2014-11-19,journal publication,TRUE,TRUE,doi,Efficacy of a psychological online intervention for depression in people with epilepsy: a randomized controlled trial,Epilepsia,2014-Dec,2014-11-19,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,0013-9580,Epilepsia,Wiley,2014-11-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01580124,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study,large,Other,Interventional,Procedure,NA,150,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-04-16,2010-11-01,2015-02-01,2015,2014-02-01,2014,NA,NA,NA,-532,1021,656,324,689,1345,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2015.09.088,26700836,https://pubmed.ncbi.nlm.nih.gov/26700836/,2015-12-22,journal publication,TRUE,TRUE,doi,Pulmonary Vein Isolation Versus Defragmentation: The CHASE-AF Clinical Trial,Journal of the American College of Cardiology,2015-Dec-22,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01450124,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,"Safety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)",large,Other,Interventional,Drug,Phase 2,29,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2011-09-18,2011-09-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-17,1170,1170,1111,1111,2281,2020-07-01,2020-09-01,2021-08-15,10.1136/jnnp-2017-317101,29248894,https://jnnp.bmj.com/content/89/4/330,2017-12-16,journal publication,TRUE,TRUE,doi,A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial),"Journal of neurology, neurosurgery, and psychiatry",2018-04,2017-12-16,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0022-3050,1468-330X","Journal of Neurology, Neurosurgery & Psychiatry",BMJ,2017-12-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01417949,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events,large,Other,Interventional,Other,Phase 4,61,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-08-10,2011-08-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,-9,1360,1360,1659,1659,3019,2020-07-01,2020-09-01,2021-08-15,10.1186/s12981-019-0250-2,31729999,https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-019-0250-2,2019-11-15,journal publication,TRUE,TRUE,doi,"Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)",AIDS research and therapy,2019-11-15,2019-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1742-6405,AIDS Research and Therapy,Springer Science and Business Media LLC,2019-11-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2532,7 +2532,7 @@ NCT01755507,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01731158,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Sequential Therapy in Metastatic Renal Cell Carinoma,large,Other,Interventional,Drug,Phase 2,22,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-09-28,2012-10-01,2016-09-01,2016,2016-09-01,2016,NA,NA,NA,3,1434,1434,-133,-133,1301,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0153018,27101285,https://pubmed.ncbi.nlm.nih.gov/27101285/,2016-04-21,journal publication,TRUE,TRUE,doi,Circulating Tumor Cell Composition in Renal Cell Carcinoma,PloS one,2016,2016-04-21,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2016-04-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01694849,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH),large,Industry,Interventional,Drug,Phase 2,270,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2012-09-24,2012-09-01,2015-12-01,2015,2015-02-01,2015,NA,NA,NA,-23,1163,860,72,375,1235,2020-07-01,2020-09-01,2021-08-15,10.1053/j.gastro.2016.01.038,26874076,https://pubmed.ncbi.nlm.nih.gov/26874076/,2016-02-11,journal publication,TRUE,TRUE,doi,"Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening",Gastroenterology,2016-05,2016-02-11,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0016-5085,Gastroenterology,Elsevier BV,2016-05-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01630434,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation,large,Industry,Interventional,Device,NA,316,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-06-25,2011-11-01,2016-04-01,2016,2014-09-01,2014,NA,NA,NA,-237,1376,798,738,1316,2114,2020-07-01,2020-09-01,2021-08-15,10.1016/s2213-2600(18)30136-x,29650408,https://pubmed.ncbi.nlm.nih.gov/29650408/,2018-04-09,journal publication,TRUE,TRUE,doi,"Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study",The Lancet. Respiratory medicine,2018-05,2018-04-09,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,2213-2600,The Lancet Respiratory Medicine,Elsevier BV,2018-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2018-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01534702,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML,large,Other,Interventional,Drug,Phase 1/Phase 2,60,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-02-14,2012-01-01,2015-09-01,2015,2013-04-01,2013,NA,NA,NA,-44,1295,412,1155,2038,2450,2020-07-01,2020-09-01,2021-08-15,10.1111/bjh.15546,30378121,https://pubmed.ncbi.nlm.nih.gov/30378121/,2018-10-30,journal publication,TRUE,TRUE,doi,Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial),British journal of haematology,2018-10,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0007-1048,British Journal of Haematology,Wiley,2018-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01534702,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML,large,Other,Interventional,Drug,Phase 1/Phase 2,60,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-02-14,2012-01-01,2015-09-01,2015,2013-04-01,2013,NA,NA,NA,-44,1295,412,1155,2038,2450,2020-07-01,2020-09-01,2021-08-15,10.1111/bjh.15546,30378121,https://pubmed.ncbi.nlm.nih.gov/30378121/,2018-10-30,journal publication,TRUE,TRUE,doi,Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial),British journal of haematology,2018-10,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0007-1048,British Journal of Haematology,Wiley,2018-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01475669,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery,large,Industry,Interventional,Biological,Phase 3,152,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-11-17,2012-01-01,2014-09-01,2014,2014-07-01,2014,NA,NA,NA,45,1019,957,1199,1261,2218,2020-07-01,2020-09-01,2021-08-15,10.1093/bja/aew169,27317703,https://pubmed.ncbi.nlm.nih.gov/27317703/,2017-12-13,journal publication,TRUE,TRUE,doi,Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy,British journal of anaesthesia,2016-07,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0007-0912,British Journal of Anaesthesia,Elsevier BV,2016-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01445171,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve,large,Industry,Interventional,Device,NA,295,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2011-08-05,2010-01-01,2017-12-01,2017,2017-12-01,2017,2020-01-15,775,775,-581,2310,2310,-1880,-1880,430,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jtcvs.2012.07.108,23058665,https://pubmed.ncbi.nlm.nih.gov/23058665/,2012-10-08,journal publication,TRUE,TRUE,doi,One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve System,The Journal of thoracic and cardiovascular surgery,2013-Jan,2012-10-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1005,1353,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,bronze,bronze,0022-5223,The Journal of Thoracic and Cardiovascular Surgery,Elsevier BV,2013-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01420744,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP,large,Industry,Interventional,Drug,Phase 2,160,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-08-19,2011-08-01,2015-04-01,2015,2015-02-01,2015,NA,NA,NA,-18,1321,1262,1104,1163,2425,2020-07-01,2020-09-01,2021-08-15,10.1007/s00134-018-5143-7,29632995,https://pubmed.ncbi.nlm.nih.gov/29632995/,2018-04-09,journal publication,TRUE,TRUE,doi,"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)",Intensive care medicine,2018-04,2018-04-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0342-4642,1432-1238",Intensive Care Medicine,Springer Science and Business Media LLC,2018-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -2540,9 +2540,9 @@ NCT01320254,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01242631,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer,large,Other,Interventional,Drug,Phase 2,25,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-11-16,2010-11-01,2014-03-01,2014,2014-03-01,2014,NA,NA,NA,-15,1201,1201,1663,1663,2864,2020-07-01,2020-09-01,2021-08-15,10.1007/s00432-018-2752-z,30232558,https://pubmed.ncbi.nlm.nih.gov/30232558/,2018-09-19,journal publication,TRUE,TRUE,doi,"Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group",Journal of cancer research and clinical oncology,2019-Mar,2018-09-19,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0171-5216,1432-1335",Journal of Cancer Research and Clinical Oncology,Springer Science and Business Media LLC,2018-09-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-09-19,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00998556,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Effect of Bromocriptine on Left Ventricular Function in Women With Peripartum Cardiomyopathy,large,Other,Interventional,Drug,Phase 2,64,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-19,2010-06-01,2016-08-01,2016,2016-03-01,2016,NA,NA,NA,225,2478,2325,360,513,2838,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehx355,28934837,https://pubmed.ncbi.nlm.nih.gov/28934837/,2017-07-27,journal publication,TRUE,TRUE,doi,Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study,European heart journal,2017-Sep-14,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2017-07-27,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00932971,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis,large,Other,Interventional,Drug,Phase 2,70,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2009-07-03,2009-06-01,2017-08-02,2017,2017-08-01,2017,NA,NA,NA,-32,2952,2951,574,575,3526,2020-07-01,2020-09-01,2021-08-15,10.1016/s1473-3099(18)30663-7,30833068,https://pubmed.ncbi.nlm.nih.gov/30833068/,2019-02-27,journal publication,TRUE,TRUE,doi,"Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial",The Lancet. Infectious diseases,2019-03,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,2,1,8,8,1126,1474,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1473-3099,The Lancet Infectious Diseases,Elsevier BV,2019-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2019-08-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00860730,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,PERCEVAL Pivotal Trial,large,Industry,Interventional,Device,NA,150,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-11,2009-01-01,2015-10-01,2015,2009-10-01,2009,NA,NA,NA,-69,2395,204,-1254,937,1141,2020-07-01,2020-09-01,2021-08-15,10.1016/j.athoracsur.2012.01.071,22541180,https://pubmed.ncbi.nlm.nih.gov/22541180/,2012-04-25,journal publication,TRUE,TRUE,doi,Sutureless perceval aortic valve replacement: results of two European centers,The Annals of thoracic surgery,2012-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4975,The Annals of Thoracic Surgery,Elsevier BV,2012-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00781807,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Rehabilitation and Outcome for Patients on LVAD Support,large,Other,Interventional,Other,NA,80,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-10-28,2008-11-01,2014-04-01,2014,2013-10-01,2013,NA,NA,NA,4,1981,1799,-649,-467,1332,2020-07-01,2020-09-01,2021-08-15,10.1093/ejcts/ezs206,22723614,https://pubmed.ncbi.nlm.nih.gov/22723614/,2012-06-21,journal publication,TRUE,TRUE,doi,"A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support",European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2012-Dec,2012-06-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1010-7940,1873-734X",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2012-06-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2013-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00111345,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Münster Hannover Münster,NA,Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents,large,Other,Interventional,Drug,Phase 2/Phase 3,550,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-05-19,2004-03-01,2017-03-01,2017,2012-03-01,2012,NA,NA,NA,-444,4304,2478,-1378,448,2926,2020-07-01,2020-09-01,2021-08-15,10.1182/blood-2013-02-484097,23704089,https://pubmed.ncbi.nlm.nih.gov/23704089/,2013-05-23,journal publication,TRUE,TRUE,doi,Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004,Blood,2013-Jul-04,2013-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,6,6,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-07-04,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-07-04,TRUE,TRUE,TRUE,TRUE,TRUE,NA +NCT00860730,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,PERCEVAL Pivotal Trial,large,Industry,Interventional,Device,NA,150,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-03-11,2009-01-01,2015-10-01,2015,2009-10-01,2009,NA,NA,NA,-69,2395,204,-1254,937,1141,2020-07-01,2020-09-01,2021-08-15,10.1016/j.athoracsur.2012.01.071,22541180,https://pubmed.ncbi.nlm.nih.gov/22541180/,2012-04-25,journal publication,TRUE,TRUE,doi,Sutureless perceval aortic valve replacement: results of two European centers,The Annals of thoracic surgery,2012-May,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4975,The Annals of Thoracic Surgery,Elsevier BV,2012-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2013-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00781807,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Rehabilitation and Outcome for Patients on LVAD Support,large,Other,Interventional,Other,NA,80,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-10-28,2008-11-01,2014-04-01,2014,2013-10-01,2013,NA,NA,NA,4,1981,1799,-649,-467,1332,2020-07-01,2020-09-01,2021-08-15,10.1093/ejcts/ezs206,22723614,https://pubmed.ncbi.nlm.nih.gov/22723614/,2012-06-21,journal publication,TRUE,TRUE,doi,"A multi-modal intervention in management of left ventricular assist device outpatients: dietary counselling, controlled exercise and psychosocial support",European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2012-Dec,2012-06-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1010-7940,1873-734X",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2012-06-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2013-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00111345,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Münster,NA,Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents,large,Other,Interventional,Drug,Phase 2/Phase 3,550,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-05-19,2004-03-01,2017-03-01,2017,2012-03-01,2012,NA,NA,NA,-444,4304,2478,-1378,448,2926,2020-07-01,2020-09-01,2021-08-15,10.1182/blood-2013-02-484097,23704089,https://pubmed.ncbi.nlm.nih.gov/23704089/,2013-05-23,journal publication,TRUE,TRUE,doi,Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004,Blood,2013-Jul-04,2013-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,1,6,6,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2013-07-04,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2014-07-04,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT03789448,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Early Access to ART for All in Swaziland: Effects on Economic Outcomes,large,Other,Interventional,Other,NA,3019,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2018-12-16,2014-09-01,2017-08-31,2017,2017-08-31,2017,NA,NA,NA,-1567,-472,-472,1089,1089,617,2020-07-01,2020-09-01,2021-08-15,10.7554/elife.58487,NA,https://elifesciences.org/articles/58487,2020-08-24,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,3,3,1097,1445,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,2050-084X,eLife,"eLife Sciences Publications, Ltd",2020-08-24,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT03013322,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Anticholium® Per Se,large,Other,Interventional,Drug,NA,20,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2017-01-01,2015-01-28,2017-02-18,2017,2017-02-18,2017,NA,NA,NA,-704,48,48,780,780,828,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcrc.2019.04.012,31035187,https://pubmed.ncbi.nlm.nih.gov/31035187/,2019-04-09,journal publication,TRUE,TRUE,doi,"Effect of physostigmine on recovery from septic shock following intra-abdominal infection - Results from a randomized, double-blind, placebo-controlled, monocentric pilot trial (Anticholium® per Se)",Journal of critical care,2019-08,2019-04-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,3,3,1291,1639,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,0883-9441,Journal of Critical Care,Elsevier BV,2019-08-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02976532,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Controlling Femoral Derotation Osteotomy With Electromagnetic Tracking,large,Other,Interventional,Other,NA,20,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2016-11-15,2013-07-01,2017-10-01,2017,2017-07-01,2017,NA,NA,NA,-1233,320,228,-131,-39,189,2020-07-01,2020-09-01,2021-08-15,10.1002/jor.23579,28419537,https://pubmed.ncbi.nlm.nih.gov/28419537/,2017-05-23,journal publication,TRUE,TRUE,doi,Electromagnetic tracking for femoral derotation osteotomy-an in vivo study,Journal of orthopaedic research : official publication of the Orthopaedic Research Society,2017-12,2017-05-23,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0736-0266,Journal of Orthopaedic Research,Wiley,2017-05-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-05-23,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -2571,20 +2571,20 @@ NCT01620710,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01619657,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis,large,Other,Interventional,Drug,Phase 2,42,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2012-06-12,2012-06-01,2017-10-01,2017,2016-11-01,2016,NA,NA,NA,-11,1937,1603,588,922,2525,2020-07-01,2020-09-01,2021-08-15,10.1164/rccm.201807-1203oc,30409023,https://pubmed.ncbi.nlm.nih.gov/30409023/,2019-05-12,journal publication,TRUE,TRUE,doi,"Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study",American journal of respiratory and critical care medicine,2019-05-15,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"1073-449X,1535-4970",American Journal of Respiratory and Critical Care Medicine,American Thoracic Society,2019-05-15,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01498835,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma,large,Other,Interventional,Drug,Phase 1,9,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2011-12-21,2012-02-01,2015-02-01,2015,2014-11-01,2014,NA,NA,NA,42,1138,1046,488,580,1626,2020-07-01,2020-09-01,2021-08-15,10.1186/s13014-016-0654-2,27255678,https://pubmed.ncbi.nlm.nih.gov/27255678/,2016-06-03,journal publication,TRUE,TRUE,doi,Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03),"Radiation oncology (London, England)",2016-Jun-03,2016-06-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,2,2,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1748-717X,Radiation Oncology,Springer Science and Business Media LLC,2016-06-03,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01486329,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer",large,Industry,Interventional,Biological,Phase 1,72,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-12-02,2011-12-01,2014-12-01,2014,2014-10-01,2014,NA,NA,NA,-1,1095,1034,147,208,1242,2020-07-01,2020-09-01,2021-08-15,10.1080/2162402x.2014.1001217,26137397,https://pubmed.ncbi.nlm.nih.gov/26137397/,2015-04-27,journal publication,TRUE,TRUE,doi,"Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial",Oncoimmunology,2015-Apr,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2162-402X,OncoImmunology,Informa UK Limited,2015-03-16,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01468766,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy,large,Other,Interventional,Other,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-11,2011-02-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,-252,994,629,35,400,1029,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdu374,25096607,https://pubmed.ncbi.nlm.nih.gov/25096607/,2014-08-05,journal publication,TRUE,TRUE,doi,"Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life",Annals of oncology : official journal of the European Society for Medical Oncology,2014-Nov,2014-08-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2014-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01468766,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy,large,Other,Interventional,Other,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-10-11,2011-02-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,-252,994,629,35,400,1029,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdu374,25096607,https://pubmed.ncbi.nlm.nih.gov/25096607/,2014-08-05,journal publication,TRUE,TRUE,doi,"Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life",Annals of oncology : official journal of the European Society for Medical Oncology,2014-Nov,2014-08-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2014-11-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01422499,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Vorinostat in Children,large,Other,Interventional,Drug,Phase 1/Phase 2,50,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2011-08-03,2012-03-01,2017-03-24,2017,2017-03-24,2017,NA,NA,NA,211,2060,2060,991,991,3051,2020-07-01,2020-09-01,2021-08-15,10.1186/s13148-019-0775-1,31823832,https://pubmed.ncbi.nlm.nih.gov/31823832/,2019-12-10,journal publication,TRUE,TRUE,doi,"Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia",Clinical epigenetics,2019-12-10,2019-12-10,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1257,1605,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,"1868-7075,1868-7083",Clinical Epigenetics,Springer Science and Business Media LLC,2019-12-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01409824,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Health Care Intervention Research- Improving Pre-natal and Maternal Care,large,Other,Interventional,Other,NA,36,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-08-03,2009-05-01,2014-04-01,2014,2010-09-01,2010,NA,NA,NA,-824,972,-336,-356,952,616,2020-07-01,2020-09-01,2021-08-15,10.1186/1472-6947-13-44,23574764,https://pubmed.ncbi.nlm.nih.gov/23574764/,2013-04-10,journal publication,TRUE,TRUE,doi,"""Quality of prenatal and maternal care: bridging the know-do gap"" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa",BMC medical informatics and decision making,2013-Apr-10,2013-04-10,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1472-6947,BMC Medical Informatics and Decision Making,Springer Science and Business Media LLC,2013-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01409824,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Health Care Intervention Research- Improving Pre-natal and Maternal Care,large,Other,Interventional,Other,NA,36,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-08-03,2009-05-01,2014-04-01,2014,2010-09-01,2010,NA,NA,NA,-824,972,-336,-356,952,616,2020-07-01,2020-09-01,2021-08-15,10.1186/1472-6947-13-44,23574764,https://pubmed.ncbi.nlm.nih.gov/23574764/,2013-04-10,journal publication,TRUE,TRUE,doi,"""Quality of prenatal and maternal care: bridging the know-do gap"" (QUALMAT study): an electronic clinical decision support system for rural Sub-Saharan Africa",BMC medical informatics and decision making,2013-Apr-10,2013-04-10,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1472-6947,BMC Medical Informatics and Decision Making,Springer Science and Business Media LLC,2013-04-10,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01301430,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.,large,Industry,Interventional,Drug,Phase 1/Phase 2,18,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-02-21,2011-09-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,192,1530,1530,846,846,2376,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ymthe.2017.08.016,28967558,https://pubmed.ncbi.nlm.nih.gov/28967558/,2017-08-24,journal publication,TRUE,TRUE,doi,Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial,Molecular therapy : the journal of the American Society of Gene Therapy,2017-Dec-06,2017-08-24,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,6,6,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,1525-0016,Molecular Therapy,Elsevier BV,2017-12-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01238770,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer,large,Other,Interventional,Drug,Phase 1/Phase 2,10,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2010-11-10,2010-11-01,2015-10-01,2015,2014-10-01,2014,NA,NA,NA,-9,1786,1421,596,961,2382,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ygyno.2017.05.013,28528917,https://pubmed.ncbi.nlm.nih.gov/28528917/,2017-05-19,journal publication,TRUE,TRUE,doi,"Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial",Gynecologic oncology,2017-08,2017-05-19,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0090-8258,Gynecologic Oncology,Elsevier BV,2017-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01216696,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Ipilimumab in Patients With Advanced Melanoma and Spontaneous Preexisting Immune Response to NY-ESO-1,large,Other,Interventional,Drug,Phase 2,25,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-09-27,2010-11-01,2016-08-01,2016,2016-08-01,2016,NA,NA,NA,35,2135,2135,522,522,2657,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ejca.2017.12.001,29306769,https://pubmed.ncbi.nlm.nih.gov/29306769/,2018-01-05,journal publication,TRUE,TRUE,doi,Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1,"European journal of cancer (Oxford, England : 1990)",2018-02,2018-01-05,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0959-8049,European Journal of Cancer,Elsevier BV,2018-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01192087,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy",large,Other,Interventional,Drug,Phase 1/Phase 2,49,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-08-30,2012-06-01,2017-07-01,2017,2015-07-01,2015,NA,NA,NA,641,2497,1766,824,1555,3321,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ijrobp.2019.09.036,31586664,https://pubmed.ncbi.nlm.nih.gov/31586664/,2019-10-03,journal publication,TRUE,TRUE,doi,The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck,"International journal of radiation oncology, biology, physics",2020-01-01,2019-10-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,54,54,1158,1506,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,0360-3016,International Journal of Radiation Oncology*Biology*Physics,Elsevier BV,2020-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2021-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01180504,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer,large,Other,Interventional,Radiation,Phase 2,36,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2016-08-01,2016,2013-08-01,2013,NA,NA,NA,-10,2182,1086,1176,2272,3358,2020-07-01,2020-09-01,2021-08-15,10.1186/s13014-019-1381-2,31639066,https://pubmed.ncbi.nlm.nih.gov/31639066/,2019-10-21,journal publication,TRUE,TRUE,doi,Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study,"Radiation oncology (London, England)",2019-Oct-21,2019-10-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1748-717X,Radiation Oncology,Springer Science and Business Media LLC,2019-10-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01106820,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life,large,Other,Interventional,Other,NA,101,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2010-04-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,-13,1631,1266,76,441,1707,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.29383,25484317,https://pubmed.ncbi.nlm.nih.gov/25484317/,2014-12-16,journal publication,TRUE,TRUE,doi,Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial,International journal of cancer,2015-Jul-15,2014-12-16,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2014-12-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01180504,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer,large,Other,Interventional,Radiation,Phase 2,36,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2016-08-01,2016,2013-08-01,2013,NA,NA,NA,-10,2182,1086,1176,2272,3358,2020-07-01,2020-09-01,2021-08-15,10.1186/s13014-019-1381-2,31639066,https://pubmed.ncbi.nlm.nih.gov/31639066/,2019-10-21,journal publication,TRUE,TRUE,doi,Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study,"Radiation oncology (London, England)",2019-Oct-21,2019-10-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1748-717X,Radiation Oncology,Springer Science and Business Media LLC,2019-10-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01106820,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life,large,Other,Interventional,Other,NA,101,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2010-04-14,2010-04-01,2014-10-01,2014,2013-10-01,2013,NA,NA,NA,-13,1631,1266,76,441,1707,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.29383,25484317,https://pubmed.ncbi.nlm.nih.gov/25484317/,2014-12-16,journal publication,TRUE,TRUE,doi,Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial,International journal of cancer,2015-Jul-15,2014-12-16,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2014-12-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2015-12-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01071837,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,APG101 in Glioblastoma,large,Industry,Interventional,Drug,Phase 2,84,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-02-18,2009-12-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-79,1686,1686,21,21,1707,2020-07-01,2020-09-01,2021-08-15,10.1158/1078-0432.ccr-14-0951-t,25338498,https://clincancerres.aacrjournals.org/content/20/24/6304,2014-10-22,journal publication,TRUE,TRUE,doi,"A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma",Clinical cancer research : an official journal of the American Association for Cancer Research,2014-Dec-15,2014-10-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2014-10-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2015-10-22,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01019434,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma,large,Other,Interventional,Drug,Phase 2,111,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-11-24,2009-10-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-54,1558,1468,235,325,1793,2020-07-01,2020-09-01,2021-08-15,10.1158/1078-0432.ccr-14-0951-t,25338498,https://pubmed.ncbi.nlm.nih.gov/25338498/,2014-10-22,journal publication,TRUE,TRUE,doi,"A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma",Clinical cancer research : an official journal of the American Association for Cancer Research,2014-Dec-15,2014-10-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2014-10-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2015-10-22,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01019434,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma,large,Other,Interventional,Drug,Phase 2,111,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-11-24,2009-10-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-54,1558,1468,235,325,1793,2020-07-01,2020-09-01,2021-08-15,10.1158/1078-0432.ccr-14-0951-t,25338498,https://pubmed.ncbi.nlm.nih.gov/25338498/,2014-10-22,journal publication,TRUE,TRUE,doi,"A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma",Clinical cancer research : an official journal of the American Association for Cancer Research,2014-Dec-15,2014-10-22,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2014-10-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2015-10-22,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00928915,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage,large,Other,Interventional,Drug,Phase 4,54,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-06-25,2009-07-01,2015-01-01,2015,2015-01-01,2015,NA,NA,NA,6,2016,2016,466,466,2482,2020-07-01,2020-09-01,2021-08-15,10.1016/s1474-4422(16)00110-1,27302126,https://pubmed.ncbi.nlm.nih.gov/27302126/,2016-04-11,journal publication,TRUE,TRUE,doi,Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial,The Lancet. Neurology,2016-May,2016-04-11,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,6,4,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1474-4422,The Lancet Neurology,Elsevier BV,2016-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00794326,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD,large,Industry,Interventional,Drug,Phase 3,140,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2008-11-18,2008-10-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-48,2204,2204,293,293,2497,2020-07-01,2020-09-01,2021-08-15,10.1053/j.ajkd.2015.07.031,26388284,https://pubmed.ncbi.nlm.nih.gov/26388284/,2015-09-20,journal publication,TRUE,TRUE,doi,Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial,American journal of kidney diseases : the official journal of the National Kidney Foundation,2016-May,2015-09-20,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,0272-6386,American Journal of Kidney Diseases,Elsevier BV,2016-05-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT00349089,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,large,Other,Interventional,Drug,Phase 2,132,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-04,2006-09-26,2014-04-14,2014,2014-04-14,2014,NA,NA,NA,84,2841,2841,-515,-515,2326,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mds578,23161898,https://pubmed.ncbi.nlm.nih.gov/23161898/,2012-11-15,journal publication,TRUE,TRUE,doi,Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study,Annals of oncology : official journal of the European Society for Medical Oncology,2013-Apr,2012-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,11,7,2332,2680,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00349089,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,large,Other,Interventional,Drug,Phase 2,132,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2006-07-04,2006-09-26,2014-04-14,2014,2014-04-14,2014,NA,NA,NA,84,2841,2841,-515,-515,2326,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mds578,23161898,https://pubmed.ncbi.nlm.nih.gov/23161898/,2012-11-15,journal publication,TRUE,TRUE,doi,Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study,Annals of oncology : official journal of the European Society for Medical Oncology,2013-Apr,2012-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,11,7,2332,2680,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02157389,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg Mannheim,NA,Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain,large,Other,Interventional,Other,NA,80,Completed,Single,NA,NA,FALSE,FALSE,FALSE,2014-06-03,2012-07-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-702,181,181,1684,1684,1865,2020-07-01,2020-09-01,2021-08-15,10.1159/000501385,31302644,https://pubmed.ncbi.nlm.nih.gov/31302644/,2019-07-12,journal publication,TRUE,TRUE,doi,Positive Treatment Expectancies Reduce Clinical Pain and Perceived Limitations in Movement Ability Despite Increased Experimental Pain: A Randomized Controlled Trial on Sham Opioid Infusion in Patients with Chronic Back Pain,Psychotherapy and psychosomatics,2019,2019-07-12,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0033-3190,1423-0348",Psychotherapy and Psychosomatics,S. Karger AG,2019-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2020-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02092753,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg Mannheim,NA,Ketogenic Or LOGI Diet In a Breast Cancer Rehabilitation Intervention (KOLIBRI),large,Other,Interventional,Other,NA,150,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2014-02-26,2014-03-01,2016-01-01,2016,2016-01-01,2016,NA,NA,NA,3,674,674,1601,1601,2275,2020-07-01,2020-09-01,2021-08-15,10.21203/rs.3.rs-28430/v1,NA,https://www.researchsquare.com/article/rs-28430/v1,2020-05-20,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,24,22,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,NA,NA,Research Square,2020-05-20,unresolved,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01566955,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg Mannheim,NA,Feasability Study of Removing the Ovaries and Fallopian Tubes,large,Other,Interventional,Procedure,NA,6,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-03-22,2012-04-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,10,984,984,1050,1050,2034,2020-07-01,2020-09-01,2021-08-15,10.1007/s00404-017-4567-6,29038843,https://pubmed.ncbi.nlm.nih.gov/29038843/,2017-10-16,journal publication,TRUE,TRUE,doi,Per-oral endoscopic salpingo-oophorectomy (POESY) in humans: a prospective clinical feasibility study,Archives of gynecology and obstetrics,2018-01,2017-10-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0932-0067,1432-0711",Archives of Gynecology and Obstetrics,Springer Science and Business Media LLC,2017-10-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2594,10 +2594,10 @@ NCT00055874,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT03467087,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Safety and Feasibility of Electrical Muscle Stimulation During Stem Cell Transplantation or Intensive Chemotherapy,small,Other,Interventional,Device,NA,45,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2018-02-27,2016-02-03,2017-03-16,2017,2017-02-16,2017,NA,NA,NA,-755,-348,-376,511,539,163,2020-07-01,2020-09-01,2021-08-15,10.1007/s00520-018-4390-z,30094730,https://pubmed.ncbi.nlm.nih.gov/30094730/,2018-08-09,journal publication,TRUE,TRUE,doi,Safety and feasibility of electrical muscle stimulation in patients undergoing autologous and allogeneic stem cell transplantation or intensive chemotherapy,Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,2019-Mar,2018-08-09,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,1265,1613,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0941-4355,1433-7339",Supportive Care in Cancer,Springer Science and Business Media LLC,2018-08-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-08-09,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02226770,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Heart-focused Anxiety in Patients With Heart Failure and ICD,small,Other,Interventional,Device,NA,100,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-17,2010-07-01,2016-10-01,2016,2014-10-01,2014,NA,NA,NA,-1386,898,167,-348,383,550,2020-07-01,2020-09-01,2021-08-15,10.1007/s00392-015-0909-1,26481915,https://pubmed.ncbi.nlm.nih.gov/26481915/,2015-10-19,journal publication,TRUE,TRUE,doi,Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the Anxiety-CHF Study,Clinical research in cardiology : official journal of the German Cardiac Society,2016-Mar,2015-10-19,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2015-10-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-10-19,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01768585,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease,small,Other,Interventional,Drug,Phase 4,50,Unknown status,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-01-11,2012-12-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-41,689,689,1612,1612,2301,2020-07-01,2020-09-01,2021-08-15,10.1097/hjh.0000000000001984,30672832,https://pubmed.ncbi.nlm.nih.gov/30672832/,2019-05-01,journal publication,TRUE,TRUE,doi,Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease,Journal of hypertension,2019-05,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,14,14,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0263-6352,Journal of Hypertension,Ovid Technologies (Wolters Kluwer Health),2019-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01495533,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Homburg Homburg,NA,Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter,small,Other,Interventional,Device,Phase 3,60,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-13,2011-12-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-12,931,719,428,640,1359,2020-07-01,2020-09-01,2021-08-15,10.1002/ccd.26216,26331782,https://pubmed.ncbi.nlm.nih.gov/26331782/,2015-09-02,journal publication,TRUE,TRUE,doi,A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2016-Jul,2015-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2015-09-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-09-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01495533,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,Paclitaxel-coated or Uncoated AngioSculpt Scoring Balloon Catheter,small,Other,Interventional,Device,Phase 3,60,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-13,2011-12-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-12,931,719,428,640,1359,2020-07-01,2020-09-01,2021-08-15,10.1002/ccd.26216,26331782,https://pubmed.ncbi.nlm.nih.gov/26331782/,2015-09-02,journal publication,TRUE,TRUE,doi,A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2016-Jul,2015-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2015-09-02,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-09-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01331473,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,PROximal Protection VErsus NON-Protection in Carotid Artery Stenting,small,Other,Interventional,Procedure,Phase 3,220,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-03-30,2011-05-01,2014-06-01,2014,2014-05-01,2014,NA,NA,NA,32,1159,1128,579,610,1738,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.researchgate.net/publication/327302891_Neue_DWI-Lasionen_beim_Carotisstent_mit_und_ohne_proximales_Protektionssystem,2016-01-01,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,6,6,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00769457,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,OptiLink HF Study: Optimization of Heart Failure Management Using Medtronic OptiVol Fluid Status Monitoring and CareLink Network,small,Industry,Interventional,Device,Phase 4,1002,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2008-10-08,2008-09-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,-37,2215,2215,501,501,2716,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehw099,26984864,https://pubmed.ncbi.nlm.nih.gov/26984864/,2016-03-16,journal publication,TRUE,TRUE,doi,Fluid status telemedicine alerts for heart failure: a randomized controlled trial,European heart journal,2016-Nov-01,2016-03-16,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2016-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-03-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT02120859,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Jena Jena,NA,Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty,small,Other,Interventional,Device,Phase 4,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2014-04-19,2012-10-01,2014-04-01,2014,2013-12-01,2013,NA,NA,NA,-565,-18,-139,826,947,808,2020-07-01,2020-09-01,2021-08-15,10.1007/s00392-016-1019-4,27379610,https://pubmed.ncbi.nlm.nih.gov/27379610/,2016-07-05,journal publication,TRUE,TRUE,doi,"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography",Clinical research in cardiology : official journal of the German Cardiac Society,2017-Jan,2016-07-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2016-07-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT02120859,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Jena,NA,Optical Coherence Tomography to Investigate FFR-Guided DEB-only Elective Coronary Angioplasty,small,Other,Interventional,Device,Phase 4,50,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2014-04-19,2012-10-01,2014-04-01,2014,2013-12-01,2013,NA,NA,NA,-565,-18,-139,826,947,808,2020-07-01,2020-09-01,2021-08-15,10.1007/s00392-016-1019-4,27379610,https://pubmed.ncbi.nlm.nih.gov/27379610/,2016-07-05,journal publication,TRUE,TRUE,doi,"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography",Clinical research in cardiology : official journal of the German Cardiac Society,2017-Jan,2016-07-05,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"1861-0684,1861-0692",Clinical Research in Cardiology,Springer Science and Business Media LLC,2016-07-05,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01247792,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,End-of-life Decision-making in Patients With Sepsis-related Organ Failure,small,Other,Interventional,Behavioral,NA,174,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-11-11,2010-08-01,2014-09-30,2014,2014-09-30,2014,NA,NA,NA,-102,1419,1419,-10,-10,1409,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcrc.2014.09.015,25311265,https://pubmed.ncbi.nlm.nih.gov/25311265/,2014-09-20,journal publication,TRUE,TRUE,doi,A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psychometric testing,Journal of critical care,2015-Feb,2014-09-20,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2163,2511,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0883-9441,Journal of Critical Care,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01108042,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Jena,NA,TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer,small,Other,Interventional,Drug,Phase 1/Phase 2,71,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-04-14,2009-11-01,2016-02-01,2016,2016-01-01,2016,NA,NA,NA,-164,2119,2088,-1199,-1168,920,2020-07-01,2020-09-01,2021-08-15,10.1186/1471-2407-12-483,23083061,https://pubmed.ncbi.nlm.nih.gov/23083061/,2012-10-20,journal publication,TRUE,TRUE,doi,"Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)",BMC cancer,2012-Oct-20,2012-10-20,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-2407,BMC Cancer,Springer Science and Business Media LLC,2012-10-20,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT03042429,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients,large,Other,Interventional,Drug,Phase 3,360,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2017-02-01,2007-01-01,2016-12-31,2016,2016-12-31,2016,NA,NA,NA,-3684,-32,-32,-2214,-2214,-2246,2020-07-01,2020-09-01,2021-08-15,10.1002/pbc.22693,21298742,https://pubmed.ncbi.nlm.nih.gov/21298742/,2010-12-09,journal publication,TRUE,TRUE,doi,"Treatment and outcomes of patients with relapsed, high-risk neuroblastoma: results of German trials",Pediatric blood & cancer,2011-Apr,2010-12-09,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1340,1688,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1545-5009,Pediatric Blood & Cancer,Wiley,2010-12-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2011-12-09,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2625,10 +2625,10 @@ NCT01544686,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01534364,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Brief Title:Effect of a Preoperative Calorie Restriction on Renal Function After Cardiac Surgery,large,Other,Interventional,Other,NA,82,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-01-30,2012-01-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-29,1098,1098,1136,1136,2234,2020-07-01,2020-09-01,2021-08-15,10.1161/jaha.117.008181,29535139,https://pubmed.ncbi.nlm.nih.gov/29535139/,2018-03-13,journal publication,TRUE,TRUE,doi,"Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial",Journal of the American Heart Association,2018-03-13,2018-03-13,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"2047-9980,2047-9980",Journal of the American Heart Association,Ovid Technologies (Wolters Kluwer Health),2018-03-20,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01491152,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Pilot Study of Whole Body Vibration for Children With Cerebral Palsy (CP) From 12 Months of Age,large,Other,Interventional,Device,NA,24,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2011-12-09,2012-01-01,2014-02-01,2014,2014-02-01,2014,NA,NA,NA,23,785,785,949,949,1734,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114341/,2016-09-07,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01344707,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS),large,Industry,Interventional,Drug,Phase 1,36,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2011-04-12,2011-03-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,-42,1419,1419,1331,1331,2750,2020-07-01,2020-09-01,2021-08-15,10.1111/ejh.13188,NA,https://onlinelibrary.wiley.com/doi/abs/10.1111/ejh.13188,2018-10-22,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0902-4441,1600-0609",European Journal of Haematology,Wiley,2019-01-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2020-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01283776,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-25,2011-03-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,35,1223,1041,288,470,1511,2020-07-01,2020-09-01,2021-08-15,10.1111/ejh.12541,25703164,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844370/,2015-03-16,journal publication,TRUE,TRUE,doi,OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation,European journal of haematology,2016-Jan,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0902-4441,European Journal of Haematology,Wiley,2015-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01283776,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-01-25,2011-03-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,35,1223,1041,288,470,1511,2020-07-01,2020-09-01,2021-08-15,10.1111/ejh.12541,25703164,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844370/,2015-03-16,journal publication,TRUE,TRUE,doi,OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation,European journal of haematology,2016-Jan,2015-03-16,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0902-4441,European Journal of Haematology,Wiley,2015-03-16,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-03-16,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01245075,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction,large,Other,Interventional,Other,Early Phase 1,10,Unknown status,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-19,2011-01-01,2017-12-01,2017,2017-06-01,2017,NA,NA,NA,43,2569,2386,-1774,-1591,795,2020-07-01,2020-09-01,2021-08-15,10.1038/mp.2012.196,23337942,https://www.nature.com/articles/mp2012196.pdf,2013-01-22,journal publication,TRUE,TRUE,doi,Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction,Molecular psychiatry,2014-Feb,2013-01-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1359-4184,1476-5578",Molecular Psychiatry,Springer Science and Business Media LLC,2013-01-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2015-02-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01213667,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD,large,Other,Interventional,Drug,Phase 4,110,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2010-10-01,2010-01-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,-273,2618,2618,-2276,-2276,342,2020-07-01,2020-09-01,2021-08-15,10.1007/s00417-011-1792-8,21901296,https://pubmed.ncbi.nlm.nih.gov/21901296/,2011-09-08,journal publication,TRUE,TRUE,doi,Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD,Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,2012-Feb,2011-09-08,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0721-832X,1435-702X",Graefe's Archive for Clinical and Experimental Ophthalmology,Springer Science and Business Media LLC,2011-09-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2012-09-08,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01187303,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL),large,Other,Interventional,Drug,Phase 2,28,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-08-19,2011-05-01,2015-09-01,2015,2013-11-01,2013,NA,NA,NA,255,1839,1170,80,749,1919,2020-07-01,2020-09-01,2021-08-15,10.1038/leu.2015.321,26585412,https://pubmed.ncbi.nlm.nih.gov/26585412/,2015-11-20,journal publication,TRUE,TRUE,doi,Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group,Leukemia,2016-06,2015-11-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2015-11-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01187303,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL),large,Other,Interventional,Drug,Phase 2,28,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-08-19,2011-05-01,2015-09-01,2015,2013-11-01,2013,NA,NA,NA,255,1839,1170,80,749,1919,2020-07-01,2020-09-01,2021-08-15,10.1038/leu.2015.321,26585412,https://pubmed.ncbi.nlm.nih.gov/26585412/,2015-11-20,journal publication,TRUE,TRUE,doi,Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group,Leukemia,2016-06,2015-11-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2015-11-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01056679,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,"Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients",large,Other,Interventional,Drug,Phase 1,30,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-09-08,2010-04-01,2016-02-01,2016,2014-04-01,2014,NA,NA,NA,205,2337,1666,1061,1732,3398,2020-07-01,2020-09-01,2021-08-15,10.1111/bjh.15741,30592027,https://pubmed.ncbi.nlm.nih.gov/30592027/,2018-12-28,journal publication,TRUE,TRUE,doi,"Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial",British journal of haematology,2019-04,2018-12-28,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0007-1048,1365-2141",British Journal of Haematology,Wiley,2018-12-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-12-28,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00953511,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Cologne Esophageal Response Prediction Study (CERP-Study),large,Other,Interventional,Genetic,NA,80,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-08-03,2009-08-01,2015-08-01,2015,2015-04-01,2015,NA,NA,NA,-2,2189,2067,458,580,2647,2020-07-01,2020-09-01,2021-08-15,10.1097/sla.0000000000001911,27741011,https://pubmed.ncbi.nlm.nih.gov/27741011/,2016-11-01,journal publication,TRUE,TRUE,doi,Molecular Markers for the Prediction of Minor Response to Neoadjuvant Chemoradiation in Esophageal Cancer: Results of the Prospective Cologne Esophageal Response Prediction (CERP) Study,Annals of surgery,2016-Nov,NA,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,10,10,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00275054,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,"Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia",large,Other,Interventional,Drug,Phase 3,825,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2006-01-10,2005-10-01,2015-06-01,2015,2007-07-01,2007,NA,NA,NA,-101,3429,537,1430,4322,4859,2020-07-01,2020-09-01,2021-08-15,10.21873/anticanres.13382,31092457,https://pubmed.ncbi.nlm.nih.gov/31092457/,2019-05-01,journal publication,TRUE,TRUE,doi,"Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in ""Real-Life"" Outside of Clinical Trials",Anticancer research,2019-May,NA,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0250-7005,1791-7530",Anticancer Research,Anticancer Research USA Inc.,2019-05-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA @@ -2654,14 +2654,14 @@ NCT01656096,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01612312,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Thrombus Aspiration in ThrOmbus Containing culpRiT Lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI),large,Other,Interventional,Procedure,Phase 4,400,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2012-05-30,2011-03-01,2016-10-01,2016,2013-06-01,2013,NA,NA,NA,-456,1585,367,-746,472,839,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2014.05.064,25212646,https://pubmed.ncbi.nlm.nih.gov/25212646/,2014-09-16,journal publication,TRUE,TRUE,doi,Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial,Journal of the American College of Cardiology,2014-Sep-16,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2014-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2015-09-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01541605,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Methylphenidate for the Treatment of Acute Mania,large,Other,Interventional,Drug,Phase 3,42,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2012-02-16,2012-03-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,14,1536,1536,571,571,2107,2020-07-01,2020-09-01,2021-08-15,10.1016/j.euroneuro.2017.11.003,29174864,https://pubmed.ncbi.nlm.nih.gov/29174864/,2017-11-23,journal publication,TRUE,TRUE,doi,"A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)",European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,2018-01,2017-11-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0924-977X,European Neuropsychopharmacology,Elsevier BV,2018-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01504256,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas,large,Other,Interventional,Drug,Phase 2,42,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-01-03,2011-10-01,2017-07-01,2017,2017-03-01,2017,NA,NA,NA,-94,2006,1884,374,496,2380,2020-07-01,2020-09-01,2021-08-15,10.1038/s41416-018-0150-6,29988111,https://pubmed.ncbi.nlm.nih.gov/29988111/,2018-07-10,journal publication,TRUE,TRUE,doi,Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer,British journal of cancer,2018-08,2018-07-10,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1158,1506,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0007-0920,1532-1827",British Journal of Cancer,Springer Science and Business Media LLC,2018-07-10,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01414231,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a,large,Other,Interventional,Drug,Phase 3,850,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-05,2002-04-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-3413,1061,849,-659,-447,402,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2012.42.2907,22965967,https://pubmed.ncbi.nlm.nih.gov/22965967/,2012-09-10,journal publication,TRUE,TRUE,doi,Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2012-Oct-10,2012-09-10,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,4,0,4,0,1,1,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2012-10-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-10-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01414231,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a,large,Other,Interventional,Drug,Phase 3,850,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-05,2002-04-01,2014-07-01,2014,2013-12-01,2013,NA,NA,NA,-3413,1061,849,-659,-447,402,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2012.42.2907,22965967,https://pubmed.ncbi.nlm.nih.gov/22965967/,2012-09-10,journal publication,TRUE,TRUE,doi,Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2012-Oct-10,2012-09-10,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,4,0,4,0,1,1,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2012-10-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2013-10-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT01404910,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery,large,Other,Interventional,Device,NA,11,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2011-07-26,2013-05-01,2015-09-01,2015,2015-09-01,2015,NA,NA,NA,645,1498,1498,23,23,1521,2020-07-01,2020-09-01,2021-08-15,10.1681/asn.2015020157,26405111,https://pubmed.ncbi.nlm.nih.gov/26405111/,2015-09-24,journal publication,TRUE,TRUE,doi,Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia,Journal of the American Society of Nephrology : JASN,2016-Mar,2015-09-24,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1046-6673,1533-3450",Journal of the American Society of Nephrology,American Society of Nephrology (ASN),2015-09-24,no_embargo_info,TRUE,['institutional repository'],TRUE,['submittedVersion'],TRUE,FALSE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01379248,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset,large,Other,Interventional,Device,Phase 4,152,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-06-20,2011-06-01,2015-05-01,2015,2014-11-01,2014,NA,NA,NA,-19,1411,1230,269,450,1680,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2015.09.010,26793952,https://pubmed.ncbi.nlm.nih.gov/26793952/,2016-01-25,journal publication,TRUE,TRUE,doi,Thrombus Aspiration in Patients With ST-Segment Elevation Myocardial Infarction Presenting Late After Symptom Onset,JACC. Cardiovascular interventions,2016-Jan-25,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2016-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2017-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01137734,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitation,large,Industry,Interventional,Device,Phase 2,30,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-05-24,2010-03-01,2014-01-01,2014,2012-02-01,2012,NA,NA,NA,-84,1318,618,-282,418,1036,2020-07-01,2020-09-01,2021-08-15,10.1093/ejcts/ezt128,23530026,https://pubmed.ncbi.nlm.nih.gov/23530026/,2013-03-25,journal publication,TRUE,TRUE,doi,Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2013-Nov,2013-03-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1873-734X,1010-7940",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2013-03-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-03-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01106391,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,"A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS (INNOVATION)",large,Industry,Interventional,Device,Phase 2,60,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2010-04-16,2010-03-01,2016-10-01,2016,2011-08-01,2011,2013-09-23,-1104,784,-46,2360,472,-1352,536,1008,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jvs.2012.09.079,23332982,https://pubmed.ncbi.nlm.nih.gov/23332982/,2013-01-18,journal publication,TRUE,TRUE,doi,First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial,Journal of vascular surgery,2013-Apr,2013-01-18,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1431,1779,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0741-5214,Journal of Vascular Surgery,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01002703,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,"Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma",large,Other,Interventional,Drug,Phase 1/Phase 2,50,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-10-23,2009-09-01,2014-10-01,2014,2012-10-01,2012,NA,NA,NA,-52,1804,1074,1055,1785,2859,2020-07-01,2020-09-01,2021-08-15,10.1007/s00432-017-2504-5,28828689,https://pubmed.ncbi.nlm.nih.gov/28828689/,2017-08-21,journal publication,TRUE,TRUE,doi,Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077),Journal of cancer research and clinical oncology,2017-Dec,2017-08-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0171-5216,1432-1335",Journal of Cancer Research and Clinical Oncology,Springer Science and Business Media LLC,2017-08-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-08-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01137734,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,CARDINAL Adjustable Annuloplasty Ring System For Treatment of Mitral Regurgitation,large,Industry,Interventional,Device,Phase 2,30,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-05-24,2010-03-01,2014-01-01,2014,2012-02-01,2012,NA,NA,NA,-84,1318,618,-282,418,1036,2020-07-01,2020-09-01,2021-08-15,10.1093/ejcts/ezt128,23530026,https://pubmed.ncbi.nlm.nih.gov/23530026/,2013-03-25,journal publication,TRUE,TRUE,doi,Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system,European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,2013-Nov,2013-03-25,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"1873-734X,1010-7940",European Journal of Cardio-Thoracic Surgery,Oxford University Press (OUP),2013-03-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2014-03-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01106391,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"A MULTICENTER, OPEN LABEL, PROSPECTIVE, NON-RANDOMIZED STUDY OF INCRAFT™ IN SUBJECTS WITH ABDOMINAL AORTIC ANEURYSMS (INNOVATION)",large,Industry,Interventional,Device,Phase 2,60,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2010-04-16,2010-03-01,2016-10-01,2016,2011-08-01,2011,2013-09-23,-1104,784,-46,2360,472,-1352,536,1008,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jvs.2012.09.079,23332982,https://pubmed.ncbi.nlm.nih.gov/23332982/,2013-01-18,journal publication,TRUE,TRUE,doi,First-in-human study of the INCRAFT endograft in patients with infrarenal abdominal aortic aneurysms in the INNOVATION trial,Journal of vascular surgery,2013-Apr,2013-01-18,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1431,1779,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,green,0741-5214,Journal of Vascular Surgery,Elsevier BV,2013-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01002703,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma",large,Other,Interventional,Drug,Phase 1/Phase 2,50,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2009-10-23,2009-09-01,2014-10-01,2014,2012-10-01,2012,NA,NA,NA,-52,1804,1074,1055,1785,2859,2020-07-01,2020-09-01,2021-08-15,10.1007/s00432-017-2504-5,28828689,https://pubmed.ncbi.nlm.nih.gov/28828689/,2017-08-21,journal publication,TRUE,TRUE,doi,Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077),Journal of cancer research and clinical oncology,2017-Dec,2017-08-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0171-5216,1432-1335",Journal of Cancer Research and Clinical Oncology,Springer Science and Business Media LLC,2017-08-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-08-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00923793,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Comparison of Individual Computer Aided Design/Manufactured (CAD/CAM) - Based Implants Consisting on Hydroxylapatite and Titanium to be Used in Cranioplasty,large,Other,Interventional,Device,Phase 3,53,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-06-17,2009-06-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-16,1749,1749,696,696,2445,2020-07-01,2020-09-01,2021-08-15,10.3171/2015.10.jns151245,26918471,https://pubmed.ncbi.nlm.nih.gov/26918471/,2016-02-26,journal publication,TRUE,TRUE,doi,Cranioplasty using custom-made hydroxyapatite versus titanium: a randomized clinical trial,Journal of neurosurgery,2017-Jan,2016-02-26,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0022-3085,1933-0693",Journal of Neurosurgery,Journal of Neurosurgery Publishing Group (JNSPG),2017-01-01,no_embargo_info,FALSE,NA,NA,[],NA,NA,NA,[],publisher,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,NA -NCT00677638,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig Leipzig,NA,Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease,large,Industry,Interventional,Device,NA,30,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-05-12,2008-06-01,2014-12-01,2014,2010-01-01,2010,NA,NA,NA,20,2394,599,-1453,342,941,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehq445,21148541,https://pubmed.ncbi.nlm.nih.gov/21148541/,2010-12-09,journal publication,TRUE,TRUE,doi,Transapical aortic valve implantation with a self-expanding anatomically oriented valve,European heart journal,2011-Apr,2010-12-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2010-12-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2011-12-09,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00677638,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease,large,Industry,Interventional,Device,NA,30,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2008-05-12,2008-06-01,2014-12-01,2014,2010-01-01,2010,NA,NA,NA,20,2394,599,-1453,342,941,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehq445,21148541,https://pubmed.ncbi.nlm.nih.gov/21148541/,2010-12-09,journal publication,TRUE,TRUE,doi,Transapical aortic valve implantation with a self-expanding anatomically oriented valve,European heart journal,2011-Apr,2010-12-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2010-12-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2011-12-09,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00508664,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,"Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)",large,Other,Interventional,Radiation,Phase 2,180,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2007-07-27,2007-07-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-26,2746,2746,1299,1299,4045,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdy332,30412221,https://pubmed.ncbi.nlm.nih.gov/30412221/,2018-08-23,journal publication,TRUE,TRUE,doi,Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II,Annals of oncology : official journal of the European Society for Medical Oncology,2018-10-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,0923-7534,Annals of Oncology,Elsevier BV,2018-10-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00491036,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Intraaortic Balloon Pump in Cardiogenic Shock II,large,Other,Interventional,Device,Phase 4,600,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2007-06-22,2009-06-01,2016-10-01,2016,2012-06-01,2012,NA,NA,NA,710,3389,1806,-1497,86,1892,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1208410,22920912,https://pubmed.ncbi.nlm.nih.gov/22920912/,2012-08-26,journal publication,TRUE,TRUE,doi,Intraaortic balloon support for myocardial infarction with cardiogenic shock,The New England journal of medicine,2012-Oct-04,2012-08-26,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,15,15,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2012-10-04,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2013-04-04,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE NCT01859429,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig Mainz,NA,Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis,large,Other,Interventional,Other,NA,1012,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-05-17,2012-04-01,2015-03-01,2015,2014-12-01,2014,NA,NA,NA,-411,653,563,872,962,1525,2020-07-01,2020-09-01,2021-08-15,10.1002/pon.4492,28665542,https://pubmed.ncbi.nlm.nih.gov/28665542/,2017-07-20,journal publication,TRUE,TRUE,doi,Effects of stepped psychooncological care on referral to psychosocial services and emotional well-being in cancer patients: A cluster-randomized phase III trial,Psycho-oncology,2017-Oct,2017-07-20,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,7,7,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1057-9249,Psycho-Oncology,Wiley,2017-07-20,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-07-20,TRUE,TRUE,FALSE,TRUE,TRUE,NA @@ -2669,7 +2669,7 @@ NCT02912598,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE, NCT02602275,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands,small,Industry,Interventional,Drug,Phase 2,53,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-10-28,2015-08-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-88,34,34,1553,1553,1587,2020-07-01,2020-09-01,2021-08-15,10.1038/s41598-020-60392-w,32123197,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052227/,2020-03-02,journal publication,TRUE,TRUE,doi,"fMRI Revealed Reduced Amygdala Activation after Nx4 in Mildly to Moderately Stressed Healthy Volunteers in a Randomized, Placebo-Controlled, Cross-Over Trial",Scientific reports,2020-03-02,2020-03-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,2045-2322,Scientific Reports,Springer Science and Business Media LLC,2020-03-02,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02434692,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG),small,Industry,Interventional,Device,NA,22,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2014-09-02,2014-05-01,2017-04-11,2017,2017-04-11,2017,NA,NA,NA,-124,952,952,892,892,1844,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ajo.2019.09.011,31545953,https://pubmed.ncbi.nlm.nih.gov/31545953/,2019-09-20,journal publication,TRUE,TRUE,doi,Telemetric Measurement of Intraocular Pressure via an Implantable Pressure Sensor-12-Month Results from the ARGOS-02 Trial,American journal of ophthalmology,2020-01,2019-09-20,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1239,1587,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,0002-9394,American Journal of Ophthalmology,Elsevier BV,2020-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02429219,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate,small,Other,Interventional,Drug,NA,60,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-02-19,2013-11-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-475,-18,-18,-178,-178,-196,2020-07-01,2020-09-01,2021-08-15,10.1016/j.juro.2014.07.117,25108273,https://pubmed.ncbi.nlm.nih.gov/25108273/,2014-08-07,journal publication,TRUE,TRUE,doi,Absorption of irrigation fluid occurs frequently during high power 532 nm laser vaporization of the prostate,The Journal of urology,2015-Jan,2014-08-07,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0022-5347,1527-3792",Journal of Urology,Ovid Technologies (Wolters Kluwer Health),2015-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-01-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT02425163,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg Magdeburg,NA,Shear Wave Elastography of Prostate Cancer,small,Other,Interventional,Device,Phase 2,73,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-02-10,2012-03-01,2015-01-01,2015,2013-03-01,2013,NA,NA,NA,-1076,-40,-711,-43,628,-83,2020-07-01,2020-09-01,2021-08-15,10.1148/radiol.14140567,25599156,https://pubmed.ncbi.nlm.nih.gov/25599156/,2014-11-19,journal publication,TRUE,TRUE,doi,Prostate cancer: diagnostic performance of real-time shear-wave elastography,Radiology,2015-Apr,2014-11-19,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0033-8419,1527-1315",Radiology,Radiological Society of North America (RSNA),2015-04-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT02425163,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Shear Wave Elastography of Prostate Cancer,small,Other,Interventional,Device,Phase 2,73,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-02-10,2012-03-01,2015-01-01,2015,2013-03-01,2013,NA,NA,NA,-1076,-40,-711,-43,628,-83,2020-07-01,2020-09-01,2021-08-15,10.1148/radiol.14140567,25599156,https://pubmed.ncbi.nlm.nih.gov/25599156/,2014-11-19,journal publication,TRUE,TRUE,doi,Prostate cancer: diagnostic performance of real-time shear-wave elastography,Radiology,2015-Apr,2014-11-19,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0033-8419,1527-1315",Radiology,Radiological Society of North America (RSNA),2015-04-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01967407,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.,small,Other,Interventional,Procedure,Phase 1/Phase 2,20,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2013-10-15,2013-10-01,2016-01-01,2016,2015-12-01,2015,NA,NA,NA,-14,808,777,-119,-88,689,2020-07-01,2020-09-01,2021-08-15,10.1007/s00270-015-1200-6,26341653,https://pubmed.ncbi.nlm.nih.gov/26341653/,2015-09-04,journal publication,TRUE,TRUE,doi,First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial,Cardiovascular and interventional radiology,2016-Feb,2015-09-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,1,2,5,5,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0174-1551,1432-086X",CardioVascular and Interventional Radiology,Springer Science and Business Media LLC,2015-09-04,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01534455,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA),small,Other,Interventional,Drug,Phase 2,43,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-02-08,2012-02-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,-7,1117,1117,1492,1492,2609,2020-07-01,2020-09-01,2021-08-15,10.1097/cad.0000000000000722,30875348,https://pubmed.ncbi.nlm.nih.gov/30875348/,2019-04-01,journal publication,TRUE,TRUE,doi,A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA),Anti-cancer drugs,2019-04,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0959-4973,Anti-Cancer Drugs,Ovid Technologies (Wolters Kluwer Health),2019-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01453179,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2),small,Industry,Interventional,Drug,Phase 4,221,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-09-30,2011-10-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,1,1248,1248,1656,1656,2904,2020-07-01,2020-09-01,2021-08-15,10.1111/jdv.15868,31407414,https://pubmed.ncbi.nlm.nih.gov/31407414/,2019-09-12,journal publication,TRUE,TRUE,doi,Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials,Journal of the European Academy of Dermatology and Venereology : JEADV,2020-Jan,2019-09-12,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,1,1,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0926-9959,1468-3083",Journal of the European Academy of Dermatology and Venereology,Wiley,2019-09-12,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -2707,10 +2707,10 @@ NCT03146832,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE, NCT02848014,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,The Effects of Interventions Aiming at Optimizing Expectations and Inducing Positive Emotions After an Acute Stressor,small,Other,Interventional,Behavioral,NA,74,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2016-06-29,2016-07-01,2016-11-30,2016,2016-11-01,2016,NA,NA,NA,2,154,125,428,457,582,2020-07-01,2020-09-01,2021-08-15,10.1016/j.psyneuen.2017.12.011,29278839,https://www.sciencedirect.com/science/article/abs/pii/S0306453017313331,2018-02-01,journal publication,TRUE,TRUE,doi,Optimizing expectations and distraction leads to lower cortisol levels after acute stress,Psychoneuroendocrinology,2018-02,2017-12-21,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1371,1719,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0306-4530,Psychoneuroendocrinology,Elsevier BV,2018-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02127736,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Pharmacological Conditioning of Sleep Patterns in Healthy Participants Using Amitriptylin,small,Other,Interventional,Drug,NA,NA,Completed,NA,NA,NA,FALSE,NA,FALSE,2014-04-29,NA,2014-09-01,2014,2014-09-01,2014,NA,NA,NA,NA,125,125,1369,1369,1494,2020-07-01,2020-09-01,2021-08-15,10.1037/pha0000194,29863388,https://pubmed.ncbi.nlm.nih.gov/29863388/,2018-06-01,journal publication,TRUE,TRUE,doi,Assessment of adverse events in clinical drug trials: Identifying amitriptyline's placebo- and baseline-controlled side effects,Experimental and clinical psychopharmacology,2018-06,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1936-2293,1064-1297",Experimental and Clinical Psychopharmacology,American Psychological Association (APA),2018-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,12,2019-06-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02125903,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Comparison of Continuous Femoral Nerve Block and Adductor Canal Block After Total Knee Replacement Therapy,small,Other,Interventional,Drug,NA,44,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2014-02-05,2013-05-01,2014-11-01,2014,2014-05-01,2014,NA,NA,NA,-280,269,85,436,620,705,2020-07-01,2020-09-01,2021-08-15,10.1007/s00402-015-2403-7,26754752,https://pubmed.ncbi.nlm.nih.gov/26754752/,2016-01-11,journal publication,TRUE,TRUE,doi,Continuous adductor canal block versus continuous femoral nerve block after total knee arthroplasty for mobilisation capability and pain treatment: a randomised and blinded clinical trial,Archives of orthopaedic and trauma surgery,2016-Mar,2016-01-11,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0936-8051,1434-3916",Archives of Orthopaedic and Trauma Surgery,Springer Science and Business Media LLC,2016-01-11,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01927991,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg Marburg,NA,Internet-based Self-help for Tinnitus: The Role of Support,small,Other,Interventional,Behavioral,NA,112,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-17,2012-09-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,-350,257,106,365,516,622,2020-07-01,2020-09-01,2021-08-15,10.1016/j.invent.2015.03.007,NA,https://www.sciencedirect.com/science/article/pii/S2214782915000184,2015-05-01,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2214-7829,Internet Interventions,Elsevier BV,2015-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01927991,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Internet-based Self-help for Tinnitus: The Role of Support,small,Other,Interventional,Behavioral,NA,112,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-08-17,2012-09-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,-350,257,106,365,516,622,2020-07-01,2020-09-01,2021-08-15,10.1016/j.invent.2015.03.007,NA,https://www.sciencedirect.com/science/article/pii/S2214782915000184,2015-05-01,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2214-7829,Internet Interventions,Elsevier BV,2015-05-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01908855,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Cognitive-Behavioral Therapy Enriched With Emotion Regulation Training for Multiple Somatoform Symptoms,small,Other,Interventional,Behavioral,NA,255,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2013-07-19,2013-10-01,2017-03-01,2017,2016-10-01,2016,NA,NA,NA,74,1321,1170,162,313,1483,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jpsychores.2017.08.010,28867416,https://pubmed.ncbi.nlm.nih.gov/28867416/,2017-08-10,journal publication,TRUE,TRUE,doi,Negative affect as mediator between emotion regulation and medically unexplained symptoms,Journal of psychosomatic research,2017-10,2017-08-10,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,30,20,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3999,Journal of Psychosomatic Research,Elsevier BV,2017-10-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01811966,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Preoperative Volume Substitution in Elective Surgery Patients,small,Other,Interventional,Other,NA,220,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-03-13,2013-03-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-12,690,690,1214,1214,1904,2020-07-01,2020-09-01,2021-08-15,10.1111/aas.13157,29851024,https://pubmed.ncbi.nlm.nih.gov/29851024/,2018-05-30,journal publication,TRUE,TRUE,doi,Pre-operative fluid bolus for improved haemodynamic stability during minor surgery: A prospectively randomized clinical trial,Acta anaesthesiologica Scandinavica,2018-10,2018-05-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0001-5172,Acta Anaesthesiologica Scandinavica,Wiley,2018-05-30,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-05-30,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01811914,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg Marburg,NA,Focused TTE for Hemodynamic Instable High Risk Patients,small,Other,Interventional,Other,NA,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-03-13,2013-03-01,2014-03-01,2014,2013-11-01,2013,NA,NA,NA,-12,353,233,1050,1170,1403,2020-07-01,2020-09-01,2021-08-15,10.1053/j.jvca.2016.11.002,28089598,https://www.jcvaonline.com/article/S1053-0770(16)30524-9/fulltext,2017-01-14,journal publication,TRUE,TRUE,doi,Impact of Focused Intraoperative Transthoracic Echocardiography by Anesthesiologists on Management in Hemodynamically Unstable High-Risk Noncardiac Surgery Patients,Journal of cardiothoracic and vascular anesthesia,2017-Apr,2016-11-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1053-0770,Journal of Cardiothoracic and Vascular Anesthesia,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01811914,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Focused TTE for Hemodynamic Instable High Risk Patients,small,Other,Interventional,Other,NA,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-03-13,2013-03-01,2014-03-01,2014,2013-11-01,2013,NA,NA,NA,-12,353,233,1050,1170,1403,2020-07-01,2020-09-01,2021-08-15,10.1053/j.jvca.2016.11.002,28089598,https://www.jcvaonline.com/article/S1053-0770(16)30524-9/fulltext,2017-01-14,journal publication,TRUE,TRUE,doi,Impact of Focused Intraoperative Transthoracic Echocardiography by Anesthesiologists on Management in Hemodynamically Unstable High-Risk Noncardiac Surgery Patients,Journal of cardiothoracic and vascular anesthesia,2017-Apr,2016-11-02,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,1053-0770,Journal of Cardiothoracic and Vascular Anesthesia,Elsevier BV,2017-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01484418,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Exposure-based Treatment for Avoidant Back Pain Patients,small,Other,Interventional,Behavioral,NA,68,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-11-28,2011-08-01,2017-08-01,2017,2015-08-01,2015,NA,NA,NA,-119,2073,1342,304,1035,2377,2020-07-01,2020-09-01,2021-08-15,10.1037/ccp0000298,29781651,https://pubmed.ncbi.nlm.nih.gov/29781651/,2018-06-01,journal publication,TRUE,TRUE,doi,Exposure and CBT for chronic back pain: An RCT on differential efficacy and optimal length of treatment,Journal of consulting and clinical psychology,2018-06,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,"1939-2117,0022-006X",Journal of Consulting and Clinical Psychology,American Psychological Association (APA),2018-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use'}]",publisher,12,2019-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01407055,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Optimizing Expectations in Cardiac Surgery Patients,small,Other,Interventional,Behavioral,Phase 2,124,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-07-25,2011-07-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-24,1346,1346,884,884,2230,2020-07-01,2020-09-01,2021-08-15,10.1097/psy.0000000000000483,28846584,https://pubmed.ncbi.nlm.nih.gov/28846584/,2017-09-01,journal publication,TRUE,TRUE,doi,Effects of Preoperative Psychological Interventions on Catecholamine and Cortisol Levels After Surgery in Coronary Artery Bypass Graft Patients: The Randomized Controlled PSY-HEART Trial,Psychosomatic medicine,2017-Sep,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1534-7796,0033-3174",Psychosomatic Medicine,Ovid Technologies (Wolters Kluwer Health),2017-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00712218,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Marburg,NA,Lymphadenectomy In Ovarian Neoplasms,small,Other,Interventional,Procedure,NA,640,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2008-07-03,2008-12-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,151,3438,3438,454,454,3892,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1808424,30811909,https://pubmed.ncbi.nlm.nih.gov/30811909/,2019-02-28,journal publication,TRUE,TRUE,doi,A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms,The New England journal of medicine,2019-02-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2019-02-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2019-08-27,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2730,7 +2730,7 @@ NCT02588300,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02545296,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,HIV Point-of-Care Test Evaluation in Infants,large,Other,Interventional,Other,NA,604,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2015-07-08,2015-07-01,2017-08-01,2017,2016-10-01,2016,NA,NA,NA,-7,755,451,549,853,1304,2020-07-01,2020-09-01,2021-08-15,10.1093/cid/ciy538,29961841,NA,2019-02-01,journal publication,TRUE,TRUE,doi,Accuracy and Operational Characteristics of Xpert Human Immunodeficiency Virus Point-of-Care Testing at Birth and Until Week 6 in Human Immunodeficiency Virus-exposed Neonates in Tanzania,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2019-02-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"1058-4838,1537-6591",Clinical Infectious Diseases,Oxford University Press (OUP),2018-06-29,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02519101,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Effects of Continuous Noninvasive Arterial Pressure Measurement on Anaesthesia,large,Other,Interventional,Device,NA,160,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2015-08-01,2015-06-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,-61,274,274,549,549,823,2020-07-01,2020-09-01,2021-08-15,10.1097/eja.0000000000000690,28922340,NA,2017-11-01,journal publication,TRUE,TRUE,doi,The impact of continuous non-invasive arterial blood pressure monitoring on blood pressure stability during general anaesthesia in orthopaedic patients: A randomised trial,European journal of anaesthesiology,2017-11,NA,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0265-0215,European Journal of Anaesthesiology,Ovid Technologies (Wolters Kluwer Health),2017-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02512328,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Improvement of Colonoscopy Preparation by New Media (APP),large,Other,Interventional,Device,Phase 1,25,Unknown status,Single,Non-Randomized,FALSE,FALSE,TRUE,FALSE,2015-02-24,2015-03-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,5,219,219,720,720,939,2020-07-01,2020-09-01,2021-08-15,10.2196/mhealth.7703,28931498,NA,2017-09-20,journal publication,TRUE,TRUE,doi,A Smartphone App for Improvement of Colonoscopy Preparation (ColoprAPP): Development and Feasibility Study,JMIR mHealth and uHealth,2017-Sep-20,2017-09-20,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2291-5222,JMIR mHealth and uHealth,JMIR Publications Inc.,2017-09-20,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT02436083,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Antibiotics in Free Flaps Reconstructions,large,Other,Interventional,Drug,Phase 4,350,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-03-09,2007-07-01,2014-12-01,2014,2012-06-01,2012,NA,NA,NA,-2808,-98,-1011,249,1162,151,2020-07-01,2020-09-01,2021-08-15,10.1002/micr.22470,26251066,NA,2015-08-07,journal publication,TRUE,TRUE,doi,The value of perioperative antibiotics on the success of oral free flap reconstructions,Microsurgery,2015-Oct,2015-08-07,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0738-1085,Microsurgery,Wiley,2015-08-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT02436083,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Antibiotics in Free Flaps Reconstructions,large,Other,Interventional,Drug,Phase 4,350,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2015-03-09,2007-07-01,2014-12-01,2014,2012-06-01,2012,NA,NA,NA,-2808,-98,-1011,249,1162,151,2020-07-01,2020-09-01,2021-08-15,10.1002/micr.22470,26251066,NA,2015-08-07,journal publication,TRUE,TRUE,doi,The value of perioperative antibiotics on the success of oral free flap reconstructions,Microsurgery,2015-Oct,2015-08-07,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0738-1085,Microsurgery,Wiley,2015-08-07,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02362802,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Myocardial Minimal Damage After Rapid Ventricular Pacing,large,Other,Interventional,Device,NA,149,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2015-02-01,2014-09-01,2017-12-01,2017,2017-05-31,2017,NA,NA,NA,-153,1034,850,836,1020,1870,2020-07-01,2020-09-01,2021-08-15,10.1038/s41598-020-61625-8,32179792,NA,2020-03-16,journal publication,TRUE,TRUE,doi,Myocardial Minimal Damage After Rapid Ventricular Pacing - the prospective randomized multicentre MyDate-Trial,Scientific reports,2020-03-16,2020-03-16,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,2045-2322,Scientific Reports,Springer Science and Business Media LLC,2020-03-16,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02349880,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,A Shared Decision-making Training for Inpatients With Schizophrenia,large,Other,Interventional,Behavioral,NA,264,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-01-23,2011-10-01,2015-03-01,2015,2014-12-01,2014,NA,NA,NA,-1210,37,-53,671,761,708,2020-07-01,2020-09-01,2021-08-15,10.1007/s00127-016-1327-z,28040825,NA,2016-12-31,journal publication,TRUE,TRUE,doi,Training patients with schizophrenia to share decisions with their psychiatrists: a randomized-controlled trial,Social psychiatry and psychiatric epidemiology,2017-02,2016-12-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0933-7954,1433-9285",Social Psychiatry and Psychiatric Epidemiology,Springer Science and Business Media LLC,2016-12-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-12-31,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02337400,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Evaluation of a Cognitive Behavioral Smoking Reduction Program,large,Other,Interventional,Behavioral,NA,155,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2015-01-09,2015-01-01,2016-04-01,2016,2016-02-01,2016,NA,NA,NA,-8,448,388,439,499,887,2020-07-01,2020-09-01,2021-08-15,10.1007/s00406-017-0818-6,28616772,NA,2017-06-14,journal publication,TRUE,TRUE,doi,"Evaluation of the cognitive behavioral smoking reduction program ""Smoke_less"": a randomized controlled trial",European archives of psychiatry and clinical neuroscience,2018-Apr,2017-06-14,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0940-1334,1433-8491",European Archives of Psychiatry and Clinical Neuroscience,Springer Science and Business Media LLC,2017-06-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-06-14,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2742,7 +2742,7 @@ NCT02247778,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02217657,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,SmartTouch Catheter for Left Anterior Line - SmarT Line Study,large,Other,Interventional,Device,NA,75,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2014-08-14,2013-08-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,-378,840,840,656,656,1496,2020-07-01,2020-09-01,2021-08-15,10.1155/2018/9784259,30320138,NA,2018-09-18,journal publication,TRUE,TRUE,doi,Benefit of Contact Force Sensing Catheter Technology for Successful Left Atrial Anterior Line Formation: A Prospective Randomized Trial,BioMed research international,2018,2018-09-18,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,"2314-6133,2314-6141",BioMed Research International,Hindawi Limited,2018-09-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02203461,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication,large,Other,Interventional,Drug,Phase 1,30,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-07-28,2014-07-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,-27,65,65,553,553,618,2020-07-01,2020-09-01,2021-08-15,10.3851/imp3049,27050630,NA,2016-04-06,journal publication,TRUE,TRUE,doi,Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study,Antiviral therapy,2016,2016-04-06,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1359-6535,Antiviral therapy,SAGE Publications,2016-01-01,no_best_permission,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,NA NCT02188589,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse,large,Industry,Interventional,Device,NA,30,Completed,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2014-07-04,2014-04-01,2017-06-01,2017,2015-12-01,2015,2016-06-17,-349,199,-94,1063,515,-55,493,1008,2020-07-01,2020-09-01,2021-08-15,10.1055/s-0037-1598655,28388804,NA,2017-04-07,journal publication,TRUE,TRUE,doi,Absorbable Implant to Treat Nasal Valve Collapse,Facial plastic surgery : FPS,2017-04,2017-04-07,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,1188,1536,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0736-6825,1098-8793",Facial Plastic Surgery,Georg Thieme Verlag KG,2017-04-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT02149927,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers,large,Other,Interventional,Drug,Early Phase 1,20,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-22,2013-06-01,2014-01-01,2014,2013-12-01,2013,NA,NA,NA,-325,-111,-142,1035,1066,924,2020-07-01,2020-09-01,2021-08-15,10.1097/aln.0000000000001322,27617689,NA,2016-11-01,journal publication,TRUE,TRUE,doi,Neural Correlates of Sevoflurane-induced Unconsciousness Identified by Simultaneous Functional Magnetic Resonance Imaging and Electroencephalography,Anesthesiology,2016-11,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0003-3022,Anesthesiology,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",journal,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT02149927,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers,large,Other,Interventional,Drug,Early Phase 1,20,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-04-22,2013-06-01,2014-01-01,2014,2013-12-01,2013,NA,NA,NA,-325,-111,-142,1035,1066,924,2020-07-01,2020-09-01,2021-08-15,10.1097/aln.0000000000001322,27617689,NA,2016-11-01,journal publication,TRUE,TRUE,doi,Neural Correlates of Sevoflurane-induced Unconsciousness Identified by Simultaneous Functional Magnetic Resonance Imaging and Electroencephalography,Anesthesiology,2016-11,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,0003-3022,Anesthesiology,Ovid Technologies (Wolters Kluwer Health),2016-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",journal,12,2017-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT02148835,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Influence of Dietary Omega-3 Fatty Acids in Various triOMEG Sausages on the HS-Omega-3 Index in Healthy Individuals,large,Other,Interventional,Other,NA,44,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,TRUE,2014-05-23,2014-05-01,2014-12-01,2014,2014-12-01,2014,2017-07-12,954,954,-22,192,192,931,931,1123,2020-07-01,2020-09-01,2021-08-15,10.3390/nu9060629,28629180,NA,2017-06-19,journal publication,TRUE,TRUE,doi,Bioavailability of Dietary Omega-3 Fatty Acids Added to a Variety of Sausages in Healthy Individuals,Nutrients,2017-Jun-19,2017-06-19,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,gold,gold,2072-6643,Nutrients,MDPI AG,2017-06-19,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02126852,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia,large,Other,Interventional,Device,NA,214,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2014-04-28,2014-04-01,2016-04-01,2016,2016-04-01,2016,NA,NA,NA,-27,704,704,521,521,1225,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://mediatum.ub.tum.de/1304544,2017-09-04,dissertation,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,8,8,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02121704,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Magnetic Endoscope Imaging in Colonoscopy: Influence on Propofol Dosage,large,Other,Interventional,Device,NA,334,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-04-15,2014-05-01,2015-11-01,2015,2015-08-01,2015,NA,NA,NA,16,565,473,263,355,828,2020-07-01,2020-09-01,2021-08-15,10.1055/s-0042-110933,27441684,NA,2016-07-21,journal publication,TRUE,TRUE,doi,Magnetic endoscope imaging for routine colonoscopy: impact on propofol dosage and patient safety - a randomized trial,Endoscopy,2016-Oct,2016-07-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0013-726X,1438-8812",Endoscopy,Georg Thieme Verlag KG,2016-07-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2017-07-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2766,8 +2766,8 @@ NCT01741532,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01729481,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Gemcitabine Plus Erlotinib in RASH-positive Patients With Metastatic Pancreatic Cancer,large,Other,Interventional,Drug,Phase 2,150,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2012-10-23,2012-07-01,2017-12-01,2017,2015-07-01,2015,NA,NA,NA,-114,1865,981,109,993,1974,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ejca.2018.02.008,29549862,NA,2018-03-20,journal publication,TRUE,TRUE,doi,Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie',"European journal of cancer (Oxford, England : 1990)",2018-05,2018-03-20,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,1,1,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,0959-8049,European Journal of Cancer,Elsevier BV,2018-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01714414,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen,large,Other,Interventional,Drug,Phase 2,120,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-10-25,2012-12-01,2017-02-01,2017,2014-06-01,2014,NA,NA,NA,37,1560,584,0,976,1560,2020-07-01,2020-09-01,2021-08-15,10.1097/qad.0000000000001362,27941394,NA,2017-02-01,journal publication,TRUE,TRUE,doi,Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire,"AIDS (London, England)",2017-02-20,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1308,1656,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,green,green,0269-9370,AIDS,Ovid Technologies (Wolters Kluwer Health),2017-02-20,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01673776,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Multimodal Approach to Improve the Outcome of Patients With a Proximal Femoral Fracture,large,Other,Interventional,Device,NA,132,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-08-20,2012-03-01,2016-10-15,2016,2016-10-01,2016,NA,NA,NA,-172,1517,1503,1067,1081,2584,2020-07-01,2020-09-01,2021-08-15,10.1007/s12630-019-01475-9,31531828,NA,2019-09-17,journal publication,TRUE,TRUE,doi,Perioperative multi-system optimization protocol in elderly hip fracture patients: a randomized-controlled trial,Canadian journal of anaesthesia = Journal canadien d'anesthesie,2019-Dec,2019-09-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1417,1765,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0832-610X,1496-8975",Canadian Journal of Anesthesia/Journal canadien d'anesthésie,Springer Science and Business Media LLC,2019-09-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-12-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01673763,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Post-ERCP Pancreatitis Prevention by Stent Insertion,large,Other,Interventional,Device,NA,169,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2011-10-17,2010-07-01,2017-08-01,2017,2016-06-01,2016,NA,NA,NA,-473,2115,1689,701,1127,2816,2020-07-01,2020-09-01,2021-08-15,10.1055/a-0886-6384,31281872,NA,2019-07-03,journal publication,TRUE,TRUE,doi,Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial,Endoscopy international open,2019-Jul,2019-07-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,"2364-3722,2196-9736",Endoscopy International Open,Georg Thieme Verlag KG,2019-07-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01655290,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI,large,Other,Interventional,Other,Phase 2,20,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-07-30,2012-08-01,2014-06-01,2014,2013-05-01,2013,NA,NA,NA,2,671,275,128,524,799,2020-07-01,2020-09-01,2021-08-15,10.1097/rli.0000000000000076,24872002,NA,2014-10-07,journal publication,TRUE,TRUE,doi,Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T,Investigative radiology,2014-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0020-9996,Investigative Radiology,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01673763,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Post-ERCP Pancreatitis Prevention by Stent Insertion,large,Other,Interventional,Device,NA,169,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2011-10-17,2010-07-01,2017-08-01,2017,2016-06-01,2016,NA,NA,NA,-473,2115,1689,701,1127,2816,2020-07-01,2020-09-01,2021-08-15,10.1055/a-0886-6384,31281872,NA,2019-07-03,journal publication,TRUE,TRUE,doi,Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial,Endoscopy international open,2019-Jul,2019-07-03,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,"2364-3722,2196-9736",Endoscopy International Open,Georg Thieme Verlag KG,2019-07-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01655290,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI,large,Other,Interventional,Other,Phase 2,20,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-07-30,2012-08-01,2014-06-01,2014,2013-05-01,2013,NA,NA,NA,2,671,275,128,524,799,2020-07-01,2020-09-01,2021-08-15,10.1097/rli.0000000000000076,24872002,NA,2014-10-07,journal publication,TRUE,TRUE,doi,Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T,Investigative radiology,2014-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0020-9996,Investigative Radiology,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01632371,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4,large,Other,Interventional,Device,Phase 4,252,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-06-26,2012-06-01,2016-11-01,2016,2015-08-01,2015,NA,NA,NA,-25,1589,1131,251,709,1840,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcin.2017.04.024,28683939,NA,2017-07-10,journal publication,TRUE,TRUE,doi,Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial,JACC. Cardiovascular interventions,2017-07-10,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1936-8798,JACC: Cardiovascular Interventions,Elsevier BV,2017-07-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-07-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01627015,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula",large,Other,Interventional,Other,NA,50,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-06-21,2012-06-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-20,649,649,716,716,1365,2020-07-01,2020-09-01,2021-08-15,10.1371/journal.pone.0151614,26987056,NA,2016-03-17,journal publication,TRUE,TRUE,doi,"Effects of a Follow-On Formula Containing Isomaltulose (Palatinose™) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled Trial",PloS one,2016,2016-03-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1932-6203,PLOS ONE,Public Library of Science (PLoS),2016-03-17,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01607099,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility,large,Other,Interventional,Procedure,NA,220,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-24,2012-09-01,2014-11-01,2014,2014-02-01,2014,NA,NA,NA,100,891,618,193,466,1084,2020-07-01,2020-09-01,2021-08-15,10.1111/jgh.13010,25968966,NA,2015-05-13,journal publication,TRUE,TRUE,doi,Single-day sodium picosulfate and magnesium citrate versus split-dose polyethylene glycol for bowel cleansing prior to colonoscopy: A prospective randomized endoscopist-blinded trial,Journal of gastroenterology and hepatology,2015-Nov,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0815-9319,Journal of Gastroenterology and Hepatology,Wiley,2015-10-12,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-10-12,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2779,23 +2779,23 @@ NCT01521715,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01462994,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST),large,Other,Interventional,Other,Phase 3,25,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2011-10-25,2011-11-01,2016-03-01,2016,2015-12-01,2015,NA,NA,NA,7,1589,1498,1112,1203,2701,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.32282,30882891,NA,2019-03-18,journal publication,TRUE,TRUE,doi,Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST),International journal of cancer,2019-10-15,2019-04-29,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,5,0,0,0,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0020-7136,1097-0215",International Journal of Cancer,Wiley,2019-04-29,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2020-10-15,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01456364,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing,large,Other,Interventional,Drug,Phase 4,70,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2011-10-18,2011-09-01,2014-05-01,2014,2014-04-01,2014,NA,NA,NA,-47,926,896,769,799,1695,2020-07-01,2020-09-01,2021-08-15,10.1080/09537104.2016.1190007,27275651,NA,2016-06-08,journal publication,TRUE,TRUE,doi,Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study,Platelets,2016-Dec,2016-06-08,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0953-7104,1369-1635",Platelets,Informa UK Limited,2016-06-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2017-11-16,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01389375,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial,large,Other,Interventional,Device,Phase 4,4524,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-07-05,2011-07-01,2014-07-01,2014,2014-07-01,2014,NA,NA,NA,-4,1092,1092,141,141,1233,2020-07-01,2020-09-01,2021-08-15,10.1001/jama.2014.15305,25399273,NA,2014-11-19,journal publication,TRUE,TRUE,doi,Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial,JAMA,2014-Nov-19,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0098-7484,JAMA,American Medical Association (AMA),2014-11-19,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2015-05-18,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT01249638,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC,large,Other,Interventional,Drug,Phase 3,516,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-29,2010-12-01,2016-12-01,2016,2013-12-01,2013,NA,NA,NA,2,2194,1098,701,1797,2895,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.18.00052,NA,NA,2018-11-02,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2019-01-01,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-01-01,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT01229306,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation,large,Other,Interventional,Procedure,NA,108,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-26,2010-07-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,-117,1163,979,413,597,1576,2020-07-01,2020-09-01,2021-08-15,10.1093/europace/euu389,25694536,NA,2015-02-18,journal publication,TRUE,TRUE,doi,"Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial","Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2015-Sep,2015-02-18,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2015-02-18,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-02-18,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01181206,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität München,large,Other,Interventional,Procedure,NA,516,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2014-02-01,2014,2013-08-01,2013,NA,NA,NA,-10,1270,1086,273,457,1543,2020-07-01,2020-09-01,2021-08-15,10.1097/sla.0000000000000954,25379844,NA,2014-11-01,journal publication,TRUE,TRUE,doi,Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206),Annals of surgery,2014-Nov,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01160419,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer,large,Other,Interventional,Drug,Phase 2,49,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-10-22,2009-12-01,2014-05-01,2014,2011-05-01,2011,NA,NA,NA,40,1652,556,235,1331,1887,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.29403,25530271,NA,2014-12-22,journal publication,TRUE,TRUE,doi,NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors,International journal of cancer,2015-Aug-01,2015-02-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2015-02-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-02-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01249638,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC,large,Other,Interventional,Drug,Phase 3,516,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-11-29,2010-12-01,2016-12-01,2016,2013-12-01,2013,NA,NA,NA,2,2194,1098,701,1797,2895,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.18.00052,NA,NA,2018-11-02,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,2,2,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2019-01-01,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-01-01,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01229306,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation,large,Other,Interventional,Procedure,NA,108,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-10-26,2010-07-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,-117,1163,979,413,597,1576,2020-07-01,2020-09-01,2021-08-15,10.1093/europace/euu389,25694536,NA,2015-02-18,journal publication,TRUE,TRUE,doi,"Recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation: is repeat pulmonary vein isolation enough? A prospective, randomized trial","Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",2015-Sep,2015-02-18,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1099-5129,1532-2092",Europace,Oxford University Press (OUP),2015-02-18,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-02-18,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01181206,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Covering of the Abdominal Wall in Laparotomies: Differences in Surgical Site Infections Between an Approved Abdominal 3M™ Steri-Drape™ Wound Edge Protector and Standard Woven Swabs at Technische Universität München,large,Other,Interventional,Procedure,NA,516,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2010-08-11,2010-08-01,2014-02-01,2014,2013-08-01,2013,NA,NA,NA,-10,1270,1086,273,457,1543,2020-07-01,2020-09-01,2021-08-15,10.1097/sla.0000000000000954,25379844,NA,2014-11-01,journal publication,TRUE,TRUE,doi,Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206),Annals of surgery,2014-Nov,NA,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0003-4932,Annals of Surgery,Ovid Technologies (Wolters Kluwer Health),2014-11-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01160419,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer,large,Other,Interventional,Drug,Phase 2,49,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-10-22,2009-12-01,2014-05-01,2014,2011-05-01,2011,NA,NA,NA,40,1652,556,235,1331,1887,2020-07-01,2020-09-01,2021-08-15,10.1002/ijc.29403,25530271,NA,2014-12-22,journal publication,TRUE,TRUE,doi,NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors,International journal of cancer,2015-Aug-01,2015-02-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0020-7136,International Journal of Cancer,Wiley,2015-02-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2016-02-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01083394,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery,large,Other,Interventional,Device,Phase 4,70,Unknown status,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2010-02-26,2010-03-01,2015-12-01,2015,2014-12-01,2014,NA,NA,NA,3,2104,1739,602,967,2706,2020-07-01,2020-09-01,2021-08-15,10.1161/jaha.117.006321,28743787,NA,2017-07-25,journal publication,TRUE,TRUE,doi,ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial,Journal of the American Heart Association,2017-Jul-25,2017-07-25,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2047-9980,Journal of the American Heart Association,Ovid Technologies (Wolters Kluwer Health),2017-07-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT00986752,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,"Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease",large,Other,Interventional,Device,Phase 4,150,Unknown status,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2009-09-29,2009-07-01,2015-03-01,2015,2014-12-01,2014,NA,NA,NA,-90,1979,1889,780,870,2759,2020-07-01,2020-09-01,2021-08-15,10.1161/circulationaha.116.025329,28424222,NA,2017-04-19,journal publication,TRUE,TRUE,doi,Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH),Circulation,2017-Jun-06,2017-04-19,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"0009-7322,1524-4539",Circulation,Ovid Technologies (Wolters Kluwer Health),2017-06-06,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2018-06-06,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00976092,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction,large,Other,Interventional,Drug,Phase 4,548,Unknown status,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2009-09-11,2009-09-01,2015-02-01,2015,2014-02-01,2014,NA,NA,NA,-10,1969,1604,-268,97,1701,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehu182,24816809,NA,2014-05-09,journal publication,TRUE,TRUE,doi,Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction,European heart journal,2014-Sep-07,2014-05-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2014-05-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2015-09-02,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00874848,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,large,Industry,Interventional,Biological,Phase 2,90,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-01,2009-08-01,2015-08-01,2015,2012-11-01,2012,2016-07-15,349,1352,122,2313,1310,593,1596,2906,2020-07-01,2020-09-01,2021-08-15,10.1007/s10637-017-0450-3,28303530,NA,2017-03-16,journal publication,TRUE,TRUE,doi,"A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer",Investigational new drugs,2017-06,2017-03-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,1,1,1858,2206,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0167-6997,1573-0646",Investigational New Drugs,Springer Science and Business Media LLC,2017-03-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT00874848,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer,large,Industry,Interventional,Biological,Phase 2,90,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,TRUE,2009-04-01,2009-08-01,2015-08-01,2015,2012-11-01,2012,2016-07-15,349,1352,122,2313,1310,593,1596,2906,2020-07-01,2020-09-01,2021-08-15,10.1007/s10637-017-0450-3,28303530,NA,2017-03-16,journal publication,TRUE,TRUE,doi,"A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer",Investigational new drugs,2017-06,2017-03-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,1,1,1858,2206,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,hybrid,hybrid,"0167-6997,1573-0646",Investigational New Drugs,Springer Science and Business Media LLC,2017-03-16,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00874107,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC),large,Industry,Interventional,Biological,Phase 2,90,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2009-04-01,2009-06-01,2016-05-01,2016,2016-04-01,2016,NA,NA,NA,61,2587,2557,667,697,3254,2020-07-01,2020-09-01,2021-08-15,10.1186/s40425-018-0324-z,29486797,NA,2018-02-27,journal publication,TRUE,TRUE,doi,"A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer",Journal for immunotherapy of cancer,2018-02-27,2018-02-27,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,3,0,3,3,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2051-1426,Journal for ImmunoTherapy of Cancer,BMJ,2018-02-27,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00776633,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation,large,Other,Interventional,Drug,Phase 4,614,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-20,2008-09-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-49,2142,1868,239,513,2381,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2015.02.050,25908066,NA,2015-04-28,journal publication,TRUE,TRUE,doi,Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial,Journal of the American College of Cardiology,2015-Apr-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00727207,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy,large,Other,Interventional,Drug,Phase 2,35,Terminated,NA,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2008-07-31,2008-05-01,2014-09-01,2014,2011-05-01,2011,NA,NA,NA,-91,2223,1004,211,1430,2434,2020-07-01,2020-09-01,2021-08-15,10.3109/10428194.2015.1028055,25754578,NA,2015-03-31,journal publication,TRUE,TRUE,doi,Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study,Leukemia & lymphoma,2015,2015-03-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2015-03-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-11-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00776633,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation,large,Other,Interventional,Drug,Phase 4,614,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2008-10-20,2008-09-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-49,2142,1868,239,513,2381,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jacc.2015.02.050,25908066,NA,2015-04-28,journal publication,TRUE,TRUE,doi,Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial,Journal of the American College of Cardiology,2015-Apr-28,NA,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,6,6,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0735-1097,Journal of the American College of Cardiology,Elsevier BV,2015-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-04-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00727207,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy,large,Other,Interventional,Drug,Phase 2,35,Terminated,NA,Non-Randomized,FALSE,FALSE,FALSE,FALSE,2008-07-31,2008-05-01,2014-09-01,2014,2011-05-01,2011,NA,NA,NA,-91,2223,1004,211,1430,2434,2020-07-01,2020-09-01,2021-08-15,10.3109/10428194.2015.1028055,25754578,NA,2015-03-31,journal publication,TRUE,TRUE,doi,Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study,Leukemia & lymphoma,2015,2015-03-31,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2015-03-31,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2016-11-02,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00688571,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Melody Transcatheter Pulmonary Valve (TPV) Post-Market Surveillance Study,large,Industry,Interventional,Device,NA,63,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2008-05-30,2007-10-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-242,2376,2376,-545,-545,1831,2020-07-01,2020-09-01,2021-08-15,10.1161/circinterventions.112.000087,23735475,NA,2013-06-04,journal publication,TRUE,TRUE,doi,Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies,Circulation. Cardiovascular interventions,2013-Jun,2013-06-04,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,2,0,2,0,2,2,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"1941-7640,1941-7632",Circulation: Cardiovascular Interventions,Ovid Technologies (Wolters Kluwer Health),2013-06-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2014-06-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00661206,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting,large,Other,Interventional,Drug,Phase 4,4005,Unknown status,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2008-04-15,2008-09-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,139,2391,2391,83,83,2474,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehu523,25616646,NA,2015-01-23,journal publication,TRUE,TRUE,doi,"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting",European heart journal,2015-May-21,2015-01-23,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2015-01-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-01-23,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00433927,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)",large,Other,Interventional,Drug,Phase 3,568,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2007-02-09,2007-01-01,2016-12-01,2016,2014-04-01,2014,NA,NA,NA,-39,3583,2608,-854,121,2729,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(14)70330-4,25088940,NA,2014-07-31,journal publication,TRUE,TRUE,doi,"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial",The Lancet. Oncology,2014-Sep,2014-07-31,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2014-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2015-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00338689,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,FALSE,FALSE,TRUE,TRUE,LMU-München,NA,European Childhood Obesity Project: Early Programming by Infant Nutrition?,large,Other,Interventional,Dietary Supplement,NA,1678,"Active, not recruiting",Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2006-06-19,2002-10-01,2022-09-01,2022,2006-08-01,2006,NA,NA,NA,-1357,5918,43,-4880,995,1038,2020-07-01,2020-09-01,2021-08-15,10.3945/ajcn.2008.27091,19386747,NA,2009-04-22,journal publication,TRUE,TRUE,doi,Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial,The American journal of clinical nutrition,2009-Jun,2009-04-22,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,19,19,-730,-382,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0002-9165,1938-3207",The American Journal of Clinical Nutrition,Oxford University Press (OUP),2009-04-22,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,TRUE,NA,NA -NCT01209286,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,36,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2010-09-23,2010-10-01,2016-10-01,2016,2012-03-01,2012,2014-12-23,-648,1027,8,2200,525,-691,984,1509,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2014.56.3247,25385737,NA,2014-11-10,journal publication,TRUE,TRUE,doi,Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2014-Dec-20,2014-11-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1431,1779,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2014-12-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT00560794,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,21,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-11-19,2008-01-01,2014-11-01,2014,2009-09-01,2009,2014-12-23,52,1939,43,2539,652,-899,988,1640,2020-07-01,2020-09-01,2021-08-15,10.1182/blood-2012-01-400515,22592608,NA,2012-05-16,journal publication,TRUE,TRUE,doi,Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab,Blood,2012-Jun-28,2012-05-16,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,2131,2479,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-06-28,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-06-28,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT01209286,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,36,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,TRUE,2010-09-23,2010-10-01,2016-10-01,2016,2012-03-01,2012,2014-12-23,-648,1027,8,2200,525,-691,984,1509,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2014.56.3247,25385737,NA,2014-11-10,journal publication,TRUE,TRUE,doi,Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2014-Dec-20,2014-11-10,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1431,1779,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2014-12-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-12-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00560794,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL),small,Industry,Interventional,Biological,Phase 2,21,Completed,None (Open Label),NA,NA,TRUE,TRUE,TRUE,2007-11-19,2008-01-01,2014-11-01,2014,2009-09-01,2009,2014-12-23,52,1939,43,2539,652,-899,988,1640,2020-07-01,2020-09-01,2021-08-15,10.1182/blood-2012-01-400515,22592608,NA,2012-05-16,journal publication,TRUE,TRUE,doi,Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab,Blood,2012-Jun-28,2012-05-16,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,3,3,2131,2479,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,closed,closed,"0006-4971,1528-0020",Blood,American Society of Hematology,2012-06-28,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2013-06-28,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE NCT03323528,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis,small,Industry,Interventional,Drug,Phase 4,321,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2017-10-24,2017-02-01,2017-11-15,2017,2017-07-02,2017,NA,NA,NA,-265,22,-114,336,472,358,2020-07-01,2020-09-01,2021-08-15,10.1111/ijcp.13272,30329199,https://onlinelibrary.wiley.com/doi/full/10.1111/ijcp.13272,2018-10-17,journal publication,TRUE,TRUE,doi,"Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-group trial (DoriPha)",International journal of clinical practice,2018-Dec,2018-10-17,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1021,1369,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1368-5031,International Journal of Clinical Practice,Wiley,2018-10-17,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02695940,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis,small,Industry,Interventional,Drug,Phase 2,69,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-02-18,2016-03-01,2016-09-01,2016,2016-09-01,2016,NA,NA,NA,12,196,196,408,408,604,2020-07-01,2020-09-01,2021-08-15,NA,NA,https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-002098-40/results,2017-10-14,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02325440,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya,small,Other,Interventional,Drug,Phase 4,15,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-09-04,2014-03-01,2016-04-01,2016,2016-04-01,2016,NA,NA,NA,-187,575,575,829,829,1404,2020-07-01,2020-09-01,2021-08-15,10.3389/fimmu.2018.01560,30050529,https://pubmed.ncbi.nlm.nih.gov/30050529/,2018-07-09,journal publication,TRUE,TRUE,doi,Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study,Frontiers in immunology,2018,2018-07-09,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,1,1,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1664-3224,Frontiers in Immunology,Frontiers Media SA,2018-07-09,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2806,11 +2806,11 @@ NCT01970384,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01956175,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Electrical Pharyngeal Stimulation for Dysphagia Therapy in Tracheostomized Stroke Patients,small,Other,Interventional,Device,NA,30,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-09-24,2013-06-01,2014-12-01,2014,2014-08-01,2014,NA,NA,NA,-115,433,311,194,316,627,2020-07-01,2020-09-01,2021-08-15,10.1007/s00134-015-3897-8,26077087,https://pubmed.ncbi.nlm.nih.gov/26077087/,2015-06-13,journal publication,TRUE,TRUE,doi,Electrical pharyngeal stimulation for dysphagia treatment in tracheotomized stroke patients: a randomized controlled trial,Intensive care medicine,2015-Sep,2015-06-13,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0342-4642,1432-1238",Intensive Care Medicine,Springer Science and Business Media LLC,2015-06-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-06-13,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01520103,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer,small,Other,Interventional,Drug,Phase 2,139,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-01-25,2012-01-01,2016-10-31,2016,2016-10-31,2016,NA,NA,NA,-24,1741,1741,932,932,2673,2020-07-01,2020-09-01,2021-08-15,10.1007/s10549-019-05280-2,31115844,https://pubmed.ncbi.nlm.nih.gov/31115844/,2019-05-21,journal publication,TRUE,TRUE,doi,VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer,Breast cancer research and treatment,2019-Aug,2019-05-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,1,1,1,1,1401,1749,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"0167-6806,1573-7217",Breast Cancer Research and Treatment,Springer Science and Business Media LLC,2019-05-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-05-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01361334,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible,small,Other,Interventional,Drug,Phase 2,20,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-05-17,2011-06-01,2016-03-01,2016,2016-03-01,2016,NA,NA,NA,15,1750,1750,1115,1115,2865,2020-07-01,2020-09-01,2021-08-15,10.1007/s00277-019-03651-9,30903275,https://pubmed.ncbi.nlm.nih.gov/30903275/,2019-03-21,journal publication,TRUE,TRUE,doi,"Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)",Annals of hematology,2019-Jun,2019-03-21,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0939-5555,1432-0584",Annals of Hematology,Springer Science and Business Media LLC,2019-03-21,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-03-21,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01352988,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Münster Münster,NA,Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus,small,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-29,2011-07-01,2014-02-01,2014,2013-10-01,2013,NA,NA,NA,63,1009,886,822,945,1831,2020-07-01,2020-09-01,2021-08-15,10.1177/0961203316644335,27147621,https://journals.sagepub.com/doi/10.1177/0961203316644335,2016-05-03,journal publication,TRUE,TRUE,doi,"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study",Lupus,2016-Oct,2016-05-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0961-2033,1477-0962",Lupus,SAGE Publications,2016-07-11,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT01352988,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus,small,Other,Interventional,Drug,Phase 2,11,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-29,2011-07-01,2014-02-01,2014,2013-10-01,2013,NA,NA,NA,63,1009,886,822,945,1831,2020-07-01,2020-09-01,2021-08-15,10.1177/0961203316644335,27147621,https://journals.sagepub.com/doi/10.1177/0961203316644335,2016-05-03,journal publication,TRUE,TRUE,doi,"Fumaric acid ester treatment in cutaneous lupus erythematosus (CLE): a prospective, open-label, phase II pilot study",Lupus,2016-Oct,2016-05-03,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0961-2033,1477-0962",Lupus,SAGE Publications,2016-07-11,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT01223677,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Rumination-focused CBT Training for the Prevention of Depression and Anxiety,small,Other,Interventional,Behavioral,Phase 1,251,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-12,2010-10-01,2014-09-01,2014,2014-09-01,2014,NA,NA,NA,-11,1420,1420,844,844,2264,2020-07-01,2020-09-01,2021-08-15,10.1016/j.brat.2016.12.015,28049069,https://pubmed.ncbi.nlm.nih.gov/28049069/,2016-12-23,journal publication,TRUE,TRUE,doi,Prevention of anxiety disorders and depression by targeting excessive worry and rumination in adolescents and young adults: A randomized controlled trial,Behaviour research and therapy,2017-03,2016-12-23,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0005-7967,Behaviour Research and Therapy,Elsevier BV,2017-03-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,24,2019-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01097967,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy,small,Other,Interventional,Other,Phase 4,246,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-04-01,2010-07-01,2016-04-01,2016,2016-04-01,2016,NA,NA,NA,91,2192,2192,-806,-806,1386,2020-07-01,2020-09-01,2021-08-15,10.1159/000356323,24435018,https://pubmed.ncbi.nlm.nih.gov/24435018/,2014-01-16,journal publication,TRUE,TRUE,doi,Longitudinal polysomnographic assessment from acute to subacute phase in infratentorial versus supratentorial stroke,"Cerebrovascular diseases (Basel, Switzerland)",2014,2014-01-16,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,13,13,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1015-9770,1421-9786",Cerebrovascular Diseases,S. Karger AG,2014-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2015-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00976222,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments,small,Other,Interventional,Drug,Phase 4,40,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-09-11,2008-12-01,2015-12-01,2015,2014-12-01,2014,NA,NA,NA,-284,2272,1907,409,774,2681,2020-07-01,2020-09-01,2021-08-15,10.1111/aos.13359,28084038,https://pubmed.ncbi.nlm.nih.gov/28084038/,2017-01-13,journal publication,TRUE,TRUE,doi,"Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study",Acta ophthalmologica,2017-Nov,2017-01-13,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1755-375X,Acta Ophthalmologica,Wiley,2017-01-13,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT00714311,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Münster Münster,NA,Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder,small,Other,Interventional,Behavioral,NA,104,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-07-09,2004-10-01,2015-02-01,2015,2009-02-01,2009,2015-02-04,3,2194,-1377,2398,207,-1737,454,661,2020-07-01,2020-09-01,2021-08-15,10.1192/bjp.bp.109.070177,20435966,https://pubmed.ncbi.nlm.nih.gov/20435966/,2010-05-01,journal publication,TRUE,TRUE,doi,Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial,The British journal of psychiatry : the journal of mental science,2010-May,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2039,2387,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2010-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2010-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT00714311,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder,small,Other,Interventional,Behavioral,NA,104,Completed,Single,Randomized,TRUE,TRUE,FALSE,TRUE,2008-07-09,2004-10-01,2015-02-01,2015,2009-02-01,2009,2015-02-04,3,2194,-1377,2398,207,-1737,454,661,2020-07-01,2020-09-01,2021-08-15,10.1192/bjp.bp.109.070177,20435966,https://pubmed.ncbi.nlm.nih.gov/20435966/,2010-05-01,journal publication,TRUE,TRUE,doi,Transference-focused psychotherapy v. treatment by community psychotherapists for borderline personality disorder: randomised controlled trial,The British journal of psychiatry : the journal of mental science,2010-May,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,8,8,2039,2387,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,bronze,bronze,"0007-1250,1472-1465",British Journal of Psychiatry,Royal College of Psychiatrists,2010-05-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2010-11-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT04209309,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal,small,Other,Interventional,Device,NA,19,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2019-12-17,2014-10-01,2016-07-01,2016,2016-07-01,2016,NA,NA,NA,-1903,-1264,-1264,1451,1451,187,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jsxm.2020.05.002,32580914,https://www.jsm.jsexmed.org/article/S1743-6095(20)30609-3/abstract,2020-06-21,journal publication,TRUE,TRUE,doi,Repetitive Transcranial Magnetic Stimulation as a Potential Tool to Reduce Sexual Arousal: A Proof of Concept Study,The journal of sexual medicine,2020-08,2020-06-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,1743-6095,The Journal of Sexual Medicine,Elsevier BV,2020-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2021-08-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02993510,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,A Randomized Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.,small,Industry,Interventional,Procedure,Phase 3,67,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2016-12-02,2003-12-01,2016-07-01,2016,2015-12-01,2015,NA,NA,NA,-4750,-154,-367,-1155,-942,-1309,2020-07-01,2020-09-01,2021-08-15,10.2174/1874325001307010133,23730377,https://pubmed.ncbi.nlm.nih.gov/23730377/,2013-05-03,journal publication,TRUE,TRUE,doi,"A Randomized, Controlled Trial Comparing Autologous Matrix-Induced Chondrogenesis (AMIC®) to Microfracture: Analysis of 1- and 2-Year Follow-Up Data of 2 Centers",The open orthopaedics journal,2013,2013-05-03,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1874-3250,The Open Orthopaedics Journal,Bentham Science Publishers Ltd.,2013-05-03,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02990208,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Diaphragmatic Breathing During Virtual Reality Exposure Therapy for Aviophobia,small,Other,Interventional,Behavioral,NA,30,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2016-12-05,2014-01-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,-1069,-431,-431,475,475,44,2020-07-01,2020-09-01,2021-08-15,10.1186/s12888-016-1181-2,28100203,https://pubmed.ncbi.nlm.nih.gov/28100203/,2017-01-18,journal publication,TRUE,TRUE,doi,Diaphragmatic breathing during virtual reality exposure therapy for aviophobia: functional coping strategy or avoidance behavior? a pilot study,BMC psychiatry,2017-01-18,2017-01-18,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,1471-244X,BMC Psychiatry,Springer Science and Business Media LLC,2017-01-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2829,14 +2829,14 @@ NCT01656135,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT01614301,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,"Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma",small,Other,Interventional,Drug,Phase 1/Phase 2,136,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-06-05,2012-05-01,2016-05-01,2016,2014-05-01,2014,NA,NA,NA,-35,1426,695,-215,516,1211,2020-07-01,2020-09-01,2021-08-15,10.1111/jdv.13391,26417987,https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.13391,2015-09-29,journal publication,TRUE,TRUE,doi,"Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial",Journal of the European Academy of Dermatology and Venereology : JEADV,2016-Nov,2015-09-29,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,"0926-9959,1468-3083",Journal of the European Academy of Dermatology and Venereology,Wiley,2015-09-29,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01540344,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Combined Anticancer Treatment of Advanced Colon Cancer,small,Other,Interventional,Procedure,Phase 2,26,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2012-02-19,2010-10-01,2017-10-01,2017,2015-09-01,2015,NA,NA,NA,-506,2051,1290,303,1064,2354,2020-07-01,2020-09-01,2021-08-15,10.1016/j.clcc.2018.07.011,30131226,https://pubmed.ncbi.nlm.nih.gov/30131226/,2018-07-31,journal publication,TRUE,TRUE,doi,"Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial",Clinical colorectal cancer,2018-12,2018-07-31,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,4,4,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,1533-0028,Clinical Colorectal Cancer,Elsevier BV,2018-12-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2019-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01229774,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty,small,Other,Interventional,Drug,Phase 3,100,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-27,2011-02-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,97,1374,1374,609,609,1983,2020-07-01,2020-09-01,2021-08-15,10.1007/s00264-015-3077-z,26728611,https://www.springermedizin.de/comparative-clinical-study-of-the-prophylaxis-of-heterotopic-oss/8241318,2016-04-01,journal publication,TRUE,TRUE,doi,Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac,International orthopaedics,2016-Apr,2016-01-04,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0341-2695,1432-5195",International Orthopaedics,Springer Science and Business Media LLC,2016-01-04,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-01-04,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01010243,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial,small,Other,Interventional,Drug,Phase 1/Phase 2,54,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-11-06,2009-10-01,2016-10-01,2016,2013-10-01,2013,NA,NA,NA,-36,2521,1425,961,2057,3482,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2019.37.15_suppl.8037,NA,https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.8037,2019-05-20,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2019-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT00355862,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma,small,Other,Interventional,Drug,Phase 3,525,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2006-07-24,2006-01-01,2014-05-01,2014,2009-04-01,2009,NA,NA,NA,-204,2838,982,610,2466,3448,2020-07-01,2020-09-01,2021-08-15,10.1097/tp.0000000000000965,26555945,https://pubmed.ncbi.nlm.nih.gov/26555945/,2016-01-01,journal publication,TRUE,TRUE,doi,"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial",Transplantation,2016-Jan,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,0,1,1,5,5,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0041-1337,Transplantation,Ovid Technologies (Wolters Kluwer Health),2016-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01010243,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial,small,Other,Interventional,Drug,Phase 1/Phase 2,54,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2009-11-06,2009-10-01,2016-10-01,2016,2013-10-01,2013,NA,NA,NA,-36,2521,1425,961,2057,3482,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2019.37.15_suppl.8037,NA,https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.8037,2019-05-20,journal publication,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2019-05-20,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2020-05-20,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE +NCT00355862,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma,small,Other,Interventional,Drug,Phase 3,525,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2006-07-24,2006-01-01,2014-05-01,2014,2009-04-01,2009,NA,NA,NA,-204,2838,982,610,2466,3448,2020-07-01,2020-09-01,2021-08-15,10.1097/tp.0000000000000965,26555945,https://pubmed.ncbi.nlm.nih.gov/26555945/,2016-01-01,journal publication,TRUE,TRUE,doi,"Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial",Transplantation,2016-Jan,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,0,1,1,5,5,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,0041-1337,Transplantation,Ovid Technologies (Wolters Kluwer Health),2016-01-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02247180,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Cognitive Rehabilitation in Alzheimer's Disease,small,Other,Interventional,Behavioral,NA,14,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2014-09-16,2014-09-01,2015-12-01,2015,2015-05-01,2015,NA,NA,NA,-15,441,227,505,719,946,2020-07-01,2020-09-01,2021-08-15,10.3233/jad-160771,28372325,https://content.iospress.com/articles/journal-of-alzheimers-disease/jad160771,2017-04-19,journal publication,TRUE,TRUE,doi,Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial,Journal of Alzheimer's disease : JAD,2017,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1387-2877,1875-8908",Journal of Alzheimer's Disease,IOS Press,2017-04-19,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,FALSE,NA,NA NCT02175953,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Short-term Caregiver Psychotherapy,small,Other,Interventional,Behavioral,Phase 2,13,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-06-24,2014-06-01,2016-05-01,2016,2015-11-01,2015,NA,NA,NA,-23,677,495,988,1170,1665,2020-07-01,2020-09-01,2021-08-15,10.1007/s00391-018-01501-3,NA,https://link.springer.com/article/10.1007/s00391-018-01501-3,2019-01-14,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,6,4,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0948-6704,1435-1269",Zeitschrift für Gerontologie und Geriatrie,Springer Science and Business Media LLC,2019-01-14,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-11-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02096562,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Knee Swelling Under Use of Compression Stockings After Outpatient Surgery,small,Other,Interventional,Other,NA,27,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-11-11,2013-07-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,-133,475,475,1500,1500,1975,2020-07-01,2020-09-01,2021-08-15,10.1186/s12891-019-2540-1,NA,https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-019-2540-1,2019-04-09,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,TRUE,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1471-2474,BMC Musculoskeletal Disorders,Springer Science and Business Media LLC,2019-04-09,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02051621,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Therapy of Atrial Flutter by Afib Ablation,small,Other,Interventional,Drug,NA,100,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2013-12-03,2010-08-01,2017-08-01,2017,2015-08-01,2015,NA,NA,NA,-1220,1337,606,-913,-182,424,2020-07-01,2020-09-01,2021-08-15,10.1016/j.hrthm.2015.01.040,25638698,https://www.sciencedirect.com/science/article/pii/S1547527115001393?via%3Dihub,2015-01-31,journal publication,TRUE,TRUE,doi,Pulmonary vein triggers play an important role in the initiation of atrial flutter: Initial results from the prospective randomized Atrial Fibrillation Ablation in Atrial Flutter (Triple A) trial,Heart rhythm,2015-May,2015-01-28,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,hybrid,hybrid,1547-5271,Heart Rhythm,Elsevier BV,2015-05-01,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01896245,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Laryngeal Injuries After Anesthesia Induction With Three Different Sevoflurane Concentrations (Without Muscle Relaxant),small,Other,Interventional,Drug,NA,90,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-07-05,2013-07-01,2014-09-01,2014,2014-08-01,2014,NA,NA,NA,-4,423,392,970,1001,1393,2020-07-01,2020-09-01,2021-08-15,10.1177/0300060517701355,28449630,https://journals.sagepub.com/doi/10.1177/0300060517701355?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov,2017-04-28,journal publication,TRUE,TRUE,doi,Sevoflurane at 1.0 MAC together with remifentanil and propofol produces clinically acceptable intubation conditions at the vocal cords: A prospective randomized study,The Journal of international medical research,2017-Jun,2017-04-28,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"0300-0605,1473-2300",Journal of International Medical Research,SAGE Publications,2017-04-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT01433523,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Rostock Rostock,NA,House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma,small,Industry,Interventional,Drug,Phase 3,834,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-26,2011-08-01,2014-02-01,2014,2013-04-01,2013,NA,NA,NA,-25,890,584,815,1121,1705,2020-07-01,2020-09-01,2021-08-15,10.1001/jama.2016.3964,27115376,https://jamanetwork.com/journals/jama/fullarticle/2516714,2016-04-26,journal publication,TRUE,TRUE,doi,Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial,JAMA,2016-Apr-26,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,1,1,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0098-7484,JAMA,American Medical Association (AMA),2016-04-26,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2016-10-26,TRUE,FALSE,FALSE,TRUE,FALSE,NA +NCT01433523,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma,small,Industry,Interventional,Drug,Phase 3,834,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-26,2011-08-01,2014-02-01,2014,2013-04-01,2013,NA,NA,NA,-25,890,584,815,1121,1705,2020-07-01,2020-09-01,2021-08-15,10.1001/jama.2016.3964,27115376,https://jamanetwork.com/journals/jama/fullarticle/2516714,2016-04-26,journal publication,TRUE,TRUE,doi,Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial,JAMA,2016-Apr-26,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,1,0,1,1,1,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,0098-7484,JAMA,American Medical Association (AMA),2016-04-26,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2016-10-26,TRUE,FALSE,FALSE,TRUE,FALSE,NA NCT01282918,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,NORDIC ICD (Cardioverter Defibrillator Implantation) Trial,small,Industry,Interventional,Device,NA,1077,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-01-18,2011-02-01,2015-05-01,2015,2014-12-01,2014,NA,NA,NA,14,1564,1413,55,206,1619,2020-07-01,2020-09-01,2021-08-15,10.1093/eurheartj/ehv292,26112885,https://academic.oup.com/eurheartj/article/36/37/2500/2466025,2015-06-25,journal publication,TRUE,TRUE,doi,Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial,European heart journal,2015-Oct-01,2015-06-25,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0195-668X,1522-9645",European Heart Journal,Oxford University Press (OUP),2015-06-25,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2016-06-25,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT00950274,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery,small,Industry,Interventional,Drug,Phase 3,81,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-07-30,2009-07-01,2017-09-01,2017,2016-03-01,2016,NA,NA,NA,-29,2955,2406,-34,515,2921,2020-07-01,2020-09-01,2021-08-15,10.1016/j.ebiom.2017.07.022,28781130,https://www.sciencedirect.com/science/article/pii/S2352396417302967?via%3Dihub,2017-07-29,journal publication,TRUE,TRUE,doi,Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133+ Application After Myocardial Infarction,EBioMedicine,2017-Aug,2017-07-29,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,3,3,1096,1444,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,gold,gold,2352-3964,EBioMedicine,Elsevier BV,2017-08-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02941432,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Black Tea Compresses for Facial Eczema and Perioral Dermatitis,large,Other,Interventional,Other,NA,26,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2016-10-16,2016-09-01,2017-09-01,2017,2017-09-01,2017,NA,NA,NA,-45,320,320,520,520,840,2020-07-01,2020-09-01,2021-08-15,10.1080/09546634.2019.1573306,30668184,https://pubmed.ncbi.nlm.nih.gov/30668184/,2019-02-03,journal publication,TRUE,TRUE,doi,Black tea dressings - a rapidly effective treatment for facial dermatitis,The Journal of dermatological treatment,2019-Dec,2019-02-03,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1096,1444,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0954-6634,1471-1753",Journal of Dermatological Treatment,Informa UK Limited,2019-02-03,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2020-02-03,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2861,8 +2861,8 @@ NCT01636752,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE, NCT01635660,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation,large,Other,Interventional,Device,NA,182,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2012-07-04,2011-10-01,2015-06-01,2015,2014-07-01,2014,NA,NA,NA,-277,1062,727,1065,1400,2127,2020-07-01,2020-09-01,2021-08-15,10.1213/ane.0000000000002735,29239965,https://pubmed.ncbi.nlm.nih.gov/29239965/,2018-05-01,journal publication,TRUE,TRUE,doi,"Videolaryngoscopy for Physician-Based, Prehospital Emergency Intubation: A Prospective, Randomized, Multicenter Comparison of Different Blade Types Using A.P. Advance, C-MAC System, and KingVision",Anesthesia and analgesia,2018-05,NA,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,0003-2999,Anesthesia & Analgesia,Ovid Technologies (Wolters Kluwer Health),2018-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2019-05-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01617343,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients,large,Other,Interventional,Behavioral,Phase 3,23,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-06-05,2012-08-01,2014-02-01,2014,2014-02-01,2014,NA,NA,NA,57,606,606,131,131,737,2020-07-01,2020-09-01,2021-08-15,10.1161/strokeaha.114.006059,24923723,https://pubmed.ncbi.nlm.nih.gov/24923723/,2014-06-12,journal publication,TRUE,TRUE,doi,Randomized controlled trial on hemifield eye patching and optokinetic stimulation in acute spatial neglect,Stroke,2014-Aug,2014-06-12,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0039-2499,1524-4628",Stroke,Ovid Technologies (Wolters Kluwer Health),2014-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2015-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01423747,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia,large,Other,Interventional,Drug,Phase 3,400,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2011-08-25,2003-07-01,2016-09-01,2016,2011-09-01,2011,NA,NA,NA,-2977,1834,7,-590,1237,1244,2020-07-01,2020-09-01,2021-08-15,10.1200/jco.2014.58.4631,25605857,https://pubmed.ncbi.nlm.nih.gov/25605857/,2015-01-20,journal publication,TRUE,TRUE,doi,Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2015-Apr-10,2015-01-20,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,9,9,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0732-183X,1527-7755",Journal of Clinical Oncology,American Society of Clinical Oncology (ASCO),2015-04-10,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,"[{'type': 'other-closed', 'terms': ''}]",publisher,12,2016-04-10,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE -NCT01338922,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Schleswig-Holstein,NA,Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM),large,Other,Interventional,Device,NA,211,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-07,2011-04-01,2016-08-01,2016,2015-07-01,2015,NA,NA,NA,-6,1943,1546,800,1197,2743,2020-07-01,2020-09-01,2021-08-15,10.1111/pedi.12777,30302877,https://pubmed.ncbi.nlm.nih.gov/30302877/,2018-10-10,journal publication,TRUE,TRUE,doi,Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial,Pediatric diabetes,2018-12,2018-10-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1399-543X,1399-5448",Pediatric Diabetes,Wiley,2018-10-10,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01269151,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Schleswig-Holstein,NA,Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD,large,Other,Interventional,Drug,NA,20,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-01-03,2010-10-01,2014-04-01,2014,2013-03-01,2013,NA,NA,NA,-94,1184,788,1101,1497,2285,2020-07-01,2020-09-01,2021-08-15,10.2147/opth.s123513,28435212,https://pubmed.ncbi.nlm.nih.gov/28435212/,2017-04-06,journal publication,TRUE,TRUE,doi,Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study,"Clinical ophthalmology (Auckland, N.Z.)",2017,2017-04-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1177-5483,Clinical Ophthalmology,Informa UK Limited,2017-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01338922,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM),large,Other,Interventional,Device,NA,211,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-07,2011-04-01,2016-08-01,2016,2015-07-01,2015,NA,NA,NA,-6,1943,1546,800,1197,2743,2020-07-01,2020-09-01,2021-08-15,10.1111/pedi.12777,30302877,https://pubmed.ncbi.nlm.nih.gov/30302877/,2018-10-10,journal publication,TRUE,TRUE,doi,Psychosocial benefits of insulin pump therapy in children with diabetes type 1 and their families: The pumpkin multicenter randomized controlled trial,Pediatric diabetes,2018-12,2018-10-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1399-543X,1399-5448",Pediatric Diabetes,Wiley,2018-10-10,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-12-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01269151,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD,large,Other,Interventional,Drug,NA,20,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-01-03,2010-10-01,2014-04-01,2014,2013-03-01,2013,NA,NA,NA,-94,1184,788,1101,1497,2285,2020-07-01,2020-09-01,2021-08-15,10.2147/opth.s123513,28435212,https://pubmed.ncbi.nlm.nih.gov/28435212/,2017-04-06,journal publication,TRUE,TRUE,doi,Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study,"Clinical ophthalmology (Auckland, N.Z.)",2017,2017-04-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,1,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,1177-5483,Clinical Ophthalmology,Informa UK Limited,2017-04-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01074697,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin,large,Other,Interventional,Drug,Phase 3,246,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2010-02-23,2010-04-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,37,1863,1863,338,338,2201,2020-07-01,2020-09-01,2021-08-15,10.1016/s1470-2045(15)00615-4,26952945,https://pubmed.ncbi.nlm.nih.gov/26952945/,2016-03-04,journal publication,TRUE,TRUE,doi,"Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial",The Lancet. Oncology,2016-Apr,2016-03-04,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1470-2045,The Lancet Oncology,Elsevier BV,2016-04-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2016-10-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01927549,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Leipzig,NA,Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock,large,Other,Interventional,Procedure,Phase 4,706,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2013-08-14,2013-04-01,2017-10-01,2017,2017-07-01,2017,NA,NA,NA,-135,1509,1417,29,121,1538,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1710261,29083953,https://pubmed.ncbi.nlm.nih.gov/29083953/,2017-10-30,journal publication,TRUE,TRUE,doi,PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock,The New England journal of medicine,2017-12-21,2017-10-30,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,10,10,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2017-12-21,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2018-06-20,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT03519698,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,"Footbaths With Ginger, Mustard & Warm Water Only in Female Adolescents With & Without Anorexia Nervosa",large,Other,Interventional,Other,NA,41,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2018-01-12,2015-12-15,2017-06-22,2017,2017-06-22,2017,NA,NA,NA,-759,-204,-204,952,952,748,2020-07-01,2020-09-01,2021-08-15,10.1155/2020/2416582,32076439,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013347/,2020-01-30,journal publication,TRUE,TRUE,doi,Increasing Warmth in Adolescents with Anorexia Nervosa: A Randomized Controlled Crossover Trial Examining the Efficacy of Mustard and Ginger Footbaths,Evidence-based complementary and alternative medicine : eCAM,2020,2020-01-30,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1167,1515,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,"1741-427X,1741-4288",Evidence-Based Complementary and Alternative Medicine,Hindawi Limited,2020-01-31,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA @@ -2901,20 +2901,20 @@ NCT01947595,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE, NCT01894113,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,"Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease.",large,Other,Interventional,Procedure,NA,382,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-02,2012-01-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-548,303,303,1891,1891,2194,2020-07-01,2020-09-01,2021-08-15,10.1186/s12931-019-1091-1,31277659,https://respiratory-research.biomedcentral.com/articles/10.1186/s12931-019-1091-1,2019-07-05,journal publication,TRUE,TRUE,doi,"Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease - a prospective, randomized, multicentre cross-over trial",Respiratory research,2019-Jul-05,2019-07-05,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,gold,gold,1465-993X,Respiratory Research,Springer Science and Business Media LLC,2019-07-05,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01883765,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Efficacy of Neurofeedback Training in Adults With ADHD,large,Other,Interventional,Behavioral,NA,118,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-02-21,2013-02-01,2016-11-01,2016,2015-12-01,2015,NA,NA,NA,-20,1349,1013,281,617,1630,2020-07-01,2020-09-01,2021-08-15,10.1016/s2215-0366(17)30291-2,28803030,https://www.sciencedirect.com/science/article/pii/S2215036617302912?via%3Dihub,2017-08-09,journal publication,TRUE,TRUE,doi,"Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial",The lancet. Psychiatry,2017-09,2017-08-09,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,2215-0366,The Lancet Psychiatry,Elsevier BV,2017-09-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2018-03-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01883531,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Crossover Trial Determining the Efficacy of Dry Powder Mannitol to Improve Lung Function in Subjects Aged 6-17 Years,large,Industry,Interventional,Drug,Phase 2,95,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2013-06-17,2013-06-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,-16,836,836,517,517,1353,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jcf.2017.02.003,28258928,https://www.sciencedirect.com/science/article/pii/S1569199317300280?via%3Dihub,2017-03-01,journal publication,TRUE,TRUE,doi,Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial,Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,2017-May,2017-03-01,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,1569-1993,Journal of Cystic Fibrosis,Elsevier BV,2017-05-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2018-05-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA -NCT01837901,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa,large,Industry,Interventional,Device,NA,88,Completed,Single,Randomized,TRUE,FALSE,FALSE,TRUE,2013-04-09,2011-07-01,2014-02-01,2014,2013-08-01,2013,2021-02-23,2579,2763,-648,298,114,1065,1249,1363,2020-07-01,2020-09-01,2021-08-15,10.1167/iovs.16-19906,28114587,https://iovs.arvojournals.org/article.aspx?articleid=2599022,2017-01-01,journal publication,TRUE,TRUE,doi,"Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year",Investigative ophthalmology & visual science,2017-01-01,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,2404,2752,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,gold,gold,1552-5783,Investigative Opthalmology & Visual Science,Association for Research in Vision and Ophthalmology (ARVO),2017-01-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT01837901,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa,large,Industry,Interventional,Device,NA,88,Completed,Single,Randomized,TRUE,FALSE,FALSE,TRUE,2013-04-09,2011-07-01,2014-02-01,2014,2013-08-01,2013,2021-02-23,2579,2763,-648,298,114,1065,1249,1363,2020-07-01,2020-09-01,2021-08-15,10.1167/iovs.16-19906,28114587,https://iovs.arvojournals.org/article.aspx?articleid=2599022,2017-01-01,journal publication,TRUE,TRUE,doi,"Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year",Investigative ophthalmology & visual science,2017-01-01,NA,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,2404,2752,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,gold,gold,1552-5783,Investigative Opthalmology & Visual Science,Association for Research in Vision and Ophthalmology (ARVO),2017-01-18,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01835002,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Transcorneal Electrical Stimulation - Multicenter Safety Study,large,Industry,Interventional,Device,NA,105,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-04-15,2012-09-01,2015-08-01,2015,2014-07-01,2014,NA,NA,NA,-226,838,442,1735,2131,2573,2020-07-01,2020-09-01,2021-08-15,10.1159/000505001,31775146,https://www.karger.com/Article/FullText/505001,2020-05-01,journal publication,TRUE,TRUE,doi,Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa: A Multicenter Safety Study of the OkuStim® System (TESOLA-Study),Ophthalmic research,2020,2019-11-26,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,12,12,1858,2206,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,green,green,"0030-3747,1423-0259",Ophthalmic Research,S. Karger AG,2019-11-26,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2020-11-26,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01797601,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application,large,Other,Interventional,Drug,NA,48,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-02-18,2013-02-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-17,407,407,426,426,833,2020-07-01,2020-09-01,2021-08-15,10.2337/dc14-2319,25795413,https://care.diabetesjournals.org/content/38/6/1044.long,2015-06-01,journal publication,TRUE,TRUE,doi,Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults,Diabetes care,2015-Jun,2015-03-20,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,"0149-5992,1935-5548",Diabetes Care,American Diabetes Association,2015-03-20,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': 'personal use only'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT01788254,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Open Label Study for the Functional Characterization of Drug Metabolism and Transport,large,Other,Interventional,Drug,Phase 1,144,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2013-01-31,2012-01-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,-396,820,820,697,697,1517,2020-07-01,2020-09-01,2021-08-15,10.1038/s41540-017-0012-5,28649438,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460240/,2017-03-28,journal publication,TRUE,TRUE,doi,Translational learning from clinical studies predicts drug pharmacokinetics across patient populations,NPJ systems biology and applications,2017,2017-03-28,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,gold,gold,2056-7189,npj Systems Biology and Applications,Springer Science and Business Media LLC,2017-03-28,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT01773902,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Protein for Premies,large,Other,Interventional,Dietary Supplement,NA,60,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2013-01-15,2012-10-01,2016-07-01,2016,2014-12-01,2014,NA,NA,NA,-106,1263,685,143,721,1406,2020-07-01,2020-09-01,2021-08-15,10.1001/jamapediatrics.2016.2681,27893064,https://jamanetwork.com/journals/jamapediatrics/fullarticle/2587682,2016-11-21,journal publication,TRUE,TRUE,doi,Effect of Increased Enteral Protein Intake on Growth in Human Milk-Fed Preterm Infants: A Randomized Clinical Trial,JAMA pediatrics,2017-01-01,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,2168-6203,JAMA Pediatrics,American Medical Association (AMA),2017-01-01,response,TRUE,['pmc'],FALSE,['publishedVersion'],FALSE,FALSE,TRUE,[],publisher,6,2017-06-30,TRUE,FALSE,FALSE,TRUE,FALSE,NA -NCT01635114,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Effect of resVida on Liver Fat Content,large,Other,Interventional,Dietary Supplement,NA,112,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-03,2012-06-01,2015-09-01,2015,2013-12-01,2013,NA,NA,NA,-32,1155,516,910,1549,2065,2020-07-01,2020-09-01,2021-08-15,10.1111/dom.13268,29484808,https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.13268,2018-02-27,journal publication,TRUE,TRUE,doi,"Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial","Diabetes, obesity & metabolism",2018-07,2018-03-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1462-8902,1463-1326","Diabetes, Obesity and Metabolism",Wiley,2018-03-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-03-22,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01635114,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Effect of resVida on Liver Fat Content,large,Other,Interventional,Dietary Supplement,NA,112,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-07-03,2012-06-01,2015-09-01,2015,2013-12-01,2013,NA,NA,NA,-32,1155,516,910,1549,2065,2020-07-01,2020-09-01,2021-08-15,10.1111/dom.13268,29484808,https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.13268,2018-02-27,journal publication,TRUE,TRUE,doi,"Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial","Diabetes, obesity & metabolism",2018-07,2018-03-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"1462-8902,1463-1326","Diabetes, Obesity and Metabolism",Wiley,2018-03-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2019-03-22,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01600014,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,"Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp",large,Industry,Interventional,Drug,Phase 3,463,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2012-05-14,2012-05-01,2014-02-01,2014,2014-02-01,2014,2015-12-17,684,684,-13,628,628,621,621,1249,2020-07-01,2020-09-01,2021-08-15,10.1111/bjd.14222,26471889,https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.14222,2015-10-15,journal publication,TRUE,TRUE,doi,"Efficacy and safety of follow-up field treatment of actinic keratosis with ingenol mebutate 0·015% gel: a randomized, controlled 12-month study",The British journal of dermatology,2016-Mar,2016-01-09,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,closed,closed,0007-0963,British Journal of Dermatology,Wiley,2016-01-09,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2017-01-09,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01480323,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2,large,Other,Interventional,Drug,Phase 2,15,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-11-23,2012-02-01,2015-06-01,2015,2014-09-01,2014,NA,NA,NA,70,1286,1013,570,843,1856,2020-07-01,2020-09-01,2021-08-15,10.1007/s00262-016-1944-0,28008452,https://link.springer.com/article/10.1007/s00262-016-1944-0,2016-12-22,journal publication,TRUE,TRUE,doi,Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study,"Cancer immunology, immunotherapy : CII",2017-Apr,2016-12-22,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,2,0,0,0,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0340-7004,1432-0851","Cancer Immunology, Immunotherapy",Springer Science and Business Media LLC,2016-12-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2017-12-22,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01443260,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,"A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis",large,Industry,Interventional,Biological,Phase 1/Phase 2,9,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-20,2012-02-01,2014-09-01,2014,2014-09-01,2014,NA,NA,NA,134,1077,1077,1354,1354,2431,2020-07-01,2020-09-01,2021-08-15,10.1158/1078-0432.ccr-18-0244,29773661,https://clincancerres.aacrjournals.org/content/24/18/4388.long,2018-05-17,journal publication,TRUE,TRUE,doi,Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-09-15,2018-05-17,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,2,1,1,1,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,bronze,"1078-0432,1557-3265",Clinical Cancer Research,American Association for Cancer Research (AACR),2018-05-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,12,2019-05-17,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01326767,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring,large,Other,Interventional,Drug,Phase 3,366,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-03-29,2011-03-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-28,1343,1343,616,616,1959,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdw290,27502710,https://www.sciencedirect.com/science/article/pii/S0923753419359186?via%3Dihub,2016-08-08,journal publication,TRUE,TRUE,doi,"Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)",Annals of oncology : official journal of the European Society for Medical Oncology,2016-10,2016-08-08,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-10-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-10-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01092533,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Myfortic for the Treatment of Non-infectious Intermediate Uveitis,large,Other,Interventional,Drug,Phase 3,44,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-03-23,2010-03-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,-22,2018,2018,713,713,2731,2020-07-01,2020-09-01,2021-08-15,10.1136/bjophthalmol-2017-310156,28903965,https://bjo.bmj.com/content/102/5/647.long,2017-09-13,journal publication,TRUE,TRUE,doi,"Enteric-coated mycophenolate sodium in the treatment of non-infectious intermediate uveitis: results of a prospective, controlled, randomised, open-label, early terminated multicentre trial",The British journal of ophthalmology,2018-05,2017-09-13,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,1,1,1,1,26,24,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0007-1161,1468-2079",British Journal of Ophthalmology,BMJ,2017-09-13,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT01055522,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma,large,Industry,Interventional,Drug,Phase 2,102,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-22,2008-06-01,2014-02-01,2014,2013-02-01,2013,NA,NA,NA,-600,1471,1106,2040,2405,3511,2020-07-01,2020-09-01,2021-08-15,10.1007/s00262-019-02383-z,NA,https://link.springer.com/article/10.1007%2Fs00262-019-02383-z,2019-09-03,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,3,1,1,1,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,"0340-7004,1432-0851","Cancer Immunology, Immunotherapy",Springer Science and Business Media LLC,2019-09-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01035190,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia,large,Other,Interventional,Drug,Phase 3,863,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-17,2010-04-01,2016-07-01,2016,2013-10-01,2013,NA,NA,NA,105,2388,1384,-260,744,2128,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1501917,26465983,https://www.nejm.org/doi/10.1056/NEJMoa1501917?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0www.ncbi.nlm.nih.gov,2015-10-15,journal publication,TRUE,TRUE,doi,Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia,The New England journal of medicine,2015-Oct-15,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-10-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-04-15,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT00204529,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB,large,Other,Interventional,Drug,Phase 3,901,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-10-01,2016-12-01,2016,2013-05-01,2013,NA,NA,NA,-346,4098,2788,1131,2441,5229,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdw225,27287206,https://www.sciencedirect.com/science/article/pii/S0923753419347532?via%3Dihub,2020-01-06,journal publication,TRUE,TRUE,doi,Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial,Annals of oncology : official journal of the European Society for Medical Oncology,2016-08,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA +NCT01055522,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma,large,Industry,Interventional,Drug,Phase 2,102,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-01-22,2008-06-01,2014-02-01,2014,2013-02-01,2013,NA,NA,NA,-600,1471,1106,2040,2405,3511,2020-07-01,2020-09-01,2021-08-15,10.1007/s00262-019-02383-z,NA,https://link.springer.com/article/10.1007%2Fs00262-019-02383-z,2019-09-03,journal publication,NA,NA,doi,NA,NA,NA,NA,NA,NA,NA,FALSE,NA,FALSE,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,3,1,1,1,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,FALSE,closed,closed,"0340-7004,1432-0851","Cancer Immunology, Immunotherapy",Springer Science and Business Media LLC,2019-09-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2020-09-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01035190,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia,large,Other,Interventional,Drug,Phase 3,863,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-12-17,2010-04-01,2016-07-01,2016,2013-10-01,2013,NA,NA,NA,105,2388,1384,-260,744,2128,2020-07-01,2020-09-01,2021-08-15,10.1056/nejmoa1501917,26465983,https://www.nejm.org/doi/10.1056/NEJMoa1501917?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0www.ncbi.nlm.nih.gov,2015-10-15,journal publication,TRUE,TRUE,doi,Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia,The New England journal of medicine,2015-Oct-15,NA,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,4,4,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,green,green,"0028-4793,1533-4406",New England Journal of Medicine,Massachusetts Medical Society,2015-10-15,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,[],journal,6,2016-04-15,TRUE,FALSE,TRUE,TRUE,TRUE,NA +NCT00204529,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB,large,Other,Interventional,Drug,Phase 3,901,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-12,2004-10-01,2016-12-01,2016,2013-05-01,2013,NA,NA,NA,-346,4098,2788,1131,2441,5229,2020-07-01,2020-09-01,2021-08-15,10.1093/annonc/mdw225,27287206,https://www.sciencedirect.com/science/article/pii/S0923753419347532?via%3Dihub,2020-01-06,journal publication,TRUE,TRUE,doi,Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial,Annals of oncology : official journal of the European Society for Medical Oncology,2016-08,2016-06-10,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,bronze,bronze,0923-7534,Annals of Oncology,Elsevier BV,2016-08-01,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],journal,12,2017-08-01,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT03147131,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Periprosthetic Bone Mineral Density Changes After Implantation Of A Short Hip Stem Compared To A Straight Stem,large,Other,Interventional,Procedure,NA,126,Unknown status,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2016-12-19,2010-08-01,2017-07-01,2017,2012-02-01,2012,NA,NA,NA,-2332,194,-1783,-582,1395,-388,2020-07-01,2020-09-01,2021-08-15,10.1007/s00402-015-2370-z,26613788,https://link.springer.com/article/10.1007%2Fs00402-015-2370-z,2015-11-27,journal publication,TRUE,TRUE,doi,Bone remodelling after femoral short stem implantation in total hip arthroplasty: 1-year results from a randomized DEXA study,Archives of orthopaedic and trauma surgery,2016-Jan,2015-11-27,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,1158,1506,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0936-8051,1434-3916",Archives of Orthopaedic and Trauma Surgery,Springer Science and Business Media LLC,2015-11-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2016-11-27,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT03085251,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Clinical System Accuracy Evaluation With OneTouch® Verio Flex Blood Glucose Monitoring System (BGMS),large,Other,Interventional,Device,NA,109,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2017-03-15,2017-03-16,2017-06-01,2017,2017-04-03,2017,NA,NA,NA,1,78,19,112,171,190,2020-07-01,2020-09-01,2021-08-15,10.1177/1932296817730380,28931322,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851221/,2017-09-21,journal publication,TRUE,TRUE,doi,Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose With Three Test Strip Lots Based on ISO 15197:2013,Journal of diabetes science and technology,2018-03,2017-09-21,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1188,1536,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"1932-2968,1932-2968",Journal of Diabetes Science and Technology,SAGE Publications,2017-09-21,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'other-closed', 'terms': ''}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT03033849,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,"User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013",large,Other,Interventional,Device,NA,189,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2017-01-16,2017-01-01,2017-03-01,2017,2017-03-01,2017,NA,NA,NA,-15,44,44,505,505,549,2020-07-01,2020-09-01,2021-08-15,10.1080/03007995.2018.1491832,29927663,https://www.tandfonline.com/doi/full/10.1080/03007995.2018.1491832,2018-07-19,journal publication,TRUE,TRUE,doi,Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors,Current medical research and opinion,2019-02,2018-07-19,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0300-7995,1473-4877",Current Medical Research and Opinion,Informa UK Limited,2018-07-19,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2019-07-19,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE @@ -2924,19 +2924,19 @@ NCT02751229,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE, NCT02595645,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps,large,Other,Interventional,Genetic,NA,101,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2015-10-29,2015-08-01,2016-10-01,2016,2016-08-01,2016,NA,NA,NA,-89,338,277,300,361,638,2020-07-01,2020-09-01,2021-08-15,10.1177/2050640617723810,29511559,https://journals.sagepub.com/doi/full/10.1177/2050640617723810,2017-07-28,journal publication,TRUE,TRUE,doi,Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study,United European gastroenterology journal,2018-Mar,2017-07-28,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1431,1779,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,bronze,green,"2050-6406,2050-6414",United European Gastroenterology Journal,Wiley,2018-03-01,no_embargo_info,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",publisher,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02358408,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,System Accuracy Evaluation of Karajishi Contour and Karajishi TS Blood Glucose Monitoring Systems Following ISO 15197:2013,large,Other,Interventional,Device,NA,136,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2015-01-26,2015-01-01,2015-04-01,2015,2015-02-01,2015,NA,NA,NA,-25,65,6,328,387,393,2020-07-01,2020-09-01,2021-08-15,10.1185/03007995.2016.1146666,26809001,https://www.tandfonline.com/doi/full/10.1185/03007995.2016.1146666,2016-02-23,journal publication,TRUE,TRUE,doi,Performance of two updated blood glucose monitoring systems: an evaluation following ISO 15197:2013,Current medical research and opinion,2016-05,2016-02-23,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"0300-7995,1473-4877",Current Medical Research and Opinion,Informa Healthcare,2016-02-23,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2017-05-03,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02061722,ClinicalTrials.gov,TRUE,2,Publ found in Google search (no ID),FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,[PETDE10] Imaging of PDE10A Enzyme Levels in Huntington's Disease Gene Expansion Carriers and Healthy Controls With PET.,large,Other,Interventional,Radiation,Early Phase 1,90,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2014-02-03,2013-01-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,-398,818,818,1361,1361,2179,2020-07-01,2020-09-01,2021-08-15,10.1002/mds.27963,31967355,https://onlinelibrary.wiley.com/doi/full/10.1002/mds.27963,2020-01-22,journal publication,TRUE,TRUE,doi,PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression,Movement disorders : official journal of the Movement Disorder Society,2020-04,2020-01-22,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,1,1,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0885-3185,1531-8257",Movement Disorders,Wiley,2020-01-22,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2021-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01942473,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-03,2012-08-01,2014-04-01,2014,2013-09-01,2013,NA,NA,NA,-2,606,394,231,443,837,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jpeds.2014.10.007,25454938,https://www.sciencedirect.com/science/article/pii/S0022347614009524?via%3Dihub,2014-11-18,journal publication,TRUE,TRUE,doi,Effects of automated adjustment of the inspired oxygen on fluctuations of arterial and regional cerebral tissue oxygenation in preterm infants with frequent desaturations,The Journal of pediatrics,2015-Feb,2014-11-18,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3476,The Journal of Pediatrics,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT01942473,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-03,2012-08-01,2014-04-01,2014,2013-09-01,2013,NA,NA,NA,-2,606,394,231,443,837,2020-07-01,2020-09-01,2021-08-15,10.1016/j.jpeds.2014.10.007,25454938,https://www.sciencedirect.com/science/article/pii/S0022347614009524?via%3Dihub,2014-11-18,journal publication,TRUE,TRUE,doi,Effects of automated adjustment of the inspired oxygen on fluctuations of arterial and regional cerebral tissue oxygenation in preterm infants with frequent desaturations,The Journal of pediatrics,2015-Feb,2014-11-18,FALSE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0022-3476,The Journal of Pediatrics,Elsevier BV,2015-02-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,12,2016-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01879241,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis,large,Other,Interventional,Drug,Phase 2,252,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2013-06-12,2013-06-01,2016-08-01,2016,2016-04-01,2016,NA,NA,NA,-11,1146,1024,687,809,1833,2020-07-01,2020-09-01,2021-08-15,10.1016/s1474-4422(18)30176-5,29934198,https://www.sciencedirect.com/science/article/pii/S1474442218301765?via%3Dihub,2018-06-19,journal publication,TRUE,TRUE,doi,"Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial",The Lancet. Neurology,2018-08,2018-06-19,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,3,3,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1474-4422,The Lancet Neurology,Elsevier BV,2018-08-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,"[{'type': 'cc-by-nc-nd', 'terms': ''}]",journal,6,2019-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01684150,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,"A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving",large,Industry,Interventional,Drug,Phase 1,51,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-09-06,2012-09-01,2016-02-01,2016,2015-11-01,2015,NA,NA,NA,-5,1243,1151,864,956,2107,2020-07-01,2020-09-01,2021-08-15,10.1182/blood-2017-12-818948,29724899,https://ashpublications.org/blood/article/131/24/2661/37193/The-DOT1L-inhibitor-pinometostat-reduces-H3K79,2018-06-14,journal publication,TRUE,TRUE,doi,The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia,Blood,2018-06-14,2018-05-03,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,bronze,green,"0006-4971,1528-0020",Blood,American Society of Hematology,2018-06-14,response,TRUE,['institutional repository'],TRUE,"['publishedVersion', 'acceptedVersion']",FALSE,TRUE,TRUE,[],journal,12,2019-06-14,TRUE,TRUE,TRUE,TRUE,TRUE,NA NCT01516827,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder (TreatChildTrauma),large,Other,Interventional,Behavioral,NA,159,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-12-13,2012-02-01,2016-06-01,2016,2016-06-01,2016,NA,NA,NA,50,1632,1632,119,119,1751,2020-07-01,2020-09-01,2021-08-15,10.1111/jcpp.12640,27677771,https://acamh.onlinelibrary.wiley.com/doi/full/10.1111/jcpp.12640,2016-09-28,journal publication,TRUE,TRUE,doi,Complex PTSD as proposed for ICD-11: validation of a new disorder in children and adolescents and their response to Trauma-Focused Cognitive Behavioral Therapy,"Journal of child psychology and psychiatry, and allied disciplines",2017-02,2016-09-28,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,5,5,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,0021-9630,Journal of Child Psychology and Psychiatry,Wiley,2016-09-28,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2018-02-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01407965,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.,large,Other,Interventional,Procedure,Phase 4,13,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2011-07-26,2012-04-01,2015-07-01,2015,2015-07-01,2015,NA,NA,NA,250,1436,1436,79,79,1515,2020-07-01,2020-09-01,2021-08-15,10.1128/aac.00259-15,26248353,https://aac.asm.org/content/59/10/6241.long,2015-09-18,journal publication,TRUE,TRUE,doi,Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery,Antimicrobial agents and chemotherapy,2015-Oct,2015-07-27,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1889,2237,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,bronze,green,"0066-4804,1098-6596",Antimicrobial Agents and Chemotherapy,American Society for Microbiology,2015-07-27,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,[],publisher,6,2016-01-27,TRUE,TRUE,FALSE,TRUE,TRUE,NA NCT01392079,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,"Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine",large,Other,Interventional,Drug,Phase 2,135,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2011-06-28,2008-02-01,2016-03-01,2016,2012-01-01,2012,NA,NA,NA,-1243,1708,187,602,2123,2310,2020-07-01,2020-09-01,2021-08-15,10.1080/10428194.2017.1390236,29063805,https://www.tandfonline.com/doi/full/10.1080/10428194.2017.1390236,2017-10-24,journal publication,TRUE,TRUE,doi,Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome,Leukemia & lymphoma,2018-07,2017-10-24,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,0,1,2,2,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,"1042-8194,1029-2403",Leukemia & Lymphoma,Informa UK Limited,2017-10-24,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,12,2019-07-03,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT01180322,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine,large,Other,Interventional,Drug,Phase 2,277,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-02,2010-11-01,2016-10-02,2016,2012-06-01,2012,NA,NA,NA,91,2253,669,857,2441,3110,2020-07-01,2020-09-01,2021-08-15,10.1038/s41375-019-0395-y,30728457,https://www.nature.com/articles/s41375-019-0395-y,2019-02-06,journal publication,TRUE,TRUE,doi,Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine,Leukemia,2019-08,2019-02-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,5,0,0,0,1430,1778,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2019-02-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA +NCT01180322,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine,large,Other,Interventional,Drug,Phase 2,277,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-08-02,2010-11-01,2016-10-02,2016,2012-06-01,2012,NA,NA,NA,91,2253,669,857,2441,3110,2020-07-01,2020-09-01,2021-08-15,10.1038/s41375-019-0395-y,30728457,https://www.nature.com/articles/s41375-019-0395-y,2019-02-06,journal publication,TRUE,TRUE,doi,Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine,Leukemia,2019-08,2019-02-06,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,5,0,0,0,1430,1778,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2019-02-06,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT00949364,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage,large,Other,Interventional,Drug,Phase 2,103,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-07-28,2009-12-01,2016-12-14,2016,2016-12-14,2016,NA,NA,NA,126,2696,2696,-51,-51,2645,2020-07-01,2020-09-01,2021-08-15,10.1038/leu.2016.299,27774990,https://www.nature.com/articles/leu2016299,2016-10-24,journal publication,TRUE,TRUE,doi,Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis,Leukemia,2017-04,2016-10-24,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,1,0,2,2,1357,1705,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,TRUE,TRUE,closed,closed,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2016-10-24,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2018-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT00850382,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Dasatinib (Sprycel™) in Patients With Newly Diagnosed Core Binding Factor (CBF) Acute Myeloid Leukemia (AML),large,Other,Interventional,Drug,Phase 1/Phase 2,89,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-02-23,2009-06-01,2015-11-01,2015,2015-11-01,2015,NA,NA,NA,98,2442,2442,898,898,3340,2020-07-01,2020-09-01,2021-08-15,10.1038/s41375-018-0129-6,29720733,https://www.nature.com/articles/s41375-018-0129-6,2018-04-17,journal publication,TRUE,TRUE,doi,Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial,Leukemia,2018-07,2018-04-17,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,1,1,2,0,1,1,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0887-6924,1476-5551",Leukemia,Springer Science and Business Media LLC,2018-04-17,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/52DS-NZFF'}]",publisher,12,2019-04-17,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE -NCT00732953,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries,large,Other,Interventional,Device,Phase 2/Phase 3,120,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-07,2009-02-01,2014-02-01,2014,2010-01-01,2010,NA,NA,NA,178,2004,512,-927,565,1077,2020-07-01,2020-09-01,2021-08-15,10.1136/hrt.2011.226563,21617163,https://heart.bmj.com/content/97/16/1338.long,2011-07-20,journal publication,TRUE,TRUE,doi,Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease,Heart (British Cardiac Society),2011-Aug,2011-05-26,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1355-6037,Heart,BMJ,2011-05-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA -NCT00670436,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions,large,Other,Interventional,Device,Phase 2,48,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-04-29,2008-02-01,2014-03-01,2014,2009-09-01,2009,NA,NA,NA,-88,2132,490,-682,960,1450,2020-07-01,2020-09-01,2021-08-15,10.1002/ccd.24409,22511572,https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.24409,2012-04-18,journal publication,TRUE,TRUE,doi,Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2013-Apr,2012-11-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2012-11-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT00732953,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries,large,Other,Interventional,Device,Phase 2/Phase 3,120,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2008-08-07,2009-02-01,2014-02-01,2014,2010-01-01,2010,NA,NA,NA,178,2004,512,-927,565,1077,2020-07-01,2020-09-01,2021-08-15,10.1136/hrt.2011.226563,21617163,https://heart.bmj.com/content/97/16/1338.long,2011-07-20,journal publication,TRUE,TRUE,doi,Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease,Heart (British Cardiac Society),2011-Aug,2011-05-26,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,3,3,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1355-6037,Heart,BMJ,2011-05-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[],publisher,NA,NA,NA,NA,NA,FALSE,NA,NA +NCT00670436,ClinicalTrials.gov,TRUE,2,Registry linked,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions,large,Other,Interventional,Device,Phase 2,48,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2008-04-29,2008-02-01,2014-03-01,2014,2009-09-01,2009,NA,NA,NA,-88,2132,490,-682,960,1450,2020-07-01,2020-09-01,2021-08-15,10.1002/ccd.24409,22511572,https://onlinelibrary.wiley.com/doi/full/10.1002/ccd.24409,2012-04-18,journal publication,TRUE,TRUE,doi,Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries,Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2013-Apr,2012-11-08,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,2,2,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,TRUE,TRUE,closed,closed,1522-1946,Catheterization and Cardiovascular Interventions,Wiley,2012-11-08,response,TRUE,['institutional repository'],TRUE,['acceptedVersion'],FALSE,TRUE,FALSE,"[{'type': 'other (non-commercial)', 'terms': 'https://perma.cc/6S5D-XMF4'}]",journal,12,2014-04-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT02820519,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,"Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain",small,Other,Interventional,Drug,Phase 2,4,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2016-06-14,2016-06-01,2017-07-21,2017,2017-07-21,2017,NA,NA,NA,-13,402,402,734,734,1136,2020-07-01,2020-09-01,2021-08-15,10.3389/fphar.2019.00838,31402867,https://www.frontiersin.org/articles/10.3389/fphar.2019.00838/full,2019-07-25,journal publication,TRUE,TRUE,doi,"Loxapine for Treatment of Patients With Refractory, Chemotherapy-Induced Neuropathic Pain: A Prematurely Terminated Pilot Study Showing Efficacy But Limited Tolerability",Frontiers in pharmacology,2019,2019-07-25,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,0,0,1,1,1,1,1138,1486,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,gold,gold,1663-9812,Frontiers in Pharmacology,Frontiers Media SA,2019-07-25,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA -NCT02585882,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke Witten/Herdecke,NA,Preventive Effect of Salt Fluoridation,small,Other,Interventional,Other,NA,441,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-10-22,2012-03-01,2015-10-01,2015,2013-08-01,2013,NA,NA,NA,-1330,-21,-812,776,1567,755,2020-07-01,2020-09-01,2021-08-15,10.1159/000479892,29136625,https://www.karger.com/Article/FullText/479892,2017-11-15,journal publication,TRUE,TRUE,doi,"Caries-Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia: A Prospective, Controlled, Interventional Study",Caries research,2017,2017-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE +NCT02585882,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Preventive Effect of Salt Fluoridation,small,Other,Interventional,Other,NA,441,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2015-10-22,2012-03-01,2015-10-01,2015,2013-08-01,2013,NA,NA,NA,-1330,-21,-812,776,1567,755,2020-07-01,2020-09-01,2021-08-15,10.1159/000479892,29136625,https://www.karger.com/Article/FullText/479892,2017-11-15,journal publication,TRUE,TRUE,doi,"Caries-Preventive Effect of Salt Fluoridation in Preschool Children in The Gambia: A Prospective, Controlled, Interventional Study",Caries research,2017,2017-11-15,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,closed,closed,"0008-6568,1421-976X",Caries Research,S. Karger AG,2017-01-01,response,TRUE,['institutional repository'],TRUE,"['acceptedVersion', 'submittedVersion']",TRUE,TRUE,FALSE,[{'type': 'other (non-commercial)'}],publisher,12,2018-01-01,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE NCT01480362,ClinicalTrials.gov,TRUE,2,Registry linked,FALSE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Treatment Study of Negative Pressure Wound Therapy for Diabetic Foot Wounds,small,Other,Interventional,Device,NA,360,Completed,Single,Randomized,TRUE,TRUE,TRUE,FALSE,2011-11-23,2011-11-01,2015-04-01,2015,2015-02-01,2015,NA,NA,NA,-22,1225,1166,1819,1878,3044,2020-07-01,2020-09-01,2021-08-15,10.1136/bmjopen-2018-026345,32209619,https://bmjopen.bmj.com/content/10/3/e026345,2020-03-24,journal publication,TRUE,TRUE,doi,Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life clinical practice: results of the German DiaFu-RCT,BMJ open,2020-03-24,2020-03-24,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0,0,0,1,4,4,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,FALSE,TRUE,gold,gold,"2044-6055,2044-6055",BMJ Open,BMJ,2020-03-01,response,TRUE,['institutional repository'],TRUE,['publishedVersion'],FALSE,FALSE,TRUE,"[{'type': 'cc-by-nc', 'terms': ''}]",journal,0,NA,TRUE,FALSE,TRUE,TRUE,TRUE,NA NCT02775019,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Health Impact of L.Reuteri Consumption in Crew Members of a Naval Ship at Sea,small,Other,Interventional,Dietary Supplement,NA,72,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-05-13,2016-05-01,2016-08-01,2016,2016-08-01,2016,NA,NA,NA,-12,80,80,1282,1282,1362,2020-07-01,2020-09-01,2021-08-15,10.1002/jper.19-0393,32017092,https://aap.onlinelibrary.wiley.com/doi/full/10.1002/JPER.19-0393,2020-02-04,journal publication,TRUE,TRUE,doi,Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial,Journal of periodontology,2020-10,2020-02-26,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,0,0,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"0022-3492,1943-3670",Journal of Periodontology,Wiley,2020-02-26,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA NCT02705456,ClinicalTrials.gov,TRUE,2,Publ found in Google ID search,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Enamel Caries in Orthodontic Patients,small,Other,Interventional,Procedure,NA,150,Completed,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2016-02-25,2014-10-01,2016-12-01,2016,2016-08-01,2016,NA,NA,NA,-512,280,158,790,912,1070,2020-07-01,2020-09-01,2021-08-15,10.1111/jicd.12399,30701704,https://pubmed.ncbi.nlm.nih.gov/30701704/,2019-01-30,journal publication,TRUE,TRUE,doi,"Impact of a non-fluoridated microcrystalline hydroxyapatite dentifrice on enamel caries progression in highly caries-susceptible orthodontic patients: A randomized, controlled 6-month trial",Journal of investigative and clinical dentistry,2019-May,2019-01-30,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,0,0,0,0,1,1,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,FALSE,TRUE,hybrid,hybrid,"2041-1618,2041-1626",Journal of Investigative and Clinical Dentistry,Wiley,2019-01-30,no_embargo_info,TRUE,['institutional repository'],TRUE,"['submittedVersion', 'acceptedVersion', 'publishedVersion']",TRUE,TRUE,TRUE,"[{'type': 'cc-by', 'terms': ''}]",article,NA,NA,NA,NA,NA,TRUE,NA,NA @@ -3320,8 +3320,8 @@ NCT01885403,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,N NCT01839071,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Influence of Vasculary Inflammation on Development of Diabetes,large,Other,Interventional,Procedure,NA,109,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-03-21,2010-06-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-1024,406,406,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01789112,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Acute Effects of a Non Excitatory Cardial Stimulation,large,Other,Interventional,Other,NA,13,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-02-08,2012-07-01,2017-06-30,2017,2017-06-30,2017,NA,NA,NA,-222,1603,1603,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1159,1507,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01644071,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Serotonergic System and Violent Video Games,large,Other,Interventional,Drug,NA,47,Completed,Double,NA,NA,FALSE,FALSE,FALSE,2012-06-20,2012-02-01,2014-06-01,2014,2014-02-01,2014,NA,NA,NA,-140,711,591,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01644045,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01644019,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen Aachen,NA,Prehospital Telemedical Support in Acute Stroke,large,Other,Interventional,Procedure,NA,28,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01644045,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Prehospital Emergency Care of Obstructive Respiratory Emergencies With the Use of Teleconsultation,large,Other,Interventional,Device,NA,17,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01644019,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Prehospital Telemedical Support in Acute Stroke,large,Other,Interventional,Procedure,NA,28,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-12,2012-08-01,2015-09-01,2015,2013-07-01,2013,NA,NA,NA,20,1146,354,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01341106,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection,large,Other,Interventional,Drug,Phase 4,7,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-04-20,2011-04-01,2015-04-01,2015,2015-01-01,2015,NA,NA,NA,-19,1442,1352,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01266187,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study),large,Other,Interventional,Procedure,NA,16,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-20,2011-07-01,2015-09-01,2015,2015-09-01,2015,NA,NA,NA,193,1716,1716,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01262729,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Aachen,NA,Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation,large,Other,Interventional,Procedure,Phase 2,5,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-16,2011-09-01,2014-12-01,2014,2014-11-01,2014,NA,NA,NA,259,1446,1416,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3332,7 +3332,7 @@ NCT02532166,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,N NCT02476500,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Construct Validity of a Large Loop Excision of the Transformation Zone (LLETZ) Training Model,small,Other,Interventional,Procedure,NA,150,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2015-05-03,2015-05-01,2015-11-01,2015,2015-11-01,2015,NA,NA,NA,-2,182,182,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02475252,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Construct Validity of a Diagnostic Hysteroscopy Training Model,small,Other,Interventional,Procedure,NA,15,Terminated,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-05-03,2015-04-01,2016-01-01,2016,2016-01-01,2016,NA,NA,NA,-32,243,243,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02077205,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Manualised Cognitive Behavioral Therapy of Anxiety Disorders in Children and Adolescents in Routine Care Setting,small,Other,Interventional,Behavioral,NA,200,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-02-04,2012-01-01,2015-12-01,2015,2014-06-01,2014,NA,NA,NA,-765,665,117,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01913899,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum Bochum,NA,Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain,small,Other,Interventional,Other,NA,70,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-30,2013-04-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-120,214,124,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01913899,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Short Term Effect of Post Surgical Treatment of Mirror Therapy of Phantom Limb Pain,small,Other,Interventional,Other,NA,70,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2013-07-30,2013-04-01,2014-03-01,2014,2013-12-01,2013,NA,NA,NA,-120,214,124,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01627938,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination,small,Other,Interventional,Drug,Phase 2,50,Unknown status,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2012-05-30,2012-04-01,2016-04-01,2016,2015-04-01,2015,NA,NA,NA,-59,1402,1036,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,18,18,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01590992,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Treatment of Globus Sensations With Psychotherapy,small,Other,Interventional,Behavioral,NA,175,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2012-04-11,2012-05-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,20,2060,2060,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01402414,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Bochum,NA,Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis,small,Other,Interventional,Radiation,NA,10,Terminated,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-19,2011-04-01,2014-02-01,2014,2014-02-01,2014,NA,NA,NA,-109,928,928,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3365,7 +3365,7 @@ NCT02345278,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,N NCT02339597,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Therapy Adherence of APAP Therapy Initiation in Sleep-lab Versus at Home,large,Other,Interventional,Procedure,NA,224,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-01-27,2014-01-01,2015-11-01,2015,2015-11-01,2015,NA,NA,NA,-26,643,643,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02314572,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses.,large,Other,Interventional,Device,Phase 4,15,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2014-12-08,2013-03-01,2015-06-01,2015,2014-12-01,2014,NA,NA,NA,-647,175,-7,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,12,12,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02096913,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury,large,Other,Interventional,Drug,Phase 1,12,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2014-03-24,2013-06-01,2017-09-01,2017,2017-09-01,2017,NA,NA,NA,-296,1257,1257,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,1096,1444,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02094287,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Berlin,NA,Placebo Effect in the Treatment of Atopic Dermatitis,large,Other,Interventional,Drug,NA,166,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2014-03-17,2010-09-01,2015-02-01,2015,2013-11-01,2013,NA,NA,NA,-1293,321,-136,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02094287,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Placebo Effect in the Treatment of Atopic Dermatitis,large,Other,Interventional,Drug,NA,166,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2014-03-17,2010-09-01,2015-02-01,2015,2013-11-01,2013,NA,NA,NA,-1293,321,-136,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02019498,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Effectiveness of App-based Relaxation for Patients With Chronic Low Back Pain (Relaxback),large,Other,Interventional,Behavioral,NA,50,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-12-18,2014-04-01,2016-07-01,2016,2016-02-01,2016,NA,NA,NA,104,926,775,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01974011,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,DPNB vs. Modified DPNB With Ventromedial Infiltration (DPNB According to Dalens' Technique),large,Other,Interventional,Procedure,NA,86,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2013-10-28,2013-11-25,2016-01-06,2016,2016-01-05,2016,NA,NA,NA,28,800,799,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,14,1700,2048,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01888055,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,FALSE,TRUE,TRUE,Berlin,NA,Influence of tDCS on Cortical Plasticity in Healthy Older Adults,large,Other,Interventional,Device,NA,0,Withdrawn,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2013-06-25,2013-05-01,2017-12-01,2017,2017-10-01,2017,NA,NA,NA,-55,1620,1559,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3392,7 +3392,7 @@ NCT01006577,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,N NCT00951834,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease,large,Other,Interventional,Drug,Phase 2/Phase 3,21,Completed,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2009-08-03,2009-10-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,59,2008,2008,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00799890,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,Sunphenon in Progressive Forms of Multiple Sclerosis,large,Other,Interventional,Drug,Phase 2/Phase 3,61,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2008-11-28,2009-05-01,2016-03-01,2016,2016-03-01,2016,NA,NA,NA,154,2650,2650,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02421172,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Berlin,NA,"Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients",large,Industry,Interventional,Biological,Phase 2,66,Completed,Double,Randomized,TRUE,TRUE,TRUE,TRUE,2015-03-18,2015-04-13,2016-11-23,2016,2016-11-23,2016,2017-11-21,363,363,26,616,616,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1378,1726,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00996229,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Münster Berlin,NA,Effects of Dietary Interventions on the Aging Brain,large,Other,Interventional,Behavioral,Phase 3,300,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-14,2009-11-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,18,1571,1509,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00996229,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Berlin Münster,NA,Effects of Dietary Interventions on the Aging Brain,large,Other,Interventional,Behavioral,Phase 3,300,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-14,2009-11-01,2014-02-01,2014,2013-12-01,2013,NA,NA,NA,18,1571,1509,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2404,2752,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT04114201,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Clinical Outcome and OR Resource Use of Total Knee Arthroplasty Using Patient-Specific or Conventional Instrumentation,small,Other,Interventional,Procedure,NA,139,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2019-10-01,2012-08-02,2017-02-23,2017,2017-02-23,2017,NA,NA,NA,-2616,-950,-950,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1286,1634,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03657953,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Outcomes 8 Years After Minimal Invasive THA,small,Other,Interventional,Other,NA,157,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2018-08-14,2006-01-01,2015-09-30,2015,2015-06-30,2015,NA,NA,NA,-4608,-1049,-1141,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1798,2146,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02652585,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Validation of a Test System for Development of Medications for Alcoholism,small,Other,Interventional,Drug,Phase 3,46,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-01-06,2016-02-01,2017-09-04,2017,2017-08-25,2017,NA,NA,NA,26,607,597,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1093,1441,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3400,7 +3400,7 @@ NCT02275884,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden, NCT02157363,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,POsitioning for Esophageal Cancer Resection,small,Other,Interventional,Procedure,NA,47,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2014-05-12,2014-06-16,2017-02-28,2017,2017-02-28,2017,NA,NA,NA,35,1023,1023,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1281,1629,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01809847,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation,small,Other,Interventional,Drug,Phase 2,20,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-12-18,2013-03-01,2015-01-01,2015,2015-01-01,2015,NA,NA,NA,73,744,744,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01246752,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) <= 60y. After First CR,small,Other,Interventional,Biological,Phase 3,356,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-11-22,2010-11-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,-21,2566,2566,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01220856,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden Dresden,NA,Reparixin in Pancreatic Islet Transplantation,small,Industry,Interventional,Drug,Phase 2,9,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2010-10-07,2010-07-28,2013-04-30,2013,2013-04-30,2013,2021-01-07,2809,2809,-71,936,936,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2681,3029,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01220856,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Reparixin in Pancreatic Islet Transplantation,small,Industry,Interventional,Drug,Phase 2,9,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,TRUE,2010-10-07,2010-07-28,2013-04-30,2013,2013-04-30,2013,2021-01-07,2809,2809,-71,936,936,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2681,3029,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01146821,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Fish OIL Optimal dosE Determination Study,small,Other,Interventional,Dietary Supplement,Phase 2,7,Terminated,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2010-06-17,2013-10-01,2017-04-01,2017,2017-04-01,2017,NA,NA,NA,1202,2480,2480,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,14,14,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00904254,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,The Use of Anti-CD4 mAb-Fragment for Imaging of Local Inflammation in Patients With Carotid Artery Stenosis,small,Other,Interventional,Radiation,Phase 2,21,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2009-05-18,2015-01-01,2016-01-01,2016,2016-01-01,2016,NA,NA,NA,2054,2419,2419,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1705,2053,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00609310,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Dresden,NA,Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence,small,Other,Interventional,Dietary Supplement,Phase 2,382,Suspended,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2008-01-24,2015-05-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,2654,3234,3234,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3425,7 +3425,7 @@ NCT02147223,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseld NCT01901458,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®,small,Other,Interventional,Device,NA,50,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2013-07-10,2014-03-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,234,479,479,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01755871,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple Sclerosis,small,Other,Interventional,Drug,Phase 4,8,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-12-19,2013-01-01,2016-02-01,2016,2016-01-01,2016,NA,NA,NA,13,1139,1108,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1674,2022,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01465594,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Study Comparing Urinary Diversion (Transurethral/Suprapubic) After Radical Prostatectomy,small,Other,Interventional,Procedure,NA,106,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-02,2011-11-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-1,1246,1246,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00977132,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf Düsseldorf,NA,Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome,small,Other,Interventional,Drug,Phase 2,23,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-09-14,2009-10-01,2014-05-01,2014,2013-05-01,2013,NA,NA,NA,17,1690,1325,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00977132,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome,small,Other,Interventional,Drug,Phase 2,23,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-09-14,2009-10-01,2014-05-01,2014,2013-05-01,2013,NA,NA,NA,17,1690,1325,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01608984,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Düsseldorf,NA,Effects of Remote Ischemic PreConditioning in Off-pump Versus On-pump Coronary Artery Bypass Grafting(RIPCON),small,Other,Interventional,Procedure,Phase 1,100,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-05-29,2012-05-01,2015-12-01,2015,2015-06-01,2015,NA,NA,NA,-28,1281,1098,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,4,4,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03717493,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder,large,Other,Interventional,Behavioral,Phase 2/Phase 3,99,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2018-10-22,2012-12-17,2017-11-01,2017,2017-05-01,2017,NA,NA,NA,-2135,-355,-539,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1035,1383,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03548974,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Internet-based MOTOmed Exercise to Reduce Spasticity and Improve Physical Function in Persons With Multiple Sclerosis,large,Other,Interventional,Behavioral,NA,57,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2017-11-02,2015-01-01,2015-10-01,2015,2015-10-01,2015,NA,NA,NA,-1036,-763,-763,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3434,9 +3434,9 @@ NCT02478944,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen NCT02129439,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,"Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients",large,Industry,Interventional,Drug,Phase 1/Phase 2,20,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2014-04-30,2014-04-01,2017-06-22,2017,2017-06-22,2017,NA,NA,NA,-29,1149,1149,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1167,1515,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02007811,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination,large,Other,Interventional,Biological,Phase 1/Phase 2,15,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-11-21,2013-11-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-20,740,740,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01409876,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy,large,Other,Interventional,Radiation,Phase 2,100,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2011-08-03,2011-09-01,2016-09-01,2016,2014-09-01,2014,NA,NA,NA,29,1856,1125,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01405235,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen Erlangen,NA,Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma,large,Other,Interventional,Drug,Phase 3,312,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-27,2006-09-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-1790,1254,310,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01405235,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma,large,Other,Interventional,Drug,Phase 3,312,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-07-27,2006-09-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-1790,1254,310,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01176214,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,"WEANING-Study: ""Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral Bleedings",large,Other,Interventional,Procedure,Phase 2,7,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-26,2010-07-01,2014-04-01,2014,2014-04-01,2014,NA,NA,NA,-25,1345,1345,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01175694,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen Erlangen,NA,Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-08-04,2010-01-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-215,1611,667,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01175694,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2010-08-04,2010-01-01,2015-01-01,2015,2012-06-01,2012,NA,NA,NA,-215,1611,667,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00074230,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Erlangen,NA,Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma,large,Other,Interventional,Biological,Phase 1/Phase 2,82,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2003-12-10,2003-07-01,2014-03-01,2014,2014-03-01,2014,NA,NA,NA,-162,3734,3734,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02842892,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,"Implication of Stiffness of the Hamstrings, Achilles Tendon and Calf Muscles for Jumping Performance",large,Other,Interventional,Other,NA,35,Completed,NA,NA,NA,FALSE,TRUE,FALSE,2016-07-18,2016-07-01,2017-04-01,2017,2017-04-01,2017,NA,NA,NA,-17,257,257,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02746692,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Faster Back Home: Efficacy of a High-intensity Endurance Training,large,Other,Interventional,Other,NA,40,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2016-04-18,2016-07-01,2017-08-01,2017,2017-08-01,2017,NA,NA,NA,74,470,470,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3451,9 +3451,9 @@ NCT01798771,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfur NCT01713790,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Innovative Training Methods for Frail Elderly in the Training Gain Stage,large,Other,Interventional,Device,NA,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-10-14,2012-10-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-13,899,899,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01615172,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Cannulation of the Artery Axiliaris for Extracorporeal Circulation,large,Other,Interventional,Procedure,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2012-06-04,2011-01-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-520,910,910,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01611116,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia,large,Other,Interventional,Drug,Phase 2,33,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2012-05-25,2012-05-01,2017-04-26,2017,2017-04-26,2017,NA,NA,NA,-24,1797,1797,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1224,1572,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01609946,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Realtime-Elastography (RTE) and Thyroid Nodules,large,Other,Interventional,Device,NA,602,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-30,2012-06-01,2014-12-01,2014,2013-12-01,2013,NA,NA,NA,2,915,550,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01567241,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Clinical Hypnosis During Insemination or Embryotransfer,large,Other,Interventional,Other,NA,282,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-03-22,2012-03-01,2014-03-01,2014,2013-08-01,2013,NA,NA,NA,-21,709,497,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01448798,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt Frankfurt,NA,Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.,large,Other,Interventional,Procedure,NA,50,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-06,2011-10-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-5,818,453,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01609946,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Realtime-Elastography (RTE) and Thyroid Nodules,large,Other,Interventional,Device,NA,602,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2012-05-30,2012-06-01,2014-12-01,2014,2013-12-01,2013,NA,NA,NA,2,915,550,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01567241,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Clinical Hypnosis During Insemination or Embryotransfer,large,Other,Interventional,Other,NA,282,Unknown status,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2012-03-22,2012-03-01,2014-03-01,2014,2013-08-01,2013,NA,NA,NA,-21,709,497,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01448798,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.,large,Other,Interventional,Procedure,NA,50,Unknown status,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-10-06,2011-10-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-5,818,453,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01244958,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis,large,Other,Interventional,Biological,Phase 3,156,Completed,Double,Randomized,TRUE,TRUE,FALSE,FALSE,2010-09-28,2010-08-01,2015-02-01,2015,2015-02-01,2015,NA,NA,NA,-58,1587,1587,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01170988,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Coronary Flow Rate Measurement in T-Grafts,large,Other,Interventional,Procedure,NA,20,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-27,2010-08-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,5,1466,1466,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01081093,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Frankfurt,NA,Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement,large,Other,Interventional,Procedure,NA,72,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-03-04,2010-04-01,2014-08-01,2014,2014-08-01,2014,NA,NA,NA,28,1611,1611,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3465,21 +3465,21 @@ NCT02277977,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg NCT02262949,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System,large,Industry,Interventional,Device,NA,31,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2014-09-25,2014-09-01,2016-07-01,2016,2015-07-01,2015,NA,NA,NA,-24,645,279,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,1,0,0,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01690572,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Drug Eluting Balloon for Prevention of Constrictive Remodeling,large,Other,Interventional,Device,NA,14,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2012-09-19,2012-10-01,2017-04-01,2017,2016-12-01,2016,NA,NA,NA,12,1655,1534,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01378845,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands,large,Other,Interventional,Drug,NA,30,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-06-16,2011-07-01,2015-09-01,2015,2015-06-01,2015,NA,NA,NA,15,1538,1446,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,4,0,1827,2175,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01252459,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg Freiburg,NA,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-02,2011-07-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,211,1307,942,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,17,17,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01252459,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme,large,Other,Interventional,Radiation,Phase 2,200,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-12-02,2011-07-01,2014-07-01,2014,2013-07-01,2013,NA,NA,NA,211,1307,942,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,17,17,2254,2602,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01065025,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,"Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies",large,Industry,Interventional,Drug,Phase 1,60,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-02-05,2010-01-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,-35,1881,1881,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01015469,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg Hamburg,NA,Banded Versus Conventional Laparoscopic Roux-en-Y (GABY),large,Other,Interventional,Procedure,Phase 4,384,Unknown status,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2009-11-17,2009-02-01,2015-03-01,2015,2014-03-01,2014,NA,NA,NA,-289,1930,1565,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02655276,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Freiburg,NA,Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children,large,Other,Interventional,Other,NA,30,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-01-08,2016-01-01,2016-05-01,2016,2016-05-01,2016,NA,NA,NA,-7,114,114,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01672216,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Giessen,NA,Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation,small,Other,Interventional,Device,Phase 3,140,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-07,2012-08-01,2015-05-01,2015,2014-05-01,2014,NA,NA,NA,-6,997,632,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03093571,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Auricular Stimulation vs. Relaxation for Pre-exam Anxiety,small,Other,Interventional,Device,NA,47,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2017-03-23,2015-04-01,2015-07-01,2015,2015-07-01,2015,NA,NA,NA,-722,-631,-631,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1889,2237,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02509559,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Effects of Propranolol (vs. Placebo) on Information Processing During Presentation of Emotionally Arousing Pictures,small,Other,Interventional,Drug,Phase 1,8,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-30,2013-10-01,2015-01-01,2015,2014-02-01,2014,NA,NA,NA,-637,-180,-514,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02507167,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8,small,Other,Interventional,Dietary Supplement,Phase 1,19,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-22,2012-11-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,-993,-233,-751,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02493283,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald Greifswald,NA,Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration,small,Other,Interventional,Drug,Phase 1,23,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-06-30,2011-09-01,2015-03-01,2015,2012-06-01,2012,NA,NA,NA,-1398,-121,-1124,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02507167,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8,small,Other,Interventional,Dietary Supplement,Phase 1,19,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-07-22,2012-11-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,-993,-233,-751,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02493283,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Greifswald,NA,Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration,small,Other,Interventional,Drug,Phase 1,23,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2015-06-30,2011-09-01,2015-03-01,2015,2012-06-01,2012,NA,NA,NA,-1398,-121,-1124,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02364167,ClinicalTrials.gov,TRUE,2,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Greifswald,NA,Acupuncture for Pain Control After Elective Caesarean Section,small,Other,Interventional,Drug,Phase 2/Phase 3,180,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-02-09,2015-01-13,2018-06-27,2018,2018-06-27,2018,NA,NA,NA,-27,1234,1234,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,3,3,797,1145,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03071796,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Influences of Multivitamin Supplementation on Health Parameters,small,Other,Interventional,Dietary Supplement,NA,80,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2017-02-21,2017-03-07,2017-06-20,2017,2017-06-15,2017,NA,NA,NA,14,119,114,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1169,1517,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01903395,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Risk-adapted Screening in First-degree Relatives of Patients With Colorectal Cancer,small,Other,Interventional,Behavioral,NA,313,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-07-11,2012-03-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-497,873,873,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01517776,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents,small,Other,Interventional,Drug,Phase 2,28,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-01-11,2012-01-01,2014-04-01,2014,2014-03-01,2014,NA,NA,NA,-10,811,780,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01362361,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,"TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)",small,Other,Interventional,Drug,Phase 2,54,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-25,2011-06-01,2016-12-01,2016,2016-06-01,2016,NA,NA,NA,7,2017,1834,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01060423,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg Halle-Wittenberg,NA,TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer,small,Other,Interventional,Drug,Phase 2,8,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-27,2010-02-01,2015-05-01,2015,2012-12-01,2012,NA,NA,NA,5,1920,1039,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01362361,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,"TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)",small,Other,Interventional,Drug,Phase 2,54,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-25,2011-06-01,2016-12-01,2016,2016-06-01,2016,NA,NA,NA,7,2017,1834,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01060423,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer,small,Other,Interventional,Drug,Phase 2,8,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-01-27,2010-02-01,2015-05-01,2015,2012-12-01,2012,NA,NA,NA,5,1920,1039,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01045512,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Halle-Wittenberg,NA,"The Role of the ""Inflammatory/ Pathogen Burden"" for Cardiac Ageing",small,Other,Interventional,Drug,Phase 2,96,Terminated,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2010-01-08,2009-10-01,2014-09-01,2014,2014-09-01,2014,NA,NA,NA,-99,1697,1697,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03141476,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Adequacy of Perioperative Cefuroxime Dosage According to the BMI,large,Other,Interventional,Drug,Phase 4,60,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2017-03-21,2017-03-01,2017-12-12,2017,2017-11-12,2017,NA,NA,NA,-20,266,236,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,994,1342,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02818959,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,First in Man Study of the JenaValve TAVI Plus System Transfemoral,large,Industry,Interventional,Device,NA,7,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2016-06-24,2013-12-01,2015-05-01,2015,2014-03-01,2014,NA,NA,NA,-936,-420,-846,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3499,12 +3499,12 @@ NCT01353443,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg, NCT01317134,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Endothelial Function in Patients With Pulmonary Arterial Hypertension,large,Other,Interventional,Device,NA,90,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,FALSE,FALSE,2011-03-15,2010-07-01,2016-07-01,2016,2015-12-01,2015,NA,NA,NA,-257,1935,1722,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01021202,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Timing of Dilation Tracheostomy in Mechanically Ventilated Chronic Obstructive Pulmonary Disease (COPD) Patients,large,Other,Interventional,Procedure,NA,40,Suspended,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-10-06,2009-10-01,2017-10-01,2017,2017-10-01,2017,NA,NA,NA,-5,2917,2917,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1066,1414,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00858793,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT,large,Other,Interventional,Procedure,Phase 1/Phase 2,5,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2009-03-09,2008-11-28,2016-08-31,2016,2016-08-31,2016,NA,NA,NA,-101,2732,2732,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1462,1810,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00711230,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients,large,Industry,Interventional,Biological,Phase 2,36,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-04,2008-04-01,2015-01-01,2015,2011-12-01,2011,NA,NA,NA,-94,2372,1245,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,20,20,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00390702,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg Hamburg,NA,Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System,large,Industry,Interventional,Device,NA,103,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2006-10-19,2006-10-01,2017-05-01,2017,2012-08-01,2012,NA,NA,NA,-18,3847,2113,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00711230,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients,large,Industry,Interventional,Biological,Phase 2,36,Completed,Quadruple,Randomized,TRUE,TRUE,FALSE,FALSE,2008-07-04,2008-04-01,2015-01-01,2015,2011-12-01,2011,NA,NA,NA,-94,2372,1245,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,20,20,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00390702,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System,large,Industry,Interventional,Device,NA,103,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2006-10-19,2006-10-01,2017-05-01,2017,2012-08-01,2012,NA,NA,NA,-18,3847,2113,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02787122,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg Marburg,NA,Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia,large,Other,Interventional,Behavioral,NA,64,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2016-03-03,2014-01-01,2017-12-31,2017,2017-12-31,2017,NA,NA,NA,-792,668,668,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,975,1323,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03667638,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Influence of Platelet Concentrates on Wound Healing,large,Other,Interventional,Combination Product,NA,5,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2018-09-09,2016-11-01,2017-12-01,2017,2017-11-01,2017,NA,NA,NA,-677,-282,-312,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,76,76,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02728453,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,SGLT2 Inhibition and Left Ventricular Mass,large,Other,Interventional,Drug,Phase 4,7,Terminated,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2016-03-24,2016-04-27,2017-09-27,2017,2017-09-25,2017,NA,NA,NA,34,552,550,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1070,1418,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT02535741,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee,large,Industry,Interventional,Device,NA,168,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2015-08-21,2006-10-01,2016-05-01,2016,2013-05-01,2013,2015-09-29,-215,881,-3246,254,-842,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1584,1932,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT02535741,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Clinical Outcome Study for the Triathlon Cruciate Retaining (CR) Total Knee,large,Industry,Interventional,Device,NA,168,Completed,None (Open Label),NA,NA,TRUE,FALSE,TRUE,2015-08-21,2006-10-01,2016-05-01,2016,2013-05-01,2013,2015-09-29,-215,881,-3246,254,-842,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1584,1932,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02527707,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Titrating-Dose of Lonafarnib in Combination With Ritonavir,large,Industry,Interventional,Drug,Phase 2,15,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2015-08-13,2015-09-01,2016-08-01,2016,2016-08-01,2016,NA,NA,NA,19,354,354,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1492,1840,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02398864,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Accuracy and Safety of Endobronchial Ultrasound (EBUS) in Suspected Non-malignant Mediastinal Lymphadenopathy,large,Other,Interventional,Procedure,NA,120,Unknown status,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2015-03-13,2015-03-01,2017-06-01,2017,2017-03-01,2017,NA,NA,NA,-12,811,719,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1188,1536,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02374567,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Pharmacovigilance in Gerontopsychiatric Patients,large,Other,Interventional,Drug,Phase 3,407,Terminated,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2015-01-05,2015-01-01,2017-06-28,2017,2017-06-28,2017,NA,NA,NA,-4,905,905,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1161,1509,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3512,7 +3512,7 @@ NCT02079688,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover NCT01336530,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,"Tepilta® Versus Oxetacaine, Antacids and Placebo",large,Industry,Interventional,Drug,Phase 3,40,Terminated,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-04-01,2011-04-01,2017-01-01,2017,2017-01-01,2017,NA,NA,NA,0,2102,2102,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1339,1687,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01117662,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients,large,Other,Interventional,Drug,Phase 3,13,Terminated,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2010-04-28,2012-05-01,2016-08-23,2016,2016-05-01,2016,NA,NA,NA,734,2309,2195,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1470,1818,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01046799,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir,large,Other,Interventional,Drug,Phase 3,20,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2010-01-09,2008-03-01,2014-10-01,2014,2014-06-01,2014,NA,NA,NA,-679,1726,1604,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00808600,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover Hannover,NA,Empowerment of Lung and Heart-lung Transplant Patients,large,Other,Interventional,Behavioral,NA,132,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-15,2009-10-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,290,1843,1659,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,32,32,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00808600,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Hannover,NA,Empowerment of Lung and Heart-lung Transplant Patients,large,Other,Interventional,Behavioral,NA,132,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2008-12-15,2009-10-01,2014-01-01,2014,2013-07-01,2013,NA,NA,NA,290,1843,1659,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,32,32,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02948907,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"""Elastography"" and ""Tissue Harmonic Imaging"" for Characterisation of Hilar and Mediastinal Lymph Nodes",large,Other,Interventional,Other,NA,100,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2016-09-19,2015-09-01,2017-05-01,2017,2017-05-01,2017,NA,NA,NA,-384,224,224,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1219,1567,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02772146,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure,large,Industry,Interventional,Device,NA,2,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2016-05-09,2016-05-11,2017-01-23,2017,2017-01-23,2017,NA,NA,NA,2,259,259,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1317,1665,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02679677,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD,large,Other,Interventional,Device,NA,40,Unknown status,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2016-01-18,2015-04-01,2016-07-01,2016,2016-07-01,2016,NA,NA,NA,-292,165,165,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1523,1871,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3525,11 +3525,11 @@ NCT01769313,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelbe NCT01666600,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,NOA-12: BIBF1120 and R-RT in Glioblastoma,large,Other,Interventional,Drug,Phase 1/Phase 2,63,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-07-12,2012-08-01,2017-09-01,2017,2017-03-01,2017,NA,NA,NA,20,1877,1693,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1096,1444,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01665885,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE),large,Other,Interventional,Device,Phase 2,60,Unknown status,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2012-08-13,2012-08-01,2015-11-01,2015,2015-08-01,2015,NA,NA,NA,-12,1175,1083,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01617980,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer,large,Other,Interventional,Other,NA,4,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-04-10,2012-04-01,2014-03-01,2014,2014-03-01,2014,NA,NA,NA,-9,690,690,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2376,2724,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01473966,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,Coffee Against Obstipation in Intensive Care Treatment,large,Other,Interventional,Dietary Supplement,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-10,2011-11-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-9,934,752,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01473966,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Coffee Against Obstipation in Intensive Care Treatment,large,Other,Interventional,Dietary Supplement,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-11-10,2011-11-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,-9,934,752,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01394367,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,"Influence of Respiratory and Exercise Therapy on Oxygen Uptake, Quality of Life and Right Ventricular Function in Severe Pulmonary Hypertension",large,Other,Interventional,Other,NA,90,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-06-28,2010-06-01,2015-05-01,2015,2015-05-01,2015,NA,NA,NA,-392,1403,1403,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01372735,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer,large,Other,Interventional,Radiation,Phase 1/Phase 2,46,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2011-06-09,2011-08-01,2017-08-01,2017,2013-08-01,2013,NA,NA,NA,53,2245,784,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1127,1475,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01362582,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer,large,Other,Interventional,Drug,Phase 3,32,Terminated,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-11-25,2010-03-01,2014-09-01,2014,2014-08-01,2014,NA,NA,NA,-269,1376,1345,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01277406,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg Heidelberg,NA,4SC-201 (Resminostat) in Advanced Colorectal Carcinoma,large,Industry,Interventional,Drug,Phase 1/Phase 2,17,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-01-10,2011-01-01,2015-02-01,2015,2013-02-01,2013,NA,NA,NA,-9,1483,753,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01277406,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,4SC-201 (Resminostat) in Advanced Colorectal Carcinoma,large,Industry,Interventional,Drug,Phase 1/Phase 2,17,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2011-01-10,2011-01-01,2015-02-01,2015,2013-02-01,2013,NA,NA,NA,-9,1483,753,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01220752,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12),large,Other,Interventional,Radiation,Phase 2,30,Unknown status,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-10-12,2010-11-01,2016-11-01,2016,2014-11-01,2014,NA,NA,NA,20,2212,1481,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,31,31,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01166308,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Carbon Ion Radiotherapy for Recurrent Gliomas,large,Other,Interventional,Radiation,NA,56,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-19,2010-12-01,2016-04-01,2016,2016-04-01,2016,NA,NA,NA,135,2083,2083,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01165671,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Heidelberg,NA,Carbon Ion Radiotherapy for Primary Glioblastoma,large,Other,Interventional,Radiation,NA,100,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-07-13,2010-07-01,2015-01-01,2015,2015-01-01,2015,NA,NA,NA,-12,1633,1633,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,2,1,1,2070,2418,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3554,9 +3554,9 @@ NCT01795053,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA NCT01407848,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea,large,Other,Interventional,Drug,Phase 2,20,Completed,Quadruple,Randomized,TRUE,FALSE,TRUE,FALSE,2011-07-28,2012-01-01,2015-07-01,2015,2015-07-01,2015,NA,NA,NA,157,1434,1434,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1889,2237,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01349296,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,BIBF 1120 and RAD001 in Solid Tumors - Phase I,large,Other,Interventional,Drug,Phase 1,18,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-05-05,2012-07-01,2016-05-01,2016,2014-10-01,2014,NA,NA,NA,423,1823,1245,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01279174,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Galileo-Hip Whole Body Vibration /Conventional Physiotherapy /Coxarthrosis,large,Other,Interventional,Other,Phase 4,40,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-01-18,2012-06-01,2015-10-01,2015,2015-06-01,2015,NA,NA,NA,500,1717,1595,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1797,2145,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01047059,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Molecular Imaging With Erlotinib and Bevacizumab,large,Other,Interventional,Drug,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-01-10,2010-01-01,2016-05-01,2016,2012-10-01,2012,NA,NA,NA,-9,2303,995,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01047059,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Molecular Imaging With Erlotinib and Bevacizumab,large,Other,Interventional,Drug,Phase 2,40,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2010-01-10,2010-01-01,2016-05-01,2016,2012-10-01,2012,NA,NA,NA,-9,2303,995,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1584,1932,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00933777,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Köln,NA,SORAVE - Sorafenib and Everolimus in Solid Tumors,large,Other,Interventional,Drug,Phase 1,36,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2009-07-02,2009-07-01,2015-02-01,2015,2014-02-01,2014,NA,NA,NA,-1,2040,1675,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,20,20,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00854256,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln Köln,NA,Trabeculectomy Versus Canaloplasty to Treat Glaucoma,large,Other,Interventional,Procedure,NA,60,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-02,2009-04-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,30,1886,1735,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00854256,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Köln,NA,Trabeculectomy Versus Canaloplasty to Treat Glaucoma,large,Other,Interventional,Procedure,NA,60,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-03-02,2009-04-01,2014-05-01,2014,2013-12-01,2013,NA,NA,NA,30,1886,1735,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02891863,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Low Energy Therapy to Convert Ventricular Tachycardias,large,Industry,Interventional,Device,Early Phase 1,9,Terminated,None (Open Label),NA,NA,FALSE,FALSE,TRUE,2016-08-29,2015-09-01,2016-03-01,2016,2016-03-01,2016,2017-03-06,370,370,-363,-181,-181,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1645,1993,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02523859,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Study of the Efficacy and Safety of Remimazolam in General Anesthesia in Adults Undergoing Cardiac Surgery,large,Industry,Interventional,Drug,Phase 3,25,Terminated,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2015-08-11,2015-07-01,2016-03-01,2016,2016-03-01,2016,NA,NA,NA,-41,203,203,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1645,1993,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01968239,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig,NA,Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT,large,Other,Interventional,Drug,Phase 2,27,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2013-10-18,2013-10-01,2016-12-20,2016,2016-06-17,2016,NA,NA,NA,-17,1159,973,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1351,1699,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3567,7 +3567,7 @@ NCT01483339,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Leipzig NCT02703870,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study,small,Other,Interventional,Device,Phase 1/Phase 2,19,Completed,Triple,Randomized,TRUE,TRUE,FALSE,FALSE,2015-09-18,2013-03-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-931,74,74,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02460861,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy,small,Other,Interventional,Procedure,NA,279,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2015-05-28,2011-11-01,2015-12-01,2015,2013-10-01,2013,NA,NA,NA,-1304,187,-604,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02039167,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease,small,Other,Interventional,Device,NA,14,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2014-01-15,2014-01-01,2017-04-12,2017,2017-03-21,2017,NA,NA,NA,-14,1183,1161,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1238,1586,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00827619,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg Magdeburg,NA,Zilver® Flex™ Vascular Stent Study,small,Industry,Interventional,Device,NA,110,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-01-22,2009-02-01,2015-11-01,2015,2011-11-01,2011,NA,NA,NA,10,2474,1013,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00827619,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Magdeburg,NA,Zilver® Flex™ Vascular Stent Study,small,Industry,Interventional,Device,NA,110,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2009-01-22,2009-02-01,2015-11-01,2015,2011-11-01,2011,NA,NA,NA,10,2474,1013,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1766,2114,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03019718,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Implementation of the Internet-based Aftercare Program 'GSA-Online Plus',large,Other,Interventional,Other,NA,88,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2017-01-06,2016-07-01,2017-10-31,2017,2017-07-01,2017,NA,NA,NA,-189,298,176,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1036,1384,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02843490,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration,large,Other,Interventional,Drug,Phase 4,71,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2016-07-21,2016-08-05,2017-11-09,2017,2017-08-17,2017,NA,NA,NA,15,476,392,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1027,1375,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02654353,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Mainz,NA,A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach,large,Other,Interventional,Procedure,Phase 4,100,Completed,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2016-01-09,2012-02-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-1438,-39,-39,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3607,22 +3607,22 @@ NCT02320851,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-Münc NCT02207309,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Pazopanib Maintenance Phase II,large,Other,Interventional,Drug,Phase 2,1,Terminated,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2014-07-31,2015-06-22,2016-07-29,2016,2016-07-29,2016,NA,NA,NA,326,729,729,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1495,1843,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02157129,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,LipoAerosol© Inhalation After Tracheostomy,large,Other,Interventional,Device,NA,100,Completed,Double,Randomized,TRUE,FALSE,TRUE,FALSE,2014-05-27,2014-05-01,2017-04-01,2017,2017-04-01,2017,NA,NA,NA,-26,1040,1040,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,6,6,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01991847,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Tertiary Prevention by Exercise in Colorectal Cancer Therapy,large,Other,Interventional,Behavioral,NA,50,Completed,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2013-11-18,2014-01-01,2015-04-01,2015,2015-04-01,2015,NA,NA,NA,44,499,499,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1980,2328,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01803217,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing,large,Other,Interventional,Other,NA,70,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-28,2007-11-01,2016-06-01,2016,2011-12-01,2011,NA,NA,NA,-1946,1189,-455,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01803217,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Evaluation of Pacemaker Algorithms to Avoid Unnecessary Right Ventricular Pacing,large,Other,Interventional,Other,NA,70,Completed,Single,Randomized,TRUE,TRUE,FALSE,FALSE,2013-02-28,2007-11-01,2016-06-01,2016,2011-12-01,2011,NA,NA,NA,-1946,1189,-455,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01714999,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Treatment of Acute Traumatic Laceration of the Olecranon and Prepatellar Bursa,large,Other,Interventional,Procedure,NA,100,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2012-10-24,2014-04-01,2015-12-01,2015,2015-09-01,2015,NA,NA,NA,524,1133,1042,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01702597,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,WBV and Acute Lateral Ankle Sprain,large,Other,Interventional,Device,NA,60,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-10-03,2012-10-01,2014-04-01,2014,2013-04-01,2013,NA,NA,NA,-2,545,180,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01702597,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,WBV and Acute Lateral Ankle Sprain,large,Other,Interventional,Device,NA,60,Unknown status,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-10-03,2012-10-01,2014-04-01,2014,2013-04-01,2013,NA,NA,NA,-2,545,180,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01690325,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON),large,Other,Interventional,Drug,Phase 2,21,Terminated,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2012-09-18,2012-09-01,2016-11-01,2016,2016-11-01,2016,NA,NA,NA,-17,1505,1505,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01548677,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer,large,Other,Interventional,Drug,Phase 2,1317,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-03-05,2013-04-01,2017-03-01,2017,2017-03-01,2017,NA,NA,NA,392,1822,1822,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,1,1,1280,1628,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01439958,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS),large,Industry,Interventional,Drug,Phase 3,14,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-22,2012-02-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,132,1166,648,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01431222,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery,large,Other,Interventional,Device,Phase 4,100,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-07,2011-09-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-6,1090,725,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01439958,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Long-term Safety Follow-up Study in the Prevention of Bronchiolitis Obliterans Syndrome (BOS),large,Industry,Interventional,Drug,Phase 3,14,Terminated,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2011-09-22,2012-02-01,2014-12-01,2014,2013-07-01,2013,NA,NA,NA,132,1166,648,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01431222,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery,large,Other,Interventional,Device,Phase 4,100,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-09-07,2011-09-01,2014-09-01,2014,2013-09-01,2013,NA,NA,NA,-6,1090,725,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01419002,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer,large,Other,Interventional,Radiation,Phase 3,5,Terminated,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-08-13,2011-10-01,2014-10-01,2014,2014-10-01,2014,NA,NA,NA,49,1145,1145,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01384994,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München LMU-München,NA,Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients,large,Other,Interventional,Drug,Phase 2,111,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-02,2011-08-01,2014-08-01,2014,2013-08-01,2013,NA,NA,NA,91,1187,822,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01384994,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients,large,Other,Interventional,Drug,Phase 2,111,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-02,2011-08-01,2014-08-01,2014,2013-08-01,2013,NA,NA,NA,91,1187,822,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01382147,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,LMU-München,NA,"Evaluation of ""Dose-dense Therapy"" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)",large,Other,Interventional,Drug,Phase 3,396,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2011-06-23,2009-07-01,2017-07-05,2017,2012-08-01,2012,NA,NA,NA,-722,2204,405,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,3,3,1154,1502,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01230073,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Treatment Satisfaction in Implantable Cardioverter Defibrillator Recipients,large,Other,Interventional,Device,Phase 4,120,Completed,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2010-10-26,2011-02-01,2017-12-01,2017,2014-07-01,2014,NA,NA,NA,98,2593,1344,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01229033,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF,large,Other,Interventional,Procedure,NA,186,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-10-26,2010-01-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-298,1163,798,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01229033,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF,large,Other,Interventional,Procedure,NA,186,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2010-10-26,2010-01-01,2014-01-01,2014,2013-01-01,2013,NA,NA,NA,-298,1163,798,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2435,2783,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01138579,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation,large,Other,Interventional,Drug,Phase 1/Phase 2,9,Terminated,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2010-06-04,2010-08-01,2016-06-01,2016,2016-05-01,2016,NA,NA,NA,58,2189,2158,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,1,1,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01029769,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia,large,Other,Interventional,Drug,NA,351,Completed,Triple,Randomized,TRUE,FALSE,TRUE,FALSE,2009-12-09,2009-12-01,2015-03-01,2015,2014-03-01,2014,NA,NA,NA,-8,1908,1543,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00845286,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,"Marathon, Genetics, Inflammation and the Cardiovascular System: MAGIC-Trial",large,Other,Interventional,Behavioral,NA,162,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2008-09-19,2008-09-01,2014-08-01,2014,2014-03-01,2014,NA,NA,NA,-18,2142,1989,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2223,2571,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00425425,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München TU-München,NA,"Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer",large,Other,Interventional,Biological,Phase 1/Phase 2,43,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2007-01-19,2006-07-01,2015-05-01,2015,2010-05-01,2010,NA,NA,NA,-202,3024,1198,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00425425,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,TU-München,NA,"Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer",large,Other,Interventional,Biological,Phase 1/Phase 2,43,Unknown status,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2007-01-19,2006-07-01,2015-05-01,2015,2010-05-01,2010,NA,NA,NA,-202,3024,1198,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1950,2298,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02788448,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,Safety and Performance Study of Large Hole Vascular Closure Device,small,Industry,Interventional,Device,NA,42,Completed,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2016-05-25,2016-01-01,2017-11-01,2017,2017-03-01,2017,NA,NA,NA,-145,525,280,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1035,1383,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02361697,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Münster,NA,DTI in Children With Multiple Sclerosis,small,Other,Interventional,Other,NA,15,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-01-19,2014-12-01,2017-12-01,2017,2016-12-01,2016,NA,NA,NA,-49,1047,682,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02253771,ClinicalTrials.gov,TRUE,2,No publ,FALSE,FALSE,TRUE,TRUE,TRUE,Münster,NA,Shockwave Therapy for Acute Low Back Pain,small,Other,Interventional,Device,NA,63,Completed,Single,Randomized,TRUE,FALSE,TRUE,FALSE,2014-08-31,2017-11-08,2019-01-15,2019,2018-09-13,2018,NA,NA,NA,1165,1598,1474,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,4,4,595,943,FALSE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3634,7 +3634,7 @@ NCT00111371,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Münster NCT02973919,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome,small,Other,Interventional,Behavioral,NA,53,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2016-11-14,2015-07-01,2016-09-01,2016,2015-12-01,2015,NA,NA,NA,-502,-74,-349,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1461,1809,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02408575,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,"Hearing Aids With ""Notched Amplification"" for the Treatment of Chronic Tinnitus",small,Other,Interventional,Device,NA,44,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-03-18,2015-02-01,2016-06-01,2016,2016-06-01,2016,NA,NA,NA,-45,441,441,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02058810,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg Magdeburg,NA,Nasal High Flow at Acute Hart Failure,small,Other,Interventional,Device,NA,46,Terminated,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2014-02-06,2010-09-01,2014-05-01,2014,2014-05-01,2014,NA,NA,NA,-1254,84,84,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01639261,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg Regensburg,NA,A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT,small,Other,Interventional,Drug,Phase 2,10,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-09,2012-07-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-8,784,510,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01639261,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT,small,Other,Interventional,Drug,Phase 2,10,Unknown status,None (Open Label),NA,NA,FALSE,TRUE,FALSE,2012-07-09,2012-07-01,2014-09-01,2014,2013-12-01,2013,NA,NA,NA,-8,784,510,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2192,2540,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01023542,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Regensburg,NA,"CNI-free ""Bottom""-up Immunosuppression in Patients Undergoing Liver Transplantation",small,Other,Interventional,Drug,Phase 2/Phase 3,45,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2009-12-01,2011-06-01,2014-12-01,2014,2014-07-01,2014,NA,NA,NA,547,1826,1673,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02120313,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Inpatient Versus Outpatient Rehabilitation After TKA,small,Other,Interventional,Other,NA,42,Completed,Double,Non-Randomized,FALSE,FALSE,TRUE,FALSE,2014-04-17,2014-04-01,2016-06-01,2016,2016-03-01,2016,NA,NA,NA,-16,776,684,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02062138,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Rostock,NA,Effectiveness of Passive and Active ROM Exercises Following TKA,small,Other,Interventional,Other,NA,60,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2014-02-06,2014-01-01,2016-04-01,2016,2016-01-01,2016,NA,NA,NA,-36,785,694,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1614,1962,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3651,10 +3651,10 @@ NCT02235220,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswi NCT01989429,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients,large,Industry,Interventional,Drug,Phase 3,788,Completed,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2013-10-28,2013-10-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-27,399,399,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01948726,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer,large,Other,Interventional,Radiation,Phase 2,150,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2013-08-23,2013-12-01,2015-03-01,2015,2015-03-01,2015,NA,NA,NA,100,555,555,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2011,2359,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01924338,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Validation of a Method to Measure Soft Tissue Thickness Using Near Infrared Laser Light,large,Other,Interventional,Device,NA,25,Unknown status,None (Open Label),Non-Randomized,FALSE,TRUE,TRUE,FALSE,2013-08-12,2013-09-01,2015-02-01,2015,2014-12-01,2014,NA,NA,NA,20,538,476,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,2039,2387,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01835340,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Schleswig-Holstein,NA,Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures,large,Other,Interventional,Device,NA,22,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-04-15,2012-10-01,2017-12-09,2017,2017-12-09,2017,NA,NA,NA,-196,1699,1699,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,997,1345,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01835340,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Breath Gas Measurement of Propofol During Anesthesia in Patients With Endourological Procedures,large,Other,Interventional,Device,NA,22,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2013-04-15,2012-10-01,2017-12-09,2017,2017-12-09,2017,NA,NA,NA,-196,1699,1699,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,1,2,2,997,1345,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01312623,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Organ Protection by Remote Ischemic Preconditioning for Surgical Treatment of Pediatric Congenital Heart Disease,large,Other,Interventional,Other,NA,31,Terminated,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-03-08,2010-03-01,2014-05-01,2014,2014-03-01,2014,NA,NA,NA,-372,1150,1089,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2315,2663,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01276002,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein,NA,Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.,large,Other,Interventional,Procedure,NA,120,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-01-12,2011-01-01,2016-12-01,2016,2016-12-01,2016,NA,NA,NA,-11,2150,2150,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00170274,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Mannheim Schleswig-Holstein Mannheim,NA,APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias,large,Industry,Interventional,Device,NA,156,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-12,2000-08-01,2014-10-01,2014,2011-06-01,2011,NA,NA,NA,-1868,3306,2088,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00170274,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Schleswig-Holstein Mannheim,NA,APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias,large,Industry,Interventional,Device,NA,156,Completed,None (Open Label),Randomized,TRUE,TRUE,FALSE,FALSE,2005-09-12,2000-08-01,2014-10-01,2014,2011-06-01,2011,NA,NA,NA,-1868,3306,2088,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2162,2510,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT04157023,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Simulator Training for Direct Ophthalmoscopy,large,Other,Interventional,Device,NA,78,Completed,Single,Non-Randomized,FALSE,TRUE,FALSE,FALSE,2019-11-01,2017-01-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,-1034,-700,-700,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03961906,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Physiotherapy in Hereditary Spastic Paraplegia,large,Other,Interventional,Behavioral,Phase 2,53,Completed,Double,Randomized,TRUE,FALSE,FALSE,FALSE,2019-05-20,2015-01-01,2017-03-30,2017,2017-03-30,2017,NA,NA,NA,-1600,-781,-781,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,2,2,1251,1599,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03531216,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Topical Rosemary Oil Application in Systemic Sclerosis,large,Other,Interventional,Other,NA,12,Completed,None (Open Label),Non-Randomized,FALSE,TRUE,FALSE,FALSE,2018-05-09,2015-11-02,2016-03-21,2016,2016-03-21,2016,NA,NA,NA,-919,-779,-779,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1625,1973,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA @@ -3680,23 +3680,23 @@ NCT01582048,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübinge NCT01538316,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Prostate Cancer Prevention Trial With Quercetin and Genistein,large,Other,Interventional,Dietary Supplement,NA,60,Unknown status,Triple,Randomized,TRUE,TRUE,TRUE,FALSE,2012-02-20,2012-03-01,2014-04-01,2014,2014-03-01,2014,NA,NA,NA,10,771,740,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2345,2693,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01289938,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine,large,Other,Interventional,Drug,Phase 1,49,Terminated,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2011-02-02,2009-07-01,2015-06-01,2015,2015-06-01,2015,NA,NA,NA,-581,1580,1580,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,4,4,1919,2267,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00961142,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia,large,Other,Interventional,Drug,Phase 2,23,Terminated,None (Open Label),NA,NA,TRUE,FALSE,FALSE,2009-08-17,2009-06-01,2015-12-30,2015,2015-12-30,2015,NA,NA,NA,-77,2326,2326,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,4,4,1707,2055,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00546845,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study,large,Other,Interventional,Device,Phase 4,180,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2007-10-17,2007-09-01,2014-06-01,2014,2012-03-01,2012,NA,NA,NA,-46,2419,1597,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00546845,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Balloon Angioplasty Versus Xpert Stent in CLI Patients XXS Study,large,Other,Interventional,Device,Phase 4,180,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2007-10-17,2007-09-01,2014-06-01,2014,2012-03-01,2012,NA,NA,NA,-46,2419,1597,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT00515970,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas,large,Other,Interventional,Procedure,NA,400,Suspended,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2007-08-13,2007-12-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,110,2667,2667,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT00167583,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen Tübingen,NA,Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB),large,Other,Interventional,Drug,Phase 3,37,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-09,2004-11-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-312,3370,3370,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,14,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT00167583,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Tübingen,NA,Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB),large,Other,Interventional,Drug,Phase 3,37,Completed,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2005-09-09,2004-11-01,2014-12-01,2014,2014-12-01,2014,NA,NA,NA,-312,3370,3370,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,14,14,2101,2449,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02743988,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Influence of Oxygen Target Range on Intermittent Hypoxemia in Preterm Infants,large,Other,Interventional,Drug,NA,36,Unknown status,None (Open Label),Randomized,TRUE,FALSE,FALSE,FALSE,2016-04-07,2015-05-01,2017-09-01,2017,2017-04-01,2017,NA,NA,NA,-342,512,359,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1096,1444,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02290067,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,System Accuracy and User Performance of Blood Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus,large,Industry,Interventional,Device,NA,130,Completed,None (Open Label),Non-Randomized,FALSE,FALSE,TRUE,FALSE,2014-10-22,2014-10-01,2014-11-01,2014,2014-11-01,2014,NA,NA,NA,-21,10,10,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02198482,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML),large,Other,Interventional,Drug,Phase 2,6,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2014-07-22,2016-02-01,2016-11-01,2016,2016-11-01,2016,NA,NA,NA,559,833,833,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1400,1748,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01866449,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme,large,Other,Interventional,Drug,Phase 2,24,Completed,None (Open Label),NA,NA,TRUE,TRUE,FALSE,2013-05-22,2013-10-01,2017-08-25,2017,2016-12-01,2016,NA,NA,NA,132,1556,1289,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1103,1451,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01837082,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Iron in Congestive Heart Failure,large,Other,Interventional,Drug,Phase 3,18,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2013-04-17,2013-04-01,2015-12-01,2015,2015-12-01,2015,NA,NA,NA,-16,958,958,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1736,2084,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01427686,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Dopamine Versus Dobutamine for Treatment of Arterial Hypotension in Term and Preterm Neonates,large,Other,Interventional,Drug,Phase 4,20,Unknown status,Quadruple,Randomized,TRUE,FALSE,FALSE,FALSE,2011-08-31,2011-06-01,2016-12-01,2016,2015-02-01,2015,NA,NA,NA,-91,1919,1250,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1370,1718,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01397149,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm Ulm,NA,Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG),large,Other,Interventional,Drug,Phase 1/Phase 2,4,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-06-30,2011-10-01,2014-11-01,2014,2013-11-01,2013,NA,NA,NA,93,1220,855,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01611207,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke Witten/Herdecke,NA,Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine,small,Other,Interventional,Device,NA,12,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-03-28,2012-06-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,65,795,613,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01397149,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Ulm,NA,Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG),large,Other,Interventional,Drug,Phase 1/Phase 2,4,Terminated,Quadruple,Randomized,TRUE,TRUE,TRUE,FALSE,2011-06-30,2011-10-01,2014-11-01,2014,2013-11-01,2013,NA,NA,NA,93,1220,855,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,2131,2479,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01611207,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Witten/Herdecke,NA,Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine,small,Other,Interventional,Device,NA,12,Terminated,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2012-03-28,2012-06-01,2014-06-01,2014,2013-12-01,2013,NA,NA,NA,65,795,613,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,2284,2632,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03505775,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Evaluation of the Muscular and Cutaneous Sodium Storage by 23Na MRI in Patients With Chronic Adrenal Insufficiency,small,Other,Interventional,Diagnostic Test,NA,32,Completed,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2018-04-12,2017-02-14,2017-10-31,2017,2017-10-31,2017,NA,NA,NA,-422,-163,-163,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,8,8,1036,1384,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT03098498,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Impact of Debridement Invasiveness on Attachment Gain After Antiinfective Periodontal Therapy,small,Other,Interventional,Procedure,NA,44,Unknown status,Single,Randomized,TRUE,FALSE,FALSE,FALSE,2017-03-27,2016-06-01,2017-12-01,2017,2017-12-01,2017,NA,NA,NA,-299,249,249,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02587338,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Cognitive Ability Training in Seniors,small,Other,Interventional,Device,NA,50,Completed,Triple,Randomized,TRUE,FALSE,FALSE,FALSE,2015-06-16,2015-05-01,2017-12-01,2017,2017-04-01,2017,NA,NA,NA,-46,899,655,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1005,1353,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT02469012,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy,small,Other,Interventional,Drug,NA,30,Unknown status,None (Open Label),NA,NA,FALSE,FALSE,FALSE,2015-05-05,2014-10-01,2017-04-01,2017,2016-10-01,2016,NA,NA,NA,-216,697,515,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,28,26,1249,1597,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01352403,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Severe Obesity: Bariatric Surgery vs. Life-Style-Intervention,small,Other,Interventional,Procedure,NA,60,Unknown status,None (Open Label),Randomized,TRUE,FALSE,TRUE,FALSE,2011-05-10,2011-05-01,2016-06-01,2016,NA,NA,NA,NA,NA,-9,1849,NA,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,NA,NA,NA,1,0,0,1553,1901,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA -NCT01348269,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg Würzburg,NA,Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome,small,Other,Interventional,Drug,Phase 3,63,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-02,2011-05-01,2015-08-26,2015,2015-08-26,2015,NA,NA,NA,-1,1577,1577,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1833,2181,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA +NCT01348269,ClinicalTrials.gov,TRUE,2,No publ,TRUE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome,small,Other,Interventional,Drug,Phase 3,63,Completed,Double,Randomized,TRUE,TRUE,TRUE,FALSE,2011-05-02,2011-05-01,2015-08-26,2015,2015-08-26,2015,NA,NA,NA,-1,1577,1577,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1833,2181,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA NCT01229631,ClinicalTrials.gov,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Würzburg,NA,"The Effect of Daily Dietary Intake of Dried Juice Concentrates of Fruit, Vegetables and Berries Upon Outcomes of Chronic Periodontitis",small,Other,Interventional,Dietary Supplement,NA,108,Completed,None (Open Label),Randomized,TRUE,TRUE,TRUE,FALSE,2010-10-26,2017-05-22,2017-09-27,2017,2017-06-30,2017,NA,NA,NA,2400,2528,2439,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1070,1418,TRUE,TRUE,FALSE,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA DRKS00008002,DRKS,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Hamburg,NA,Efficacy of a psychological online intervention for people with anxiety symptoms,large,Other,Interventional,Not given,NA,180,"Recruiting complete, follow-up complete",Blinded,Randomized controlled trial,TRUE,FALSE,FALSE,FALSE,2015-04-10,2014-07-29,2015-04-08,2015,NA,NA,NA,NA,NA,-255,-2,NA,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1973,2321,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA DRKS00007817,DRKS,TRUE,2,No publ,FALSE,TRUE,TRUE,TRUE,TRUE,Homburg,NA,"Probiotic supplementation in patients with chronic liver disease, resulting from the hepatitis C virus",small,Other,Interventional,Not given,NA,30,Recruiting stopped after recruiting started,Blinded,Randomized controlled trial,TRUE,FALSE,FALSE,FALSE,2015-02-16,2013-07-10,2016-04-17,2016,NA,NA,NA,NA,NA,-586,426,NA,NA,NA,NA,2020-07-01,2020-09-01,2021-08-15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,NA,NA,NA,0,0,0,1598,1946,TRUE,TRUE,FALSE,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA diff --git a/data/processed/trials.rds b/data/processed/trials.rds index 925a9fe..76b024e 100644 Binary files a/data/processed/trials.rds and b/data/processed/trials.rds differ diff --git a/scripts/14_prepare-trials.R b/scripts/14_prepare-trials.R index fb2f94d..9b16a4f 100644 --- a/scripts/14_prepare-trials.R +++ b/scripts/14_prepare-trials.R @@ -430,6 +430,16 @@ city_lookup <- left_join(city_lookup_iv, by = "city_id") %>% select(-city_id) +# Some trials have different lead cities across IV versions, so unite manually +trials <- + trials %>% + mutate(lead_cities = case_when( + id == "NCT00847444" ~ "Düsseldorf LMU_München", + id == "NCT00996229" ~ "Berlin Münster", + id == "NCT01783639" ~ "Hamburg Leipzig", + TRUE ~ lead_cities + )) + # In order to correct lead cities, unnest, join in correct names, and re-nest trials <- trials %>% @@ -437,12 +447,44 @@ trials <- tidyr::unnest(lead_cities) %>% distinct(id, lead_cities, iv_version, .keep_all = TRUE) %>% left_join(city_lookup, by = "lead_cities") %>% - group_by(id) %>% + group_by(id, iv_version) %>% mutate(lead_cities = stringr::str_c(city, collapse = " ")) %>% ungroup() %>% select(-city) %>% distinct() +# Lead cities should not be NA for iv2 +iv2_missing_lead_cities <- + trials %>% + filter(iv_version == 2 & is.na(lead_cities)) + +if (nrow(iv2_missing_lead_cities) > 0) { + stop("There are IV2 trials missing lead cities!") +} + +# Check for single appearance of umc per id, per iv version +umcs_per_id_per_iv <- + trials %>% + mutate(lead_cities = strsplit(as.character(lead_cities), " ")) %>% + tidyr::unnest(lead_cities) %>% + janitor::get_dupes(id, lead_cities, iv_version) + +if (nrow(umcs_per_id_per_iv) > 0) { + stop("A single UMC appears more than once per trial (per iv version)!") +} + +# Check for same umcs per id across iv versions +different_umcs_per_id_across_iv <- + trials %>% + group_by(id) %>% + mutate(n_lead_cities_types = n_distinct(lead_cities)) %>% + ungroup() %>% + filter(n_lead_cities_types > 1) + +if (nrow(different_umcs_per_id_across_iv) > 0) { + stop("A single trial has different UMCs across iv versions!") +} + # In order to correct facility cities, unnest, join in correct names, and re-nest trials <- trials %>% @@ -450,12 +492,32 @@ trials <- tidyr::unnest(facility_cities) %>% distinct(id, facility_cities, iv_version, .keep_all = TRUE) %>% left_join(city_lookup, by = c("facility_cities" = "lead_cities")) %>% - group_by(id) %>% + group_by(id, iv_version) %>% mutate(facility_cities = stringr::str_c(city, collapse = " ")) %>% ungroup() %>% select(-city) %>% distinct() +# Facility cities should always be NA for iv2 +iv2_extra_facility_cities <- + trials %>% + filter(iv_version == 2 & !is.na(facility_cities)) + +if (nrow(iv2_extra_facility_cities) > 0) { + stop("There are IV2 trials with extra facility cities!") +} + +# Check for single appearance of umc per id, per iv version +umcs_per_id_per_iv <- + trials %>% + mutate(facility_cities = strsplit(as.character(facility_cities), " ")) %>% + tidyr::unnest(facility_cities) %>% + janitor::get_dupes(id, facility_cities, iv_version) + +if (nrow(umcs_per_id_per_iv) > 0) { + stop("A single UMC appears more than once per trial (per iv version)!") +} + # Reorganize columns ------------------------------------------------------ trials <-